Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3013603	p-psa	ug/l (ug/l)	76557	297702	0.30%
3013603	p-psa	— (—)	36906	127087	100.00%	Distribution not available
3013603	s-psa	ug/l (ug/l)	33778	69803	0.00%
3013603	s-psa-t	ug/l (ug/l)	8338	33455	0.00%
3013603	s-psa	— (—)	2672	5803	100.00%	Distribution not available
3013603	p-psa-t	ug/l (ug/l)	2271	10965	0.00%
3013603	s-psa-t	— (—)	1524	5375	100.00%	Distribution not available
3013603	p-prostataspesifinenantigeeni	ug/l (ug/l)	846	1047	0.00%
3013603	s-prostataspesifinenantigeeni,kokonais	ug/l (ug/l)	494	578	0.00%
3013603	prostataspesifinenantigeeni	ug/l (ug/l)	402	462	0.00%
3013603	p-psaleik	— (—)	400	2015	100.00%	Distribution not available
3013603	p-psasäde	ug/l (ug/l)	328	1492	0.00%
3013603	p-psasäde	— (—)	208	879	100.00%	Distribution not available
3013603	p-psamob	ug/l (ug/l)	171	575	0.00%
3013603	p-psaleik	ug/l (ug/l)	147	163	0.00%
3013603	p-psa-suh	ug/l (ug/l)	133	252	0.00%
3013603	prostataspesifinenantigeeni,kokonais	ug/l (ug/l)	122	173	0.00%
3013603	s-psa/oma	ug/l (ug/l)	100	183	0.00%
3013603	s-prostataspesifinenantigeeni,kokonais	— (—)	88	96	100.00%	Distribution not available
3013603	p-psamob	— (—)	81	287	100.00%	Distribution not available
3013603	prostataspesifinenantigeeni,totaali	ug/l (ug/l)	72	109	0.00%
3013603	s-prostataspesifinenantigeeni	ug/l (ug/l)	72	89	0.00%
3013603	s-psa-suh	ug/l (ug/l)	59	90	0.00%
3013603	prostataspesifinenantigeeni	— (—)	57	80	100.00%	Distribution not available
3013603	s-psa-suh,s-psa	ug/l (ug/l)	46	66	0.00%
3013603	p-prostataspesifinenantigeeni	— (—)	45	51	100.00%	Distribution not available
3013603	p-prostataspesifinenantigeeni,kokonais	ug/l (ug/l)	44	51	0.00%
3013603	p-prostataspesifinenantigeeni(pi)	ug/l (ug/l)	39	50	0.00%
3013603	p-psagen	ug/l (ug/l)	31	36	0.00%
3013603	p-psagen	— (—)	27	30	100.00%	Distribution not available
3013603	p-psa-t	— (—)	22	22	100.00%	Distribution not available
3013603	s-psa	mg/l (ug/l)	7	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Inflammatory diseases of prostate (prostatitis)

4554

30908

3.54

310.56

6.2

4.2

3.22

2.75

ug/l

0.29

4237

27302

Artrosis, including avohilmo

17592

73400

1.46

310.46

4.8

4.5

3.03

3.35

ug/l

0.45

15864

66053

Unspecified haematuria

11981

68692

1.98

307.65

6.3

4.9

4.66

3.33

ug/l

2.82

10812

60804

Malignant neoplasm of prostate, including Hilmo

12530

54882

3.31

307.65

11.6

3.8

9.72

1.97

ug/l

26.75

11268

49503

Hernia

18848

84789

1.73

307.65

4.7

4.5

2.89

3.10

ug/l

0.28

16983

76396

All kidney diseases

18262

91382

1.52

307.65

4.9

4.6

4.00

2.91

ug/l

2.45

16471

82297

Genitourinary diseases

15013

54660

1.59

307.65

4.8

3.6

3.05

2.53

ug/l

0.89

13808

48910

Sensorineural hearing loss

15986

81473

1.53

307.65

5.5

4.8

3.30

3.47

ug/l

0.27

14203

73161

Sleep apnoea

19860

89122

1.69

307.65

4.9

4.7

2.74

3.17

ug/l

0.65

17769

80425

malignant neoplasm of male genital organs

12309

54678

3.20

307.65

11.8

3.7

9.72

1.97

ug/l

28.41

11023

49305

Abnormalities of breathing

16296

70357

1.47

307.65

4.6

4.5

2.69

3.34

ug/l

1.65

14563

63617

Pain in throat and chest

16643

70342

1.60

307.65

4.7

4.5

2.79

3.33

ug/l

1.00

14923

63611

Any death

8118

83967

0.58

307.65

4.9

5.2

8.94

2.26

ug/l

15.70

6925

76106

Injuries to the head

20604

97231

1.42

307.65

4.6

4.7

3.18

ug/l

0.00

18233

87772

Conductive and sensorineural hearing loss

16483

83665

1.51

307.65

5.4

4.8

3.28

3.42

ug/l

0.21

14657

75224

Intracranial trauma

10428

50583

1.62

307.65

4.5

2.92

3.08

ug/l

0.23

9298

45921

Abnormal findings on examination of blood, without diagnosis

12833

86175

1.80

307.65

8.6

4.6

6.49

3.02

ug/l

11.97

11787

76920

Symptoms and signs involving the urinary system

18670

86312

2.12

307.65

6.0

4.5

4.11

3.01

ug/l

3.48

17089

77136

Diseases of male genital organs

19516

70597

2.06

307.65

5.3

3.8

3.29

2.90

ug/l

0.72

18068

63010

Inguinal hernia

17510

84228

1.78

307.65

5.0

4.5

3.31

3.11

ug/l

0.21

15813

76021

Hyperplasia of prostate

15899

61112

3.74

307.65

6.3

4.1

3.84

3.20

ug/l

1.17

14881

54210

Malignant neoplasm of prostate

12091

53257

3.35

307.65

12.0

3.8

9.93

1.99

ug/l

28.62

10818

47980

Abnormal serum enzyme levels

10207

73768

2.32

307.65

9.7

4.8

7.41

2.96

ug/l

13.52

9478

65717

Other disorders of ear

18374

89036

1.52

307.65

5.2

4.6

3.24

3.28

ug/l

0.05

16392

80243

Sleep apnoea, including avohilmo

19864

88131

1.59

307.65

4.9

4.7

2.72

3.20

ug/l

0.74

17761

79484

Metabolic disorders

18321

85822

1.44

307.61

4.7

4.6

2.88

3.31

ug/l

1.01

16448

77379

Retention of urine

9871

59707

1.81

303.35

6.3

5.0

5.93

3.56

ug/l

3.31

9005

52589

Disorders of lipoprotein metabolism and other lipidaemias

17609

84153

1.46

301.15

4.9

4.6

2.64

3.31

ug/l

3.27

15853

75875

Dental operations

13955

53120

1.53

296.93

5.2

4.6

3.95

3.54

ug/l

0.44

12493

47400

682

18254

0.23

289.28

3.0

5.0

2.10

3.56

ug/l

3.95

541

16379

Other diseases of intestines

19357

85548

1.40

283.18

4.9

4.4

3.08

3.15

ug/l

0.08

17462

77055

Renal tubulo-interstitial diseases

15754

89520

1.44

282.28

5.1

4.9

4.81

3.06

ug/l

3.81

14117

80292

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

17328

86995

1.41

276.62

4.9

4.6

2.73

3.35

ug/l

2.12

15416

78610

Parasetamol

15135

57579

1.46

276.57

4.6

4.3

3.17

3.04

ug/l

0.14

13605

52152

Pure hypercholesterolaemia

16129

81671

1.46

273.27

5.1

4.7

2.76

3.36

ug/l

2.49

14600

73597

Other diseases of hard tissues of teeth

12874

49398

1.52

272.23

5.4

4.6

3.57

3.31

ug/l

0.25

11516

44266

Chronic periodontitis, including avohilmo

18358

96451

1.41

270.87

5.1

4.6

3.20

2.98

ug/l

0.35

16311

87223

Periodontitis

18376

96471

1.40

267.88

5.1

4.6

3.20

2.99

ug/l

0.35

16323

87239

Codeine

17276

72513

1.41

262.41

4.8

4.5

3.11

2.63

ug/l

0.92

15499

65451

Codeine or tramadol medication

21043

91359

1.36

262.11

4.9

4.6

3.02

3.25

ug/l

0.41

18854

82257

Abnormal spermatozoa

4403

32802

5.32

252.76

10.2

5.1

8.32

3.34

ug/l

6.26

4072

29345

Coxibs

6005

20493

1.80

250.80

5.1

4.5

2.87

4.93

ug/l

3.83

5360

18158

Persons encountering health services for specific procedures and health care

19157

90639

1.37

250.28

5.0

4.5

4.80

2.61

ug/l

7.27

17236

81689

Diseases of oral cavity, salivary glands and jaws

12994

50203

1.49

249.17

5.2

4.6

3.89

3.52

ug/l

0.39

11631

44886

Spondylopathies

16146

75109

1.42

249.01

5.0

4.7

2.96

3.42

ug/l

0.97

14551

67338

Other bacterial diseases

18422

92196

1.38

247.98

4.7

4.6

4.12

2.84

ug/l

3.32

16533

83164

Tramadol

15147

71940

1.42

239.77

4.9

4.5

2.88

2.68

ug/l

0.41

13510

64898

Statin medication

10766

43959

1.50

239.25

4.1

4.2

2.51

3.38

ug/l

3.19

9710

39892

Benign neoplasms

19681

86784

1.36

232.25

4.9

4.5

2.83

3.32

ug/l

1.35

17769

78113

Arthrosis

15070

64311

1.43

231.30

4.9

4.6

3.07

3.44

ug/l

0.46

13620

57900

Diseases of pulp and periapical tissues and dental caries

13724

53828

1.44

227.34

5.1

4.7

3.78

3.42

ug/l

0.47

12247

48216

Artificial joint operation, meniscal resection

18547

96964

1.37

225.32

5.0

4.7

2.55

3.28

ug/l

2.19

16787

87228

Gonarthrosis

14047

62163

1.44

224.50

5.0

4.7

2.87

3.53

ug/l

1.19

12679

55907

Dental caries, including avohilmo

15113

60140

1.41

223.08

5.1

4.7

3.92

3.41

ug/l

0.66

13491

53925

Finngen Rheumatological endpoints

17722

79875

1.36

223.01

4.6

4.5

2.99

3.29

ug/l

0.40

15954

72046

Shoulder lesions

15539

74098

1.41

222.02

4.9

4.7

2.31

3.36

ug/l

7.76

14229

66555

Injuries to the wrist and hand

17686

97898

1.35

215.69

4.6

4.7

2.75

3.04

ug/l

0.36

15940

88212

Chronic apical periodontitis

19979

91930

1.33

213.18

4.9

4.6

3.15

3.06

ug/l

0.11

17779

83005

Injuries to the shoulder and upper arm

15932

102153

1.38

212.86

4.8

4.7

2.46

3.25

ug/l

5.24

14370

91970

Sleep disorders (combined)

19913

84204

1.33

212.57

4.9

4.7

2.83

3.34

ug/l

0.82

17827

75804

Oter anti-inflammatory and antirheumatic agents, non-steroids

5329

19666

1.83

211.55

5.4

4.6

3.07

5.11

ug/l

3.15

4697

17408

Caries of dentine, including avohilmo

15644

62837

1.39

210.60

5.1

4.7

3.83

3.37

ug/l

0.60

13966

56397

Condition for Implicit Sepsis (Organ dysfunction codes)

16407

90086

1.36

208.28

4.7

4.6

3.30

3.02

ug/l

0.38

14609

81391

Gonarthrosis [arthrosis of knee](FG)

16144

74955

1.39

207.14

5.1

4.7

2.78

3.44

ug/l

1.41

14564

67520

Biguanides

17556

85968

1.35

203.45

4.5

4.7

2.68

3.39

ug/l

3.37

15566

77795

Dipeptidyl peptidase 4 (DPP-4) inhibitors

11885

74530

1.48

202.89

4.9

5.1

2.60

3.61

ug/l

7.28

10451

67212

Rotator cuff syndrome

12730

71422

1.44

202.58

5.0

4.7

2.22

3.38

ug/l

10.13

11718

64167

Dorsalgia

17965

77160

1.34

200.88

4.8

4.6

2.92

3.35

ug/l

0.88

16215

69196

Emergency coronary revascularization (for ACS)

16899

82785

1.37

200.19

4.5

4.7

2.58

3.38

ug/l

2.98

15168

74661

Other dorsopathies, not elsewhere classified

18354

77200

1.33

200.05

4.8

4.6

2.97

3.35

ug/l

0.71

16614

69228

Oxicams

5272

20105

1.77

198.90

5.2

4.6

2.47

5.00

ug/l

5.85

4720

17813

Other heart diseases, wide

15138

72924

1.36

198.50

4.3

4.4

2.68

3.00

ug/l

0.54

13626

66279

Erysipelas

14907

91005

1.39

197.44

4.7

3.35

2.88

ug/l

0.66

13310

82107

Symptoms and signs involving cognition, perception, emotional state and behaviour

17570

96805

1.33

195.07

5.0

4.7

3.24

3.26

ug/l

0.03

15641

87185

Other bacterial diseases

17618

95927

1.34

194.17

4.8

4.6

4.50

2.84

ug/l

4.75

15752

86545

Diseases of oesophagus, stomach and duodenum

19339

94300

1.32

192.71

4.9

4.6

2.85

3.30

ug/l

1.07

17384

84954

Other intervertebral disc disorders

15771

76139

1.35

185.83

4.8

4.6

2.89

3.32

ug/l

0.76

14463

68329

Cardiac arrhythmias

8899

42584

1.47

185.63

4.2

4.3

2.73

2.89

ug/l

0.14

8070

39112

Other special examinations and investigations of persons without complaint or reported diagnosis

13542

53824

1.39

182.87

4.7

4.4

3.03

3.15

ug/l

0.13

12275

48386

Medical observation and evaluation for suspected diseases and conditions

13382

53808

1.38

178.91

4.9

4.4

2.76

3.10

ug/l

1.03

11942

48375

Meniscus derangement

11718

62024

1.43

177.82

4.9

4.6

2.43

3.18

ug/l

3.82

10666

55965

Polyarthropathies

12494

64124

1.39

176.00

4.6

2.94

3.45

ug/l

1.46

11099

57702

Hypothyreosis and Thyroxine purchase for inclusion criteria

9486

81487

0.72

173.50

5.0

2.74

3.55

ug/l

1.62

8349

72981

Concussion

8312

50506

1.46

171.01

4.5

4.6

2.61

3.08

ug/l

1.18

7402

45849

Other joint disorders

15637

66202

1.33

170.72

4.7

4.5

2.60

3.33

ug/l

3.10

14060

59606

Other soft tissue disorders, not elsewhere classified

16190

76825

1.32

168.69

4.9

4.6

2.76

3.46

ug/l

2.45

14582

68952

Other arrhythmias

10945

64293

1.40

167.60

5.1

4.7

3.08

3.24

ug/l

0.17

9773

58212

Diverticular disease of intestine

14747

76409

1.36

167.48

5.5

4.7

3.19

3.40

ug/l

0.27

13230

68584

Percutaneous Coronary Intervention

15259

76085

1.35

166.57

4.4

4.7

2.31

3.19

ug/l

7.40

13739

68914

Disorders of choroid and retina

15798

91936

1.34

165.53

5.3

4.8

3.23

3.43

ug/l

0.31

14010

82565

Hypothyroidism, other/unspecified

9450

80772

0.72

164.17

5.0

2.71

3.54

ug/l

1.70

8318

72360

Paracetamol or NSAID medication

3348

10359

1.83

161.11

4.7

4.1

4.57

4.41

ug/l

0.04

2975

9248

Disease of hard tissues of teeth, NOS

11425

46933

1.40

161.02

5.3

4.6

2.30

3.12

ug/l

2.90

10331

42233

Soft tissue disorders

18327

77529

1.29

160.99

4.7

4.6

2.61

3.53

ug/l

4.66

16570

69517

Acetic acid derivatives and related substances

5633

20464

1.61

160.90

5.1

4.5

2.88

5.06

ug/l

4.02

5002

18131

Hypertension, essential

13472

61014

1.35

157.32

4.4

4.3

2.75

3.26

ug/l

0.81

12158

55352

Polyuria

5143

37659

1.73

155.35

6.1

5.0

2.19

3.31

ug/l

5.55

4721

33231

Other (not insulin) diabetes medications

17309

84655

1.30

155.14

4.5

4.7

2.53

3.40

ug/l

4.95

15343

76615

Benign neoplasm of colon, rectum, anus and anal canal

12616

88937

1.37

153.84

5.5

5.0

3.06

3.52

ug/l

0.79

11362

79521

Episodal and paroxysmal disorders

18560

78016

1.28

152.49

4.7

4.6

2.90

3.46

ug/l

0.95

16584

70213

Influenza and pneumonia

17572

92272

1.29

152.38

4.3

4.7

3.14

3.03

ug/l

0.21

15795

83419

Diabetes medication

17505

86005

1.28

145.55

4.4

4.7

2.48

3.36

ug/l

5.24

15526

77849

All pneumoniae

16997

94079

1.28

145.26

4.4

4.7

3.22

3.04

ug/l

0.40

15231

85067

Type 2 diabetes, definitions combined, including avohilmo

16639

80010

1.29

145.16

4.5

4.7

2.57

3.43

ug/l

4.51

14778

72504

Type 2 diabetes, strict (exclude DM1)

16759

81359

1.29

145.05

4.5

4.7

2.57

3.42

ug/l

4.49

14891

73689

Gonarthrosis,primary

17786

91879

1.29

144.58

5.3

4.8

2.78

3.44

ug/l

1.70

15990

82511

Hypertension

13445

61229

1.33

144.44

4.3

2.73

3.25

ug/l

0.83

12160

55550

Coronary revascularization (ANGIO or CABG)

15079

76103

1.32

144.31

4.4

4.7

2.26

3.19

ug/l

8.18

13592

68931

Hypertensive diseases

13441

61231

1.33

144.19

4.3

2.73

3.25

ug/l

0.83

12156

55551

Type 2 diabetes, definitions combined

16701

81101

1.29

144.01

4.5

4.7

2.57

3.42

ug/l

4.45

14837

73462

Pneumonias (Asthma/COPD co-morbidities)

16920

94166

1.28

143.46

4.4

4.7

3.23

3.04

ug/l

0.42

15159

85142

Testicular dysfunction

1224

7206

5.87

141.97

4.7

3.8

1.37

1.96

ug/l

10.04

1154

6602

Diabetes, insulin treatment (Kela reimbursement)

17833

89945

1.28

140.41

4.4

4.7

2.57

3.39

ug/l

4.30

15802

81335

Other heart diseases

7132

34660

1.45

140.36

3.9

2.08

2.68

ug/l

1.96

6476

31837

Fitting and adjustment of other devices

7314

50823

1.49

139.91

5.6

5.3

3.31

3.33

ug/l

0.02

6657

44904

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

16507

82423

1.29

139.52

4.4

4.7

2.53

3.38

ug/l

4.38

14635

74671

Neoplasms

13196

56307

1.32

139.19

5.1

3.1

3.32

1.71

ug/l

5.42

12016

51120

Hypothyroidism, strict autoimmune

7860

67372

0.72

138.91

4.9

5.1

2.86

3.84

ug/l

1.64

6891

60314

Diseases of the ear and mastoid process

20051

84561

1.26

138.65

4.8

4.4

2.98

3.17

ug/l

0.25

18064

76331

Implicit Sepsis

15205

92055

1.30

138.11

4.7

4.8

3.55

3.12

ug/l

0.59

13440

83036

Fall on same level

20153

92733

1.25

137.75

4.6

3.18

3.11

ug/l

0.09

17872

83881

Other antidepressants

20059

86736

1.26

137.62

4.8

4.7

2.78

3.38

ug/l

1.65

17726

78479

Opioids

16946

72862

1.28

137.33

4.7

4.5

3.68

2.69

ug/l

2.41

15190

65719

Condition for Implicit Sepsis (Organ dysfunction codes)

15656

91727

1.29

137.05

4.7

3.36

3.06

ug/l

0.39

13858

82850

Disorders of lens

13791

70991

1.33

136.58

5.3

4.8

2.81

3.45

ug/l

2.67

12255

64173

Diabetes, varying definitions

16955

82618

1.27

135.65

4.4

4.7

2.49

3.37

ug/l

4.89

15056

74837

Symptoms and signs involving the circulatory and respiratory systems

16989

70513

1.27

134.53

4.5

2.73

3.33

ug/l

1.36

15243

63763

Testicular hypofunction

1099

6391

6.57

134.35

4.8

3.8

1.36

1.96

ug/l

9.12

1037

5859

Hypogonadotropic hypogonadism

924

4907

6.09

134.11

4.8

3.5

1.19

1.76

ug/l

9.38

858

4524

Diabetes mellitus

16958

82636

1.27

131.20

4.4

4.7

2.49

3.37

ug/l

4.88

15060

74853

Gingivitis and periodontal diseases

18899

82166

1.26

131.04

5.1

4.6

3.33

3.23

ug/l

0.12

16881

74082

Type 2 diabetes

16801

81923

1.27

130.17

4.4

4.7

2.49

3.39

ug/l

5.05

14921

74207

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

16629

94795

1.27

129.92

4.4

4.7

3.27

3.03

ug/l

0.54

14892

85716

Disorders of the thyroid gland

11555

92705

0.77

129.54

5.1

4.9

2.84

3.48

ug/l

1.41

10209

83158

Basal cell carcinoma, including avohilmo

8506

46141

1.42

127.34

5.8

3.9

3.33

2.04

ug/l

9.35

7475

41240

Diseases of pulp and periapical tissues, including avohilmo

18287

79652

1.26

126.72

5.0

4.7

3.34

3.25

ug/l

0.09

16328

71700

All chronic kidney diseases

10827

72004

1.36

126.49

4.9

5.0

4.39

3.25

ug/l

2.51

9652

64300

Pneumonia, organism unspecified

15704

91896

1.27

126.31

4.5

4.7

3.34

3.04

ug/l

0.67

14009

83091

Coxarthrosis

10659

57057

1.37

125.57

5.4

4.9

3.79

3.68

ug/l

0.08

9552

51159

Exposure to unspecified factor

16794

101508

1.26

125.12

4.7

2.51

3.17

ug/l

3.11

14825

91690

Hypothyroidism, strict autoimmune, 3 medication purchases required

7767

67716

0.73

124.43

4.9

5.0

2.55

3.56

ug/l

3.60

6806

60480

Type 2 diabetes, wide definition

14786

79033

1.29

122.39

4.6

4.7

2.55

3.46

ug/l

5.56

13107

71561

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

9041

48883

1.39

121.88

5.7

3.8

3.23

2.01

ug/l

8.89

7944

43778

L02BX Other hormone antagonists and related agents

1838

13565

8.85

121.10

19.6

5.3

34.61

3.14

ug/l

17.65

1784

12030

Non-invasive ventilation

4113

26072

1.59

120.07

5.0

4.7

2.35

3.10

ug/l

3.14

3837

24032

Dorsopathies

17981

77235

1.25

116.48

4.7

4.6

3.16

3.35

ug/l

0.24

16263

69257

Senile cataract

12841

65531

1.32

116.41

5.4

5.0

2.92

3.62

ug/l

2.73

11364

59060

Hypertensive diseases (excluding secondary)

7723

34624

1.39

115.84

3.8

3.9

2.10

2.68

ug/l

1.87

7028

31803

Basal cell carcinoma

8115

44487

1.41

115.81

5.9

3.9

3.43

2.06

ug/l

9.35

7103

39696

Malignant neoplasm of bronchus and lung

2125

26643

0.55

115.31

4.3

4.0

2.47

2.24

ug/l

1.14

1805

23593

Persons encountering health services for examination and investigation

13045

53825

1.30

115.01

4.6

4.4

3.51

3.15

ug/l

0.35

11739

48387

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6425

24114

1.43

114.86

4.3

3.3

2.49

2.00

ug/l

1.59

5812

21880

GASTRO-related operations

12538

51196

1.29

114.59

4.6

3.8

3.34

2.47

ug/l

1.62

11256

46543

Any gastric operation

12538

51196

1.29

114.59

4.6

3.8

3.34

2.47

ug/l

1.62

11256

46543

Pain (limb, back, neck, head abdominally)

14788

61774

1.28

114.57

4.6

2.61

3.63

ug/l

4.60

13349

55452

Other malignant neoplasms of skin (=non-melanoma skin cancer)

8448

46183

1.39

114.04

5.8

3.9

3.33

2.04

ug/l

8.75

7403

41275

Malignant neoplasm of respiratory system and intrathoracic organs

2588

31121

0.58

113.22

4.3

4.0

2.52

2.19

ug/l

2.27

2210

27619

Propionic acid derivatives

5533

20535

1.49

112.77

5.0

4.5

3.99

5.05

ug/l

0.57

4913

18194

Malignant neoplasm of skin

9208

50836

1.37

112.71

5.7

3.8

3.36

1.99

ug/l

9.35

8099

45592

Presence of other functional implants

11172

63792

1.33

111.88

5.6

5.2

3.68

3.93

ug/l

0.28

9575

56979

Actinic keratosis

7082

51899

1.44

111.67

6.0

5.6

3.88

4.31

ug/l

0.24

6224

45682

Malignant neoplasm, wide definition for exclusion

14784

72607

1.27

111.04

6.5

3.4

4.75

1.76

ug/l

11.62

13303

65972

Bleeding

15767

95251

1.26

110.68

5.0

4.7

4.05

3.10

ug/l

1.22

13989

85874

Presence of cardiac and vascular implants and grafts

10779

66927

1.37

109.65

5.0

5.1

2.78

3.87

ug/l

5.72

9532

59950

L02BB Anti-androgens

3016

23171

2.45

109.34

18.1

5.2

26.37

3.12

ug/l

17.31

2865

20349

Skin changes due to chronic exposure to nonionizing radiation

7178

52565

1.43

109.31

6.0

5.6

3.86

4.30

ug/l

0.25

6308

46268

Arthropathies

15583

66229

1.25

108.80

4.5

3.03

3.37

ug/l

0.40

14008

59630

Diseases of the eye and adnexa

14148

59127

1.26

104.76

4.4

4.2

2.70

3.04

ug/l

0.49

12765

53766

Cardiovascular diseases (excluding rheumatic etc)

7919

35595

1.34

102.44

3.7

3.9

1.80

2.63

ug/l

5.61

7203

32665

Conduction disorders

6284

40106

1.46

102.41

5.4

3.30

3.95

ug/l

0.99

5435

35809

Lumbar disc prolapse

11339

72090

1.29

101.92

4.6

2.88

2.97

ug/l

0.09

10423

64929

7490

55182

1.40

101.82

6.0

5.6

3.92

4.21

ug/l

0.16

6587

48628

Provisional assignment of new diseases of uncertain etiology

8398

67510

1.34

101.56

4.9

2.78

3.37

ug/l

1.59

7664

60345

Codes for special purposes

8404

67596

1.34

101.12

4.9

2.78

3.37

ug/l

1.60

7670

60420

Neurological diseases

14024

58884

1.26

100.47

4.4

4.6

2.96

3.34

ug/l

0.43

12577

53225

ILD medications: prednisolone, methylprednisolone, prednisone

19140

92296

1.22

100.24

5.0

4.6

4.19

2.93

ug/l

4.21

17178

83156

Antihypertensive medication - note that there are other indications

7206

29470

1.36

99.95

3.9

2.17

2.78

ug/l

2.14

6531

26987

Malignant neoplasm

14313

71475

1.25

99.07

6.8

3.4

4.80

1.77

ug/l

14.93

12856

64908

Hypopituitarism

1440

8786

2.24

98.43

4.9

4.0

1.37

2.25

ug/l

8.05

1325

8014

Abdominal and pelvic pain

19440

84427

1.22

98.02

4.7

4.6

2.76

3.37

ug/l

1.74

17555

76015

Solid cancers, helper endpoint

14183

70728

1.25

97.55

6.9

3.4

4.89

1.78

ug/l

15.37

12731

64214

Continuous positive airway pressure

4146

26165

1.57

97.54

5.0

4.7

2.42

3.35

ug/l

2.56

3542

24102

Excessive earwax

10071

81605

1.32

97.53

5.4

5.0

2.54

3.35

ug/l

3.83

9024

73097

Mycoses

13856

102012

1.25

97.21

4.8

4.7

2.53

3.03

ug/l

1.81

12402

92068

Lung cancer and mesothelioma

2733

32359

0.61

96.08

4.5

5.7

2.39

4.40

ug/l

7.32

2342

28848

Dyspnoea

15456

97736

1.24

94.78

5.0

4.8

3.15

3.34

ug/l

0.29

13646

87990

Other symptoms and signs involving the urinary system

2380

16694

1.90

94.76

6.9

4.8

4.19

3.34

ug/l

0.63

2272

14819

Covid-19 confirmed case

6455

51224

1.40

94.74

5.1

5.2

2.94

3.59

ug/l

1.49

5847

45570

Malignant neoplasm of bronchus and lung, including Hilmo

2676

31235

0.62

94.42

4.4

4.0

2.44

2.19

ug/l

1.75

2294

27701

ILD medications

19678

92556

1.21

93.66

4.9

4.6

3.76

2.92

ug/l

2.55

17669

83391

Redundant prepuce, phimosis and paraphimosis

5555

44179

1.52

92.59

4.7

3.7

2.61

2.39

ug/l

0.36

5006

39544

Any event in cancer register

15013

75309

1.24

91.83

6.8

3.5

4.67

2.05

ug/l

11.61

13485

68446

Haemorrhage from respiratory passages

7136

51996

1.38

91.60

5.2

5.1

3.69

3.85

ug/l

0.10

6296

46556

Gout

6980

50417

1.44

91.40

4.9

5.1

3.49

3.94

ug/l

0.66

6169

45010

Anti-inflammatory and antirheumatic products, non-steroids

5384

20535

1.43

91.32

5.0

4.5

3.87

5.05

ug/l

0.66

4803

18194

Acute tubulo-interstitial nephritis

9661

68656

1.29

90.91

5.6

5.2

5.85

3.42

ug/l

3.73

8652

60968

Inflammatory bowel disease treatment related agents

19708

95915

1.20

90.68

4.9

4.6

3.80

3.03

ug/l

2.25

17673

86380

Major coronary heart disease event

15432

80074

1.24

90.48

4.4

4.7

2.33

3.26

ug/l

7.56

13904

72381

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

14262

73320

1.24

89.82

4.5

4.9

3.24

3.32

ug/l

0.13

12778

66059

14262

73320

1.24

89.82

4.5

4.9

3.24

3.32

ug/l

0.13

12778

66059

Factors influencing health status and contact with health services

7540

30336

1.37

89.81

4.5

4.1

3.31

2.45

ug/l

0.87

6772

27567

Benign neoplasm: Colon

10467

84233

1.30

89.37

5.5

5.1

3.03

3.56

ug/l

0.79

9420

75174

Myocardial infarction, unclassifiable

3201

38235

0.64

89.29

4.5

5.5

6.64

4.49

ug/l

0.62

2771

33620

Diseases of the musculoskeletal system and connective tissue

9116

37013

1.30

88.76

4.4

4.3

3.09

3.54

ug/l

0.39

8242

33282

Other disorders of penis

2686

20139

1.95

87.08

5.4

4.1

2.39

2.63

ug/l

0.29

2397

17879

Use of hypnotics and sedatives

19311

96839

1.20

87.06

5.0

4.6

2.77

3.28

ug/l

1.83

17138

87467

Presence of other devices

4493

34428

1.48

86.47

5.6

2.70

4.89

ug/l

8.25

4201

30437

Persons encountering health services in other circumstances, wide

20878

94192

1.19

86.17

4.7

3.30

3.17

ug/l

0.14

18905

84584

COPD, hospital admissions 1, only main diagnosis

5515

58557

0.71

86.03

4.7

5.5

3.80

4.24

ug/l

0.26

4707

51890

Coxarthrosis [arthrosis of hip](FG)

11028

65521

1.29

85.87

5.4

5.0

3.75

3.69

ug/l

0.04

9882

58700

Ischemic heart diseases

14825

76577

1.24

85.58

4.3

4.7

2.27

3.18

ug/l

7.15

13339

69369

Constipation

15219

90769

1.22

85.01

5.6

4.8

4.17

3.30

ug/l

1.32

13472

81409

Atrial fibrillation and flutter

6120

31467

1.40

84.98

4.2

2.31

2.86

ug/l

1.29

5565

28906

Impotence

1678

12117

2.82

84.59

6.1

4.1

2.11

2.70

ug/l

1.01

1506

10740

Mood [affective] disorders

12380

94424

0.81

82.78

4.2

4.6

2.20

2.92

ug/l

3.68

10946

85559

Fever of other and unknown origin

9679

71792

1.28

82.73

5.1

4.8

4.16

3.00

ug/l

1.56

8667

64494

Depression

10952

88212

0.81

82.17

4.2

4.5

2.19

2.82

ug/l

2.51

9684

80164

Symptoms and signs involving the digestive system and abdomen

19255

84427

1.20

81.89

4.7

4.6

2.77

3.37

ug/l

1.77

17362

76015

Any operation in hilmo

879

2232

2.32

81.84

3.6

2.0

1.88

1.38

ug/l

2.40

791

2109

Hydrocele

3427

26798

1.75

81.75

5.1

4.4

2.89

3.28

ug/l

0.57

3086

23417

Mood disorders

12439

94563

0.82

81.49

4.2

4.6

2.20

2.92

ug/l

3.76

11001

85677

Orchitis and epididymitis

2637

19916

1.90

81.13

5.4

4.2

3.01

2.96

ug/l

0.04

2408

17585

Spermatocele

2355

17886

2.15

80.66

5.2

4.3

3.45

3.00

ug/l

0.32

2155

15732

COPD, hospital admissions 3, with asthma pneumonia sepsis

4335

46714

0.69

80.37

4.4

5.5

3.22

4.43

ug/l

2.39

3690

41332

Malaise and fatigue

8934

59635

1.29

80.28

4.9

5.0

5.16

3.20

ug/l

1.82

7852

53240

AV-block

4200

28715

1.53

80.16

5.4

5.7

3.55

4.49

ug/l

1.01

3606

25471

Other cataract

8310

52118

1.32

79.98

5.4

5.1

2.65

3.88

ug/l

6.13

7353

46701

Neurological diseases, wide definition

4125

15239

1.44

79.34

4.0

4.2

2.14

3.15

ug/l

3.39

3714

13997

Bacterial infection, other or unspecified

10878

78192

1.27

78.87

5.4

5.0

5.57

3.12

ug/l

8.45

9693

69971

Implicit Sepsis

13877

90441

1.23

78.52

4.8

4.9

3.77

3.17

ug/l

0.82

12221

81455

Dizziness and giddiness

12416

84106

1.24

77.92

5.2

4.9

3.20

3.52

ug/l

0.45

11097

75280

Dislocation, sprain and strain of joints and ligaments of knee

9372

72060

1.27

77.79

4.3

2.14

2.59

ug/l

1.80

8599

65618

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

9363

76392

1.28

77.47

4.7

4.6

2.30

2.96

ug/l

2.51

8476

69028

Valvular heart disease excluding rheumatic fever

9343

56858

1.30

75.95

5.0

2.68

3.49

ug/l

4.01

8175

51280

Hard cardiovascular diseases

14377

74146

1.22

75.84

4.3

4.6

2.34

3.15

ug/l

4.98

12965

67206

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

16362

98461

1.20

75.69

5.0

4.7

4.36

3.05

ug/l

3.46

14464

88789

Follow-up examination after treatment for conditions other than malignant neoplasms

4244

36744

0.72

75.57

4.8

4.6

4.33

3.02

ug/l

0.58

3893

32941

General examination and investigation of persons without complaint and reported diagnosis

12097

53669

1.24

75.52

4.5

4.4

3.29

3.07

ug/l

0.19

10986

48278

Non-rheumatic valve diseases

9319

56715

1.29

75.23

5.0

2.68

3.49

ug/l

4.03

8157

51147

Presbycusis

2421

17067

1.64

75.17

6.0

5.6

7.07

4.94

ug/l

0.39

1937

14873

Cardiovascular diseases

7115

30607

1.30

73.96

3.6

3.8

1.76

2.54

ug/l

6.00

6507

28100

Other retinal disorders

11763

78774

1.25

73.36

5.3

5.0

3.34

3.61

ug/l

0.35

10373

70317

COPD, hospital admission 2, with asthma infections

5203

54689

0.72

73.25

4.4

5.4

3.01

4.21

ug/l

3.17

4441

48549

First line medication for Crohn's disease

18993

90459

1.18

71.81

5.0

4.5

4.17

2.76

ug/l

4.09

17077

81533

Oral corticosteroids

18264

95437

1.18

71.61

5.1

4.6

4.08

3.04

ug/l

3.27

16342

85957

Diseases of the skin and subcutaneous tissue

18031

79505

1.19

70.22

4.7

4.6

2.75

3.44

ug/l

3.02

16160

71602

Disorders of other endocrine glands

5110

39596

1.34

69.34

4.9

4.6

2.24

2.96

ug/l

1.47

4640

35655

Varicose veins

6836

62723

0.78

68.23

5.2

4.71

3.70

ug/l

0.48

6051

55742

Spinal stenosis

9965

64718

1.26

68.11

5.4

5.0

2.58

3.70

ug/l

5.40

8977

57681

Complications of surgical and medical care, not elsewhere classified

16532

99582

1.19

67.95

5.2

4.7

3.19

3.22

ug/l

0.03

14755

89618

Alcoholic liver disease

1399

19906

0.55

67.83

3.9

4.8

3.15

3.23

ug/l

0.02

1196

18008

Endocrine, nutritional and metabolic diseases

13142

57215

1.21

67.82

4.3

4.4

2.32

3.45

ug/l

6.25

11798

52071

Depression medications

3780

14153

1.42

67.09

3.3

2.6

1.45

1.61

ug/l

3.88

3390

13298

Later onset COPD

4687

45638

0.72

66.78

5.0

5.9

3.38

4.81

ug/l

2.79

4004

40084

Other hearing loss

4845

37925

1.38

66.44

5.6

5.3

4.95

4.44

ug/l

0.17

4143

33506

Any prescribed medicine buy

121

9.21

66.44

4.9

1.7

2.93

1.56

ug/l

1.94

110

Other diseases of upper respiratory tract

19302

89245

1.17

66.00

5.0

4.7

2.63

3.42

ug/l

3.61

17379

80075

Atrial fibrillation and flutter with reimbursement

5336

27448

1.38

65.87

4.5

4.4

3.12

3.11

ug/l

0.00

4834

25125

Hyperlipidaemia, other/unspecified

8199

64220

1.30

65.72

5.2

5.1

2.96

3.58

ug/l

1.31

7219

57393

Dermatophytosis

10610

91173

1.24

65.65

4.8

4.7

2.62

2.98

ug/l

0.82

9502

82283

Triptan medication for migraine, single purchase ok

5335

45470

0.77

65.59

4.0

3.8

1.84

2.20

ug/l

2.22

4880

41542

Migraine, single triptan purchase ok & required. ICD-code if available is included

5335

45470

0.77

65.59

4.0

3.8

1.84

2.20

ug/l

2.22

4880

41542

Liquid cancers, helper endpoint

6812

49387

1.31

64.72

5.8

3.8

5.91

1.98

ug/l

4.24

6084

44322

Mood disorders, excluding more controls

12284

84645

0.83

64.06

4.2

4.8

2.21

3.00

ug/l

3.92

10862

76840

Infections, IBD-co-morbidities

2561

13217

1.53

63.97

4.6

2.56

3.48

ug/l

2.13

2311

12103

In situ neoplasms

4874

38768

1.35

63.95

5.8

5.5

3.05

4.01

ug/l

2.24

4272

34142

Other neurological diseases

12858

88308

1.21

62.74

5.0

2.95

3.57

ug/l

2.25

11544

78875

Other disorders of prostate

1064

7370

2.86

62.14

7.5

4.5

5.01

3.48

ug/l

1.07

985

6429

Hypothyroidism (congenital or acquired)

3275

13710

1.43

61.87

3.9

2.7

1.51

1.64

ug/l

2.25

2974

12888

Exposure to other specified factors

11845

94338

1.21

61.33

4.4

4.6

2.44

2.86

ug/l

0.84

10648

85404

Hypothyroidism, levothyroxine purchases

3254

13662

1.43

60.71

4.0

2.7

1.51

1.64

ug/l

2.33

2955

12842

Hypothyroidism and >3 levothyroxin purchases

3254

13662

1.43

60.71

4.0

2.7

1.51

1.64

ug/l

2.33

2955

12842

Other external causes of accidental injury

13681

59624

1.20

60.61

4.7

2.84

3.48

ug/l

2.15

12174

53944

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2419

18111

1.61

60.06

5.5

4.1

3.90

2.34

ug/l

2.00

2128

15949

Anxiety disorders, excluding more controls

9365

71490

0.82

59.66

4.1

4.5

2.61

2.73

ug/l

0.11

8368

65355

Other disorders of bladder

2755

21452

1.61

59.32

6.3

5.2

3.57

3.38

ug/l

0.05

2409

19109

Acute alcohol intoxication

4115

50550

0.73

58.08

4.3

4.7

2.72

3.23

ug/l

1.07

3602

45666

Non-small cell lung cancer, including Hilmo

1892

24262

0.64

57.76

4.6

4.0

2.44

2.26

ug/l

0.78

1622

21479

Symptoms and signs involving the skin and subcutaneous tissue

10417

88049

1.21

57.41

5.1

4.9

2.43

3.23

ug/l

4.64

9392

78958

Accidents

13628

59624

1.19

57.14

4.7

2.86

3.48

ug/l

2.00

12141

53944

Degeneration of macula and posterior pole

8536

58247

1.26

56.71

5.8

5.5

3.69

4.18

ug/l

0.52

7520

51416

Abnormalities of heart beat

4997

39583

1.32

56.58

5.2

5.0

3.34

3.76

ug/l

0.22

4437

35427

General symptoms and signs

18226

81385

1.16

56.37

4.6

4.5

3.49

2.83

ug/l

1.07

16405

73455

Gastro-oesophageal reflux disease

11497

86600

1.21

55.99

5.2

4.8

2.58

3.29

ug/l

2.73

10285

77956

Pacemaker

6700

54584

1.31

55.72

5.2

5.5

3.60

4.25

ug/l

0.52

5846

48257

COPD related to multimorbidity

6877

67659

0.78

55.44

4.7

5.5

3.23

4.04

ug/l

0.80

5873

60136

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6224

32303

1.28

55.20

4.2

4.1

3.81

2.81

ug/l

0.72

5666

29663

Syncope and collapse

8359

61227

1.25

55.07

5.1

5.0

4.18

3.19

ug/l

0.79

7375

54706

Pain in limb

12842

75283

1.19

54.70

4.9

4.6

2.90

3.48

ug/l

1.43

11521

67564

Contraceptive management

3187

29109

0.73

54.63

3.3

1.63

1.71

ug/l

0.30

3008

26898

Certain infectious and parasitic diseases

12973

56792

1.19

54.47

4.6

3.13

3.20

ug/l

0.08

11701

51153

Persons encountering health services in circumstances related to reproduction

5524

45398

0.78

54.44

3.6

3.5

1.67

1.97

ug/l

1.87

5170

41787

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2084

27155

0.65

52.76

4.0

4.9

2.78

3.19

ug/l

0.20

1803

24507

Coronary atherosclerosis

12808

71845

1.20

52.22

4.6

4.9

2.39

3.31

ug/l

6.37

11477

64986

Other and unspecified tonsillitis

5158

35455

1.30

52.03

3.4

3.5

1.72

1.99

ug/l

2.57

4783

32751

Exclusions for E4_PCOS_BROAD

2259

16684

1.49

51.96

5.0

4.4

2.37

2.99

ug/l

0.47

2057

15099

Ischaemic heart disease, wide definition

14437

79753

1.18

51.38

4.5

4.8

2.38

3.19

ug/l

5.79

12968

72228

Anxiety disorders

9493

76674

0.83

51.24

4.1

4.3

2.59

2.61

ug/l

0.01

8478

69876

Other headache syndromes

4311

34412

1.31

50.63

4.7

4.5

2.06

2.89

ug/l

4.43

3889

31094

Bacterial infection, other or unspecified

9977

75729

1.22

50.46

5.4

5.1

5.74

3.19

ug/l

8.06

8857

67689

Anaemias

2710

13224

1.42

50.14

3.8

2.7

2.98

1.66

ug/l

2.24

2461

12433

Complications of medical and surgical care

11419

92231

1.19

49.95

5.2

4.9

3.40

3.39

ug/l

0.01

10201

82629

Alcohol dependence

4765

56566

0.75

49.84

4.1

4.7

2.81

3.04

ug/l

0.28

4155

51252

Nerve, nerve root and plexus disorders

18119

99949

1.15

49.56

4.8

4.7

2.24

3.36

ug/l

11.65

16433

89786

Falls/tendency to fall

18089

81285

1.15

49.56

4.6

3.06

3.17

ug/l

0.18

16147

73532

Mental and behavioural disorders due to alcohol, excluding acute intoxication

8197

93277

0.81

49.51

4.1

4.7

2.84

3.00

ug/l

0.23

7155

84511

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2029

10601

1.55

48.61

4.7

5.1

3.03

3.95

ug/l

0.65

1772

9633

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3471

27246

1.35

48.50

5.1

4.6

2.08

2.93

ug/l

2.81

3113

24508

Mouth breathing

7848

68049

1.25

48.11

4.8

4.6

2.17

2.82

ug/l

2.73

7182

61737

Neurotic, stress-related and somatoform disorders

9336

75440

0.84

47.98

4.1

4.3

2.60

2.57

ug/l

0.02

8332

68776

Deviated nasal septum

7400

64266

1.27

47.40

4.8

4.6

2.63

2.95

ug/l

0.40

6716

58207

Heart failure and antihypertensive medication

4376

23383

1.34

46.79

4.2

4.4

2.89

3.23

ug/l

0.47

3859

21362

Gastrointestinal diseases

8606

36827

1.21

46.77

4.4

4.1

2.88

3.12

ug/l

0.18

7738

33317

Other medical care

7886

61239

1.23

46.73

6.7

5.1

11.94

3.09

ug/l

12.28

6895

54439

Non-small cell lung cancer, squamous, helper endpoint

506

8410

0.47

46.26

4.2

5.5

2.43

4.81

ug/l

4.01

426

7330

Chronic diseases of tonsils and adenoids

8566

62722

0.83

45.66

4.1

4.3

1.87

2.67

ug/l

8.30

7895

57048

Malignant neoplasm of bladder, including Hilmo

2985

24225

1.51

45.39

5.4

4.1

3.31

2.27

ug/l

2.07

2582

21462

Excessive attrition of teeth

7531

64580

1.22

45.25

4.9

4.5

2.53

2.77

ug/l

0.34

6756

58542

Cystitis

9565

65340

0.84

45.17

6.1

5.1

3.81

3.59

ug/l

0.22

8615

57920

Angina pectoris

11337

67229

1.20

44.81

4.9

5.0

2.37

3.45

ug/l

8.19

10164

60654

Alcohol use disorder, ICD-based

7482

85459

0.81

44.30

4.1

4.6

2.90

3.02

ug/l

0.16

6527

77469

COPD, early/later onset

7982

76368

0.81

43.47

4.7

5.4

3.24

3.85

ug/l

0.64

6846

68050

Sub-endpoint used in defining T1D endpoints

3269

40018

0.75

43.34

3.7

4.6

2.08

3.32

ug/l

6.12

2902

35926

Urethral stricture

1585

12343

1.88

42.78

6.7

5.1

3.20

3.49

ug/l

0.21

1404

10986

COPD, hospital admissions

7916

75900

0.82

42.48

4.7

5.4

3.26

3.86

ug/l

0.62

6789

67628

Care involving use of rehabilitation procedures

10244

83106

1.18

42.25

4.7

4.6

3.25

2.67

ug/l

0.52

9314

74796

Chronic kidney disease

6385

54250

1.27

42.13

4.6

5.4

3.34

4.20

ug/l

1.16

5678

47993

Cerebrovascular diseases (FINNGEN)

5109

30208

1.28

41.80

4.1

4.2

2.70

2.94

ug/l

0.32

4630

27697

Persons encountering health services in other circumstances

5597

46944

1.25

41.45

4.9

4.8

3.75

3.04

ug/l

0.32

4917

42115

Urolithiasis

7204

63257

1.26

41.34

5.3

5.1

3.44

ug/l

0.00

6443

56561

Caries of enamel

10163

83124

0.85

40.91

4.7

4.4

1.96

2.69

ug/l

9.73

9123

75595

Internal derangement of knee

6414

54795

1.24

40.74

4.6

2.71

3.16

ug/l

0.78

5692

49513

Diaphragmatic hernia

5099

42889

1.27

40.67

5.3

5.0

2.56

3.47

ug/l

4.68

4580

38270

Diseases of arteries, arterioles and capillaries (FINNGEN)

4783

27810

1.30

40.63

4.1

4.4

2.43

3.08

ug/l

1.30

4260

25477

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

11344

90623

1.18

40.56

5.0

2.64

3.61

ug/l

6.88

10035

81130

Other diseases of anus and rectum

4785

40014

1.28

40.45

6.6

5.0

3.83

3.62

ug/l

0.16

4245

35587

STROKE

9460

56605

1.19

40.35

4.6

4.7

3.08

3.09

ug/l

0.02

8560

51527

Diseases of arteries, arterioles and capillaries

13180

87951

1.17

39.64

4.8

5.1

2.80

3.55

ug/l

3.60

11567

79036

Mental and behavioural disorders due to alcohol

9347

100708

0.84

39.37

4.1

4.7

2.79

3.14

ug/l

0.72

8170

91136

Spondylosis

9614

69370

1.19

39.35

5.1

4.8

2.82

3.23

ug/l

0.54

8653

62214

Dermatitis and eczema

15115

103609

0.88

39.34

4.6

4.7

2.40

3.25

ug/l

6.26

13584

93270

3255

24809

1.35

39.16

5.9

5.7

4.19

4.68

ug/l

0.19

2790

21713

Non-small cell lung cancer

1231

16660

0.64

38.79

4.5

4.0

2.40

2.24

ug/l

0.88

1049

14708

Missing teeth due to accident, extraction or parodontitis

10002

83879

1.18

38.45

5.4

5.0

3.00

3.15

ug/l

0.16

8735

75460

Squamous cell neoplasms and carcinomas of the skin

1541

11549

1.59

38.34

5.4

4.1

4.13

2.32

ug/l

1.83

1346

10142

Erectile dysfunction

2361

20047

1.76

37.52

8.9

5.3

4.31

3.61

ug/l

0.55

1825

17938

Early onset COPD

3385

40508

0.75

37.42

4.2

5.0

3.33

3.29

ug/l

0.01

2915

36543

Hernia of abdominal wall, postoperative

3431

28295

1.34

36.97

5.3

4.3

2.48

2.60

ug/l

0.14

3051

25639

Complications of procedures, not elsewhere classified

12852

95766

1.15

36.77

5.2

4.8

2.92

3.27

ug/l

0.62

11482

86120

Injury of muscle and tendon at shoulder and upper arm level

7762

69066

1.23

36.50

5.0

4.9

2.31

3.05

ug/l

3.84

7078

62337

Pain associated with micturition

1379

9949

1.53

36.45

6.1

4.8

2.23

3.62

ug/l

1.53

1252

8809

Chronic rhinitis, nasopharyngitis and pharyngitis

3893

32108

1.28

36.03

4.9

4.5

2.15

3.03

ug/l

2.92

3520

29018

Renal failure

9461

74926

1.20

35.98

4.6

5.3

3.72

3.78

ug/l

0.06

8380

66610

Seborrhoeic keratosis

3326

27324

1.32

35.64

5.8

5.3

3.08

3.50

ug/l

0.63

3034

24296

Other disorders of male genital organs

933

6728

1.94

35.35

4.5

3.7

2.08

2.15

ug/l

0.09

858

5998

Irritable bowel syndrome

2545

19950

1.33

35.16

5.0

4.5

2.05

3.00

ug/l

2.49

2313

17936

Other skin changes

2806

22755

1.35

34.40

5.4

5.3

2.59

3.70

ug/l

2.80

2519

20261

Insulin medication

10863

82194

1.16

33.83

4.4

4.8

2.74

3.46

ug/l

2.11

9560

74301

Tinnitus

3420

28285

1.30

33.66

5.3

4.8

2.01

3.02

ug/l

5.39

3097

25499

Haemorrhoids and perianal venous thrombosis

5166

44234

1.24

33.18

5.5

5.0

4.00

3.70

ug/l

0.13

4658

39347

Disorders of lacrimal system

4326

36161

1.24

32.72

5.4

4.9

2.52

3.20

ug/l

2.43

3896

32298

Visual disturbances and blindness

7092

62104

1.19

32.50

5.0

2.84

3.26

ug/l

0.67

6316

55588

Other functional intestinal disorders

6426

51813

1.20

32.46

5.3

5.0

4.06

3.88

ug/l

0.10

5749

45990

Impingement syndrome of shoulder

4169

35429

1.28

32.24

5.1

4.8

2.21

3.14

ug/l

3.88

3814

31940

Used for control exclusion in common control thyroid runs

19125

88962

1.12

32.00

4.5

4.7

2.28

3.41

ug/l

10.91

17086

80245

Calculus of kidney and ureter

6451

57180

1.23

31.77

5.2

5.0

3.27

3.36

ug/l

0.06

5774

51195

Zoster [herpes zoster]

6857

59155

1.19

31.60

5.3

5.2

2.59

3.53

ug/l

5.13

6146

52672

Wet age-related macular degeneration

2612

20562

1.35

31.60

6.0

5.7

4.59

4.56

ug/l

0.01

2285

17969

Small cell lung cancer, helper endpoint

181

3687

0.38

31.42

3.6

5.4

1.84

4.95

ug/l

2.05

155

3220

Inguinal hernia, bilateral

2883

24736

1.47

31.13

5.2

5.1

2.65

3.30

ug/l

2.20

2588

22172

Paroxysmal tachycardia

3321

22979

1.29

30.73

4.7

4.6

3.43

3.36

ug/l

0.04

2979

20855

Inguinal or femoral hernia, bilateral

2901

24917

1.45

30.42

5.2

5.1

2.65

3.30

ug/l

2.19

2603

22330

Persons encountering health services for other counselling and medical advice, not elsewhere classified

18671

93556

1.11

30.30

4.8

4.7

3.01

3.12

ug/l

0.18

17080

84088

Bacterial pneumonia (organism specified)

6514

66955

0.84

30.21

4.4

5.1

3.42

3.83

ug/l

0.57

5832

59620

Cough

5567

45522

1.21

30.19

5.2

5.0

2.84

3.53

ug/l

1.36

5009

40871

Vocal cord dysfunction

1872

13035

1.38

29.72

5.1

4.8

2.69

3.63

ug/l

0.93

1662

11967

Non-small cell lung cancer, squamous

506

7679

0.55

29.57

4.2

3.9

2.43

2.37

ug/l

0.12

426

6746

Other disorders of eyelid

6431

53736

1.19

29.54

5.6

5.3

4.11

3.74

ug/l

0.20

5728

47571

Low back pain

11656

75738

1.14

29.18

4.8

4.6

2.57

3.22

ug/l

2.24

10551

67996

Acute sinusitis

6436

52055

1.18

29.00

4.1

4.3

2.16

2.69

ug/l

1.61

5841

47278

Primary coxarthrosis, bilateral

4549

39242

1.24

28.95

5.5

5.3

3.19

3.53

ug/l

0.45

4087

34838

Adjustment and management of implanted device

3579

30534

1.30

28.71

5.2

5.4

3.24

3.15

ug/l

0.10

3090

26977

Other diseases of urinary system

16937

87660

1.12

28.71

6.0

4.7

4.33

3.24

ug/l

1.47

15172

78544

Disorders of vestibular function (Vertigo)

5997

51520

1.19

28.64

5.3

5.1

3.25

3.38

ug/l

0.08

5361

46030

Early onset COPD, excluding more controls

3385

39549

0.78

28.15

4.2

5.0

3.33

3.67

ug/l

0.12

2915

35804

Examination and observation for other reasons

10172

52963

1.15

28.07

4.7

4.4

2.71

3.03

ug/l

0.38

9251

47686

Visual disturbances

6478

56988

1.18

28.00

5.0

4.9

2.85

3.24

ug/l

0.54

5798

51075

Other disorders of lacrimal gland

3423

28505

1.25

27.90

5.3

4.9

2.23

3.03

ug/l

4.43

3077

25513

Dysphagia

3968

33874

1.25

27.89

5.2

2.35

3.81

ug/l

7.99

3500

30102

Exclusions for E4_PCOS_CONSORTIUM

2655

20698

0.79

27.75

4.5

4.1

1.60

2.59

ug/l

4.82

2325

18651

Injury, poisoning and certain other consequences of external causes

8202

36391

1.16

27.75

4.6

4.7

3.14

3.60

ug/l

0.38

7329

32773

Blepharochalasis

3429

28738

1.26

27.69

5.9

5.4

2.88

3.37

ug/l

0.90

3050

25515

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9276

82436

1.15

27.66

5.2

5.0

3.04

3.30

ug/l

0.29

8281

73742

Type 1 diabetes, wide definition, subgroup 2

1656

0.19

27.65

2.6

5.3

3.29

3.57

ug/l

0.07

1446

Hypotension

3022

25419

1.31

27.60

5.4

4.53

4.09

ug/l

0.18

2628

22404

Myalgia

2396

19284

1.30

27.19

5.0

4.6

2.10

3.17

ug/l

2.61

2159

17290

Chronic sinusitis

5587

48647

1.19

27.19

4.8

4.6

2.70

3.08

ug/l

0.38

5037

43896

Carcinoma in situ of skin of other and unspecified parts of face

1326

10182

1.50

27.17

5.9

5.8

2.67

4.89

ug/l

3.32

1141

8921

Cervical disc disorders

6103

53872

1.20

27.14

4.9

4.7

2.62

3.11

ug/l

0.97

5557

48390

Any event in hilmo or specialist outpatient

175

394

3.04

26.88

3.9

1.9

2.13

1.55

ug/l

0.96

157

367

Tonsillectomy and adenotomy

4131

33933

0.83

26.81

3.6

1.51

2.01

ug/l

10.60

3790

31082

Coxarthrosis, primary

10405

80190

1.15

26.68

5.5

5.2

3.80

3.57

ug/l

0.17

9323

71418

Other benign neoplasms of skin

5128

44629

1.21

26.64

5.5

5.1

3.57

3.46

ug/l

0.11

4556

39777

Sulfonylureas

5849

52388

0.83

26.45

4.8

5.6

3.30

4.36

ug/l

1.70

4999

46501

Status post-ami

5274

45107

0.81

26.35

5.0

5.6

3.75

4.09

ug/l

0.21

4608

40143

Other CVD (FINNGEN)

2180

13810

1.37

26.03

5.2

5.4

4.88

3.94

ug/l

0.30

1913

12338

External causes of morbidity and mortality

10225

46127

1.14

26.02

4.7

3.24

3.48

ug/l

0.21

9166

41657

Retinal detachments and breaks

6294

56021

1.19

25.93

5.4

5.2

3.21

3.46

ug/l

0.34

5634

50005

Disturbances of skin sensation

2990

24800

1.26

25.92

4.8

4.5

1.88

2.81

ug/l

3.70

2700

22413

Symptoms and signs involving the nervous and musculoskeletal systems

8538

76787

1.15

25.79

4.8

5.0

2.82

3.44

ug/l

0.74

7717

68651

Coxarthrosis, primary, with hip surgery

7933

66842

1.17

25.79

5.5

5.3

4.07

3.59

ug/l

0.32

7100

59376

Necrosis of pulp, including avohilmo

8291

74244

1.15

25.58

4.6

4.3

2.25

2.63

ug/l

2.08

7442

67634

Neuromuscular dysfunction of bladder

1516

11938

1.44

25.46

5.4

5.0

2.06

3.33

ug/l

3.00

1413

10658

4842

36844

1.22

25.34

5.9

5.7

3.97

4.72

ug/l

0.49

4203

32273

Other/unspecified dorsalgia

4829

41492

1.20

25.21

4.7

4.6

3.72

3.17

ug/l

0.31

4325

37168

Other diseases of lip and oral mucosa

4801

41633

1.20

25.17

5.1

4.7

3.01

3.02

ug/l

0.00

4330

37515

Obesity related asthma

4981

43531

1.20

24.83

4.7

4.8

2.53

3.02

ug/l

0.63

4478

39290

Pain, not elsewhere classified

3588

30445

1.23

24.78

5.0

4.7

2.33

2.80

ug/l

1.69

3256

27420

Functional dyspepsia

2935

24444

1.26

24.49

5.3

4.8

1.87

3.29

ug/l

6.67

2642

21928

Umbilical hernia

5584

49767

1.21

24.49

4.8

4.6

2.51

2.73

ug/l

0.30

5038

45106

Carcinoma in situ, bladder

830

6448

1.98

24.48

5.8

5.5

2.62

3.28

ug/l

1.42

746

5722

Acute alcohol intoxication, ICD10

2929

34371

0.79

24.22

4.0

4.4

2.41

2.90

ug/l

0.83

2557

31271

Diseases of external ear

5236

46073

1.20

24.20

5.4

4.9

2.65

3.35

ug/l

1.62

4528

41402

Bacterial pneumonia, not elsewhere classified

5693

56495

0.85

24.15

4.5

5.2

3.28

3.67

ug/l

0.55

5117

50537

Oedema, not elsewhere classified

4889

42182

1.20

24.03

5.5

5.1

4.53

3.15

ug/l

0.65

4314

37603

Diseases of inner ear

7683

66723

1.16

24.02

5.3

5.0

3.30

3.29

ug/l

0.00

6898

59683

Implicit viral Sepsis

4630

40452

1.21

23.91

4.9

5.2

2.64

3.48

ug/l

2.47

4139

36073

Diabetic retinopathy, strict definition

1947

20916

0.75

23.85

3.9

4.7

2.07

2.75

ug/l

2.65

1680

18573

Other CVD

3383

29041

1.26

23.81

5.3

5.4

4.50

3.96

ug/l

0.26

2954

25601

Other and unspecified disorders of vitreous body

5313

46055

1.19

23.75

5.8

5.3

2.40

3.37

ug/l

4.81

4766

41110

Acute upper respiratory infections of multiple and unspecified sites

10611

71525

1.13

23.73

4.2

4.6

2.50

3.18

ug/l

2.50

9588

64507

Carcinoma in situ of other and unspecified sites

878

6862

1.87

23.56

5.7

5.5

2.62

4.01

ug/l

1.39

789

6089

Fibroblastic disorders

4413

38708

1.23

23.37

5.4

5.1

3.08

3.94

ug/l

1.88

3914

34385

Injuries to the knee and lower leg

18719

96749

1.10

23.30

4.7

2.52

3.24

ug/l

3.87

16871

87004

Abrasion of teeth

3629

30944

1.22

23.24

5.1

4.6

2.25

2.72

ug/l

1.55

3299

27916

Melanocytic naevi

3479

29615

1.23

23.19

5.3

4.8

2.48

3.09

ug/l

1.23

3156

26609

Benign paroxysmal vertigo

3235

27392

1.24

22.96

5.4

5.1

3.57

3.25

ug/l

0.11

2884

24473

Small cell lung cancer

181

3363

0.44

22.70

3.6

3.9

1.84

2.30

ug/l

2.14

155

2950

Small cell lung cancer, including Hilmo

181

3363

0.44

22.70

3.6

3.9

1.84

2.30

ug/l

2.14

155

2950

Benign neoplasm: Rectum

3145

27055

1.28

22.67

5.5

5.2

2.75

3.39

ug/l

1.41

2844

24173

Heart failure, not strict

13515

84981

1.12

22.64

4.7

4.9

3.07

3.29

ug/l

0.51

11991

76725

Benign neoplasm: Rectum, anus and anal canal

3472

30050

1.26

22.61

5.5

5.2

2.93

3.49

ug/l

0.98

3138

26842

Open wound of head

10262

90720

1.14

22.60

4.7

3.39

3.19

ug/l

0.13

8946

81909

Temporomandibular joint disorders, including avohilmo

2834

23153

1.23

22.58

4.9

4.3

2.01

2.50

ug/l

0.94

2531

20940

Transient ischemic attack

9423

69696

1.14

22.53

5.2

5.3

3.15

3.79

ug/l

1.56

8468

62039

Complications of internal orthopaedic prosthetic devices, implants and grafts

3273

28001

1.25

22.46

5.3

2.64

3.49

ug/l

2.55

2931

24916

Macular pucker

2614

22196

1.31

22.39

6.0

5.6

3.13

3.96

ug/l

1.23

2322

19691

Erysipelas

10924

89039

1.13

22.02

4.7

4.8

3.60

2.94

ug/l

0.73

9706

80153

Other and unspecified nerve root and plexus disorders, also in other diseases

2922

24811

1.26

21.83

4.8

4.4

2.35

2.82

ug/l

0.47

2691

22526

Bacterial pneumoniae

6082

59832

0.86

21.82

4.4

5.2

3.21

3.58

ug/l

0.56

5462

53588

Enthesopathies of lower limb, excluding foot

2804

23591

1.25

21.77

4.9

4.5

2.87

2.92

ug/l

0.03

2545

21298

Substance abuse

10189

103984

0.89

21.76

4.1

4.7

2.67

3.16

ug/l

1.32

8891

94061

Disorders of conjunctiva

8364

74291

0.88

21.73

4.8

4.5

2.36

2.90

ug/l

1.99

7549

67035

Soft tissue disorders related to use, overuse and pressure

3839

33247

1.22

21.61

4.8

4.7

2.32

3.22

ug/l

3.27

3481

29887

Other specified/unspecified arthritis

3625

31228

1.22

21.35

4.7

4.8

2.68

3.38

ug/l

1.81

3238

28083

Peripheral artery operations in Hilmo

1955

23318

0.76

21.27

4.2

5.4

5.56

4.11

ug/l

0.22

1686

20702

Chronic periodontitis, complicated

9677

88073

1.14

21.26

5.1

4.8

2.74

3.00

ug/l

0.86

8525

79641

Primary open-angle glaucoma, strict

3820

33184

1.22

20.86

5.6

5.5

4.81

4.10

ug/l

0.21

3308

29326

Lower back pain or/and sciatica

16649

101369

1.10

20.84

4.8

4.7

2.45

3.26

ug/l

4.80

15101

91129

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

4760

42172

1.20

20.82

4.4

4.6

1.62

2.66

ug/l

12.23

4253

38510

Glucagon-like peptide-1 (GLP-1) analogues

4760

42172

1.20

20.82

4.4

4.6

1.62

2.66

ug/l

12.23

4253

38510

Other extrapyramidal and movement disorders in other diseases

3171

27176

1.24

20.77

5.3

5.1

2.39

3.44

ug/l

3.14

2814

24298

Special screening examination for neoplasms

1158

9149

1.48

20.49

6.1

4.7

3.55

3.21

ug/l

0.50

990

8175

10888

106163

0.89

20.47

4.1

4.7

2.82

3.21

ug/l

0.79

9522

95935

Voice disturbances

2923

24782

1.23

20.44

5.6

5.1

3.57

3.35

ug/l

0.07

2649

22117

Nonorganic sleeping disorders, excluding more controls

2102

17251

1.28

20.38

4.5

4.4

1.89

2.94

ug/l

2.49

1910

15751

Subjective visual disturbances

2826

23910

1.24

20.28

5.1

4.9

2.08

3.10

ug/l

3.69

2542

21479

Gout, idiopatic and unspecified

5944

54242

1.21

20.20

4.9

5.3

3.33

3.55

ug/l

0.27

5249

48359

Certain infectious and parasitic diseases

15622

72719

1.10

20.02

4.6

4.7

3.35

3.03

ug/l

0.48

14055

65542

Dermatitis

8773

79737

1.13

19.93

4.7

4.9

2.51

3.28

ug/l

3.30

7864

71554

Atherosclerosis, excluding cerebral and coronary sclerosis

7491

64783

0.87

19.86

4.7

5.5

4.00

4.05

ug/l

0.02

6477

57579

Nonorganic sleeping disorders

2102

17300

1.27

19.85

4.5

4.3

1.89

2.90

ug/l

2.31

1910

15650

Other degenerative diseases of the nervous system

4464

29312

1.19

19.81

4.7

5.4

3.56

3.91

ug/l

0.36

3839

26115

Other and unspecified dermatitis

6832

61533

1.15

19.78

4.7

4.9

2.48

3.24

ug/l

3.43

6142

55215

Malignant melanoma, including Hilmo

2860

24587

1.26

19.78

5.8

3.9

3.27

2.09

ug/l

2.66

2525

21951

Open wound of wrist and hand

8379

74952

1.14

19.67

4.6

4.5

2.96

2.82

ug/l

0.08

7524

68064

Calculus of lower urinary tract

1266

10441

1.54

19.60

6.2

5.3

4.02

3.83

ug/l

0.10

1125

9279

Alcohol use disorder, Swedish definition

10557

104280

0.89

19.58

4.1

4.7

2.82

3.17

ug/l

0.66

9245

94259

Cardiac arrest

1043

11228

0.69

19.56

4.3

5.3

2.52

4.02

ug/l

2.22

906

10027

Degenerative macular diseases

1709

13992

1.33

19.44

5.5

5.4

5.08

4.19

ug/l

0.19

1513

12384

Palmar fascial fibromatosis [Dupuytren]

3572

31658

1.26

19.41

5.6

5.3

3.33

4.13

ug/l

1.31

3133

28047

Benign neoplasm: Colon, unspecified

4520

40302

1.20

19.23

5.6

5.3

2.93

3.68

ug/l

1.25

4008

35960

Disorders of sclera, cornea, iris and ciliary body

7788

70801

1.14

19.22

4.6

2.69

2.97

ug/l

0.38

7029

63904

Fissure and fistula of anal and rectal regions

3782

33079

1.21

19.22

5.2

4.6

2.22

3.09

ug/l

3.89

3390

29774

Pain in thoracic spine

1611

12944

1.31

19.17

4.6

4.3

2.00

3.03

ug/l

1.62

1491

11672

Symptoms and signs involving speech and voice

4043

35371

1.19

19.15

5.4

5.2

3.39

3.46

ug/l

0.03

3616

31524

Dilated cardiomyopathy

2002

23354

0.76

19.08

4.1

5.1

2.74

3.32

ug/l

0.89

1761

20940

Glaucoma suspect

4785

42449

1.18

18.92

5.4

5.2

2.65

3.64

ug/l

3.91

4231

37858

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8448

77172

1.13

18.59

5.2

5.1

3.05

3.39

ug/l

0.36

7553

68958

Other disorders of veins

4337

37870

1.18

18.57

5.1

4.9

3.05

3.14

ug/l

0.07

3852

33994

Primary open-angle glaucoma

4717

40612

1.18

18.16

5.7

5.5

4.73

4.16

ug/l

0.21

4094

35846

Carcinoma in situ of skin

1257

10087

1.40

18.12

5.7

5.5

2.96

3.84

ug/l

0.72

1104

8919

Other enthesopathies

3626

31572

1.19

18.06

4.6

4.5

1.99

3.05

ug/l

5.70

3307

28477

Chronic gastritis

3991

35160

1.19

18.04

5.5

5.3

2.84

3.93

ug/l

3.06

3523

31129

Injuries to the abdomen, lower back, lumbar spine and pelvis

5693

50595

1.15

17.90

4.8

3.01

3.31

ug/l

0.41

5051

45341

Familial hypercholesterolemia

2915

25432

1.25

17.89

5.1

5.4

3.28

3.90

ug/l

0.45

2618

22603

Appendicitis, broad definition

11471

96194

1.11

17.79

4.5

4.6

2.36

2.96

ug/l

3.69

10404

86870

Mixed conductive and sensorineural hearing loss

1760

14590

1.31

17.76

5.3

5.2

2.72

3.55

ug/l

1.38

1536

12953

Gout, strict definition

4346

39422

1.23

17.64

4.9

5.4

3.31

3.67

ug/l

0.40

3834

35154

Cervicalgia

2452

20764

1.24

17.58

5.1

4.7

2.48

3.20

ug/l

1.12

2226

18583

Diseases of appendix

11532

96430

1.11

17.57

4.5

4.6

2.36

2.97

ug/l

3.69

10462

87081

Other arthritis (FG)

4208

37184

1.18

17.39

4.7

4.8

2.60

3.25

ug/l

2.08

3764

33458

Intracranial injury

9313

81126

1.12

17.38

4.8

3.41

3.35

ug/l

0.06

8233

72941

Gout, unspecified

4827

43965

1.21

17.34

4.9

5.4

3.49

3.61

ug/l

0.10

4240

39215

Migraine with aura

1317

10339

1.30

17.19

4.3

4.1

1.96

2.44

ug/l

1.90

1216

9398

Non-small cell lung cancer, adenocarcinoma, helper endpoint

683

8974

0.67

17.15

4.8

5.5

2.43

4.18

ug/l

2.84

586

7908

Deforming dorsopathies

3048

26270

1.20

17.07

4.8

4.6

1.88

2.97

ug/l

5.11

2755

23603

Acute appendicitis

10760

93182

1.11

17.06

4.4

4.5

2.35

2.92

ug/l

3.20

9771

84252

Autoimmune diseases

19324

92625

1.08

17.03

4.5

4.7

2.48

3.38

ug/l

4.47

17212

83542

Hernia of abdominal wall

8503

78521

1.13

17.01

5.0

4.8

2.66

3.10

ug/l

0.96

7602

70826

Erosion of teeth , including avohilmo

2670

22799

1.22

16.97

4.8

4.3

1.83

2.52

ug/l

3.43

2408

20686

Other chronic obstructive pulmonary disease

7832

69893

0.88

16.83

4.7

5.4

3.23

3.86

ug/l

0.65

6725

62309

Localized swelling, mass and lump of skin and subcutaneous tissue

4375

38891

1.17

16.78

5.2

4.9

2.67

3.37

ug/l

1.28

3945

34891

Impacted cerumen

1540

12739

1.33

16.65

6.0

5.3

2.30

3.99

ug/l

3.33

1245

11367

Covid-19 suspected case

2161

18119

1.24

16.64

4.6

4.4

2.70

2.91

ug/l

0.15

2014

16363

Transport accidents

6864

53630

1.13

16.63

4.4

4.5

2.37

3.13

ug/l

3.09

6195

48789

Behavioural syndromes associated with physiological disturbances and physical factors

10587

81151

0.91

16.61

4.5

4.4

2.24

2.85

ug/l

2.44

9606

73486

COPD-related respiratory insufficiency

1791

21012

0.77

16.60

4.4

5.5

2.90

4.21

ug/l

1.33

1498

18610

Sciatica+with lumbago

7367

61864

1.13

16.47

4.6

2.36

2.94

ug/l

1.52

6736

55749

Combinations of oral blood glucose lowering drugs

5949

54510

1.17

16.39

4.7

5.1

2.47

3.33

ug/l

2.46

5336

49321

Glaucoma, exfoliation

1389

11286

1.33

16.34

6.0

5.7

3.87

5.14

ug/l

0.79

1214

9893

Male infertility

839

6515

1.49

16.30

3.4

2.6

1.53

1.40

ug/l

0.42

787

5964

Respiratory insufficiency

1068

13204

0.73

16.28

4.0

5.6

2.70

5.44

ug/l

3.35

871

11725

Disorders of vitreous body

6840

60250

1.13

16.22

5.6

5.2

2.57

3.32

ug/l

3.05

6127

53809

Other systemic involvement of connective tissue (FG)

2418

20238

1.22

16.17

5.2

2.29

3.77

ug/l

5.90

2134

17936

Heartburn

1369

11085

1.32

16.13

5.0

4.7

2.22

3.14

ug/l

1.46

1245

10003

Cholelithiasis

11115

82447

0.91

16.13

5.2

5.1

3.08

3.65

ug/l

1.73

9879

73628

Other specific joint derangements/joint disorders

10552

63065

1.10

16.10

4.5

2.34

3.05

ug/l

3.28

9579

56989

Benign neoplasm: Ascending colon

2266

19519

1.27

16.09

6.0

5.3

2.79

3.58

ug/l

1.11

2065

17422

Other symptoms and signs involving the circulatory and respiratory systems

946

7383

1.41

16.04

5.4

4.8

4.72

3.56

ug/l

0.20

861

6651

Degeneration of nervous system due to alcohol

315

4389

0.54

16.01

3.8

5.0

3.51

2.66

ug/l

0.28

272

3951

Benign neoplasm: Sigmoid colon

3188

28139

1.22

15.86

5.5

5.2

2.72

3.35

ug/l

1.10

2898

25174

Autoimmune diseases excluding thyroid diseases, strict definition

17675

91226

1.08

15.86

4.4

4.7

2.43

3.40

ug/l

7.36

15879

82290

Type of accident

3964

35161

1.17

15.69

4.7

4.6

2.68

2.91

ug/l

0.35

3579

31760

Other and unspecified polyneuropathies, also in other diseases

3660

32744

1.21

15.64

5.2

2.69

3.64

ug/l

1.42

3306

29243

Striking against or struck by other objects

5266

47537

1.15

15.62

4.5

4.3

2.26

2.67

ug/l

1.14

4693

43191

Degeneration of the brain due to alcohol

315

4373

0.54

15.61

3.8

5.0

3.51

2.91

ug/l

0.18

272

3931

Any reimbursement code in KELA

7392

33646

1.12

15.55

4.0

3.5

2.13

1.97

ug/l

0.48

6679

30933

Autoimmune diseases excluding thyroid diseases

17966

92495

1.08

15.52

4.4

4.7

2.43

3.38

ug/l

7.38

16130

83430

Extrapyramidal and movement disorders

5703

51784

1.15

15.46

5.1

5.3

3.23

3.65

ug/l

0.38

5060

46081

Diarrhoea and gastroenteritis of presumed infectious origin

10416

87060

1.10

15.44

4.2

4.5

2.48

3.23

ug/l

1.99

9376

78438

Other symptoms and signs involving cognitive functions and awareness

7674

64307

1.13

15.43

4.9

5.1

3.27

3.80

ug/l

0.69

6768

57280

Restless leg syndrome

1426

11638

1.30

15.38

5.4

4.9

2.20

3.22

ug/l

1.92

1286

10428

Other symptoms and signs involving the nervous and musculoskeletal systems

5359

48344

1.14

15.23

4.7

4.9

2.52

3.28

ug/l

1.81

4881

43329

Other sleep disorders

1748

14712

1.28

15.20

5.0

4.8

2.28

3.14

ug/l

3.12

1592

13262

Fall on same level involving ice and snow

7512

68901

1.12

15.11

4.7

2.57

3.05

ug/l

1.27

6737

62002

Benign lipomatous neoplasm

4124

36820

1.17

15.08

5.2

4.8

3.75

3.13

ug/l

0.32

3750

33098

Carcinoma in situ of skin of ear and external auricular canal

366

2691

2.19

15.05

5.8

2.33

4.01

ug/l

2.60

318

2336

Mental and behavioural disorders due to psychoactive substance use

10546

104495

0.91

15.00

4.1

4.7

2.69

3.16

ug/l

1.28

9202

94496

Ectropion of eyelid

742

5776

1.52

14.95

5.4

5.6

6.28

4.11

ug/l

0.62

645

5047

Panic disorder

1079

8460

1.32

14.90

3.7

1.50

2.02

ug/l

3.30

958

7748

Vasomotor and allergic rhinitis

3686

31831

1.16

14.84

4.4

4.1

1.94

2.77

ug/l

4.06

3348

28903

Diseases of liver

4676

51761

0.87

14.79

4.4

4.8

2.60

3.10

ug/l

0.67

4131

46655

Myocardial infarction, with ST-elevation

3226

35980

0.83

14.75

4.8

5.3

3.19

3.74

ug/l

0.68

2816

31984

Other and unspecified anaemias

7318

64273

1.13

14.75

5.4

5.3

6.11

3.81

ug/l

2.59

6392

56990

Carcinoma in situ of skin of trunk

588

4497

1.63

14.52

5.9

5.7

2.46

3.90

ug/l

2.73

515

3941

Aplastic and other anaemias

7885

67969

1.12

14.48

5.3

6.06

3.74

ug/l

2.96

6899

60307

Insulin, fast-acting (human)

1275

15600

0.78

14.33

3.4

4.2

1.79

3.01

ug/l

2.47

1143

14112

Other anaemias

7363

64602

1.13

14.29

5.4

5.3

6.09

3.81

ug/l

2.59

6431

57291

Cervicobrachial syndrome

2414

20745

1.21

14.27

4.6

4.5

2.37

3.00

ug/l

0.97

2243

18683

Ill-defined and unknown causes of mortality

1171

14110

0.75

14.27

4.3

5.3

4.26

4.37

ug/l

0.04

977

12541

Polymyalgia rheumatica

1771

14976

1.27

14.24

5.5

2.44

4.12

ug/l

4.09

1559

13260

Alcohol withdrawal state with delirium

1180

13955

0.73

14.20

4.1

4.5

2.42

2.78

ug/l

0.37

1017

12666

Hallux rigidus

1659

13879

1.27

14.19

5.2

5.1

1.92

3.41

ug/l

6.04

1465

12422

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4305

38617

1.16

14.13

4.7

4.6

2.64

2.95

ug/l

0.55

3882

34898

Spondylolisthesis/Spondylolysis

2174

18601

1.23

14.13

4.8

4.6

1.86

3.07

ug/l

3.70

1979

16748

Viral infections characterized by skin and mucous membrane lesions

5930

54027

1.13

14.09

4.4

4.5

2.08

2.87

ug/l

6.56

5379

48968

Disorders of vitreous body and globe

7047

62227

1.12

14.02

5.6

5.2

2.66

3.32

ug/l

2.43

6313

55572

Trigger finger

1641

13716

1.26

13.88

5.2

4.7

2.08

3.40

ug/l

2.56

1503

12348

Leisure time condition

2302

19849

1.22

13.87

4.9

4.7

2.70

3.27

ug/l

0.75

2041

17861

Transplanted organ and tissue status

1575

13311

1.30

13.82

3.5

4.4

1.79

2.72

ug/l

2.59

1479

12137

Nasal polyp

3706

33351

1.19

13.79

5.0

4.8

3.38

3.45

ug/l

0.04

3352

30022

Gout, FINNGEN

6980

64881

1.15

13.78

4.9

5.3

3.49

3.82

ug/l

0.46

6169

57776

Ptosis of eyelid

1498

12534

1.29

13.78

5.7

5.3

3.47

3.57

ug/l

0.03

1362

11175

Alzheimer’s disease (Atypical or mixed), excluding more controls

1441

9570

1.31

13.71

4.7

6.0

7.25

5.42

ug/l

0.19

1193

8356

Superficial injury of head

2971

26070

1.19

13.59

4.6

4.7

4.54

3.28

ug/l

0.30

2618

23490

Other spirochaetal diseases

3796

33872

1.16

13.57

5.5

4.9

2.44

2.99

ug/l

1.69

3340

30478

Ganglion

2052

17443

1.22

13.54

4.5

4.4

2.50

3.05

ug/l

0.55

1854

15699

Other respiratory disorders and diseases

2899

32672

0.84

13.49

4.6

5.3

3.34

4.13

ug/l

1.01

2462

28934

Other diseases of the respiratory system

2899

32672

0.84

13.49

4.6

5.3

3.34

4.13

ug/l

1.01

2462

28934

Cardiomyopathy (excluding other)

2227

25253

0.81

13.46

4.2

5.2

2.69

3.58

ug/l

1.77

1948

22696

Viral warts

2360

20363

1.21

13.43

4.6

4.4

1.89

2.83

ug/l

2.76

2164

18448

Cyst of kidney

1228

10259

1.35

13.32

5.5

5.2

2.28

3.94

ug/l

2.32

1109

9151

Other spirochaetal diseases

3745

33431

1.16

13.31

5.5

4.9

2.45

2.99

ug/l

1.59

3294

30077

Entropion and trichiasis of eyelid

1375

11529

1.31

13.30

5.4

5.6

3.86

4.27

ug/l

0.18

1223

10126

Use of pramipexole

2749

24104

1.19

13.25

5.4

5.1

2.74

3.45

ug/l

0.90

2468

21492

Contact with and exposure to communicable diseases

2294

19542

1.20

13.24

4.1

3.7

2.37

1.98

ug/l

0.41

2054

17837

Polyneuropathies and other disorders of the peripheral nervous system

4097

37188

1.18

13.19

5.1

5.2

2.77

3.56

ug/l

1.17

3698

33229

Other arthrosis

9242

59624

1.11

13.19

5.0

4.7

2.52

3.24

ug/l

1.75

8364

53767

Diseases of salivary glands

3524

31278

1.16

13.18

4.8

4.7

2.55

2.98

ug/l

0.84

3166

28193

Spirochaetal infections, other/unspecified

3736

33370

1.16

13.16

5.5

4.9

2.45

2.99

ug/l

1.57

3285

30031

Candidiasis

2555

22138

1.19

13.11

5.1

4.9

2.35

3.21

ug/l

2.18

2273

19827

Keratitis

4801

43478

1.14

13.08

4.5

4.6

2.69

2.84

ug/l

0.12

4336

39258

Lyme disease

3708

33123

1.16

13.05

5.5

4.9

2.46

2.99

ug/l

1.50

3260

29801

Calcific aortic valvular stenosis, operated

5747

51359

1.14

12.96

5.2

5.6

2.77

4.38

ug/l

8.30

5040

45302

Calcific aortic valvular stenosis

5747

51359

1.14

12.96

5.2

5.6

2.77

4.38

ug/l

8.30

5040

45302

Calcific aortic valvular stenosis, diagnosis (helper)

5744

51335

1.14

12.93

5.2

5.6

2.77

4.38

ug/l

8.29

5037

45279

Operations 2 for CAVS

5744

51335

1.14

12.93

5.2

5.6

2.77

4.38

ug/l

8.29

5037

45279

Malignant melanoma

2281

19924

1.23

12.93

5.8

3.9

3.47

2.04

ug/l

2.54

2005

17827

Malignant melanoma of skin, including Hilmo

2354

20621

1.22

12.90

5.8

3.9

3.38

2.05

ug/l

2.54

2095

18442

Traumatic subdural haemorrhage

2660

22629

1.22

12.86

5.2

5.4

4.81

4.08

ug/l

0.32

2336

20176

Obesity due to excess calories

5726

52247

1.12

12.86

4.4

4.6

2.22

2.83

ug/l

1.18

5050

47364

Other inflammation of eyelid

1478

12333

1.26

12.83

5.4

5.0

4.60

2.93

ug/l

0.34

1320

11038

Other shoulder lesions

1087

8796

1.31

12.82

4.5

4.3

1.59

2.73

ug/l

7.00

980

7911

Viral Sepsis

3189

28427

1.18

12.62

4.7

5.2

2.64

3.55

ug/l

1.79

2845

25369

Implicit viral Sepsis

3184

28381

1.18

12.61

4.7

5.2

2.64

3.55

ug/l

1.79

2840

25327

Calcific aortic valvular stenosis, including rheumatic fever

5759

51481

1.14

12.60

5.2

5.6

2.78

4.37

ug/l

8.27

5051

45416

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

4661

42388

1.15

12.54

4.5

4.4

2.57

2.81

ug/l

0.34

4217

38475

Other disorders of patella

1860

15824

1.22

12.54

4.4

4.0

2.64

2.61

ug/l

0.02

1700

14498

Benign neoplasm of other and unspecified endocrine glands

1705

14524

1.25

12.51

5.4

4.9

2.08

3.06

ug/l

3.03

1555

13050

Major coronary heart disease event excluding revascularizations

11726

73671

1.09

12.44

4.6

4.9

2.82

3.43

ug/l

2.19

10421

66433

Peripheral artery disease

8047

68482

0.90

12.42

4.7

5.5

3.88

3.95

ug/l

0.03

6994

60996

L04AD Calcineurin inhibitors

1507

12745

1.27

12.41

3.3

4.3

1.78

2.06

ug/l

1.95

1423

11583

Type 1 diabetes

2993

33696

0.85

12.40

3.6

4.5

1.87

3.24

ug/l

6.75

2670

30591

Benign neoplasm: Skin of other and unspecified parts of face

1357

11337

1.28

12.32

5.7

5.2

4.35

3.86

ug/l

0.20

1197

10065

Hydronephrosis

1828

15763

1.25

12.30

7.1

5.3

11.71

3.41

ug/l

3.74

1649

14000

Hyperkinetic disorders, excluding more controls

523

3609

1.42

12.29

2.5

2.3

0.97

1.25

ug/l

4.51

462

3370

Sequelae with surgical and medical care as external cause

2813

24892

1.19

12.29

5.1

2.21

3.42

ug/l

5.17

2519

22265

Benign neoplasm: Transverse colon

1827

15877

1.26

12.23

5.6

5.3

2.77

3.60

ug/l

0.86

1666

14206

Lichen ruber planus, wide definition including periferal and oral lichen planus

2288

19853

1.20

12.23

5.0

4.8

2.02

3.08

ug/l

2.72

2054

17850

Symptoms and signs concerning food and fluid intake

1458

12252

1.27

12.23

4.8

5.2

2.44

2.95

ug/l

0.75

1294

10900

Kidney transplant status

834

6721

1.41

12.22

3.3

4.4

1.78

2.16

ug/l

2.71

800

6097

Amputation

1519

17622

0.79

12.21

4.0

5.4

6.53

4.12

ug/l

0.29

1318

15656

Unspecific neurodegenerative disorder

7197

45630

1.12

12.21

5.0

5.9

5.04

4.52

ug/l

0.23

6116

40063

Benign neoplasm: Caecum

1643

14106

1.27

12.21

6.0

5.4

4.38

3.72

ug/l

0.13

1497

12574

Nontraumatic intracranial haemmorrhage

2674

30148

0.84

12.19

4.8

5.3

7.34

3.93

ug/l

0.64

2383

26726

Fracture of lumbar spine and pelvis

2909

25711

1.18

12.18

5.0

5.1

3.42

3.74

ug/l

0.24

2567

22863

Sleep disorders

9975

77163

0.92

12.17

4.5

4.4

2.23

2.82

ug/l

2.10

9062

69896

Malignant neoplasm of pancreas

722

9079

0.72

12.13

4.1

3.9

2.65

2.13

ug/l

1.37

603

8070

Persons with potential health hazards related to communicable diseases

3378

29684

1.15

12.09

4.3

4.0

3.30

2.45

ug/l

0.41

3042

27039

Asthma, unspecified (mode), excluding more controls

7630

52834

1.11

12.04

4.9

4.8

2.65

3.35

ug/l

1.85

6843

48004

Acute appendicitis, no complications

7958

73570

1.10

12.04

4.4

4.3

2.21

2.69

ug/l

2.00

7270

66907

Fracture of rib(s), sternum and thoracic spine

5671

52350

1.14

12.03

5.0

4.9

3.43

3.31

ug/l

0.07

5009

47026

Other diseases of intestine

2341

20600

1.21

11.92

5.2

4.9

2.60

3.23

ug/l

1.57

2127

18449

Other disorders of kidney and ureter

2104

18425

1.23

11.88

4.8

5.1

2.33

3.51

ug/l

2.99

1921

16491

Hallux valgus (acquired)

2187

18247

0.84

11.84

5.2

5.1

2.43

3.48

ug/l

3.57

1929

16259

Acute alcohol intoxication ICD-9

460

5959

0.66

11.75

4.7

4.9

2.09

2.93

ug/l

2.01

418

5335

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

795

6422

1.42

11.72

5.2

4.0

2.41

2.09

ug/l

1.03

692

5707

Pleural plaque

2469

22396

1.28

11.72

6.0

5.8

3.49

4.35

ug/l

0.87

2104

19761

Generalized anxiety disorder

1046

8408

1.28

11.70

3.9

3.7

4.59

1.92

ug/l

0.39

919

7673

Use of memantine

4295

32360

1.15

11.69

4.9

5.8

4.14

5.21

ug/l

1.18

3633

28208

Use of other anti-dementia drugs

4295

32360

1.15

11.69

4.9

5.8

4.14

5.21

ug/l

1.18

3633

28208

Caries of dentine

3679

32272

1.16

11.66

4.6

4.4

4.06

3.09

ug/l

1.46

3288

29305

Malignant neoplasm of oesophagus, including Hilmo

518

6556

0.67

11.63

4.1

3.8

2.39

1.99

ug/l

2.17

454

5877

Testicular dysfunction, other/unspecified

125

774

3.59

11.61

4.2

4.0

1.39

1.66

ug/l

1.11

119

701

Other specified/unspecified hearing loss

1172

9744

1.30

11.59

5.1

3.34

3.81

ug/l

0.24

1086

8664

Other systemic involvement of connective tissue

2475

21607

1.18

11.58

5.2

2.28

3.66

ug/l

5.24

2184

19168

Achilles tendinitis

1523

12971

1.26

11.58

5.1

4.6

3.43

2.85

ug/l

0.24

1392

11684

Retinal breaks without detachment

2355

20738

1.21

11.57

5.5

5.0

3.06

3.23

ug/l

0.10

2113

18629

Injuries to the thorax

8302

77650

1.10

11.54

4.8

3.13

3.30

ug/l

0.16

7338

69864

Alzheimer disease, excluding more controls

3084

18149

1.18

11.51

4.9

5.9

3.68

4.50

ug/l

0.82

2646

16038

Alzheimer’s disease (Atypical or mixed)

1441

12126

1.27

11.50

4.7

5.9

7.25

5.29

ug/l

0.21

1193

10544

Herpesviral [herpes simplex] infections

1958

16779

1.20

11.47

4.7

4.5

2.10

3.05

ug/l

1.99

1785

15115

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1687

14449

1.24

11.46

5.1

4.6

3.17

2.80

ug/l

0.23

1539

13061

Disorders of skin appendages

5526

50528

1.12

11.39

4.6

4.5

2.23

2.87

ug/l

2.59

4982

45667

Carcinoma in situ of prostate

192

1460

6.81

11.38

10.3

5.1

6.13

2.41

ug/l

18.75

186

1309

Oesophageal varices

499

6404

0.68

11.31

3.5

4.8

1.49

2.97

ug/l

6.45

422

5773

Retinal vascular occlusion

1924

16800

1.23

11.28

5.4

3.34

4.07

ug/l

0.57

1711

14875

Cardiodefibrillation

7612

71362

1.12

11.25

5.1

5.3

2.86

3.51

ug/l

1.89

6744

63738

Follow-up examination after treatment for malignant neoplasms

1388

11714

1.26

11.25

6.9

5.3

4.35

3.64

ug/l

0.47

1216

10294

Carcinoma in situ of skin of scalp and neck

514

4061

1.63

11.24

5.9

5.7

2.10

4.93

ug/l

1.94

432

3570

Colonic or urogenital fistula

3948

35803

1.15

11.16

5.2

4.8

2.24

3.03

ug/l

3.26

3529

32248

Migraine without aura

775

6010

1.31

11.16

3.9

3.7

1.51

2.00

ug/l

4.91

717

5477

Selective serotonin reuptake inhibitors

17469

86785

1.07

11.15

4.6

4.7

2.64

3.41

ug/l

2.16

15366

78511

Malignant neoplasm of pancreas, including Hilmo

961

11620

0.76

11.13

4.3

3.9

2.60

2.15

ug/l

1.38

814

10341

Other and unspecified vascular occlusions

1426

12168

1.27

11.13

5.5

5.4

2.97

4.39

ug/l

1.62

1272

10800

Bronchitis

16356

97858

1.07

11.13

4.4

4.8

2.86

3.34

ug/l

1.51

14646

87879

Other symptoms and signs involving the digestive system and abdomen

1147

9379

1.26

11.09

5.6

5.0

1.88

3.84

ug/l

2.77

1001

8370

Injury of muscle and tendon at lower leg level

2853

25663

1.19

11.05

4.8

4.5

2.83

2.90

ug/l

0.04

2595

23306

Cerebrovascular diseases

13329

88849

1.08

11.02

4.9

5.0

3.42

3.28

ug/l

0.18

11799

79882

Benign neoplasm: Skin of eyelid, including canthus

1793

15451

1.22

11.00

5.5

5.2

4.33

3.79

ug/l

0.25

1590

13772

Adenocarcinoma of pancreas

219

3252

0.59

10.99

3.5

3.9

2.85

2.11

ug/l

0.68

171

2890

Disorders of thyroid, IBD co-morbidities

1988

12005

1.20

10.99

5.1

4.7

2.73

3.63

ug/l

1.40

1741

10970

Progressive vascular leukoencephalopathy

513

3918

1.49

10.93

4.9

5.8

3.50

4.95

ug/l

0.56

454

3429

Other bursopathies

1892

16458

1.22

10.82

5.0

4.8

2.74

3.39

ug/l

0.46

1726

14751

Otitis externa

2830

25189

1.17

10.78

5.0

4.7

2.64

3.08

ug/l

0.44

2491

22729

Other viral diseases

3933

35212

1.13

10.75

4.0

2.00

2.57

ug/l

2.35

3619

32051

Systemic connective tissue disorders

3410

30546

1.14

10.72

5.0

5.2

2.59

3.58

ug/l

2.18

3015

27185

Recurrent or chronic depression

4081

31745

0.88

10.71

4.0

1.69

2.46

ug/l

4.34

3654

29354

Recurrent aphthous stomatitis , including avohilmo

1378

11594

1.24

10.70

5.0

4.9

2.07

3.22

ug/l

2.01

1252

10368

Asthma (diagnoses ohter than nonallergic)

11281

99192

0.93

10.66

4.7

4.8

2.57

3.37

ug/l

3.70

10117

88962

Retinal vascular disorders

1951

17117

1.22

10.64

5.4

3.34

4.11

ug/l

0.62

1734

15143

Dental caries

4123

36102

1.14

10.64

4.5

4.4

3.87

3.05

ug/l

1.32

3700

32750

Anoxic brain damage

135

2131

0.50

10.63

3.9

5.1

2.09

3.72

ug/l

1.99

115

1876

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3458

31092

1.15

10.60

4.2

2.05

2.51

ug/l

1.47

3153

28331

Conjunctivitis (acute, non atopic)

3022

26832

1.16

10.59

4.6

4.4

2.42

2.82

ug/l

0.70

2749

24286

Chronic laryngitis and laryngotracheitis

1791

15501

1.22

10.58

5.5

5.0

2.18

3.79

ug/l

3.93

1549

13869

Melanoma in situ

659

5267

1.43

10.49

6.1

5.4

4.57

3.36

ug/l

0.34

556

4678

Transient global amnesia

1097

9134

1.29

10.49

5.7

5.3

2.52

3.59

ug/l

1.48

992

8154

Lichen planus, including avohilmo

2001

17414

1.20

10.48

5.0

4.8

2.05

3.22

ug/l

2.57

1795

15646

Disorders of ocular muscles, binocular movement, accommodation and refraction

5171

46951

1.11

10.46

4.7

4.5

2.77

2.93

ug/l

0.17

4640

42403

Adenocarcinoma and ductal carcinoma of pancreas

304

4204

0.64

10.42

3.5

3.9

2.67

2.10

ug/l

0.76

248

3727

Viral infections characterized by skin and mucous membrane lesions

12422

100442

1.07

10.41

4.8

4.7

2.24

3.08

ug/l

8.87

11258

90425

Polyarthrosis

1754

13962

1.20

10.39

5.4

5.1

2.86

3.56

ug/l

0.61

1549

12405

Insomnia

9326

72514

0.92

10.38

4.4

4.3

2.20

2.78

ug/l

1.90

8490

65724

Malignant neoplasm of bladder

1479

12888

1.29

10.37

4.9

4.0

3.11

2.27

ug/l

1.33

1248

11376

COPD

8239

71536

0.91

10.37

4.7

5.3

3.24

3.83

ug/l

0.63

7077

63812

Non-small cell lung cancer, adenocarcinoma

683

8451

0.73

10.36

4.8

4.0

2.43

2.16

ug/l

1.36

586

7481

Alcoholic cardiomyopathy

1055

0.35

10.35

4.0

4.7

2.17

2.60

ug/l

0.41

949

Pleural plaque with presence of asbestos

1939

17598

1.32

10.35

6.0

5.8

3.37

4.14

ug/l

0.64

1630

15513

Cardiomyopathies, Primary/intrinsic

2178

24326

0.83

10.34

4.2

5.2

2.71

3.49

ug/l

1.55

1910

21883

Left bundle-branch block

1141

9614

1.29

10.34

5.4

5.3

2.97

3.74

ug/l

0.77

982

8631

Other mental disorders due to brain damage and dysfunction and to physical disease

1736

15114

1.23

10.34

5.1

5.4

2.93

4.19

ug/l

1.39

1505

13512

Anxiety (asthma-related co-morbidities)

5673

47735

0.90

10.33

3.8

4.0

2.58

2.39

ug/l

0.12

5041

43881

Accidental poisoning by and exposure to alcohol

104

1844

0.49

10.24

3.4

4.4

1.70

2.24

ug/l

1.30

1662

Zoster [herpes zoster]

2290

20202

1.18

10.21

5.0

5.2

2.37

3.68

ug/l

4.15

2041

17972

Dementia, including avohilmo

7944

51205

1.10

10.16

5.0

5.8

3.75

4.29

ug/l

0.62

6810

45173

Abnormal involuntary movements

1757

15253

1.22

10.16

4.9

5.0

1.98

3.44

ug/l

3.70

1582

13675

Abnormal findings on diagnostic imaging of other body structures

1483

12656

1.23

10.13

5.5

5.0

2.84

3.21

ug/l

0.44

1350

11366

Malignant neoplasm of oesophagus

355

4620

0.64

10.06

3.8

2.32

1.99

ug/l

1.28

306

4136

Panhypopituitarism

315

2305

1.69

9.99

5.6

4.8

1.62

2.53

ug/l

3.83

290

2059

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

590

7348

0.72

9.89

4.1

3.9

2.19

2.23

ug/l

0.10

483

6531

Lateral epicondylitis

1580

13591

1.22

9.83

4.4

4.2

1.78

2.77

ug/l

2.92

1470

12343

Cervicocranial syndrome

1006

8278

1.27

9.83

5.2

4.7

2.75

3.20

ug/l

0.23

926

7388

Atopic dermatitis

4829

43264

0.90

9.80

4.2

2.20

2.61

ug/l

1.28

4389

39338

Varicose veins of other sites

1096

9292

1.30

9.73

5.1

4.3

2.04

2.30

ug/l

0.75

1004

8429

Cholelithiasis, broad definition with cholecystitis

11998

85205

0.93

9.71

5.2

5.0

3.05

3.60

ug/l

1.80

10661

76180

Melanocytic naevi of trunk

1487

12782

1.23

9.69

5.5

4.9

3.01

3.15

ug/l

0.08

1352

11485

Acute upper respiratory infections

14310

92666

0.94

9.66

4.6

4.9

2.61

3.46

ug/l

4.43

12872

82968

Other ill-defined and unspecified causes of mortality

1072

12560

0.78

9.65

4.4

5.3

3.98

4.27

ug/l

0.11

889

11154

Memory loss

1240

10564

1.26

9.64

5.3

5.5

3.98

4.31

ug/l

0.11

1082

9399

Hypertensive heart and/or renal disease

5208

36052

1.13

9.62

4.9

5.3

3.24

4.33

ug/l

1.29

4518

32052

Trochanteric bursitis

831

6667

1.28

9.59

5.1

4.9

1.95

3.73

ug/l

2.00

758

5894

Abnormal weight loss

1227

10442

1.26

9.53

4.9

5.2

2.54

3.90

ug/l

1.29

1089

9316

Sudden idiopathic hearing loss

1442

12454

1.24

9.48

5.6

5.0

2.82

3.28

ug/l

0.43

1287

11147

Other and unspecified iron deficiency

4157

37958

1.13

9.43

5.0

5.3

3.74

3.79

ug/l

0.04

3616

33728

Examination and encounter for administrative purposes

881

7387

1.34

9.24

5.3

4.9

2.14

3.05

ug/l

4.10

807

6579

Other viral diseases, not elsewhere classified

2673

23697

1.15

9.23

4.1

1.96

2.76

ug/l

2.49

2452

21497

Infections of the skin and subcutaneous tissue

9208

86014

1.08

9.22

4.3

4.5

2.22

2.90

ug/l

4.64

8284

77868

Ascites

753

9177

0.76

9.17

4.2

5.0

4.91

3.84

ug/l

0.31

663

8220

Disturbance of activity and attention

481

3524

1.37

9.17

2.5

2.3

0.97

1.15

ug/l

2.84

422

3249

Barrett oesophagus

958

8176

1.35

9.15

5.6

4.9

2.51

3.40

ug/l

0.67

848

7362

Organic, including symptomatic, mental disorders

9029

60699

1.09

9.15

4.9

5.6

3.81

3.90

ug/l

0.08

7769

53860

Implicit bacterial Sepsis

8490

69199

1.09

9.15

4.7

5.2

4.16

3.52

ug/l

0.61

7500

61747

Sequelae of external causes of morbidity and mortality

3542

32263

1.14

9.14

5.0

2.41

3.27

ug/l

2.99

3167

28903

Other viral diseases

3238

29133

1.14

9.12

4.0

4.1

2.05

2.64

ug/l

1.93

2972

26537

Superficial injury of wrist and hand

2097

18449

1.17

9.10

4.4

4.2

2.00

2.64

ug/l

1.75

1894

16749

1180

9923

1.23

9.00

4.6

4.4

2.10

2.49

ug/l

0.86

1059

8955

Invasive ventilation

833

9973

0.77

8.98

3.8

5.0

3.34

3.03

ug/l

0.10

694

8938

Other predominantly sexually transmitted diseases, not elsewhere classified

1130

9407

1.23

8.97

3.5

3.3

1.69

1.70

ug/l

0.01

1011

8599

Thoracic aortic aneurysm

3363

31183

1.18

8.93

5.3

5.4

2.40

3.49

ug/l

4.31

2931

28009

Plantar fascial fibromatosis

854

6977

1.28

8.93

5.0

4.6

2.41

2.90

ug/l

0.48

792

6236

Contact with machinery

2556

23408

1.21

8.90

4.8

4.6

2.25

2.79

ug/l

1.76

2339

21216

Weight loss

1270

10881

1.24

8.90

4.9

5.2

2.55

3.87

ug/l

1.30

1127

9704

Disorders of refraction and accommodation

2527

22405

1.15

8.89

4.6

4.3

2.18

2.83

ug/l

1.30

2265

20341

Ethmoidectomy

1733

15192

1.20

8.88

5.1

4.4

2.08

2.42

ug/l

1.49

1546

13790

Chalazion

1367

11742

1.22

8.88

5.0

4.6

3.40

2.63

ug/l

0.51

1232

10583

Noise effects on inner ear

978

8508

1.39

8.88

5.0

4.7

3.04

2.52

ug/l

0.26

920

7691

Benign neoplasm of male genital organs

538

4510

1.64

8.86

6.3

5.1

2.65

2.95

ug/l

0.24

473

4027

Benign neoplasm: Pituitary gland, craniopharyngeal duct

632

5062

1.36

8.85

5.2

4.7

1.77

2.34

ug/l

3.38

574

4544

Asthma, unspecified (mode)

7896

55761

1.09

8.83

4.9

4.8

2.65

3.41

ug/l

2.26

7067

50491

Seborrhoeic dermatitis

1576

13833

1.23

8.78

4.8

4.9

2.13

3.50

ug/l

2.75

1389

12442

Hyperkinetic disorders

523

3903

1.34

8.76

2.5

2.3

0.97

1.17

ug/l

3.64

462

3598

Abdominal aortic aneurysm (AAA)

2062

22609

0.83

8.76

4.8

5.7

2.94

5.19

ug/l

5.26

1764

19789

Unspecified fall

7246

66916

1.09

8.75

4.8

3.10

3.22

ug/l

0.15

6369

60065

Injuries to the neck

2874

25911

1.15

8.72

4.7

4.5

2.15

2.93

ug/l

2.51

2589

23396

Stomatitis and related lesions

2006

17667

1.17

8.70

4.7

4.6

2.19

3.10

ug/l

1.74

1800

15922

Other superficial mycoses

1061

8912

1.25

8.62

4.3

4.2

1.84

2.27

ug/l

1.71

954

8080

Dislocation, sprain and strain of joints and ligaments at neck level

1464

12608

1.20

8.61

4.6

4.2

2.01

2.28

ug/l

0.81

1331

11446

Diseases of middle ear and mastoid

5948

52329

0.91

8.53

4.3

4.4

2.17

2.92

ug/l

4.10

5310

47299

Disorders of muscles

1349

11636

1.22

8.52

4.5

3.15

3.46

ug/l

0.14

1224

10462

11521

106293

0.93

8.45

4.1

4.7

2.79

3.21

ug/l

0.96

10092

96042

Speech therapy

3288

29920

1.13

8.43

5.2

5.0

4.61

3.27

ug/l

0.40

3102

26787

Malignant neoplasm of liver and intrahepatic bile ducts

370

4723

0.68

8.42

3.8

3.9

2.12

2.13

ug/l

0.02

296

4193

Bacterial Sepsis

8777

71015

1.09

8.41

4.8

5.2

4.79

3.48

ug/l

0.97

7736

63424

All influenza

4065

37451

1.12

8.36

4.4

4.8

3.38

3.32

ug/l

0.03

3638

33750

Superficial injury of lower leg

2504

22380

1.15

8.36

4.6

4.5

2.16

3.05

ug/l

2.44

2247

20197

Unspecified urinary incontinence

490

3752

1.35

8.33

6.4

5.0

3.45

2.96

ug/l

0.32

425

3247

Other disorders of conjunctiva

1958

17406

1.18

8.29

5.6

5.2

3.13

3.74

ug/l

0.40

1741

15549

Adhesive capsulitis of shoulder

2156

19215

1.17

8.27

4.8

2.62

3.38

ug/l

1.11

1976

17201

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

3561

32243

1.12

8.25

4.1

3.9

1.87

2.41

ug/l

1.86

3222

29430

Fracture at wrist and hand level

5200

48237

1.11

8.25

4.3

2.68

2.66

ug/l

0.01

4709

43839

Ventral hernia

3361

30700

1.13

8.25

5.2

5.0

3.14

3.33

ug/l

0.15

2966

27492

Other pulmonary diagnosis

12834

61155

1.07

8.24

4.5

4.6

2.65

3.24

ug/l

1.86

11576

55560

Diplopia

1759

15522

1.19

8.24

5.0

3.24

3.61

ug/l

0.15

1558

13927

Olecranon bursitis

1385

12298

1.27

8.22

4.5

4.7

2.39

3.53

ug/l

1.39

1260

11070

Unspecified kidney failure

1788

15924

1.21

8.22

4.5

5.4

4.29

4.17

ug/l

0.06

1602

14088

Cardiomyopathy

3024

32940

0.87

8.17

4.2

5.2

2.64

3.60

ug/l

3.04

2653

29594

Adenocarcinoma and papillary adenocarcinoma of stomach

297

3947

0.67

8.16

4.1

3.8

2.24

2.15

ug/l

0.20

264

3507

Parkinson's disease, strict definition, excluding more controls

2374

20444

1.18

8.15

5.0

5.7

4.70

4.26

ug/l

0.15

2104

18219

Asthma/COPD (KELA code 203)

13412

96331

0.94

8.11

4.6

4.7

2.54

3.26

ug/l

3.14

12007

86895

Somatoform disorder

1447

12494

1.19

8.10

4.7

4.4

2.15

2.87

ug/l

0.76

1307

11303

Periapical abscess

6888

64735

1.09

8.05

4.6

4.5

2.67

2.70

ug/l

0.05

6170

58854

Open wound of lower leg

1892

16754

1.18

8.03

4.6

2.88

3.17

ug/l

0.20

1657

15124

FESS (DNB20)

1643

14454

1.20

8.01

5.1

4.4

2.09

2.38

ug/l

1.10

1462

13133

Type 1 diabetes, wide definition

2432

27020

0.87

8.00

3.5

4.4

1.92

2.94

ug/l

3.86

2179

24599

Urticaria

2417

21564

1.14

8.00

4.7

4.4

2.08

2.86

ug/l

2.11

2189

19461

Intentional self-harm by hanging, strangulation and suffocation

980

0.40

7.99

3.1

4.4

1.63

2.42

ug/l

1.18

878

Normotensive glaucoma

952

8029

1.26

7.92

5.7

5.5

9.68

3.74

ug/l

0.55

810

7101

Superficial injury of abdomen, lower back and pelvis

1812

15995

1.18

7.92

4.8

4.6

2.10

3.33

ug/l

2.77

1611

14423

Asthma (only as main-diagnosis)

9914

60573

0.93

7.86

4.6

4.7

2.52

3.25

ug/l

2.01

8931

55024

Benign neoplasm of eye and adnexa

1221

10527

1.23

7.85

5.7

5.1

3.25

3.41

ug/l

0.07

1081

9394

Mycoses

3654

33572

1.12

7.83

4.8

4.9

2.85

3.15

ug/l

0.41

3279

30155

5011

46068

1.10

7.80

4.2

4.4

2.98

3.00

ug/l

0.02

4507

41543

Undetermined asthma

1555

13587

1.19

7.79

5.2

5.0

2.44

3.40

ug/l

1.36

1387

12272

Diseases of tongue

607

4872

1.32

7.79

5.3

4.6

2.07

2.78

ug/l

2.07

550

4356

Injury of eye and orbit

2232

20078

1.17

7.77

4.2

2.35

2.75

ug/l

0.43

2034

18310

Other disorders of the genitourinary system

694

5601

1.28

7.75

7.2

5.4

2.86

4.43

ug/l

1.06

579

4904

Suppurative and necrotic conditions of lower respiratory tract

790

9268

0.77

7.71

4.6

5.0

2.71

3.54

ug/l

0.71

695

8305

Diabetic nephropathy

2272

24674

0.86

7.71

3.9

4.9

2.35

3.13

ug/l

1.78

2057

21719

Visual impairment including blindness (binocular or monocular)

780

6469

1.28

7.66

5.3

5.1

2.64

4.06

ug/l

1.20

668

5750

Use of galantamine

1048

8979

1.25

7.62

5.1

5.8

2.71

4.87

ug/l

3.69

907

7823

Other enthesopathy of foot (+metatarsalgia)

788

6484

1.26

7.59

4.7

4.6

1.92

2.81

ug/l

2.73

712

5767

Lesion of ulnar nerve

2236

20195

1.17

7.52

4.6

4.5

2.04

3.14

ug/l

3.18

2033

18306

Alzheimer’s disease (Late onset), excluding more controls

2484

14723

1.16

7.48

4.9

6.1

4.57

4.94

ug/l

0.19

2141

12937

All anxiety disorders

5675

48132

0.92

7.48

3.8

3.9

2.58

2.35

ug/l

0.14

5042

44054

Urticaria and erythema

3190

29010

1.12

7.46

4.8

4.5

2.16

2.95

ug/l

3.05

2878

26138

Metatarsalgia

728

5956

1.27

7.43

4.8

4.6

1.92

2.83

ug/l

2.59

660

5291

Undetermined asthma, excluding more controls

1555

13638

1.18

7.41

5.2

5.1

2.44

3.76

ug/l

1.87

1387

12317

Abnormalities of gait and mobility

1890

16961

1.18

7.39

4.9

5.4

4.18

3.85

ug/l

0.06

1676

15019

Other and unspecified visual disturbances

1077

9207

1.23

7.38

4.9

4.8

3.09

2.80

ug/l

0.13

985

8254

Allergic rhinitis

2340

20682

1.14

7.38

4.1

3.8

1.76

2.26

ug/l

1.70

2123

18827

Abnormal findings on diagnostic imaging of lung

8732

79574

1.08

7.37

5.0

5.2

2.61

3.80

ug/l

8.29

7701

70892

Migraine with aura and triptan purchases

498

3861

1.31

7.36

3.9

3.6

1.61

1.85

ug/l

0.93

471

3476

Primary hyperparathyroidism

757

6227

1.26

7.35

5.3

5.2

3.29

3.04

ug/l

0.08

671

5502

Lichen planus

1291

11189

1.20

7.34

5.0

4.9

2.19

3.18

ug/l

1.42

1156

10019

conjunctival haemorrhage

1002

8589

1.25

7.31

5.7

5.2

2.54

3.24

ug/l

1.24

886

7670

Superficial injury of shoulder and upper arm

1417

12414

1.20

7.22

4.8

4.6

2.07

3.11

ug/l

2.09

1280

11204

Diabetic maculopathy

1477

15673

0.84

7.18

3.7

4.7

1.81

2.70

ug/l

5.77

1311

13933

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3623

32191

1.11

7.18

4.6

4.1

1.90

2.65

ug/l

3.08

3273

29117

Dermatophytosis

2144

19416

1.17

7.16

4.6

4.9

3.05

3.32

ug/l

0.20

1926

17467

Psychiatric diseases

16878

81219

1.05

7.15

4.5

4.8

2.88

3.19

ug/l

0.61

14971

73652

Colorectal cancer

3906

35462

1.12

7.15

4.9

3.9

3.11

2.11

ug/l

3.54

3397

31590

Diarrhoea and gastroenteritis of presumed infectious origin

14362

98721

0.95

7.13

4.3

4.7

2.59

3.28

ug/l

1.49

12945

88775

Melanocytic naevi, other sites/unspecified

914

7751

1.25

7.11

5.1

4.7

2.23

2.63

ug/l

0.90

834

6974

Migraine without aura and triptan purchases

482

3739

1.31

7.09

3.7

3.5

1.48

1.81

ug/l

1.83

448

3402

Phlebitis and thrombophlebitis (not including DVT)

2953

26990

1.13

7.08

5.0

4.9

4.04

2.95

ug/l

0.66

2644

24276

Other disorders of the musculoskeletal system and connective tissue

1896

16965

1.17

7.07

4.9

4.8

2.22

3.34

ug/l

2.50

1710

15242

Vestibular neuronitis

1152

9996

1.22

7.06

5.1

4.8

2.43

2.85

ug/l

0.91

1032

8983

Misadventures to patients during surgical and medical care

1792

15966

1.17

7.06

5.3

5.1

2.66

3.30

ug/l

1.13

1622

14280

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

4092

37641

1.12

7.05

10.8

3.9

23.85

2.04

ug/l

18.29

3687

33622

Alzheimer disease, including avohilmo

5819

38482

1.10

7.05

4.9

5.9

6.07

4.87

ug/l

0.47

4974

33600

Parkinson's disease, excluding more controls

2519

21683

1.15

7.02

4.9

5.6

4.55

4.17

ug/l

0.13

2231

19344

Corneal ulcer

2338

21130

1.15

7.00

4.3

4.4

3.20

2.88

ug/l

0.13

2098

19137

Alzheimer’s disease (undefined)

857

0.41

6.97

3.1

5.6

27.94

10.75

ug/l

0.35

737

COPD differential diagnosis

12740

60965

1.06

6.96

4.4

4.7

2.66

3.25

ug/l

1.83

11473

55375

Benign neoplasm: Descending colon

1134

9939

1.24

6.94

5.5

5.2

2.87

3.79

ug/l

0.59

1028

8866

Subarachnoid haemorrhage

1103

12704

0.83

6.92

4.7

5.1

7.20

3.86

ug/l

0.32

998

11308

Injury of muscle and tendon at hip and thigh level

1420

12553

1.20

6.88

4.8

4.6

2.19

2.89

ug/l

1.21

1274

11378

Stenosis and insufficiency of lacrimal passages

784

6533

1.25

6.86

5.5

5.1

3.15

3.13

ug/l

0.01

702

5793

ILD differential diagnosis

12732

60951

1.06

6.84

4.4

4.7

2.66

3.24

ug/l

1.84

11466

55363

Triptan medication for migraine, min. 3 purchases

2487

21107

0.89

6.81

3.8

3.7

1.70

1.88

ug/l

0.97

2286

19260

Other disorders of nervous system

994

8604

1.25

6.77

4.8

4.9

2.19

2.85

ug/l

1.75

897

7721

Asthma, hospital admissions , main diagnosis only

10177

94191

0.94

6.76

4.6

4.7

2.62

3.31

ug/l

2.12

9156

84566

Ménière disease

986

8442

1.23

6.73

5.5

5.1

3.80

3.59

ug/l

0.08

896

7511

Other viral diseases, not elsewhere classified

2043

18276

1.15

6.73

4.2

4.3

2.00

2.69

ug/l

1.89

1866

16564

Other/unspecified synovitis and tenosynovitis

1255

10926

1.19

6.71

4.5

4.6

2.87

3.31

ug/l

0.33

1116

9798

Malignant neoplasm of stomach

629

7496

0.77

6.71

4.3

3.8

3.55

2.13

ug/l

1.04

545

6665

Injuries to the elbow and forearm

7368

68586

0.93

6.71

4.7

4.5

2.72

2.93

ug/l

0.40

6627

61808

Allergic conjunctivitis

3808

34106

1.10

6.70

4.6

4.1

1.88

2.65

ug/l

3.48

3440

30854

Fall on and from ladder

1629

14793

1.22

6.68

5.4

4.9

2.60

3.33

ug/l

0.89

1490

13328

Conjunctivitis

6644

58986

0.93

6.64

4.6

4.3

2.12

2.75

ug/l

3.52

6024

53389

Spirochaetal infections, other/unspecified

1016

8764

1.23

6.61

5.7

5.0

2.43

2.80

ug/l

0.65

882

7875

Benign neoplasm: Prostate

196

1557

2.39

6.60

8.1

5.5

2.89

2.95

ug/l

0.03

166

1370

Excluding asthma or asthma-COPD overlap

12760

61155

1.06

6.55

4.4

4.6

2.66

3.24

ug/l

1.83

11480

55560

Retinal detachment with retinal break

2258

20634

1.16

6.53

5.3

5.0

3.13

3.42

ug/l

0.24

2026

18516

Insulin, intermediate and long-acting

10222

95074

1.07

6.50

4.4

4.9

2.67

3.27

ug/l

1.72

9013

85548

Intracerebral haemorrhage

1733

19228

0.86

6.39

4.8

5.4

7.03

4.41

ug/l

0.39

1534

16955

Need for other prophylactic measures

700

5876

1.27

6.37

5.2

4.6

2.70

2.45

ug/l

0.30

649

5294

Unstable angina pectoris

7512

56434

1.08

6.35

5.1

5.4

3.94

3.87

ug/l

0.03

6684

50377

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

858

9900

0.80

6.33

4.3

3.9

2.16

2.15

ug/l

0.02

721

8804

Nausea and vomiting

2845

25461

1.12

6.31

4.8

5.0

3.73

3.70

ug/l

0.02

2502

22635

Amputation of ankle bones

268

3433

0.68

6.31

3.4

5.3

1.71

3.16

ug/l

3.54

225

3050

Macular hole

688

5787

1.28

6.30

5.6

5.5

2.56

3.45

ug/l

1.82

610

5102

Flat foot [pes planus] (acquired)

664

5474

1.25

6.30

4.9

4.5

1.94

2.74

ug/l

2.43

597

4894

Care involving dialysis

1422

12741

1.20

6.29

3.6

4.8

2.52

2.72

ug/l

0.17

1334

11441

Bicipital tendinitis

745

6352

1.28

6.27

4.6

4.5

2.31

2.75

ug/l

0.34

688

5703

Brain glioblastoma and astrocytoma

144

2065

0.61

6.26

3.1

3.5

2.30

1.78

ug/l

0.73

123

1859

Pyothorax

624

7300

0.77

6.19

4.7

5.0

2.81

3.13

ug/l

0.24

558

6540

Nontoxic goitre/thyroid nodule

1673

14818

1.15

6.19

5.8

5.3

2.99

3.91

ug/l

0.75

1498

13067

Chronic lower respiratory diseases

18764

96482

1.05

6.13

4.5

4.7

2.73

3.26

ug/l

1.38

16809

87033

Benign neoplasm: Skin of ear and external auricular canal

561

4665

1.32

6.12

5.9

5.4

3.75

4.27

ug/l

0.16

479

4121

Spontaneous rupture of synovium and tendon

1065

9283

1.21

6.10

5.0

4.8

2.04

3.36

ug/l

2.48

944

8298

Iridocyclitis

2875

26428

1.12

6.09

4.7

4.6

2.77

3.04

ug/l

0.28

2595

23804

Otalgia

556

4524

1.27

6.07

5.2

4.6

2.04

2.61

ug/l

1.08

486

4046

Effects of foreign body entering through natural orifice

4245

39791

1.10

6.04

4.4

2.80

2.73

ug/l

0.06

3865

36143

Moderate visual impairment, binocular

322

2485

1.40

6.02

5.4

5.3

2.99

4.02

ug/l

0.68

261

2177

Cardiomyopathies, Secondary/extrinsic

1057

0.48

6.02

3.9

4.7

1.93

2.63

ug/l

0.81

951

Synovial cyst of popliteal space [Baker]

803

6834

1.23

5.97

5.1

4.9

2.44

3.19

ug/l

0.77

721

6048

Otitis externa, unspecified

1230

10802

1.18

5.97

5.1

4.6

2.03

2.69

ug/l

3.06

1113

9751

Other peripheral vertigo

976

8447

1.21

5.91

5.6

5.1

2.76

3.05

ug/l

0.39

870

7515

Fibromyalgia

225

1603

1.43

5.89

3.6

3.8

1.60

2.03

ug/l

0.88

202

1439

Other bacterial intestinal infections

2976

27435

1.11

5.88

4.9

3.08

3.51

ug/l

0.41

2679

24539

Other predominantly sexually transmitted diseases, not elsewhere classified

934

7964

1.19

5.87

3.7

3.4

1.77

1.75

ug/l

0.02

836

7276

Other specified disorders of external ear

760

6652

1.32

5.86

6.1

5.1

2.91

3.08

ug/l

0.11

670

5977

Malignant neoplasm of stomach, including Hilmo

758

8794

0.80

5.86

4.4

3.9

3.44

2.12

ug/l

1.22

659

7832

Amputation of thigh

320

4023

0.72

5.85

3.8

5.6

5.14

4.97

ug/l

0.02

272

3510

Infections with a predominantly sexual mode of transmission

1969

17644

1.13

5.84

3.8

3.7

1.97

1.90

ug/l

0.13

1753

16070

Exposure to excessive natural cold

102

1520

0.57

5.84

4.1

4.8

2.25

2.45

ug/l

0.14

1359

Obsessive-compulsive disorder

427

3377

1.31

5.84

3.4

3.5

1.38

1.81

ug/l

1.70

374

3112

Benign neoplasm: Choroid

721

6124

1.26

5.84

5.8

5.2

2.51

2.93

ug/l

0.62

632

5469

Brain glioblastoma

121

1750

0.59

5.84

3.1

3.6

2.14

1.86

ug/l

0.41

102

1570

Pulmonary oedema

159

2214

0.64

5.84

3.7

5.4

2.49

3.57

ug/l

1.31

135

1950

Malignant melanoma of skin

1671

15088

1.17

5.82

5.8

3.9

3.77

2.01

ug/l

2.30

1485

13497

Post-traumatic stress disorder

365

2818

1.32

5.81

3.6

1.51

1.78

ug/l

0.99

320

2585

Carcinoma in situ of skin of upper limb, including shoulder

387

3147

1.41

5.81

5.6

5.7

2.91

3.43

ug/l

0.47

336

2766

Hypertensive Renal Disease

653

5571

1.30

5.80

4.5

5.5

2.64

5.16

ug/l

1.88

600

4911

Vasomotor rhinitis (mode)

746

6327

1.24

5.79

5.5

4.8

2.24

2.88

ug/l

1.40

675

5662

Superficial injury of hip and thigh

1845

16642

1.15

5.78

5.0

5.1

3.04

3.87

ug/l

0.83

1653

14844

Malignant neoplasm of testis

312

2494

1.49

5.75

4.2

3.2

1.79

1.62

ug/l

0.38

277

2267

Artificial joint re-operation

787

6740

1.24

5.72

5.2

2.06

3.15

ug/l

3.79

711

6006

Benign neoplasm of other and ill-defined parts of digestive system

2133

19420

1.14

5.68

5.5

5.2

2.66

3.52

ug/l

1.50

1921

17325

Tuberculosis

717

8369

0.81

5.68

4.5

5.3

4.34

4.64

ug/l

0.08

624

7317

Open wound of forearm

1334

11882

1.18

5.62

4.7

4.5

3.04

ug/l

0.00

1183

10715

Amputation of foot

369

4450

0.72

5.62

3.5

5.4

1.95

3.12

ug/l

3.11

320

3960

Perforation of tympanic membrane

1164

10248

1.19

5.61

5.1

4.9

2.78

3.34

ug/l

0.51

1019

9202

Respiratory tuberculosis

620

7303

0.79

5.57

4.5

5.3

4.37

4.42

ug/l

0.01

535

6405

Respiratory tuberculosis, confirmed and not-confirmed

620

7302

0.79

5.56

4.5

5.3

4.37

4.42

ug/l

0.01

535

6403

Other disorders of eye and adnexa

1194

10472

1.17

5.56

4.9

4.6

2.09

3.01

ug/l

1.22

1076

9400

Iron deficiency anaemia

5434

50478

1.08

5.55

5.0

5.3

3.90

3.96

ug/l

0.04

4756

44759

Brachial plexus disorders

746

6309

1.22

5.55

4.2

4.1

2.22

2.12

ug/l

0.07

703

5756

Dementia

7410

48597

1.08

5.55

5.0

5.9

4.65

4.33

ug/l

0.14

6342

42827

Pleural plaque without asbestos

719

6283

1.30

5.50

5.9

5.7

5.15

4.77

ug/l

0.09

617

5514

Diabetic retinopathy

5212

30694

1.09

5.49

4.8

2.60

2.87

ug/l

0.37

4549

27224

Phobic anxiety disorders

932

7997

1.19

5.48

3.6

3.4

1.86

1.75

ug/l

0.17

824

7359

Pain in joint

8631

57662

0.94

5.46

4.6

4.5

2.27

3.13

ug/l

3.73

7840

52018

Faecal incontinence

445

3560

1.28

5.45

6.8

5.2

3.49

3.21

ug/l

0.10

399

3119

Idiopathic gout

2046

18973

1.17

5.43

4.9

5.3

2.82

3.57

ug/l

1.14

1826

16954

Vascular dementia (mixed)

276

2156

1.46

5.42

4.7

6.0

10.87

6.67

ug/l

0.20

227

1894

Unattended death

1380

0.56

5.42

3.6

5.0

5.39

2.58

ug/l

0.51

1225

Radiculopathy

2193

20053

1.13

5.41

5.0

3.22

3.67

ug/l

0.24

1941

17808

Anogenital herpesviral [herpes simplex] infection

585

4827

1.24

5.38

4.2

3.8

1.67

1.87

ug/l

0.70

529

4393

Melanocytic naevi of other and unspecified parts of face

493

4035

1.28

5.35

5.4

4.8

2.28

2.62

ug/l

0.48

437

3601

Other and unspecified injuries of head

826

7130

1.22

5.34

4.6

4.7

3.26

2.85

ug/l

0.16

731

6406

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1100

9709

1.19

5.33

4.9

4.7

2.92

2.66

ug/l

0.11

975

8744

Vascular dementia

1298

11153

1.17

5.33

4.7

5.8

5.34

6.35

ug/l

0.21

1094

9718

Secondary hypertension

1218

10707

1.18

5.32

3.9

4.8

2.26

3.37

ug/l

1.95

1106

9621

Carcinoma in situ of skin of lower limb, including hip

253

1945

1.46

5.32

5.9

5.8

3.31

3.57

ug/l

0.13

224

1692

Other/unspecified enthesopathies of lower limb, excluding foot

637

5348

1.24

5.30

4.6

4.2

2.65

2.30

ug/l

0.26

573

4818

Abnormal results of function studies

1046

9190

1.19

5.29

4.7

2.30

2.81

ug/l

1.21

926

8281

Cholecystitis

2174

19949

1.13

5.28

5.1

5.3

3.55

4.05

ug/l

0.33

1937

17651

Alzheimer’s disease (undefined), excluding more controls

749

0.46

5.27

3.1

5.8

27.94

7.21

ug/l

0.46

642

Melanoma in situ of trunk

275

2202

1.52

5.26

6.2

5.4

7.48

2.86

ug/l

0.65

235

1942

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

475

3896

1.29

5.23

4.5

4.1

1.84

2.44

ug/l

1.31

445

3505

Other gastritis (incl. Duodenitis)

3418

31918

1.10

5.21

5.0

2.92

3.63

ug/l

0.80

3087

28469

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

845

7312

1.21

5.20

5.5

4.7

2.33

2.49

ug/l

0.32

758

6572

Benzodiazepine use

14605

104076

0.96

5.20

4.8

4.7

3.25

3.20

ug/l

0.05

12734

93983

Pruritus

877

7564

1.19

5.16

5.1

5.0

2.35

3.83

ug/l

1.64

786

6706

Ocular pain

627

5259

1.23

5.16

4.9

4.5

2.08

2.43

ug/l

0.35

569

4703

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

999

8841

1.21

5.16

5.0

4.8

2.86

2.65

ug/l

0.19

908

7961

Use of rivastigmine

1978

18014

1.14

5.15

4.9

5.7

6.03

4.85

ug/l

0.17

1691

15682

DVT of lower extremities and pulmonary embolism

6465

61261

1.07

5.14

5.1

3.71

3.75

ug/l

0.03

5721

54618

Glucosamine medication

5537

46684

0.93

5.11

5.8

5.4

2.95

3.84

ug/l

2.59

4865

41334

Other and unspecified urticaria

1532

13704

1.14

5.10

4.8

4.4

2.06

2.49

ug/l

2.23

1383

12358

Other fall from one level to another

3375

31510

1.10

5.10

4.7

2.77

2.98

ug/l

0.18

3075

28443

Melanoma in situ of other and unspecified parts of face

177

1317

1.60

5.10

6.3

5.6

2.86

4.37

ug/l

0.83

147

1154

Malignant neoplasm of testis, including Hilmo

358

2950

1.42

5.10

4.3

3.3

2.35

1.67

ug/l

0.66

316

2671

Injuries to unspecified part of trunk, limb or body region

1263

11264

1.17

5.08

4.7

4.8

2.79

3.30

ug/l

0.39

1115

10080

Acute and subacute iridocyclitis

2406

22143

1.12

5.07

4.7

4.6

2.90

3.07

ug/l

0.13

2180

19984

Residual foreign body in soft tissue

753

6519

1.23

5.07

4.7

4.2

2.09

2.47

ug/l

0.73

696

5884

Glaucoma-related operations

665

5685

1.25

5.07

6.3

5.4

5.04

4.15

ug/l

0.23

588

5036

Congenital malformations of the urinary system

634

5370

1.24

5.06

4.4

4.7

2.04

2.64

ug/l

1.61

578

4811

Colitis due to radiation

206

1608

1.63

5.04

10.9

5.5

7.10

3.98

ug/l

0.54

185

1385

Early lumbar disc prolapse, operated

1018

8914

1.18

5.03

2.9

2.7

1.40

1.46

ug/l

0.33

963

8331

Myocardial infarction, without ST-elevation

8399

73572

1.07

5.00

4.8

5.3

3.38

3.88

ug/l

0.72

7388

65435

Sexual dysfunction

278

2226

1.46

4.94

4.4

4.2

2.43

2.23

ug/l

0.09

255

2016

Volume depletion

1399

12606

1.16

4.93

4.7

5.2

5.64

4.44

ug/l

0.21

1187

11185

Nontoxic multinodular goitre

1030

8983

1.17

4.92

6.0

5.3

3.41

3.94

ug/l

0.22

918

7903

Alcohol abuse, main dg

2305

24904

0.89

4.90

4.2

4.4

2.37

2.78

ug/l

0.50

2043

22668

Other noninfective gastroenteritis and colitis

2675

24685

1.11

4.89

5.2

4.8

2.67

3.28

ug/l

1.03

2377

22134

Other otitis externa (chronic)

756

6533

1.22

4.89

5.3

4.8

4.28

3.51

ug/l

0.18

636

5871

Thyrotoxicosis, other and/or unspecified

1390

12385

1.14

4.89

4.8

2.40

2.85

ug/l

0.93

1202

11102

DVT of lower extremities

2779

25827

1.11

4.88

5.1

5.0

4.29

3.28

ug/l

0.53

2491

23130

Other complications of surgical and medical care, not elsewhere classified

980

8593

1.18

4.86

5.0

4.8

7.40

2.82

ug/l

0.56

877

7716

Malignant neoplasm of colon, including Hilmo

2930

27300

1.11

4.85

5.1

4.0

3.25

2.13

ug/l

2.90

2571

24311

Pollen allergy

1020

8779

1.16

4.84

3.7

3.4

1.66

1.77

ug/l

0.20

899

8022

Cardiac murmurs and other cardiac sounds

658

5498

1.21

4.83

5.1

4.8

2.56

3.78

ug/l

0.87

592

4911

Cutaneous abscess, furuncle and carbuncle

3683

34533

1.09

4.83

4.3

4.5

2.19

2.85

ug/l

2.68

3331

31284

Vascular dementia (subcortical)

439

3647

1.31

4.82

4.6

5.9

2.42

6.04

ug/l

2.28

397

3185

Disorders of eyelid, lacrimal system and orbit

12542

91847

1.05

4.81

5.4

4.9

3.69

3.36

ug/l

0.30

11234

82216

Right bundle-branch block

632

5466

1.27

4.81

5.5

5.4

5.08

3.96

ug/l

0.21

539

4896

Headache

7682

64282

0.94

4.80

4.7

4.5

2.29

2.67

ug/l

1.20

6937

58044

Collagenous colitis

840

7292

1.20

4.79

5.1

4.9

2.13

3.43

ug/l

1.41

749

6517

Pneumonitis due to solids and liquids

1193

13240

0.85

4.77

4.3

5.2

3.43

4.45

ug/l

0.93

992

11757

Asthma, excluding more controls

11355

56933

1.05

4.77

4.5

4.6

2.46

3.21

ug/l

2.28

10279

51862

Thyrotoxicosis

1670

15050

1.13

4.77

5.0

4.8

2.47

3.37

ug/l

1.39

1447

13456

Foreign body on external eye

2972

27892

1.12

4.77

4.1

4.2

2.51

2.38

ug/l

0.14

2739

25509

Small fibre neuropathy

456

3847

1.33

4.76

5.1

5.0

1.95

2.76

ug/l

1.52

404

3440

Adult respiratory distress syndrome

134

1823

0.63

4.74

4.0

5.2

1.60

2.84

ug/l

4.22

115

1614

Hepatocellular carcinoma

316

3805

0.72

4.74

4.1

4.0

2.15

2.12

ug/l

0.04

257

3370

Disorders of parathyroid gland

1566

13916

1.13

4.74

4.9

5.1

2.78

3.97

ug/l

1.02

1379

12352

Congenital malformations of the urinary system

584

4943

1.24

4.72

4.3

4.6

2.07

2.66

ug/l

1.42

538

4425

Viral warts

992

8727

1.18

4.70

4.4

4.5

1.83

2.47

ug/l

3.02

915

7876

Personal history of other diseases and conditions

454

3680

1.25

4.70

5.0

4.2

2.61

2.12

ug/l

0.26

401

3307

Social phobias

596

5010

1.22

4.68

3.6

3.3

1.79

1.72

ug/l

0.07

520

4622

Exposure to other and unspecified inanimate mechanical forces

955

8433

1.19

4.68

4.2

4.3

2.28

2.32

ug/l

0.05

860

7645

Alcohol abuse, main dg, excluding more controls

2305

24855

0.89

4.67

4.2

4.5

2.37

2.76

ug/l

0.46

2043

22782

Carbimazole or st.post thyroidectomy, condition for graves disease

1327

11824

1.14

4.65

4.9

4.7

2.08

2.63

ug/l

2.50

1169

10613

Bipolar affective disorders

1836

16697

1.12

4.65

3.9

4.0

2.00

2.27

ug/l

0.62

1638

15265

Atypical facial pain

362

2906

1.30

4.63

5.0

4.7

1.88

2.81

ug/l

1.34

326

2609

Postprocedural musculoskeletal disorders, not elsewhere classified

860

7551

1.20

4.63

5.2

5.0

2.35

2.89

ug/l

1.00

779

6730

Hyperparathyroidism

1416

12548

1.14

4.61

4.8

5.1

2.77

4.10

ug/l

1.04

1248

11120

Spondylopathies (FG)

1627

14760

1.14

4.61

4.4

4.3

3.23

2.78

ug/l

0.29

1467

13379

Paralytic ileus and intestinal obstruction

3951

37194

1.09

4.60

4.9

5.0

3.11

3.66

ug/l

0.86

3453

33046

Other hammer toe(s) (acquired)

1278

10501

1.15

4.57

5.0

5.1

2.31

3.80

ug/l

2.46

1103

9321

Postprocedural endocrine and metabolic disorders, not elsewhere classified

672

5711

1.20

4.56

4.8

4.5

2.00

2.59

ug/l

1.69

604

5107

Other reaction to severe stress, and adjustment disorders

2996

27795

1.09

4.56

4.0

3.8

2.62

2.29

ug/l

0.24

2683

25426

Struck by thrown, projected or falling objec

768

6730

1.22

4.54

4.4

4.3

2.05

2.30

ug/l

0.51

718

6124

Other and unspecified disorders of skin and subcutaneous tissue

681

5865

1.22

4.54

5.7

5.0

2.27

2.90

ug/l

1.26

594

5231

Benign neoplasm: Adrenal gland

978

8682

1.19

4.53

5.5

5.0

2.28

2.77

ug/l

1.64

900

7784

Strabismus

2746

25401

1.10

4.52

4.7

4.6

3.01

3.06

ug/l

0.03

2460

22910

Oxycodone

6713

58062

1.07

4.51

6.6

4.9

11.03

2.94

ug/l

14.55

5892

52015

Prepatellar bursitis

906

8120

1.23

4.50

4.8

4.4

2.46

2.67

ug/l

0.23

821

7321

Malignant neoplasm of urinary organs

1682

15463

1.15

4.50

5.0

3.9

3.34

2.06

ug/l

2.27

1490

13847

Ankylosing spondylitis

1233

11087

1.16

4.48

4.5

4.3

3.70

2.49

ug/l

0.86

1106

10026

L01XE Protein kinase inhibitors

561

6523

0.81

4.46

3.8

5.3

2.54

3.01

ug/l

0.90

491

5815

Hepatocellular carcinoma, including Hilmo

441

5136

0.77

4.46

4.4

3.9

2.04

2.11

ug/l

0.13

370

4580

Anterior Iridocyclitis

2510

23272

1.11

4.46

4.7

4.6

2.86

3.07

ug/l

0.18

2271

21016

Clear cell adenocarcinoma of kidney

788

6994

1.24

4.46

5.1

3.8

2.57

1.95

ug/l

4.20

697

6310

Disorder of lipoprotein metabolism, unspecified

2346

21847

1.12

4.43

5.0

5.3

2.47

3.84

ug/l

3.79

2054

19459

Injury of unspecified body region

904

7971

1.19

4.42

4.8

4.9

2.49

3.31

ug/l

0.64

796

7132

Postprocedural disorders of nervous system

410

3342

1.26

4.40

4.3

3.8

1.86

2.19

ug/l

0.32

375

3051

Type 1 diabetes, strict (exclude DM2)

630

7354

0.83

4.40

3.0

3.3

1.64

1.86

ug/l

0.35

560

6756

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1770

16324

1.14

4.39

5.3

3.9

3.30

2.04

ug/l

2.52

1579

14627

Benign neoplasm of mouth and pharynx

1376

12456

1.15

4.38

4.9

2.41

3.49

ug/l

1.27

1215

11185

Schizophrenia

1793

19569

0.89

4.38

3.0

3.9

1.90

2.13

ug/l

0.35

1602

17895

Myocardial infarction

9835

66776

1.06

4.37

4.7

5.0

2.92

3.46

ug/l

1.75

8704

60244

Hypothyroidism, drug reimbursement

1276

8027

1.14

4.37

4.8

3.1

1.98

1.94

ug/l

0.19

1137

7467

Injury of muscle and tendon at wrist and hand level

2238

20782

1.12

4.37

4.6

4.4

1.87

2.62

ug/l

3.45

2050

18925

Familial hypercholesterolemia, with ischemic heart disease

1820

16876

1.15

4.36

5.1

5.6

2.48

4.24

ug/l

4.43

1623

14970

Retinoschisis and retinal cysts

355

2946

1.35

4.35

5.5

5.2

3.40

2.80

ug/l

0.30

311

2620

Herpesviral [herpes simplex] infections

1099

9774

1.16

4.35

4.6

4.8

2.37

3.26

ug/l

1.10

992

8769

Aneurysms, operations, SAH

1790

19521

0.89

4.33

4.6

5.0

5.22

3.45

ug/l

0.26

1622

17466

Neuralgia and neuritis, unspecified

522

4410

1.24

4.33

5.1

4.5

2.76

3.09

ug/l

0.20

481

3931

Other metabolic disorders

798

6910

1.18

4.33

4.7

4.5

1.93

2.74

ug/l

2.54

720

6200

Hepatic failure, not elsewhere classified

401

4775

0.78

4.33

4.0

4.9

2.52

2.85

ug/l

0.28

358

4270

Intestinal adhesions without obstruction

1116

10001

1.17

4.33

5.0

2.66

3.72

ug/l

1.49

964

8933

Superficial injury of forearm

969

8558

1.17

4.32

4.5

1.93

2.95

ug/l

1.33

889

7692

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1285

11611

1.16

4.32

5.2

5.1

2.73

3.67

ug/l

1.08

1140

10386

Tuberculosis, wide

832

9422

0.84

4.31

4.6

5.2

4.13

4.39

ug/l

0.09

720

8255

Lung transplant status

130

958

1.69

4.31

3.2

4.4

1.34

1.95

ug/l

2.80

107

868

Use of antiglaucoma preparations and miotics

933

8257

1.18

4.31

5.7

5.4

4.02

4.63

ug/l

0.26

817

7258

Pediculosis, acariasis and other infestations

1666

15162

1.13

4.30

4.1

3.36

2.32

ug/l

0.55

1481

13806

Lung transplantation

130

958

1.69

4.30

3.2

4.4

1.34

1.95

ug/l

2.80

107

868

Conductive hearing loss, unspecified

912

8050

1.18

4.29

4.9

4.7

2.53

2.83

ug/l

0.24

812

7217

L04AA Selective immunosuppressants

2442

22624

1.10

4.28

3.6

4.4

1.88

2.84

ug/l

3.43

2249

20492

Type 1 diabetes, definitions combined

641

7452

0.84

4.27

3.0

3.3

1.62

1.85

ug/l

0.38

571

6844

Tuberculosis, IBD comorbidity

816

9237

0.84

4.23

4.6

5.2

4.18

4.41

ug/l

0.08

705

8088

Malignant neoplasm of colon

2218

20583

1.12

4.23

5.0

4.0

3.47

2.12

ug/l

2.56

1938

18318

Thiazolidinediones

2035

18926

1.13

4.22

4.8

5.4

2.67

3.72

ug/l

1.40

1780

17027

Cluster headache, wide

414

3436

1.27

4.22

4.1

1.68

2.27

ug/l

2.75

365

3146

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

2405

22423

1.11

4.21

7.8

3.9

10.30

2.00

ug/l

3.40

2207

20118

Amputation of toe

1104

12153

0.85

4.21

4.1

5.3

7.40

3.99

ug/l

0.31

963

10826

Disorders of mineral metabolism

1059

9473

1.17

4.20

4.7

4.9

4.46

3.76

ug/l

0.36

931

8511

Malignant neoplasm of renal pelvis, including Hilmo

220

1764

1.50

4.19

4.6

4.0

2.56

2.06

ug/l

0.76

175

1550

Gluteal tendinitis

247

1915

1.34

4.19

5.6

4.9

1.69

2.66

ug/l

3.38

220

1687

Complications following myocardial infarction

1209

0.59

4.18

4.0

5.7

2.75

3.47

ug/l

0.52

1052

Colorectal adenocarcinoma

3299

31018

1.10

4.17

4.8

3.9

3.22

2.14

ug/l

3.04

2875

27656

Benign neoplasm: Stomach

1034

9223

1.16

4.16

5.7

5.2

3.04

3.16

ug/l

0.09

937

8182

Acute pharyngitis

1741

15782

1.12

4.15

3.7

3.6

1.90

1.91

ug/l

0.02

1596

14540

Intermittent heterotropia

375

3051

1.27

4.15

5.0

4.3

2.35

2.17

ug/l

0.16

332

2756

Implicit fungal Sepsis

804

7075

1.19

4.15

5.2

5.3

2.73

3.05

ug/l

0.44

719

6311

Chromosomal abnormalities, not elsewhere classified

124

860

1.51

4.14

3.1

3.5

1.04

1.89

ug/l

1.59

109

787

Sleep disorders, other/unspecified

247

1921

1.34

4.13

3.8

3.9

1.55

1.95

ug/l

1.21

220

1747

Benign neoplasm of urinary organs

568

4885

1.24

4.13

5.9

5.4

2.69

3.24

ug/l

0.78

508

4316

Diseases of the respiratory system

9682

46634

1.05

4.12

4.7

4.9

2.81

3.51

ug/l

1.82

8681

42033

Disorders of male genital organs in diseases classified elsewhere

141

1087

1.74

4.12

5.6

3.7

8.75

1.62

ug/l

0.59

129

970

Raynaud syndrome

699

6048

1.19

4.12

4.6

4.7

2.24

2.46

ug/l

0.30

624

5430

Preparatory care for dialysis

741

6585

1.23

4.11

3.8

4.9

2.61

2.70

ug/l

0.08

703

5925

Undefined dementia

1330

13528

0.88

4.10

4.1

5.5

5.36

5.65

ug/l

0.06

1126

11693

Dislocation, sprain and strain of joint and ligaments of hip

445

3754

1.27

4.09

4.9

5.2

3.65

3.10

ug/l

0.21

404

3338

Human immunodeficiency virus [HIV] disease resulting in other conditions

208

2601

0.71

4.08

3.2

3.5

2.06

1.69

ug/l

0.44

195

2405

Other and unspecified injuries of shoulder and upper arm

375

3111

1.29

4.08

4.8

4.5

2.04

2.62

ug/l

0.95

334

2802

Rheumatoid arthritis

3339

31916

0.92

4.07

4.6

5.0

2.51

3.70

ug/l

5.04

2974

28477

Malignant neoplasm of brain

319

3880

0.77

4.07

3.3

3.4

2.30

1.79

ug/l

0.99

281

3498

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

762

6649

1.18

4.05

3.7

3.6

1.97

2.19

ug/l

0.32

695

6080

Viral hepatitis, IBD co-morbidity

626

5394

1.21

4.05

3.3

3.5

1.96

2.36

ug/l

0.29

536

5010

Nonalcoholic fatty liver disease

1076

9637

1.16

4.03

4.3

4.2

1.86

2.13

ug/l

0.72

974

8731

Other diseases of oesophagus

1448

13235

1.14

4.03

5.2

5.1

2.71

4.05

ug/l

2.07

1304

11777

Rosacea

960

8503

1.16

4.02

5.0

4.9

2.03

2.82

ug/l

3.16

853

7617

Haemangioma, any site

835

7353

1.18

4.02

5.3

4.8

2.21

2.80

ug/l

1.68

761

6599

Other and unspecified glaucoma

828

7317

1.19

4.01

5.5

5.4

3.30

4.32

ug/l

0.74

703

6470

Orthopaedic devices associated with adverse incidents

228

1806

1.41

4.01

6.9

5.4

3.56

2.82

ug/l

0.27

199

1595

Dislocation of lens

212

1663

1.42

4.00

5.4

5.2

6.81

7.14

ug/l

0.02

187

1466

Open wound of ankle and foot

1491

13636

1.14

4.00

4.3

4.6

2.06

2.94

ug/l

1.99

1319

12320

Dependence on enabling machines and devices, not elsewhere classified

1185

0.61

3.98

2.4

4.8

1.71

2.43

ug/l

1.47

1044

Other crystal arthropathies

275

2238

1.37

3.98

5.6

5.2

2.43

3.51

ug/l

1.00

239

1957

Adverse effects, not elsewhere classified

1566

14236

1.12

3.97

4.7

4.6

2.24

2.59

ug/l

0.56

1401

12815

Osteonecrosis

773

6823

1.20

3.96

7.7

4.8

7.04

2.62

ug/l

3.78

706

6152

Papulosquamous disorders

5297

50474

1.07

3.96

4.6

4.8

2.15

3.08

ug/l

5.17

4733

45524

Use of entacapone

1019

0.58

3.95

4.7

5.3

5.41

3.79

ug/l

0.30

882

Coeliac disease

1104

9880

1.15

3.94

4.5

4.8

2.19

2.79

ug/l

1.29

1004

8857

Enlarged lymph nodes

2130

19737

1.11

3.92

4.6

4.8

3.32

2.74

ug/l

0.36

1931

17716

Oral lichen planus, including avohilmo , including avohilmo

438

3655

1.24

3.92

5.1

4.6

1.67

2.29

ug/l

3.41

398

3285

Special screening examination for other diseases and disorders

1456

13257

1.13

3.92

4.6

4.8

2.97

2.94

ug/l

0.02

1382

11861

Follicular cysts of skin and subcutaneous tissue

2509

23423

1.10

3.92

4.9

4.6

2.39

3.02

ug/l

1.53

2264

21183

Systemic atrophies primarily affecting the central nervous system

466

5427

0.80

3.91

4.6

5.1

9.33

3.79

ug/l

0.92

405

4826

Cluster headache, strict

379

3144

1.27

3.91

4.1

4.0

1.67

2.24

ug/l

2.33

335

2893

Pilonidal cyst

1167

10539

1.15

3.90

3.5

1.51

1.82

ug/l

2.17

1075

9675

Implicit bacterial Sepsis

7706

65779

1.06

3.89

4.7

5.3

4.37

3.60

ug/l

0.68

6793

58629

Gingival hyperplasia

436

3693

1.27

3.89

5.1

4.9

2.90

2.65

ug/l

0.18

410

3317

Explicit Sepsis

7374

66176

1.06

3.89

5.0

5.3

4.68

3.58

ug/l

0.80

6520

58989

Other congenital malformations

912

8047

1.16

3.89

4.3

4.4

2.34

2.32

ug/l

0.01

832

7263

Crystal arthropathies, rheuma endpoint

275

2245

1.37

3.88

5.6

5.2

2.43

3.37

ug/l

0.82

239

1961

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

210

2615

0.72

3.86

4.7

4.0

2.41

2.13

ug/l

0.67

177

2314

Asthma-related infections

7551

70953

1.05

3.86

4.4

4.7

2.93

3.47

ug/l

0.95

6748

63520

Asthma, hospital admission 2, infections

7551

70953

1.05

3.86

4.4

4.7

2.93

3.47

ug/l

0.95

6748

63520

Respiratory tuberculosis, not confirmed

452

5285

0.80

3.86

4.5

5.4

3.06

4.60

ug/l

1.04

388

4631

Use of donepezil

2799

25125

1.10

3.85

4.9

5.8

7.41

4.69

ug/l

0.56

2356

21897

Calcific tendinitis of shoulder

539

4609

1.22

3.84

4.8

4.5

3.85

2.66

ug/l

0.22

491

4112

Sequelae of injuries, of poisoning and of other consequences of external causes

3320

31293

1.09

3.84

4.3

1.97

2.70

ug/l

2.65

2951

28491

Other disorders of cornea

1042

9343

1.15

3.83

4.6

2.12

2.79

ug/l

1.96

942

8395

Insulin, fast-acting or short human

5485

57328

0.94

3.82

4.1

4.8

2.48

3.20

ug/l

1.82

4861

51548

Other disorders of skin and subcutaneous tissue

9934

85212

1.05

3.82

5.0

2.89

3.50

ug/l

1.91

8896

76076

Delirium, not induced by alcohol and other psychoactive substances

1847

17076

1.12

3.82

4.7

5.4

5.55

4.36

ug/l

0.51

1582

15157

Budesonide

1494

13626

1.12

3.80

5.2

4.4

2.92

2.72

ug/l

0.12

1357

12291

Disorders of calcium metabolism

736

6477

1.19

3.79

5.0

5.51

4.34

ug/l

0.45

657

5826

Tongue abnormality

554

4760

1.21

3.78

5.4

4.9

2.04

2.66

ug/l

1.58

500

4242

Other vitreous opacities

464

3956

1.25

3.77

5.6

5.2

2.74

2.90

ug/l

0.16

424

3519

Use of disulfiram, acamprosate or naltrexone

1511

13939

1.14

3.77

4.0

3.8

2.11

1.99

ug/l

0.16

1323

12804

Hypertrophy of breast in women and men

801

6996

1.16

3.76

5.5

4.6

2.34

2.85

ug/l

0.83

732

6217

Malignant neoplasm, without specification of site

315

3800

0.78

3.76

4.7

3.9

3.77

2.21

ug/l

0.96

271

3360

Malignant neoplasm of brain, including Hilmo

484

5640

0.81

3.76

3.8

3.5

2.72

1.86

ug/l

1.26

432

5072

Traumatic amputation of wrist and hand

908

8273

1.22

3.76

4.9

4.7

2.80

2.78

ug/l

0.01

842

7482

Hyperprolactinaemia

180

1353

1.38

3.76

4.7

4.2

1.41

2.28

ug/l

2.08

167

1223

Mixed disorders of conduct and emotions, excluding more controls

289

1.80

3.76

2.1

1.8

1.28

0.93

ug/l

0.22

265

Other and unspecified injuries of lower leg

635

5498

1.19

3.74

4.3

1.92

2.48

ug/l

1.39

574

4981

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1842

17022

1.12

3.74

4.9

5.1

2.88

3.63

ug/l

0.56

1631

15192

L02BG Aromatase inhibitors

111

756

1.47

3.73

3.1

2.7

1.24

1.45

ug/l

0.61

511

Suggestive for eosinophilic asthma

1329

12151

1.14

3.73

5.0

4.9

3.22

3.50

ug/l

0.10

1189

10937

Abnormal blood-pressure reading, without diagnosis

401

3348

1.25

3.72

5.1

4.6

1.93

2.50

ug/l

2.33

355

3000

Recurrent dislocation and subluxation of joint

641

5560

1.19

3.72

3.6

3.4

1.88

2.20

ug/l

0.43

584

5093

Alcohol induced polyneuropathy

153

1908

0.66

3.72

4.2

4.9

1.75

2.47

ug/l

1.68

138

1715

Acne

523

4426

1.20

3.71

3.4

3.3

1.70

1.65

ug/l

0.05

482

4055

Malignant neoplasm of larynx

228

2762

0.72

3.71

4.3

3.9

2.44

2.08

ug/l

0.75

196

2457

Anosmia

256

1991

1.33

3.70

5.8

3.5

1.81

2.17

ug/l

1.75

229

1825

Seminoma of testis, including Hilmo

191

1535

1.51

3.70

3.9

3.2

1.73

1.60

ug/l

0.35

170

1395

Congenital malformations and deformations of the musculoskeletal system

648

5567

1.18

3.69

4.1

4.0

1.93

2.00

ug/l

0.08

586

5048

Infective bursitis

529

4640

1.26

3.69

4.8

4.5

4.05

2.64

ug/l

0.31

478

4161

Other follicular disorders

790

6984

1.18

3.69

4.0

4.3

1.87

2.39

ug/l

1.26

714

6346

Crushed, pushed or stepped on by crowd or human stampede

698

6102

1.18

3.68

4.0

3.6

1.87

1.92

ug/l

0.07

647

5567

Cellulitis

3275

30922

1.09

3.68

4.4

4.7

2.24

3.05

ug/l

2.63

2927

27948

Viral and other specified intestinal infections

2445

21918

1.09

3.66

4.0

3.9

2.04

2.82

ug/l

1.21

2264

19819

Drowning and submersion while in natural water

710

0.51

3.66

5.1

2.15

2.63

ug/l

0.32

632

Reactive arthropathies

1065

9597

1.15

3.65

4.7

4.5

2.65

3.19

ug/l

0.46

967

8677

Acne vulgaris

400

3315

1.23

3.64

3.1

2.9

1.29

1.54

ug/l

1.18

369

3050

Colon adenocarcinoma

1774

16446

1.12

3.62

5.0

3.9

3.70

2.15

ug/l

2.26

1556

14626

Other/unspecified soft tissue disorders related to use, overuse and pressure

269

2169

1.31

3.60

4.8

4.3

1.69

2.46

ug/l

2.47

231

1946

Laparoscopic right hemicolectomy

786

7021

1.19

3.60

5.5

5.4

3.70

3.14

ug/l

0.22

709

6241

Speech and linguistic disorders, excluding more controls

475

3769

1.21

3.60

3.6

4.0

2.38

2.24

ug/l

0.09

418

3423

Malignant neoplasm of eye, brain and central nervous system

424

4968

0.81

3.60

3.7

3.5

2.33

1.83

ug/l

1.38

378

4478

Human immunodeficiency virus [HIV] disease

233

2837

0.74

3.60

3.5

3.6

2.01

1.76

ug/l

0.29

216

2624

Unspecified jaundice

614

6975

0.83

3.60

4.1

5.1

2.37

3.94

ug/l

1.70

521

6210

Carcinoma in situ of other and unspecified digestive organs

545

4791

1.25

3.59

5.6

5.2

3.15

3.05

ug/l

0.05

490

4268

Carcinoma in situ of skin, other sites/unspecified

209

1680

1.42

3.58

6.0

5.6

5.62

3.62

ug/l

0.29

176

1459

Other/unspecified enthesopathies, not elsewhere classified

1016

9145

1.15

3.56

4.8

4.7

2.28

3.51

ug/l

1.46

894

8170

Dental pulpitis, including avohilmo

12165

81430

0.96

3.56

4.2

4.4

2.30

2.67

ug/l

1.17

11031

74085

Nummular dermatitis

1248

11425

1.15

3.55

4.9

5.1

2.91

3.74

ug/l

0.40

1112

10236

Monoarthritis, not elsewhere classified

482

4133

1.23

3.54

4.4

4.6

2.18

2.81

ug/l

1.29

430

3697

Infections with a predominantly sexual mode of transmission

2518

21815

1.08

3.53

3.7

3.6

1.86

2.12

ug/l

0.59

2251

19884

Other specified and unspecified disorders of lens

545

1.65

3.52

7.3

5.6

8.25

2.90

ug/l

0.67

468

Infectious mononucleosis

547

4688

1.19

3.52

3.3

3.1

2.25

1.65

ug/l

0.90

504

4320

Other/unspecified disorders of vestibular function

410

3469

1.25

3.51

5.0

5.1

2.62

3.00

ug/l

0.25

374

3091

Paralytic strabismus

966

8721

1.16

3.51

5.2

5.1

4.30

3.53

ug/l

0.18

854

7794

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

923

7270

1.14

3.51

2.6

2.04

1.38

ug/l

0.33

819

6680

Benign neoplasm: Rectosigmoid junction

582

5117

1.22

3.50

5.8

5.2

2.06

2.96

ug/l

2.99

519

4558

therapeutic use

380

3216

1.27

3.50

6.2

5.3

2.84

2.92

ug/l

0.04

341

2850

Glaucoma

8561

71111

1.05

3.49

5.5

5.2

3.83

3.78

ug/l

0.03

7514

63211

Bitten or struck by other mammals

869

7715

1.15

3.49

4.3

4.2

2.23

2.28

ug/l

0.06

774

6973

Foreign body entering into or through eye or natural orifice

1211

11071

1.15

3.48

4.4

4.3

2.10

2.39

ug/l

0.74

1110

10052

Monoamine oxidase A inhibitors

1377

12594

1.13

3.48

4.9

4.8

1.88

3.06

ug/l

3.38

1220

11448

Septicaemia

7298

65791

1.06

3.47

5.0

5.2

4.71

3.33

ug/l

1.08

6452

58571

Status epilepticus

362

4280

0.80

3.46

4.1

4.8

3.79

2.96

ug/l

0.27

323

3848

Other disorders of pigmentation

412

3485

1.24

3.46

5.5

5.0

2.15

2.73

ug/l

1.06

371

3102

Lung diseases due to external agents

2163

23070

0.91

3.46

4.8

5.3

3.76

4.18

ug/l

0.32

1824

20395

Panniculitis affecting regions of neck and back

390

3287

1.25

3.46

4.9

4.5

5.12

2.55

ug/l

0.38

347

2935

Alzheimer’s disease (Early onset)

381

4514

0.81

3.45

4.0

5.4

3.57

4.96

ug/l

0.66

325

3961

Lesion of lateral popliteal nerve

731

6518

1.19

3.45

4.5

4.7

2.13

2.88

ug/l

2.00

661

5868

Malignant neoplasm of hypopharynx

779

0.52

3.45

3.4

3.8

1.96

2.02

ug/l

0.07

698

Other and unspecified effects of external causes

2628

24584

1.08

3.45

4.4

2.43

2.83

ug/l

0.52

2331

22248

Dermatographic urticaria

377

3135

1.23

3.44

4.8

4.5

1.75

2.27

ug/l

2.17

339

2814

Diabetic neuropathy

1638

17488

0.89

3.43

4.5

4.8

2.56

2.89

ug/l

0.18

1451

15466

Thyrotoxicosis with diffuse goitre

697

6084

1.16

3.42

4.9

4.6

2.19

2.65

ug/l

1.08

611

5463

Asthma (only as main-diagnosis), excluding more controls

9620

56933

0.96

3.42

4.6

2.42

3.21

ug/l

2.26

8686

51862

Other specified/unspecified bacterial intestinal infections

760

6754

1.17

3.41

5.1

4.9

2.51

3.49

ug/l

0.73

705

6032

Psoriatic arthropathies

1254

11441

1.13

3.41

4.2

4.5

1.96

3.06

ug/l

2.55

1112

10386

Diabetic retinopathy, excluding more controls

3817

20309

1.08

3.40

4.5

4.8

2.49

2.61

ug/l

0.13

3347

18059

Dislocation, sprain and strain of joints and ligaments of thorax

406

3455

1.25

3.40

4.6

1.90

2.59

ug/l

1.50

373

3125

Nontoxic single thyroid nodule

439

3710

1.21

3.40

5.7

5.1

2.48

2.88

ug/l

0.57

389

3295

Malignant neoplasm, without specification of site, including Hilmo

474

5479

0.82

3.40

4.8

3.8

3.34

2.21

ug/l

1.08

414

4843

Benign neoplasm: Kidney

390

3309

1.26

3.39

5.9

5.4

2.91

3.04

ug/l

0.10

346

2924

Pulmonary heart disease

4301

40987

1.07

3.39

5.0

5.1

3.52

3.66

ug/l

0.16

3775

36558

Presbyopia

700

6184

1.18

3.39

4.4

4.2

2.10

2.13

ug/l

0.03

640

5639

Certain disorders involving the immune mechanism

2384

22325

1.09

3.39

4.4

4.6

2.43

2.90

ug/l

0.85

2160

20188

Other and unspecified rosacea

759

6715

1.17

3.38

5.0

4.8

1.90

2.88

ug/l

3.42

678

6013

Malignant neoplasm of kidney, except renal pelvis

1515

14054

1.13

3.37

5.1

3.8

3.35

2.06

ug/l

2.08

1356

12623

Alcohol-induced chronic pancreatitis

1153

12465

0.86

3.37

4.2

4.4

3.73

2.23

ug/l

0.54

1029

11345

Hyperhidrosis

197

1530

1.34

3.36

5.3

4.3

1.97

2.26

ug/l

0.37

173

1377

Hypertensive Heart Disease

4541

34013

1.07

3.36

5.0

5.3

3.36

4.43

ug/l

1.07

3908

30192

Pulmonary embolism

4301

40999

1.07

3.35

5.0

5.1

3.52

3.65

ug/l

0.15

3775

36584

Anaemia in chronic diseases classified elsewhere

383

3293

1.29

3.35

5.0

5.2

9.78

3.09

ug/l

2.54

348

2925

Malignant neoplasm of other and unspecified parts of biliary tract

133

1732

0.69

3.35

4.3

3.9

2.03

2.04

ug/l

0.01

112

1532

Type1 diabetes, definitions combined, early onset

229

2873

0.78

3.34

2.1

2.2

1.12

ug/l

0.01

207

2655

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

4645

34941

1.06

3.33

9.9

5.0

8.09

3.36

ug/l

6.18

4271

31078

Haemangioma and lymphangioma, any site

876

7836

1.15

3.32

5.2

4.8

2.19

2.76

ug/l

1.78

796

7045

Disorders of eyelid in diseases classified elsewhere

281

2297

1.29

3.32

5.0

4.8

17.16

2.93

ug/l

0.50

257

2056

Scabies

1275

11607

1.12

3.32

4.0

3.9

2.27

2.08

ug/l

0.13

1128

10614

Adenocarcinoma and Papillary adenocarcinoma of kidney

229

1925

1.47

3.32

5.2

3.8

2.16

1.90

ug/l

1.03

216

1726

Other condition

1724

15962

1.11

3.31

4.3

2.61

2.43

ug/l

0.17

1600

14491

Additional codes for the location of defect, injury or illness

617

5416

1.19

3.31

4.9

4.8

3.77

2.71

ug/l

0.29

579

4866

Peripheral retinal degeneration

336

2814

1.27

3.31

5.0

4.7

2.04

2.68

ug/l

1.10

303

2525

Other disorders of bone

2287

21375

1.09

3.30

4.5

4.3

1.94

2.75

ug/l

2.39

2060

19473

Elevated blood glucose level

1067

9697

1.14

3.29

4.5

4.3

2.28

2.96

ug/l

0.76

931

8702

Overexertion and strenuous or repetitive movements

1254

11476

1.13

3.29

4.2

2.10

2.29

ug/l

0.36

1141

10426

Benign neoplasm of bone and articular cartilage

867

7764

1.15

3.28

4.8

4.4

1.95

2.29

ug/l

1.52

802

7024

Exposure to excessive heat of man-made origin

1034

0.61

3.28

3.9

4.8

1.79

2.58

ug/l

1.02

902

Disorders of synovium and tendon in diseases classified elsewhere

307

2579

1.30

3.28

4.7

4.5

1.91

2.82

ug/l

1.45

289

2314

Herpesviral keratitis and keratoconjunctivitis

509

4423

1.21

3.27

4.9

2.35

2.68

ug/l

0.42

457

3957

Abnormal findings on diagnostic imaging of central nervous system

476

4097

1.21

3.27

4.4

4.6

3.64

2.37

ug/l

0.48

412

3698

Seminoma of testis

162

1299

1.52

3.27

4.0

3.2

1.85

1.60

ug/l

0.69

144

1175

Sequelae of other accidents

144

1855

0.71

3.26

4.0

4.9

4.98

2.72

ug/l

0.32

120

1634

483

5580

0.83

3.26

4.1

5.2

5.67

5.24

ug/l

0.06

428

4856

Other abnormal findings in urine

229

1873

1.36

3.26

6.2

5.3

2.45

3.76

ug/l

1.12

205

1633

Dentofacial anomalies [including malocclusion]

5921

49662

0.95

3.25

4.6

4.1

1.90

2.40

ug/l

2.78

5326

45141

Vascular dementia (multiple infarctions)

116

1555

0.69

3.25

4.4

5.7

2.54

8.86

ug/l

1.50

1346

Other congenital malformations of skin

612

5342

1.18

3.25

4.6

4.5

2.11

2.39

ug/l

0.62

558

4802

Medial epicondylitis

367

3091

1.24

3.25

4.5

4.2

2.00

2.33

ug/l

0.67

334

2788

Muscle strain

347

2914

1.26

3.25

4.2

2.84

2.64

ug/l

0.08

314

2610

All influenza (not pneumonia)

2213

20728

1.10

3.24

4.2

4.5

2.61

3.05

ug/l

0.49

1998

18811

Vascular dementia (undefined)

507

4349

1.21

3.24

4.6

5.8

5.35

6.75

ug/l

0.32

415

3767

Fenamates

1331

9898

0.90

3.24

4.8

4.4

2.78

3.63

ug/l

0.59

1188

8799

Haemorrhage, not elsewhere classified

554

4871

1.21

3.22

5.1

5.4

2.48

3.19

ug/l

1.54

480

4305

Cramp and spasm

535

4668

1.20

3.22

4.7

1.90

2.52

ug/l

1.71

486

4189

Noninfective enteritis and colitis

5967

57186

1.05

3.21

4.8

4.6

2.50

3.05

ug/l

1.59

5362

51504

Lichen sclerosus et atrophicus

361

3000

1.22

3.21

4.7

4.4

2.31

2.10

ug/l

0.17

319

2673

Inguinal hernia, unilateral

314

2628

1.28

3.20

5.5

5.1

2.28

3.01

ug/l

0.89

286

2322

Inguinal of femoral hernia, unilateral

314

2628

1.28

3.20

5.5

5.1

2.28

3.01

ug/l

0.89

286

2322

Femoral hernia, unilateral

314

2628

1.28

3.20

5.5

5.1

2.28

3.01

ug/l

0.89

286

2322

Malignant neoplasm of head and neck

1220

13213

0.88

3.20

4.4

3.8

2.72

1.98

ug/l

1.13

1054

11879

Cluster headache, wide,, including avohilmo

509

4410

1.20

3.19

4.2

4.0

1.80

2.01

ug/l

0.72

452

4011

Arthropod-borne viral fevers and viral haemorrhagic fevers

2448

23008

1.09

3.19

4.8

4.7

3.45

3.06

ug/l

0.17

2283

20736

Macular cyst

372

3181

1.26

3.19

5.7

5.4

2.68

2.86

ug/l

0.19

332

2822

Toxic effect of alcohol

246

2956

0.76

3.18

3.7

4.2

2.10

2.13

ug/l

0.03

218

2688

Arterial embolism and thrombosis

760

8440

0.86

3.18

4.3

5.4

3.22

4.24

ug/l

0.40

658

7468

Inflammatory disorders of male genital organs, not elsewhere classified

290

2487

1.37

3.18

4.7

4.1

2.83

2.07

ug/l

0.62

264

2188

Polycystic kidney disease

326

2749

1.28

3.17

3.7

4.6

1.94

2.64

ug/l

1.48

304

2472

Atrophic disorders of skin

645

5631

1.16

3.17

4.9

4.4

2.24

2.42

ug/l

0.21

579

5018

Autoimmune diseases related-to ILD

11764

103548

0.96

3.16

4.5

4.7

2.43

3.15

ug/l

4.11

10543

93320

Medicines for HER+ breast cancer

201

1474

1.30

3.16

4.6

3.7

1.62

2.12

ug/l

1.01

157

1135

Abscess of lung

181

2231

0.73

3.15

4.2

4.9

2.30

2.83

ug/l

0.59

150

1992

Scleritis and episcleritis

506

4376

1.20

3.14

4.4

1.81

2.14

ug/l

1.53

472

3954

Pyogenic arthritis

1006

9161

1.15

3.14

4.5

4.8

7.93

3.60

ug/l

0.39

904

8228

Hypo-osmolality and hyponatraemia

2209

20572

1.09

3.14

4.8

5.1

3.90

3.56

ug/l

0.22

1920

18363

Fentanyl

1261

13709

0.89

3.14

6.6

5.0

8.21

3.47

ug/l

4.04

1077

12163

Superficial injury of ankle and foot

1083

9812

1.13

3.14

4.3

4.2

2.38

2.24

ug/l

0.08

990

8893

Family history of malignant neoplasm

515

4429

1.18

3.13

5.3

4.3

1.99

2.30

ug/l

0.59

467

3986

Unspecified misadventure during surgical and medical care

711

6354

1.18

3.13

5.3

5.0

2.40

2.67

ug/l

0.47

646

5684

Cirrhosis of liver, NAS

735

8134

0.85

3.12

4.0

5.0

1.87

3.46

ug/l

2.00

640

7306

Cystic kidney disease

423

3648

1.23

3.12

4.4

4.7

2.03

2.56

ug/l

1.34

389

3278

Cluster headache, strict, including avohilmo

474

4094

1.21

3.10

4.2

4.0

1.80

1.97

ug/l

0.51

422

3728

IgA nephropathy (IgA glomerulonephritis)

372

3208

1.27

3.10

3.9

4.5

2.01

2.32

ug/l

0.76

349

2895

Other deformities of toe(s)

251

2036

1.28

3.10

5.1

4.8

2.35

3.34

ug/l

0.77

205

1801

Meralgia paraesthetica

385

3289

1.24

3.09

4.9

4.6

1.84

2.31

ug/l

0.80

350

2986

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

767

6847

1.16

3.09

5.1

5.2

2.32

3.18

ug/l

2.26

689

6083

Abnormal findings on examination of urine, without diagnosis

611

5425

1.20

3.09

5.0

2.20

3.12

ug/l

2.12

549

4851

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

287

2378

1.27

3.08

4.7

4.1

1.84

2.05

ug/l

0.45

265

2174

Other keratitis

1231

11264

1.12

3.08

4.4

4.3

2.12

2.82

ug/l

0.99

1129

10205

Other obstructive and reflux uropathy

460

3972

1.21

3.07

5.8

5.0

8.08

2.85

ug/l

1.23

398

3506

Asthma

11902

60573

1.04

3.06

4.5

4.7

2.54

3.25

ug/l

2.14

10755

55024

Other/unspecified seropositive rheumatoid arthritis

2197

23495

0.92

3.06

4.4

5.1

2.53

3.50

ug/l

2.22

1952

20974

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

885

7965

1.14

3.04

4.9

4.8

8.29

2.96

ug/l

0.59

780

7156

Mixed and other personality disorders

741

6596

1.16

3.04

3.7

1.72

1.83

ug/l

0.19

655

6051

Procreative management

2506

22282

0.93

3.03

3.8

3.4

1.69

1.81

ug/l

0.47

2319

20371

Other congenital malformations of urinary system

354

1.77

3.03

4.5

4.4

1.55

1.90

ug/l

0.53

316

Type 1 diabetes, strict definition

413

4832

0.83

3.02

2.4

2.6

1.19

1.37

ug/l

1.20

373

4497

Other or ill-defined heart diseases

648

7264

0.85

3.02

3.8

4.7

1.86

3.36

ug/l

1.97

575

6586

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

429

3738

1.24

3.01

3.9

4.5

2.20

2.25

ug/l

0.07

399

3376

Occlusion and stenosis of arteries, not leading to stroke

140

1787

0.71

3.01

4.7

5.7

3.44

3.60

ug/l

0.05

127

1543

Other and unspecified drugs and medicaments

835

7500

1.15

3.01

5.0

4.8

8.64

2.90

ug/l

0.60

742

6721

Complications of genitourinary prosthetic devices, implants and grafts

231

1875

1.30

3.01

6.2

5.1

4.40

3.59

ug/l

0.26

203

1641

Seropositive rheumatoid arthritis, wide

2231

23830

0.92

3.01

4.4

5.1

2.52

3.49

ug/l

2.27

1982

21281

Unspecified acute lower respiratory infection

2352

22164

1.09

3.01

3.9

4.4

2.47

2.89

ug/l

0.46

2163

20126

Isolated growth hormone deficiency

150

2.05

2.99

5.3

3.7

1.14

1.44

ug/l

0.79

129

Separation of retinal layers (serosa)

683

6148

1.19

2.99

4.6

4.3

2.18

2.09

ug/l

0.29

625

5593

Sequelae of injuries of upper limb

1214

11147

1.13

2.99

4.3

4.2

2.07

2.33

ug/l

0.31

1086

10137

COPD (mode)

6131

46480

1.06

2.98

4.7

5.3

3.19

3.82

ug/l

0.47

5287

41814

Chondropathies

1690

15692

1.10

2.98

4.5

4.2

1.83

2.41

ug/l

4.56

1518

14274

Malignant neoplasm of endocrine gland

532

4634

1.18

2.97

5.2

3.6

2.20

1.81

ug/l

1.67

477

4160

Unspecified chronic bronchitis

388

4495

0.82

2.96

5.3

5.1

2.50

4.58

ug/l

1.28

337

3962

Superficial injury of thorax

2092

19628

1.09

2.96

4.8

4.6

2.84

3.32

ug/l

0.40

1848

17719

Other and unspecified follicular disorders

530

4670

1.20

2.96

4.4

4.6

2.21

2.46

ug/l

0.30

479

4217

Disorders of optic nerve and visual pathways

853

7667

1.14

2.96

4.8

4.7

3.68

2.77

ug/l

0.32

764

6872

Other dialysis

481

4247

1.23

2.96

3.3

4.8

1.86

2.36

ug/l

2.20

463

3812

Hypermetropia

587

5150

1.17

2.95

5.1

4.7

2.76

2.49

ug/l

0.16

529

4602

Spinal osteochondrosis

135

1038

1.43

2.95

4.4

3.9

1.43

2.22

ug/l

1.59

127

940

Occupational exposure to risk-factors

611

5503

1.21

2.93

4.9

5.1

2.58

2.68

ug/l

0.08

547

4920

Bell's palsy

1442

13338

1.11

2.93

5.0

4.7

2.52

3.43

ug/l

1.22

1286

11994

Trigeminal neuralgia

469

4056

1.19

2.92

5.0

4.9

2.10

3.02

ug/l

1.68

416

3619

Cystic kidney disease

386

3324

1.24

2.92

4.3

4.7

2.04

2.60

ug/l

1.28

358

2983

Other strabismus

1897

17593

1.09

2.91

4.6

4.3

2.31

2.90

ug/l

0.95

1712

15960

Use of riluzole

496

0.50

2.91

3.4

5.1

16.68

2.39

ug/l

0.45

443

Other embolism and thrombosis

1677

15618

1.10

2.91

4.9

5.0

6.76

3.25

ug/l

0.80

1490

14008

Other rupture of muscle

639

1.59

2.90

5.2

4.6

1.71

2.84

ug/l

1.02

574

Sequelae of cerebrovascular disease

6111

54582

0.95

2.90

4.8

5.4

4.72

3.91

ug/l

0.39

5338

48495

Persons encountering health services for specific procedures, not carried out

956

8677

1.14

2.90

4.4

2.76

2.23

ug/l

0.26

834

7846

Other necrotizing vasculopathies (FG)

696

6225

1.16

2.89

4.9

5.2

3.79

3.07

ug/l

0.23

607

5515

Convulsions, not elsewhere classified

3215

33407

0.93

2.89

4.3

4.6

2.52

2.70

ug/l

0.33

2821

30127

Emotionally unstable personality disorder

699

6188

1.15

2.88

3.4

1.31

1.75

ug/l

4.79

608

5707

Mesothelioma

136

1679

0.69

2.87

4.5

4.2

2.50

2.10

ug/l

0.73

113

1484

Disorders of acoustic nerve

314

2661

1.26

2.87

5.8

4.9

3.24

2.71

ug/l

0.21

282

2377

Nonischemic cardiomyopathy

1541

16462

0.90

2.87

4.2

5.1

2.79

3.91

ug/l

1.85

1358

14807

Focal epilepsy

2574

27226

0.93

2.87

4.3

4.9

3.05

3.26

ug/l

0.21

2289

24432

Other diseases of gallbladder

442

3828

1.20

2.86

5.0

5.1

2.32

4.28

ug/l

1.06

391

3383

Contact with nonpowered hand tool

777

7085

1.18

2.84

5.1

4.4

1.98

2.36

ug/l

1.35

704

6425

Other disorders starting during childhood or adolecense, excluding more controls

131

934

1.36

2.84

2.9

2.6

1.17

1.44

ug/l

0.85

122

859

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1938

17576

1.09

2.84

4.3

4.4

1.88

2.49

ug/l

5.67

1725

15914

Ulcerative proctitis

663

5907

1.16

2.83

4.8

4.4

3.31

2.17

ug/l

0.40

596

5333

Embolic stroke

648

7190

0.85

2.83

4.7

5.6

2.91

4.65

ug/l

1.69

570

6318

Melanocytic naevi of lower limb, including hip

369

3147

1.22

2.82

5.1

4.8

2.03

2.45

ug/l

1.36

336

2834

Ankylosing spondylitis, ICD10

1157

10643

1.13

2.82

4.5

4.3

3.61

2.37

ug/l

0.81

1038

9666

Other benign neoplasms of connective and other soft tissue

1055

9636

1.13

2.82

5.1

4.8

2.14

3.26

ug/l

1.72

949

8627

Peritonsillar abscess

2572

24267

1.08

2.81

4.2

4.1

2.21

2.78

ug/l

1.02

2338

22111

Use of levodopa decarboxylase inhibitor

2288

21654

1.09

2.81

5.1

5.6

4.57

4.12

ug/l

0.14

2022

19126

Disorders of psychological development

652

5332

1.15

2.80

3.3

3.5

2.07

1.97

ug/l

0.08

573

4815

Cerebral cysts

493

5620

0.85

2.79

3.8

4.8

1.69

2.80

ug/l

5.10

432

5039

Malignant neoplasm of larynx, including Hilmo

308

3544

0.78

2.79

4.4

3.9

2.52

2.08

ug/l

1.15

265

3163

Myositis

327

2793

1.25

2.78

4.6

4.8

3.34

2.59

ug/l

0.37

304

2487

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1770

16235

1.09

2.77

4.4

3.09

2.88

ug/l

0.10

1583

14639

Rheumatic valve diseases

200

2444

0.77

2.76

4.2

5.2

2.92

3.77

ug/l

0.55

174

2142

Erythema intertrigo

282

2379

1.27

2.76

4.8

5.1

2.25

2.96

ug/l

0.64

246

2123

Alzheimer’s disease (Early onset), excluding more controls

381

4166

0.83

2.75

4.0

5.3

3.57

5.98

ug/l

1.58

325

3662

Other disorders involving the immune mechanism, not elsewhere classified

450

3959

1.22

2.75

3.9

4.5

2.17

2.26

ug/l

0.14

418

3573

Diffuse large B-cell lymphoma, helper endpoint

651

5858

1.18

2.75

4.7

3.8

3.36

2.02

ug/l

1.07

578

5233

Diffuse large B-cell lymphoma, including Hilmo

651

5858

1.18

2.75

4.7

3.8

3.36

2.02

ug/l

1.07

578

5233

Diffuse large B-cell lymphoma

651

5858

1.18

2.75

4.7

3.8

3.36

2.02

ug/l

1.07

578

5233

Complications of other internal prosthetic devices, implants and grafts

434

3775

1.20

2.74

4.8

5.1

2.12

3.07

ug/l

2.09

382

3352

Fall on and from stairs and steps

3092

29362

1.07

2.74

4.6

4.8

2.82

3.12

ug/l

0.30

2760

26421

Heterophoria

559

4909

1.17

2.74

5.0

4.5

2.08

2.47

ug/l

0.79

502

4422

Patellar tendinitis

203

1654

1.32

2.74

3.9

3.4

1.59

1.80

ug/l

0.40

187

1515

Myopia

880

7934

1.13

2.73

4.2

4.0

2.01

2.16

ug/l

0.36

786

7196

Unspecified visual impairment (binocular)

158

1248

1.36

2.73

4.5

4.8

2.45

2.59

ug/l

0.08

148

1111

Fracture of femur

3420

32541

0.94

2.73

4.8

5.2

4.78

4.46

ug/l

0.11

2960

28684

Specific development disorders of scholastic skills

180

1397

1.30

2.73

2.4

2.5

1.03

1.24

ug/l

1.31

161

1290

Other or unspecified ileus, impaction or obstruction

2889

27445

1.08

2.72

4.8

5.0

3.01

3.66

ug/l

1.19

2526

24415

Other specified and unspecified retinal disorders

422

3679

1.21

2.72

5.0

4.9

2.48

2.63

ug/l

0.15

385

3288

Heart failure and coronary heart disease

7803

56913

0.95

2.72

4.6

5.4

3.06

3.87

ug/l

2.46

6767

50774

Benign neoplasm of brain and other parts of central nervous system

724

6514

1.15

2.72

5.3

4.9

3.14

2.69

ug/l

0.37

649

5845

Other specified/unspecified dorsopathies

326

2766

1.23

2.71

4.6

4.5

2.56

2.67

ug/l

0.07

286

2475

Asthma, including avohilmo

17714

101674

0.97

2.70

4.6

4.7

2.53

3.31

ug/l

4.34

15959

91419

Dronedarone medication

459

4069

1.23

2.70

5.6

5.4

2.95

2.93

ug/l

0.01

398

3653

Duodenal ulcer

1815

19263

0.91

2.68

5.0

5.2

4.20

4.22

ug/l

0.01

1585

17058

Toxic effect of ethanol

388

4468

0.83

2.68

3.4

4.1

1.77

2.30

ug/l

1.18

344

4050

Pathological resorption of teeth

406

3531

1.21

2.68

5.1

4.6

3.99

2.54

ug/l

0.58

371

3193

Torsion of testis

235

1949

1.29

2.68

3.3

2.7

1.75

1.33

ug/l

1.52

219

1778

Other infective otitis externa

695

6249

1.16

2.66

5.1

4.8

2.08

3.04

ug/l

2.72

611

5610

Type 1 diabetes, wide definition, subgroup 1

2379

25177

0.93

2.66

3.5

4.4

1.91

2.89

ug/l

3.36

2133

22952

Caught, crushed, jammed or pinched in or between objects

685

6173

1.16

2.65

4.2

2.08

2.12

ug/l

0.07

631

5592

Thyroiditis, ILD-related definition

583

5133

1.15

2.64

4.9

4.6

3.11

2.58

ug/l

0.27

521

4565

Tubulo-interstitial nephritis, not specified as acute or chronic

698

6258

1.15

2.64

4.8

5.2

4.64

3.40

ug/l

0.75

616

5503

Alcoholic gastritis

231

2692

0.76

2.62

4.8

4.5

2.21

2.35

ug/l

0.20

210

2408

Other disorders starting during childhood or adolescence

131

980

1.34

2.62

2.9

2.7

1.17

1.24

ug/l

0.23

122

884

Early lumbar disc prolapse operation

1051

9615

1.12

2.62

2.9

2.8

1.40

1.45

ug/l

0.25

994

8956

Reactive arthropathies, FINNGEN

808

7321

1.14

2.61

4.5

2.37

2.60

ug/l

0.28

735

6593

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2161

22983

0.93

2.61

4.4

5.1

2.53

3.51

ug/l

2.18

1922

20537

Drug-induced neutropenia

581

6522

0.86

2.60

5.4

5.0

4.43

2.74

ug/l

1.65

506

5821

Injury of urinary and pelvic organs

318

2747

1.26

2.60

4.7

2.73

2.62

ug/l

0.05

279

2455

Xerosis cutis

213

1773

1.32

2.60

5.5

5.3

1.79

2.63

ug/l

2.86

193

1570

Vertigo of central origin

172

1386

1.34

2.59

5.3

3.74

2.67

ug/l

0.54

145

1216

Benign neoplasm: Tongue

324

2781

1.24

2.59

4.5

4.8

1.79

2.35

ug/l

2.02

292

2482

Personality and behavioural disorders due to brain disease, damage and dysfunction

162

1981

0.74

2.59

4.3

4.8

3.26

2.35

ug/l

0.45

122

1774

Astigmatism

569

5037

1.16

2.58

4.7

1.91

2.70

ug/l

1.58

507

4521

Malignant neoplasm of thyroid gland, including Hilmo

538

4739

1.16

2.58

5.5

3.6

2.18

1.80

ug/l

2.31

484

4256

Hyperfunction of pituitary gland

301

2531

1.22

2.58

4.7

4.4

1.52

2.28

ug/l

3.22

277

2268

Acute laryngitis and tracheitis

821

7274

1.13

2.57

3.5

3.3

1.48

1.86

ug/l

1.70

735

6624

Malignant neoplasm of heart, mediastinum and pleura

155

1891

0.73

2.57

4.5

4.1

2.51

2.08

ug/l

0.95

129

1679

Secondary polycythaemia

383

3367

1.24

2.57

4.6

4.5

1.84

2.35

ug/l

1.77

342

3027

Acute nasopharyngitis (common cold)

2111

19837

1.09

2.57

3.3

1.66

1.76

ug/l

0.53

1991

18427

Viral pneumonia

1869

17575

1.09

2.56

4.5

5.0

2.60

3.41

ug/l

0.83

1673

15815

Mesothelioma, including Hilmo

173

2075

0.74

2.56

4.7

4.2

2.58

2.12

ug/l

0.98

140

1847

Speech and linguistic disorders

475

3967

1.17

2.55

3.6

3.7

2.38

2.14

ug/l

0.16

418

3569

Peripheral arterial reconstruction

3026

31597

0.93

2.55

4.6

5.5

4.75

4.15

ug/l

0.13

2605

27947

Osteonecrosis due to drugs

202

1683

1.34

2.55

16.7

5.2

19.05

2.46

ug/l

4.37

192

1498

Viral haemorrhagic fevers, not elsewhere classified/unspecified

2062

19425

1.09

2.55

4.8

4.7

3.73

2.88

ug/l

0.36

1922

17522

Other secondary gonarthrosis

677

6113

1.16

2.54

5.0

4.8

1.99

2.78

ug/l

3.03

609

5464

Vascular disorders of the intestines

987

9079

1.13

2.53

5.1

5.3

3.26

4.20

ug/l

0.93

865

8020

Discitis, unspecified

264

2260

1.29

2.53

4.8

5.0

2.14

2.71

ug/l

0.98

234

1993

Other diseases of stomach and duodenum

804

7314

1.14

2.53

5.1

5.0

2.12

3.80

ug/l

2.19

723

6515

Disorder of external ear, unspecified

405

3546

1.21

2.52

4.5

4.7

2.93

2.37

ug/l

0.38

352

3184

Other specified/unspecified inflammatory spondylopathies

362

3106

1.20

2.52

4.1

3.9

2.05

2.11

ug/l

0.05

334

2803

Loose body in joint

387

3402

1.23

2.51

4.9

4.6

2.24

2.91

ug/l

0.97

357

3045

Other disorders of optic [2nd] nerve and visual pathways

665

5977

1.15

2.51

4.8

4.9

4.16

2.76

ug/l

0.40

591

5345

Mandibular retrognathia

398

3423

1.19

2.50

4.3

3.9

1.67

1.87

ug/l

0.67

370

3126

Non-seminoma of testis, including Hilmo

679

1.53

2.49

3.3

2.7

1.19

1.39

ug/l

0.61

626

Other and unspecified local infections of skin and subcutaneous tissue

1232

11425

1.11

2.48

4.7

4.8

2.17

3.55

ug/l

1.98

1106

10259

Femoral hernia

513

4556

1.18

2.48

5.6

5.1

2.63

3.22

ug/l

0.71

464

4043

Obesity

7493

70010

1.04

2.48

4.4

4.6

2.16

2.82

ug/l

1.94

6615

63504

Acute peritonitis

779

8531

0.88

2.48

4.1

4.9

2.21

3.43

ug/l

1.62

711

7614

Fracture of neck

977

9035

1.14

2.47

5.1

5.0

2.37

3.47

ug/l

1.37

868

8070

Malignant neoplasm of thyroid gland

471

4128

1.17

2.46

5.2

3.6

2.10

1.80

ug/l

1.54

426

3702

Carcinoma in situ of rectum

196

1656

1.37

2.46

5.4

5.2

2.72

2.63

ug/l

0.06

180

1479

Diseases of the digestive system

7459

72032

1.04

2.45

5.0

5.1

3.65

3.69

ug/l

0.03

6561

64218

Other and unspecified injuries of ankle and foot

341

2924

1.20

2.44

4.0

4.2

2.51

2.12

ug/l

0.20

309

2654

Simple and mucopurulent chronic bronchitis

461

5197

0.85

2.43

5.5

5.2

2.56

4.35

ug/l

1.40

405

4581

Agoraphobia

177

1418

1.28

2.42

3.0

3.1

1.23

1.48

ug/l

1.08

147

1311

Other congenital malformations of the digestive system

406

3505

1.19

2.41

4.5

4.8

2.17

2.65

ug/l

0.79

368

3138

Valvular operations

2946

28234

1.08

2.41

4.7

5.3

2.76

3.61

ug/l

2.36

2625

25341

Urethritis and urethral syndrome

198

1623

1.28

2.41

5.1

4.2

1.99

2.08

ug/l

0.10

172

1460

Other chronic obstructive pulmonary disease, including avohilmo

9937

84102

0.96

2.40

4.8

5.2

3.05

3.72

ug/l

0.98

8563

75283

Hypotension due to drugs

220

1862

1.31

2.40

5.0

5.4

2.72

3.81

ug/l

0.67

190

1637

Endovascular or surgical operations to intracerebral aneurysms

567

6330

0.87

2.40

4.3

4.8

2.01

2.73

ug/l

2.76

518

5683

Motor neuron disease

227

2671

0.79

2.39

3.9

5.4

5.94

3.75

ug/l

0.38

195

2399

Disturbances of smell and taste

377

3274

1.20

2.39

5.5

4.8

1.75

2.74

ug/l

2.51

347

2943

Wide developmental disorders, excluding more controls

126

950

1.33

2.38

2.5

2.7

1.10

1.57

ug/l

0.77

106

887

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

316

0.45

2.38

7.6

4.3

2.78

2.46

ug/l

0.17

270

Unspecified privation

1320

12288

1.10

2.38

4.8

4.7

2.37

3.45

ug/l

1.53

1171

11047

Respiratory tuberculosis, clinically confirmed

137

1693

0.74

2.38

3.9

5.2

2.74

3.94

ug/l

0.78

121

1468

Other bacterial intestinal infections

2347

22243

1.08

2.38

4.9

5.0

3.37

3.78

ug/l

0.29

2109

19826

Viral pneumonia (known virus, not influenza)

343

2989

1.23

2.38

4.6

5.1

2.31

3.13

ug/l

1.09

308

2662

Other disorders of Eustachian tube

278

2362

1.23

2.37

5.3

4.7

2.24

2.74

ug/l

0.52

257

2126

Oral lichen planus

175

1413

1.29

2.37

5.0

4.9

1.56

2.49

ug/l

2.71

155

1268

Focal epilepsy, strict definition

2424

25522

0.93

2.37

4.3

4.9

3.14

3.25

ug/l

0.10

2152

22908

Amblyopia ex anopsia

313

2672

1.21

2.37

4.6

4.5

1.90

2.54

ug/l

1.29

269

2410

Episcleritis

411

3586

1.18

2.35

4.4

4.3

1.76

2.13

ug/l

1.50

382

3244

Type 1 diabetes, strict definition, subgroup 1

381

4388

0.85

2.35

2.4

2.5

1.19

1.35

ug/l

0.93

344

4080

Other general symptoms and signs

384

3297

1.18

2.34

4.9

4.7

3.05

2.30

ug/l

0.27

338

2951

Arthropod-borne viral fevers and viral haemorrhagic fevers

1448

13585

1.10

2.34

4.7

4.6

2.05

2.64

ug/l

3.30

1355

12283

Gastroduodenal ulcer

4351

45002

0.95

2.34

5.0

5.2

3.34

4.26

ug/l

1.41

3844

39821

Polypectomy (DHB20)

1207

11303

1.12

2.33

4.8

4.7

5.28

2.70

ug/l

0.67

1100

10194

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

170

1398

1.33

2.32

6.5

5.5

2.70

3.09

ug/l

0.27

145

1221

Schizophrenia or delusion

3408

35648

0.94

2.32

3.4

4.1

2.32

2.64

ug/l

0.29

3014

32518

Overjet

511

1.45

2.32

5.2

3.7

1.55

1.60

ug/l

0.07

457

Benign neoplasm: Testis

102

827

1.64

2.32

5.1

5.0

3.57

2.83

ug/l

0.16

737

Anogenital herpesviral [herpes simplex] infection

366

3157

1.18

2.32

4.2

3.8

1.76

1.87

ug/l

0.22

328

2889

Obesity and other hyperalimentation

7524

70292

1.04

2.32

4.4

4.6

2.16

2.83

ug/l

1.97

6645

63748

Other and specified injuries of hip and thigh

268

2290

1.25

2.30

5.0

1.96

3.43

ug/l

1.89

231

2039

Sarcoidosis

1633

15336

1.09

2.30

4.5

4.6

2.54

2.82

ug/l

0.35

1470

13871

Candidiasis

1184

10951

1.10

2.30

5.0

4.8

2.74

3.25

ug/l

0.49

1054

9806

Schizophrenia, schizotypal and delusional disorders

3431

35870

0.95

2.29

3.4

4.1

2.32

2.64

ug/l

0.30

3033

32702

Sacroiliitis, not elsewhere classified

278

2347

1.21

2.29

3.0

3.4

1.33

1.92

ug/l

2.51

254

2141

Bruxism

646

1.41

2.29

4.3

3.7

1.48

1.75

ug/l

0.79

587

Anankastic personality disorder

288

2449

1.21

2.29

4.0

1.54

1.94

ug/l

1.31

263

2245

N06DA Anticholinesterases

5342

40714

1.05

2.28

4.9

5.9

5.37

4.74

ug/l

0.20

4535

35614

Use of anticholinesterases

5342

40714

1.05

2.28

4.9

5.9

5.37

4.74

ug/l

0.20

4535

35614

Malignant neoplasm of hypopharynx, including Hilmo

1174

0.68

2.28

3.7

3.8

3.04

2.03

ug/l

0.48

1038

Motor neuron disease (with DMD)

229

2684

0.79

2.28

3.9

5.4

5.89

3.74

ug/l

0.37

197

2412

Sacrococcygeal disorders, not elsewhere classified

176

1423

1.27

2.27

5.1

4.3

1.75

2.33

ug/l

1.24

164

1282

Congenital deformities of feet

266

2246

1.22

2.27

3.9

4.0

2.29

1.93

ug/l

0.20

245

2051

292

3347

0.81

2.27

4.9

5.6

2.52

4.86

ug/l

1.01

245

2926

Suicide or other Intentional self-harm

2348

24782

0.94

2.27

3.7

4.1

2.35

2.55

ug/l

0.15

2028

22607

Disorders resulting from impaired renal tubular function

506

4547

1.18

2.26

3.4

4.9

2.21

2.57

ug/l

0.55

477

4067

Sequelae of other external causes

617

5564

1.15

2.26

4.7

4.8

2.84

2.68

ug/l

0.11

555

4965

Radial styloid tenosynovitis [de Quervain]

292

2479

1.20

2.24

5.0

4.1

1.67

2.24

ug/l

1.74

263

2228

Mixed disorders of conduct and emotions

336

1.54

2.23

2.1

1.8

1.28

0.91

ug/l

0.24

303

Thyrotropin deficiency

640

1.44

2.22

5.8

4.3

1.54

2.42

ug/l

1.03

575

Aphakia

214

1801

1.28

2.22

5.0

4.9

7.76

4.00

ug/l

0.32

186

1612

Mental and behavioural disorders due to sedatives or hypnotics

721

6553

1.13

2.22

3.5

3.8

1.46

2.10

ug/l

2.69

614

5981

Graves disease, strict definition

429

3748

1.16

2.22

4.4

4.3

2.04

2.29

ug/l

0.35

371

3371

Benign neoplasm: Conjunctiva

350

3057

1.20

2.21

5.5

5.0

4.95

2.82

ug/l

0.46

317

2728

Asthma and allergy

739

6586

1.12

2.21

3.8

3.7

2.21

1.87

ug/l

0.25

678

6004

Giant cell arteritis

450

3999

1.18

2.20

5.4

5.5

4.65

3.11

ug/l

0.34

394

3518

Disorders of continuity of bone

840

7674

1.12

2.20

4.6

4.3

2.30

2.41

ug/l

0.16

753

6950

Ankylosing hyperostosis [Forestier]

225

1933

1.30

2.20

5.6

4.8

2.20

2.57

ug/l

0.64

206

1716

Other and unspecified mood [affective] disorders

456

4015

1.16

2.18

3.4

3.7

1.36

1.94

ug/l

3.36

413

3699

Fasciculation

137

1104

1.35

2.18

5.0

4.6

1.73

2.32

ug/l

0.93

128

998

Non-Hodgkin lymphoma, all, including Hilmo

2033

19304

1.08

2.18

4.7

3.9

2.94

2.03

ug/l

2.28

1793

17288

Carcinoma in situ of colon

310

2730

1.25

2.18

5.8

5.3

3.40

3.04

ug/l

0.11

275

2431

Pervasive developmental disorders excl. Autism + Asperger

241

1.65

2.18

2.1

2.7

0.75

1.30

ug/l

1.47

221

Seronegative rheumatoid arthritis

1021

9411

1.11

2.18

4.7

5.0

2.26

3.48

ug/l

2.19

900

8388

Fracture of foot, except ankle

2609

24817

1.07

2.18

4.4

4.3

2.59

2.74

ug/l

0.16

2345

22558

Benign neoplasm of meninges

731

6630

1.12

2.17

5.9

5.2

2.62

3.80

ug/l

1.03

651

5862

Psoriatic and enteropathic arthropathies

1404

13137

1.09

2.17

4.3

4.5

2.04

2.87

ug/l

1.90

1247

11905

Dissection of aorta

485

5353

0.85

2.17

4.8

5.3

2.86

4.00

ug/l

0.57

417

4751

Rheumatic fever incl heart disease

290

3350

0.83

2.17

4.5

5.2

2.71

4.69

ug/l

0.84

259

2951

Fibrosis and cirrhosis of liver

911

9846

0.89

2.16

4.1

5.0

2.14

3.36

ug/l

1.47

800

8843

Myocarditis

717

6553

1.14

2.16

3.7

4.3

2.50

2.47

ug/l

0.03

645

5975

Asthma and allergy, excluding more controls

739

6596

1.12

2.15

3.8

3.7

2.21

1.84

ug/l

0.28

678

6026

Inflammation of lacrimal passages (chronic)

129

1022

1.33

2.15

5.3

5.1

3.11

2.86

ug/l

0.10

117

890

Failure and rejection of transplanted organs and tissues

186

1561

1.31

2.15

3.9

4.2

2.32

2.16

ug/l

0.10

174

1427

Other local infections of skin and subcutaneous tissue

1328

12430

1.10

2.14

4.7

4.8

2.22

3.50

ug/l

1.99

1186

11173

Car occupant injured in other and unspecified transport accidents

1900

17923

1.08

2.14

4.4

4.3

2.95

2.80

ug/l

0.09

1718

16193

Emotional disorders starting during childhood or adolecense, excluding more controls

707

1.35

2.14

2.3

2.2

0.82

1.13

ug/l

2.23

667

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2351

24796

0.94

2.14

3.7

4.1

2.35

2.55

ug/l

0.15

2029

22609

Campylobacter enteritis

332

2905

1.21

2.13

4.7

4.6

1.96

2.39

ug/l

0.94

293

2614

Other disorders of glucose regulation and pancreatic internal secretion

874

9488

0.90

2.13

4.0

4.8

2.01

3.33

ug/l

2.10

755

8502

Other chondrocalcinosis

185

1561

1.32

2.13

5.0

5.4

2.70

2.91

ug/l

0.11

160

1377

Unspecified dementia

1331

12798

0.92

2.13

4.1

5.7

5.36

6.23

ug/l

0.19

1127

11130

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1795

16395

1.08

2.12

4.3

4.4

1.90

2.48

ug/l

4.67

1600

14862

Coagulation defects, purpura and other haemorrhagic conditions

2335

22200

1.07

2.11

4.6

5.0

3.02

3.42

ug/l

0.46

2065

19885

Primary angle-closure glaucoma

468

4176

1.17

2.11

5.8

5.2

2.74

4.37

ug/l

0.88

409

3693

Noninfectious colitis NAS

1343

12538

1.09

2.11

4.5

4.6

2.32

3.06

ug/l

1.05

1199

11245

Rheumatism, unspecified

465

4097

1.15

2.10

4.9

4.6

2.20

2.71

ug/l

0.97

412

3602

Hypertrophic scar

318

2743

1.19

2.08

4.7

4.3

2.01

2.51

ug/l

0.59

294

2475

Congenital malformations of the nervous system

114

885

1.33

2.07

3.4

3.8

1.49

2.06

ug/l

0.82

105

800

Patent foramen ovale

236

2011

1.24

2.07

4.6

4.1

1.67

2.01

ug/l

0.75

192

1838

Congenital malformations and deformations of the musculoskeletal system

459

4032

1.15

2.07

4.1

3.9

2.09

1.99

ug/l

0.09

419

3658

Other diseases of blood and blood-forming organs

899

8317

1.12

2.07

4.5

4.8

2.79

3.34

ug/l

0.28

787

7444

Other postsurgical states

746

6829

1.13

2.07

4.9

4.8

2.27

2.91

ug/l

1.42

686

6128

Injury of nerves at wrist and hand level

530

4793

1.16

2.06

4.3

4.2

1.84

2.15

ug/l

1.15

480

4359

Hypertrophic disorders of skin

359

3127

1.17

2.06

4.9

4.4

1.97

2.54

ug/l

0.83

331

2818

Other specified/unspecified spondylopathies

297

2583

1.22

2.06

5.5

5.1

2.27

4.59

ug/l

0.79

272

2273

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

215

2513

0.80

2.06

4.4

3.9

1.94

2.05

ug/l

0.30

181

2238

Respiratory tuberculosis, bacteriologically and histologically confirmed

208

2439

0.80

2.06

4.4

5.1

6.64

5.08

ug/l

0.15

184

2143

Biomechanical lesions, not elsewhere classified

538

4850

1.15

2.05

4.7

5.0

2.15

2.81

ug/l

1.30

480

4336

Disorders of synovium and tendon

7040

59875

1.04

2.05

4.7

4.6

2.44

3.17

ug/l

2.10

6370

53998

Wide developmental disorders

126

986

1.30

2.05

2.5

2.6

1.10

1.17

ug/l

0.21

106

909

Other mycoses, not elsewhere classified/unspecified

191

1603

1.27

2.04

5.1

4.6

2.49

2.30

ug/l

0.12

171

1450

Other abnormalities of plasma proteins

207

1761

1.27

2.04

6.1

4.7

3.47

2.45

ug/l

1.07

182

1547

Lesion of plantar nerve

348

3027

1.17

2.04

5.7

4.9

2.04

2.93

ug/l

1.69

319

2697

Other and unspecified erythematous conditions

276

2376

1.21

2.03

5.2

4.8

2.43

2.50

ug/l

0.05

246

2102

Heart failure and bmi 25plus

6186

42944

0.96

2.02

4.7

5.2

2.84

3.72

ug/l

2.40

5314

38204

Schizophrenia or delusion, excluding more controls

3408

35160

0.95

2.02

3.4

4.1

2.32

2.56

ug/l

0.21

3014

32297

Allergic contact dermatitis

827

7560

1.11

2.02

4.4

4.5

2.09

2.67

ug/l

1.61

749

6789

247

2111

1.22

2.02

4.2

3.8

1.56

1.98

ug/l

1.05

223

1939

Toxic effect of contact with venomous animals

400

3540

1.17

2.02

5.0

4.7

2.22

2.27

ug/l

0.08

372

3190

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

686

0.62

2.02

6.2

4.7

2.22

2.01

ug/l

0.18

604

Fracture of forearm

4613

43831

0.96

2.01

4.8

4.6

2.92

3.03

ug/l

0.13

4141

39394

Fourth [trochlear] nerve palsy

302

2650

1.22

2.01

5.2

5.3

2.32

3.03

ug/l

0.90

271

2360

Nutritional anaemias

6622

61985

1.04

2.00

5.0

5.3

3.84

4.02

ug/l

0.20

5794

54899

Intestinal infectious diseases

17271

100477

0.98

2.00

4.5

4.7

2.71

3.32

ug/l

1.49

15574

90275

Gilbert syndrome

771

1.42

2.00

4.7

4.4

1.93

2.40

ug/l

0.39

702

Rash and other nonspecific skin eruption

857

7881

1.11

1.99

4.8

4.9

2.40

3.60

ug/l

1.29

781

7008

Pterygium

475

4308

1.18

1.99

5.9

5.4

5.73

3.01

ug/l

0.56

417

3818

Malignant neoplasm of other and ill-defined sites, including Hilmo

128

1574

0.76

1.98

5.5

3.9

4.82

2.17

ug/l

1.33

114

1373

Malignant neoplasm of penis, including Hilmo

150

1295

1.47

1.98

7.5

3.9

28.57

2.01

ug/l

0.65

136

1145

Spondyloarthritis

2301

21910

1.07

1.96

4.6

3.31

3.29

ug/l

0.01

2060

19719

Other diseases of spinal cord

378

3359

1.18

1.96

5.0

4.9

2.83

2.69

ug/l

0.13

343

3015

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

314

3566

0.84

1.96

4.8

5.4

3.21

4.98

ug/l

0.76

267

3114

Amyloidosis

305

2683

1.22

1.96

4.8

5.4

2.56

3.44

ug/l

1.01

271

2362

Benign neoplasm: Cranial nerves

331

2915

1.20

1.96

5.8

5.0

3.33

2.72

ug/l

0.25

295

2600

Endocrine disorders, other/unspecified

163

1343

1.27

1.95

4.9

4.6

1.70

2.30

ug/l

1.38

137

1208

Focal epilepsy, mode (most common among epilepsy diagnosis)

2277

23872

0.94

1.95

4.4

4.9

3.13

3.28

ug/l

0.12

2030

21433

Benign neoplasm: Skin of lip

145

1190

1.31

1.95

5.0

2.49

2.41

ug/l

0.06

131

1055

Speech disturbances, not elsewhere classified

1158

10836

1.10

1.95

5.0

5.2

2.88

4.30

ug/l

1.65

997

9619

Embedded and impacted teeth

1356

11989

0.93

1.94

3.6

3.4

2.29

1.81

ug/l

0.41

1251

10900

Unknown and unspecified causes of morbidity

817

7523

1.11

1.94

4.9

2.95

2.94

ug/l

0.01

770

6698

Effects of other external causes

308

2689

1.19

1.94

3.4

3.8

1.68

1.82

ug/l

0.28

280

2474

Complications peculiar to reattachment and amputation

885

0.68

1.94

3.8

4.8

2.09

2.70

ug/l

0.45

797

Congenital malformations, deformations and chromosomal abnormalities

6338

58533

1.04

1.94

4.1

4.2

2.02

2.68

ug/l

4.26

5715

53143

Other symptoms and signs involving general sensations and perceptions

364

3207

1.17

1.94

4.6

4.8

1.84

3.26

ug/l

2.80

310

2865

Hypoglycaemia, other or unspecified

682

7446

0.89

1.93

3.9

4.7

1.94

3.37

ug/l

1.80

597

6674

Chondrocostal junction syndrome [Tietze]

236

2004

1.21

1.93

4.5

1.67

2.29

ug/l

1.81

214

1807

Acute renal failure

3882

37534

1.06

1.93

4.5

5.3

4.17

3.66

ug/l

0.57

3436

33395

Pneumothorax

1087

11575

0.90

1.93

4.8

5.1

4.91

3.82

ug/l

0.38

967

10357

Cholecystectomy

8741

77284

0.97

1.93

5.1

2.89

3.63

ug/l

2.35

7815

68875

Lactose intolerance

220

1860

1.22

1.92

4.5

1.48

2.91

ug/l

2.08

209

1676

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2351

24609

0.94

1.92

3.7

4.2

2.35

2.77

ug/l

0.35

2029

22639

Respiratory tuberculosis, confirmed

201

2347

0.80

1.91

4.4

5.1

6.81

5.19

ug/l

0.15

178

2058

Vascular dementia (other)

752

1.42

1.91

5.6

2.22

4.44

ug/l

1.41

658

Other erythematous conditions

303

2640

1.19

1.91

5.2

4.9

2.37

2.58

ug/l

0.23

269

2336

Senility

724

1.36

1.90

4.9

5.7

14.87

3.71

ug/l

0.59

617

Crystalline deposits in vitreous body

144

1207

1.35

1.90

5.4

2.83

2.81

ug/l

0.01

127

1065

Emphysema

1222

12938

0.91

1.89

4.5

5.4

2.90

4.27

ug/l

1.56

1045

11489

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2519

26294

0.94

1.89

5.5

3.9

5.43

2.06

ug/l

7.24

2189

23542

Other epidermal thickening

511

4623

1.15

1.89

4.8

5.1

3.39

3.30

ug/l

0.02

467

4104

Malignant neoplasm of rectum, including Hilmo

2044

19516

1.08

1.89

4.7

3.9

2.70

2.06

ug/l

3.16

1779

17464

Other and unspecified mononeuropathies of upper limb

349

3091

1.18

1.87

4.6

4.4

1.59

2.24

ug/l

3.35

323

2810

Other bursitis of elbow

163

1397

1.35

1.87

5.2

4.8

2.19

2.50

ug/l

0.34

149

1232

Peroneal tendinitis

124

995

1.30

1.86

4.8

4.1

1.84

2.20

ug/l

0.44

112

896

Benign lipomatous neoplasm of other sites/unspecified

1012

9431

1.10

1.86

5.3

5.1

6.10

3.56

ug/l

0.35

910

8393

Congenital malformations of eye, ear, face and neck

464

4146

1.14

1.86

4.5

4.3

2.16

2.18

ug/l

0.03

410

3747

Personal history of malignant neoplasm

188

1559

1.22

1.85

4.6

2.38

ug/l

0.01

158

1356

Hyperkalaemia

885

8246

1.12

1.85

4.7

5.3

3.38

4.20

ug/l

0.54

788

7316

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

303

2650

1.19

1.84

5.1

4.7

2.01

2.26

ug/l

0.42

283

2382

Traumatic subarachnoid haemorrhage

577

5286

1.15

1.84

4.7

5.0

6.08

3.70

ug/l

0.29

509

4752

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

237

2016

1.20

1.83

5.6

5.0

1.79

2.63

ug/l

1.70

198

1768

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1130

10612

1.10

1.83

4.7

4.6

2.06

2.62

ug/l

2.22

1057

9605

Dermatitis due to substances taken internally

479

4304

1.14

1.83

5.3

4.9

2.53

3.16

ug/l

0.52

418

3836

Pulmonary heart disease, diseases of pulmonary circulation

4668

45211

1.05

1.83

5.0

5.2

3.46

3.69

ug/l

0.31

4081

40297

Arterial embolism and thrombosis of lower extremity artery

448

4941

0.86

1.83

4.1

5.4

2.05

3.99

ug/l

1.59

388

4368

Scoliosis

406

3591

1.15

1.82

5.2

4.6

2.14

2.46

ug/l

0.35

356

3181

Adhesive middle ear disease

150

1238

1.28

1.82

5.0

4.6

2.19

2.40

ug/l

0.24

128

1102

Pleural effusion

2588

26915

0.94

1.82

4.9

5.4

3.09

3.93

ug/l

1.62

2245

23875

Cardiomyopathy, other and unspecified

1129

12000

0.91

1.82

4.2

5.1

2.50

3.48

ug/l

1.60

986

10814

Personal history of medical treatment

111

892

1.34

1.82

4.7

4.8

3.15

3.27

ug/l

0.03

786

Contusion of other and unspecified parts of foot

397

3526

1.15

1.81

4.2

4.1

1.54

2.09

ug/l

2.93

369

3207

Unspecified human immunodeficiency virus [HIV] disease

130

1545

0.75

1.81

3.4

3.6

2.19

1.78

ug/l

0.28

121

1432

Other abnormal immunological findings in serum

140

1142

1.27

1.80

4.4

4.2

2.20

2.23

ug/l

0.03

127

1007

Pyogenic granuloma

193

1640

1.25

1.80

4.4

4.7

2.00

2.42

ug/l

0.56

175

1472

Recurrent dislocation of patella

183

1520

1.22

1.80

3.0

3.2

1.36

1.86

ug/l

1.27

164

1388

Psychotic depression

589

5356

1.13

1.79

4.2

4.6

1.75

3.32

ug/l

1.36

516

4886

Tularaemia

168

1420

1.28

1.79

5.2

4.7

1.88

2.40

ug/l

1.06

162

1282

Benign neoplasm: Scrotum

832

1.57

1.79

4.3

4.7

1.68

2.41

ug/l

1.00

748

Emotional disorders and disorders of social functioning with onset specific to childhood

717

1.31

1.79

2.0

0.81

1.00

ug/l

1.10

656

Foreign body in respiratory tract

469

4220

1.14

1.79

4.9

4.8

5.60

2.58

ug/l

0.56

418

3779

All-cause Heart Failure

10709

77079

0.97

1.79

4.7

5.3

3.42

3.68

ug/l

0.38

9321

68956

Kela-code for behavioural disturbances in mental retardation

916

0.71

1.79

4.0

4.7

1.81

2.36

ug/l

0.35

823

Kela-code for severe mental illness

4188

43339

0.96

1.78

3.7

4.2

2.51

2.63

ug/l

0.10

3701

39419

Drug-induced adrenocortical insufficiency

154

1278

1.27

1.77

5.3

4.8

10.56

2.45

ug/l

0.50

136

1150

Event of undetermined intent

749

6914

1.11

1.77

4.1

4.2

1.87

2.28

ug/l

1.17

669

6268

Temporal arteritis

386

3452

1.17

1.77

5.6

5.5

5.01

3.20

ug/l

0.35

337

3039

Parkinson's disease, strict definition

2374

22794

1.07

1.77

5.0

5.5

4.70

3.95

ug/l

0.27

2104

20179

Other congenital malformations of the digestive system

347

3042

1.16

1.77

4.5

4.8

2.25

2.74

ug/l

0.65

316

2721

Other and unspecified coagulation defects

393

3497

1.15

1.77

4.2

4.6

2.35

2.51

ug/l

0.13

357

3153

Other coagulation defects

658

6021

1.12

1.77

4.4

4.8

3.02

3.84

ug/l

0.41

585

5391

Postzoster neuralgia

175

1481

1.26

1.76

5.4

5.3

2.51

3.40

ug/l

0.63

151

1305

Extracorporeal dialysis

994

9343

1.11

1.76

3.6

4.9

2.39

2.90

ug/l

0.52

932

8379

Emotional disorders starting during childhood or adolescence

743

1.31

1.75

2.3

2.2

0.82

1.05

ug/l

1.49

692

Viral and other specified intestinal infections

1762

16271

1.07

1.75

3.9

3.8

2.18

2.69

ug/l

0.49

1614

14704

Causalgia

136

1114

1.28

1.75

4.1

4.0

1.87

2.48

ug/l

0.82

126

1016

Other melanin hyperpigmentation

204

1742

1.23

1.75

6.0

5.3

2.32

3.17

ug/l

0.77

179

1549

Eustachian salpingitis and obstruction

634

5789

1.12

1.73

3.5

3.1

2.06

1.62

ug/l

0.63

553

5315

Flatulence and related conditions

108

869

1.33

1.73

5.4

5.1

1.70

2.79

ug/l

1.36

764

Benign neoplasm: Anus and anal canal

340

3030

1.18

1.73

5.6

5.2

4.43

2.95

ug/l

0.40

306

2673

Hyperaldosteronism

353

3158

1.18

1.73

5.5

4.9

2.47

2.45

ug/l

0.02

324

2836

Other and unspecified iridocyclitis

441

3969

1.15

1.73

4.6

2.17

2.47

ug/l

0.42

398

3563

Disorders of speech understanding and production

264

2241

1.18

1.72

4.4

4.7

3.46

2.87

ug/l

0.23

232

1995

Hordeolum and other deep inflammation of eyelid

552

5022

1.13

1.72

4.7

4.5

2.60

2.27

ug/l

0.19

509

4516

Thyrotoxicosis with toxic multinodular goitre

320

2806

1.16

1.72

5.7

5.2

3.60

3.31

ug/l

0.11

274

2450

Disorders of adult personality and behaviour

2664

25503

1.05

1.72

3.6

3.9

2.15

2.11

ug/l

0.05

2348

23360

Tracheo-bronchomalasia

240

1.62

1.72

4.8

4.0

1.39

1.96

ug/l

1.42

213

Spasmodic torticollis

200

1696

1.21

1.71

4.5

4.6

1.94

2.35

ug/l

0.79

180

1537

Post-traumatic wound infection, not elsewhere classified

358

3208

1.18

1.71

4.1

4.4

1.85

2.31

ug/l

1.46

312

2896

Other appendicitis

928

8643

1.10

1.71

5.1

4.4

2.24

2.53

ug/l

0.36

828

7816

Other facial nerve disorders

252

2188

1.20

1.71

5.5

4.6

2.71

2.39

ug/l

0.21

231

1955

Personality disorders, excluding more controls

2524

24133

1.06

1.70

3.7

3.9

2.09

2.36

ug/l

0.31

2234

22289

Inhalation and ingestion of food causing obstruction of respiratory tract

1110

0.74

1.70

4.2

4.9

3.00

3.23

ug/l

0.07

986

Other and unspecified mononeuropathies of lower limb

236

2040

1.20

1.69

4.8

4.6

2.14

2.48

ug/l

0.45

209

1838

Ulcer of oesophagus

1211

11468

1.10

1.69

5.1

5.2

3.72

4.08

ug/l

0.13

1075

10250

Insulin, fast-acting

5466

56143

0.96

1.69

4.1

4.9

2.48

3.12

ug/l

1.52

4847

50543

Secondary right heart disease

434

4789

0.87

1.68

4.2

5.4

2.40

4.54

ug/l

1.57

367

4223

Undescended testicle

661

1.36

1.67

4.3

4.2

1.68

1.84

ug/l

0.30

589

Malignant neoplasm of renal pelvis

785

1.41

1.67

4.3

4.1

2.17

2.23

ug/l

0.08

684

Other infestations

190

1629

1.24

1.67

5.4

4.8

12.29

2.42

ug/l

0.73

173

1452

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

238

2069

1.21

1.67

5.2

4.8

1.81

2.68

ug/l

2.49

205

1844

Congenital deformities of feet

168

1408

1.23

1.66

3.6

3.9

2.75

1.93

ug/l

0.33

157

1287

Pigmented purpuric dermatosis

118

971

1.32

1.65

5.4

4.8

2.35

2.60

ug/l

0.18

109

874

Alzheimer disease

4786

33991

1.04

1.65

4.8

5.9

6.84

4.94

ug/l

0.67

4041

29651

Other necrotizing vasculopathies

790

7334

1.11

1.65

4.8

5.2

3.59

3.21

ug/l

0.12

690

6523

Fall involving bed

375

3369

1.16

1.65

4.7

5.5

8.81

3.74

ug/l

0.44

328

2956

Malignant neoplasm of lip, including Hilmo

169

1451

1.28

1.64

5.1

4.1

2.78

2.24

ug/l

0.53

150

1277

Tularaemia

229

1996

1.22

1.64

5.0

4.6

1.86

2.49

ug/l

1.61

220

1804

Disorder of the sleep-wake schedule

164

1381

1.24

1.64

3.8

4.2

2.19

2.13

ug/l

0.03

147

1245

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

15886

100009

1.02

1.64

5.0

4.7

4.02

3.15

ug/l

0.99

14163

90028

Other disorders of iris and ciliary body

327

2917

1.18

1.64

4.5

4.9

2.06

2.91

ug/l

1.45

282

2603

Other bursitis of hip

154

1285

1.25

1.64

5.2

4.9

3.98

2.87

ug/l

0.31

136

1122

Other pulmonary heart/vessel disease

495

5418

0.88

1.63

4.3

5.4

2.54

4.49

ug/l

1.60

419

4774

Melanocytic naevi of scalp and neck

228

1976

1.20

1.63

4.9

4.8

2.02

2.49

ug/l

0.91

206

1763

Nosocomial condition (hospital)

560

1.43

1.63

4.9

4.7

1.75

2.36

ug/l

1.03

499

Sequelae of injuries of lower limb

1073

10070

1.09

1.63

4.3

4.2

1.70

2.46

ug/l

4.27

966

9148

Benign neoplasm: Cerebral meninges

639

5855

1.11

1.63

5.9

5.3

2.56

3.96

ug/l

1.11

570

5177

Salpingitis and oophoritis

105

1.81

1.62

1.4

1.1

—

1.07

—

Venous thromboembolism

8298

78376

1.03

1.62

5.1

3.45

3.63

ug/l

0.19

7355

69983

Papilloedema, unspecified

198

1696

1.22

1.62

5.2

4.7

9.11

2.48

ug/l

0.64

176

1520

Giant cell arteritis with polymyalgia rheumatica

386

3474

1.16

1.61

5.6

5.5

5.01

3.03

ug/l

0.39

337

3063

Asthma, hospital admissions 3, pneumonia

4850

46986

1.04

1.61

4.6

5.1

3.25

4.05

ug/l

1.07

4304

41723

Asthma-related pneumonia or sepsis

4850

46986

1.04

1.61

4.6

5.1

3.25

4.05

ug/l

1.07

4304

41723

Asthma-related pneumonia

4843

46920

1.04

1.61

4.6

5.1

3.25

4.06

ug/l

1.07

4298

41664

Other specified/unspecified soft tissue disorders

367

3271

1.15

1.61

4.9

2.65

3.38

ug/l

0.68

333

2873

Poisoning by drugs, medicaments and biological substances

2258

21580

1.06

1.61

3.5

3.9

2.11

2.33

ug/l

0.16

1949

19680

Benign neoplasm: Long bones of lower limb

334

2976

1.16

1.61

4.7

4.2

1.89

2.04

ug/l

0.30

303

2713

Other congenital malformations

523

4739

1.12

1.61

3.8

4.3

1.80

2.32

ug/l

1.46

482

4265

Other salmonella infections

459

4162

1.14

1.60

4.9

4.5

2.05

3.58

ug/l

0.89

408

3745

Other misadventures during surgical and medical care

278

2461

1.19

1.60

5.6

4.9

3.13

2.51

ug/l

0.66

251

2193

Poisoning by medicine

2003

19091

1.06

1.60

3.4

3.9

2.18

2.35

ug/l

0.10

1733

17412

Family history of certain disabilities and chronic diseases leading to disablement

290

2541

1.16

1.60

4.3

3.8

1.86

1.99

ug/l

0.27

261

2303

Heart failure, strict

10887

78177

0.97

1.60

4.7

5.3

3.32

3.66

ug/l

0.58

9480

69965

Frostbite with tissue necrosis

448

0.61

1.60

3.8

4.8

1.24

2.72

ug/l

1.31

398

Bullous disorders

684

6331

1.11

1.60

4.8

5.2

3.72

3.95

ug/l

0.05

613

5619

Retinal haemorrhage

284

2515

1.19

1.60

5.2

5.1

2.31

2.60

ug/l

0.31

252

2228

Other blood glucose lowering drugs, excl. Insulins

2420

23263

1.06

1.60

4.8

5.3

3.00

3.70

ug/l

0.45

2141

20889

Papillary adenocarcinoma of thyroid gland

326

2884

1.16

1.60

5.2

3.5

2.06

1.78

ug/l

1.07

295

2580

Unspecified mental disorder

4524

46651

0.96

1.60

3.7

4.2

2.46

2.65

ug/l

0.17

4004

42397

Lactose intolerance, other/unspecified

196

1673

1.21

1.59

4.6

4.5

1.47

3.01

ug/l

1.96

185

1501

Benign neoplasm: Lip

265

2342

1.20

1.59

5.5

5.0

4.08

2.81

ug/l

0.36

224

2080

Autism spe, excluding more controls

774

1.29

1.59

2.5

2.6

1.20

ug/l

0.00

722

Ectopic pregnancy

1.95

1.59

1.3

1.1

—

2.15

—

Pemphigoid

336

3015

1.17

1.58

4.9

5.6

5.66

3.65

ug/l

0.27

304

2645

Bursitis of shoulder

250

2189

1.19

1.58

5.1

4.5

7.01

2.83

ug/l

0.41

229

1956

Other respiratory diseases principally affecting the interstitium

2801

29011

0.95

1.57

4.8

5.4

3.26

3.93

ug/l

0.54

2434

25707

Periodontal disease, other/unspecified

248

2170

1.19

1.56

5.3

4.7

3.97

2.15

ug/l

0.47

221

1943

Nail disorders

802

7454

1.10

1.55

4.4

4.3

1.86

2.30

ug/l

1.70

738

6735

Injury of nerves at forearm level

173

1488

1.25

1.55

4.7

4.3

1.96

2.11

ug/l

0.20

160

1361

Other congenital malformations of male genital organs

477

1.41

1.55

4.0

1.75

1.70

ug/l

0.04

426

Other and unspecified injuries of wrist and hand

318

2822

1.16

1.55

5.0

4.3

1.86

2.19

ug/l

0.76

283

2576

Suppurative and unspecified otitis media

3026

27870

0.96

1.55

3.9

4.0

1.90

2.66

ug/l

2.40

2703

25297

Multiple system atrophy (rare forms of Parkinsonism)

355

0.58

1.54

3.5

5.7

3.94

2.72

ug/l

0.33

314

Bullous pemphigoid

282

2515

1.19

1.54

4.7

5.6

2.31

3.67

ug/l

1.95

255

2204

Benign neoplasm: Skin of scalp and neck

281

2491

1.18

1.54

5.2

5.1

2.29

3.04

ug/l

0.94

255

2209

Convalescence

448

4056

1.13

1.54

4.8

2.11

2.29

ug/l

0.61

397

3646

Bacterial intestinal infections, IBD co-morbidities

2312

22186

1.06

1.53

4.9

5.0

3.39

3.62

ug/l

0.15

2080

19769

Epiphora

173

1472

1.22

1.53

5.4

5.1

2.53

2.95

ug/l

0.35

156

1298

Undescended testis, unilateral

495

1.39

1.53

4.0

4.2

1.54

1.89

ug/l

0.72

439

Pediculosis, acariasis and other infestations

802

7492

1.10

1.53

4.0

4.2

1.68

2.13

ug/l

2.39

710

6835

Other and unspecified syphilis

389

0.60

1.52

4.1

3.9

2.15

1.83

ug/l

0.31

352

Contact with other sharp object(s)

747

6940

1.10

1.52

4.6

4.0

2.30

2.01

ug/l

0.25

673

6335

Hyperkinetic disorders (excl. ADHD)

632

1.32

1.52

2.1

2.2

0.82

1.11

ug/l

2.65

589

Foreign body or object entering through skin

862

8077

1.10

1.51

4.4

4.2

2.65

2.24

ug/l

0.21

781

7336

Horner syndrome

143

1210

1.27

1.51

4.1

4.5

1.81

2.39

ug/l

1.02

125

1094

Intestinal malabsorption

486

4438

1.13

1.51

4.3

4.6

1.89

2.64

ug/l

1.84

428

3999

Other specified disorders of muscle

342

3073

1.16

1.50

4.0

4.1

2.12

2.48

ug/l

0.32

307

2747

Diseases of peritoneum

1085

11510

0.92

1.50

4.4

5.0

2.28

3.63

ug/l

2.71

987

10268

Fracture of skull and facial bones

3143

30372

1.05

1.50

4.3

4.39

2.74

ug/l

0.47

2803

27607

Hypocalcemia

239

2102

1.19

1.49

5.4

4.9

8.31

2.49

ug/l

2.26

208

1888

Chromophobe cell carcinoma of kidney

755

1.41

1.49

5.1

4.0

4.25

2.03

ug/l

0.49

673

Other bursal cyst

170

1458

1.23

1.49

6.4

4.8

1.99

3.17

ug/l

1.03

161

1285

Vitreous haemorrhage

1400

13317

1.08

1.48

4.8

5.0

2.96

3.23

ug/l

0.15

1238

11951

Chronic pancreatitis

2126

22068

0.94

1.48

4.3

4.7

3.03

3.08

ug/l

0.02

1898

19926

Diabetic maculopathy, excluding more controls

1489

15624

0.93

1.48

3.6

4.9

1.80

3.54

ug/l

5.05

1321

14113

Other superficial mycoses

240

2113

1.19

1.47

4.5

4.3

1.88

2.18

ug/l

0.50

218

1914

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

119

0.35

1.47

3.7

5.3

3.21

2.44

ug/l

—

104

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1631

15608

1.07

1.47

4.6

3.9

2.66

2.03

ug/l

2.34

1405

13983

Melanocytic naevi of upper limb, including shoulder

208

1806

1.20

1.47

5.9

5.0

2.20

3.16

ug/l

0.93

192

1614

Acute generalized exanthematous pustulosis

372

3347

1.14

1.47

5.2

5.0

2.78

3.05

ug/l

0.15

328

2968

Injuries involving multiple body regions

382

3451

1.14

1.46

4.5

4.4

1.76

2.69

ug/l

1.95

338

3109

Microscopic polyangiitis

571

1.40

1.46

4.4

5.1

2.71

2.64

ug/l

0.03

503

Appendectomy

7684

71799

1.03

1.45

4.3

2.44

2.74

ug/l

0.69

6960

65115

Hereditary corneal dystrophies

289

2569

1.16

1.45

5.0

5.2

2.42

3.08

ug/l

0.53

255

2282

Benign neoplasm: Skin of trunk

425

3865

1.13

1.44

5.5

4.9

2.80

2.65

ug/l

0.11

387

3448

Sixth [abducent] nerve palsy

436

3990

1.14

1.44

5.4

5.2

3.16

3.01

ug/l

0.10

383

3552

Autism

102

821

1.27

1.44

2.5

1.16

1.12

ug/l

0.12

751

Iridocyclitis in diseases classified elsewhere

209

1827

1.20

1.44

4.7

2.97

2.43

ug/l

0.28

186

1650

Abscess of anal and rectal regions

1292

12278

1.08

1.43

4.2

2.46

2.85

ug/l

0.34

1168

11176

Adenocarcinoma and papilloma adenocarcinoma of rectum

1560

14924

1.07

1.43

4.6

3.9

2.66

2.02

ug/l

2.26

1347

13363

Corneal scars and opacities

317

2849

1.16

1.43

5.1

4.8

1.98

2.73

ug/l

1.35

289

2551

Parkinson's disease, including avohilmo

2652

25643

1.06

1.43

5.0

5.5

4.45

3.95

ug/l

0.19

2349

22699

Other salmonella infections

402

3651

1.14

1.43

5.1

4.7

2.09

3.80

ug/l

0.85

351

3270

Malignant neoplasm of floor of mouth

782

0.71

1.43

4.7

3.7

2.26

1.92

ug/l

0.33

693

Other specified and unspecified disorders of eyelid

165

1422

1.24

1.42

5.1

5.0

1.74

2.81

ug/l

2.32

151

1260

Viral pneumonia (unknown virus, not influenza)

880

8263

1.09

1.42

4.2

4.6

2.93

2.73

ug/l

0.08

797

7456

Injury of muscle and tendon at ankle and foot level

297

2661

1.17

1.42

4.9

4.4

2.40

2.31

ug/l

0.07

275

2406

Other abnormal auditory perceptions

597

1.33

1.42

5.0

4.4

1.68

2.05

ug/l

0.66

530

Other abnormal findings of blood chemistry

524

4824

1.12

1.42

4.5

2.72

2.39

ug/l

0.46

472

4311

Otosclerosis

751

6998

1.10

1.42

5.4

5.0

2.13

3.00

ug/l

2.67

656

6253

Other septicaemia

6386

60023

1.03

1.42

5.0

5.2

4.96

3.44

ug/l

1.04

5647

53379

Osteoporosis

1782

15866

1.06

1.42

5.2

2.65

3.97

ug/l

2.62

1513

14042

Malignant neoplasm of ureter, including Hilmo

145

1260

1.30

1.41

4.8

4.2

2.25

2.09

ug/l

0.16

124

1103

Other secondary coxarthrosis

375

3399

1.14

1.41

4.5

4.8

2.03

2.78

ug/l

1.18

332

3017

Benign neoplasm: Liver/bile ducts

196

1696

1.19

1.41

5.4

4.8

2.68

2.27

ug/l

0.58

185

1515

Diabetes insipidus

693

1.32

1.40

4.8

4.4

2.88

2.20

ug/l

0.26

622

Inflammation of lacrimal passages (acute and unspecified)

118

976

1.25

1.40

3.8

4.7

5.85

2.37

ug/l

0.66

107

868

Dislocation, sprain and strain of joints and ligaments of elbow

479

4370

1.12

1.40

4.0

1.78

1.96

ug/l

0.52

437

3967

Other arterial embolism and thrombosis

344

3786

0.87

1.40

4.6

5.4

4.56

4.36

ug/l

0.03

298

3345

Persistent mood disorders

1894

18109

1.06

1.40

4.3

4.5

2.17

3.11

ug/l

2.04

1661

16402

Allergic urticaria

536

4910

1.11

1.39

4.7

4.4

2.33

2.40

ug/l

0.05

484

4397

Anomalies of dental arch relationship, including avohilmo

1399

11945

1.06

1.39

4.5

4.1

1.84

2.25

ug/l

1.74

1237

10881

Lower leg

408

1.42

1.39

4.9

4.6

3.08

2.26

ug/l

0.49

358

Nonalcoholic steatohepatitis

742

1.32

1.39

4.5

4.1

1.51

2.17

ug/l

0.59

677

Superficial injuries involving multiple body regions

256

2267

1.17

1.39

4.6

4.4

1.83

2.20

ug/l

0.98

224

2040

Dialysis

584

5433

1.12

1.38

3.3

4.8

1.91

2.76

ug/l

2.30

562

4880

Other specific arthropathies, wide

209

1827

1.19

1.38

4.3

4.4

2.05

2.52

ug/l

0.86

194

1636

Iron deficiency

718

1.28

1.37

4.6

1.68

2.46

ug/l

0.94

640

Generalized epilepsy, mode (most common among epilepsy diagnosis)

190

2191

0.84

1.37

3.2

4.2

1.43

2.22

ug/l

2.85

172

1981

Ingrowing nail

519

4773

1.11

1.36

3.9

4.0

1.70

2.04

ug/l

1.39

473

4336

Pedal cyclist injured in other and unspecified transport accidents

1282

12171

1.07

1.36

4.4

4.3

2.00

2.42

ug/l

1.69

1158

11028

Other sexually transmitted chlamydial diseases

433

3921

1.11

1.36

3.0

2.6

1.55

1.36

ug/l

0.44

390

3619

Amyloidosis, other/unspecified

251

2246

1.19

1.36

4.9

5.4

2.25

3.33

ug/l

1.52

222

1984

Severe visual impairment, binocular

468

1.41

1.36

6.4

5.0

1.91

2.39

ug/l

0.59

408

Autoimmune hyperthyroidism

299

2656

1.14

1.36

4.4

4.6

2.29

2.42

ug/l

0.17

260

2379

Purpura and other haemorrhagic conditions

1682

16091

1.06

1.35

4.6

5.0

2.98

3.61

ug/l

0.60

1478

14417

Chondromalacia

296

2655

1.16

1.35

5.6

4.5

2.12

2.21

ug/l

0.13

262

2402

Other and unspecified injuries of abdomen, lower back and pelvis

144

1226

1.23

1.35

4.8

4.5

2.28

2.25

ug/l

0.01

133

1094

Other and unspecified injuries of neck

614

1.33

1.35

4.0

4.1

1.65

1.82

ug/l

0.26

549

Malignant neoplasm of other connective and soft tissue, including Hilmo

528

4884

1.12

1.35

4.9

3.8

2.70

1.95

ug/l

1.59

467

4378

Mixed specific developmental disorders

245

1.45

1.34

1.7

0.82

0.94

ug/l

0.64

225

Septal defects

473

4233

1.11

1.34

4.5

4.4

1.67

2.37

ug/l

2.08

403

3833

Myocardial infarction, strict

9349

65406

1.03

1.33

4.8

5.1

3.17

3.50

ug/l

0.39

8265

58944

Diastasis of muscle

671

1.32

5.3

4.6

1.81

2.65

ug/l

0.87

604

Disorders of gallbladder, biliary tract and pancreas

15656

97233

1.02

1.32

5.0

4.8

2.90

3.37

ug/l

1.63

13939

87467

Seropositive rheumatoid arthritis, strict definition

1203

12699

0.94

1.32

4.4

5.0

2.34

3.56

ug/l

1.94

1083

11362

Multiple myeloma, including Hilmo

613

5718

1.11

1.32

4.8

3.9

3.08

2.10

ug/l

2.06

545

5085

Osteitis due to dental implant

659

1.34

1.31

5.2

5.0

2.34

2.53

ug/l

0.13

584

Bronchitis, not specified as acute or chronic

1166

11070

1.08

1.31

4.4

4.5

3.16

3.27

ug/l

0.05

1058

10001

Collapsed vertebra, not elsewhere classified

564

1.34

1.31

5.4

5.0

3.90

2.52

ug/l

0.71

496

Other and unspecified syphilis

471

0.66

1.31

3.6

3.7

1.94

1.69

ug/l

0.30

431

Decubitus ulcer and pressure area

794

8433

0.91

1.31

4.2

5.3

2.52

4.07

ug/l

1.93

693

7464

Acute gastritis

938

8851

1.08

1.30

4.8

4.9

3.27

4.10

ug/l

0.24

834

7921

Osteomyelitis

949

10006

0.92

1.30

4.4

5.0

7.91

3.80

ug/l

0.32

817

8978

Artificial opening status

748

7027

1.10

1.30

4.8

5.0

3.04

3.09

ug/l

0.04

629

6301

Adrenocortical insufficiency

301

2700

1.15

1.30

5.1

4.8

6.90

2.98

ug/l

0.47

271

2419

Mental and behavioural disorders due to opioids

329

2964

1.14

1.30

3.2

3.0

1.14

1.62

ug/l

2.39

265

2732

Benign neoplasm of middle ear and respiratory system

1171

11148

1.08

1.30

5.0

4.9

2.73

3.53

ug/l

0.91

1046

9988

Tibial collateral bursitis [Pellegrini-Stieda]

716

1.29

4.1

4.3

1.26

1.97

ug/l

2.85

649

Paget disease

653

1.38

1.28

5.9

5.3

2.31

2.73

ug/l

0.35

579

Other and unspecified acne

768

1.27

4.1

3.9

1.70

2.05

ug/l

0.32

698

Other congenital malformations of face and neck

244

2164

1.16

1.27

4.5

4.2

2.32

2.02

ug/l

0.44

217

1963

Tick-borne viral encephalitis

458

1.42

1.27

5.2

4.7

3.07

1.88

ug/l

0.48

410

Dissocial personality disorder

202

2268

0.84

1.27

3.3

3.4

5.79

1.74

ug/l

0.46

168

2095

Thrombocytopenia, unspecified

963

9118

1.08

1.27

4.7

5.1

3.60

3.57

ug/l

0.01

828

8148

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

128

1110

1.29

1.26

4.6

4.0

2.04

2.01

ug/l

0.03

112

979

Diseases of the myoneural junction and muscle

1682

16141

1.06

1.26

4.4

4.9

3.28

3.62

ug/l

0.26

1475

14466

Chronic lymphocytic leukaemia, helper endpoint

433

4007

1.14

1.26

4.9

4.0

9.59

2.09

ug/l

0.52

390

3570

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

433

4007

1.14

1.26

4.9

4.0

9.59

2.09

ug/l

0.52

390

3570

Chronic lymphocytic leukaemia

433

4007

1.14

1.26

4.9

4.0

9.59

2.09

ug/l

0.52

390

3570

Chronic iridocyclitis

457

4197

1.12

1.26

4.8

4.7

3.80

2.61

ug/l

0.49

408

3785

Gastric ulcer

2672

27589

0.95

1.26

4.9

5.2

2.73

4.01

ug/l

3.33

2370

24415

Benign neoplasm: Small intestine

467

4313

1.12

1.26

5.2

5.3

2.28

2.99

ug/l

1.21

412

3832

Malignant neoplasm of bone and articular cartilage

120

1023

1.26

1.25

4.2

3.8

3.30

1.94

ug/l

0.69

108

901

Personality disorders

2524

24336

1.05

1.25

3.7

3.9

2.09

2.11

ug/l

0.01

2234

22287

Encephalopathy

115

1340

0.79

1.25

3.2

5.0

1.46

3.24

ug/l

2.51

101

1193

Open wound of thorax

176

1996

0.83

1.25

3.8

4.1

1.69

2.07

ug/l

0.90

149

1834

Other articular cartilage disorders

318

2891

1.15

1.25

4.5

2.03

2.99

ug/l

1.60

297

2600

Other and/or unspecified nontoxic goitre

396

3595

1.11

1.25

5.4

5.2

2.13

3.27

ug/l

2.46

359

3189

Otorrhagia

758

1.31

1.24

4.4

4.7

2.00

2.51

ug/l

0.51

671

Primary gonarthrosis, bilateral

7759

65166

1.03

1.24

5.4

5.2

2.56

3.58

ug/l

5.32

6972

58104

Other injuries of upper limb, level unspecified

146

1263

1.23

1.24

4.5

4.6

2.89

2.17

ug/l

0.43

134

1128

Benign neoplasm: Parathyroid gland

804

1.27

1.24

5.7

5.2

1.99

2.87

ug/l

0.88

713

Rare circulating lymphoid malignancy

710

0.73

1.24

4.1

4.0

1.94

2.18

ug/l

0.38

610

Follow-up care involving plastic surgery

219

1925

1.16

1.24

5.8

5.2

1.93

2.32

ug/l

1.35

167

1696

D07AA Corticosteroids, weak (group I)

1234

11690

1.06

1.23

4.3

4.4

1.94

3.02

ug/l

2.15

1085

10512

Nondiabetic hypoglycaemic coma

324

0.62

1.23

2.8

4.3

1.02

1.76

ug/l

4.33

286

Burns and corrosions

1846

17745

1.06

1.23

4.3

2.09

2.87

ug/l

1.57

1667

16127

Polyarthritis, unspecified

380

3471

1.13

1.23

4.8

4.7

2.19

2.98

ug/l

1.54

338

3097

Cardiomyopathy in other diseases

768

1.34

1.23

5.3

5.4

2.76

3.10

ug/l

0.23

690

Hemiplegia

457

4959

0.90

1.23

4.5

5.0

3.36

4.06

ug/l

0.21

406

4397

Other acquired deformities of musculoskeletal system and connective tissue

540

5017

1.11

1.23

4.5

4.3

2.08

2.33

ug/l

0.39

490

4543

Cholesteatoma of middle ear

702

6597

1.10

1.23

5.2

5.1

3.07

3.92

ug/l

0.44

614

5895

Other disorders of adrenal gland

371

3377

1.12

1.22

5.0

4.8

6.17

2.94

ug/l

0.48

333

3021

Polycythaemia vera

427

3938

1.13

1.22

4.5

3.8

1.97

2.00

ug/l

0.06

384

3509

Dacryoadenitis

479

1.35

1.22

4.9

4.5

2.39

2.88

ug/l

0.25

426

Contusion of toe(s) with damage to nail

117

992

1.25

1.21

4.6

4.3

1.92

2.33

ug/l

0.27

100

889

Other orthopaedic follow-up care

590

5491

1.10

1.21

4.6

1.77

2.36

ug/l

2.03

540

4942

Other degenerative diseases of the basal ganglia

279

2547

1.18

1.21

4.7

5.6

4.23

3.26

ug/l

0.21

245

2248

Other diseases of pericardium

675

6347

1.10

1.20

4.7

5.2

1.94

3.48

ug/l

1.71

605

5741

Paralytic ileus

557

5200

1.11

1.20

4.4

4.9

3.71

3.66

ug/l

0.01

477

4634

Specific personality disorders

2067

19868

1.05

1.20

3.7

3.9

2.32

2.07

ug/l

0.25

1825

18152

Calcaneal spur

795

1.26

1.20

4.5

4.6

2.69

2.43

ug/l

0.11

707

L02BA Anti-estrogens

106

872

1.22

1.20

5.8

4.5

1.98

2.45

ug/l

0.48

687

Benign neoplasm: salivary glands, exclude unknown (D119)

1124

10703

1.07

1.19

5.0

2.30

3.38

ug/l

1.89

993

9585

Second line medication for Crohn's disease

6853

67084

1.03

1.19

4.2

4.6

2.24

2.91

ug/l

3.20

6159

60646

Personal history of certain other diseases

590

1.28

1.19

4.6

3.9

1.54

1.78

ug/l

0.35

528

Other diseases of liver

2092

20160

1.05

1.19

4.6

2.11

3.01

ug/l

2.11

1858

18207

Other/unspecified reactive arthropathies

673

6299

1.09

1.18

4.6

4.5

2.50

2.57

ug/l

0.06

613

5685

Other disorders of urethra and urinary system

8299

61053

0.98

1.18

6.2

5.1

5.18

3.75

ug/l

1.09

7315

54003

Acquired absence of organs, not elsewhere classified

159

1395

1.22

1.17

4.1

4.8

4.09

3.26

ug/l

0.20

145

1229

Parapsoriasis

209

1858

1.18

1.17

4.9

4.8

1.80

2.46

ug/l

1.78

184

1667

Anisometropia and aniseikonia

265

2378

1.15

1.17

4.9

2.20

3.03

ug/l

1.01

230

2134

Allergic colitis

351

1.35

1.17

4.6

3.6

1.65

2.70

ug/l

0.53

310

Benign neoplasm: Other and unspecified parts of mouth

375

3441

1.13

1.17

5.2

4.9

1.89

2.51

ug/l

2.22

337

3086

Desensitization to allergens

244

2165

1.14

1.16

3.7

3.1

1.28

1.62

ug/l

1.23

225

1989

Crohn's disease of small intestine

661

6181

1.09

1.16

4.3

4.2

1.89

2.31

ug/l

1.42

607

5588

Crushing injury of wrist and hand

286

2628

1.18

1.16

4.3

4.6

2.13

2.79

ug/l

0.76

263

2377

Unspecified protein-energy malnutrition

423

1.37

1.16

3.8

4.9

2.37

3.45

ug/l

0.49

351

Benign neoplasm: Appendix

131

1133

1.23

1.15

6.0

5.1

2.43

2.87

ug/l

0.32

117

1005

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

651

1.30

1.15

5.3

4.9

1.61

2.50

ug/l

1.08

584

Gout due to impairment of renal function

195

1761

1.22

1.14

4.3

5.2

2.37

2.68

ug/l

0.33

183

1569

Iron deficiency anaemia secondary to blood loss (chronic)

1890

18194

1.05

1.14

5.1

5.3

3.81

4.08

ug/l

0.15

1663

16159

Communicating hydrocephalus

189

2131

0.85

1.14

4.1

5.2

2.85

2.84

ug/l

0.00

172

1888

Abnormal findings in nipple discharge synovial fluid wound secretions

128

1096

1.22

1.14

4.4

4.49

1.90

ug/l

0.46

114

983

Other and unspecified myopathies

1265

12109

1.07

1.14

4.4

5.0

3.60

ug/l

0.00

1100

10820

Respiratory conditions due to other external agents

168

1910

0.85

1.14

4.8

5.4

3.56

3.23

ug/l

0.11

142

1684

Malnutrition

185

1629

1.18

1.14

4.0

5.1

3.05

2.75

ug/l

0.13

157

1433

Autism spe

810

1.23

1.14

2.5

1.20

1.12

ug/l

0.21

740

Glaucoma secondary to eye trauma

104

894

1.29

1.14

5.6

5.2

2.47

2.73

ug/l

0.22

792

Autonomic disorders

250

2250

1.15

1.14

4.4

4.8

2.23

2.97

ug/l

0.82

219

2009

ILD-related respiratory insufficiency

464

4966

0.89

1.14

4.4

5.5

2.15

3.33

ug/l

2.05

400

4402

Other aneurysm

939

8950

1.09

1.13

4.8

5.3

3.32

4.07

ug/l

0.33

821

7944

Anomalies of pupillary function

135

1156

1.20

1.13

5.3

4.3

2.66

2.32

ug/l

0.19

119

1047

Generalized skin eruption due to drugs and medicaments

316

2867

1.13

5.3

5.1

2.83

3.16

ug/l

0.16

277

2546

Other disorders of binocular movement

148

1277

1.19

1.13

4.7

4.6

16.88

2.32

ug/l

0.73

137

1148

Benign neoplasm: Parotid gland

1017

9678

1.07

1.13

5.0

2.34

3.06

ug/l

2.72

896

8659

L04AX Other immunosuppressants

6665

65277

1.03

1.12

4.2

4.7

2.25

2.93

ug/l

3.15

5989

58985

Encephalocele

2.57

1.12

2.6

5.8

1.09

2.13

ug/l

—

Other congenital malformations of skin

278

2503

1.13

1.12

3.9

4.5

1.76

2.18

ug/l

1.08

258

2256

Hypercalcemia

435

4021

1.11

1.12

4.8

5.2

4.88

3.03

ug/l

0.97

387

3575

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

304

1.46

1.12

6.5

3.6

2.21

1.97

ug/l

0.15

272

Crohn disease

1362

13021

1.06

1.11

4.1

4.2

2.05

2.40

ug/l

0.85

1243

11801

Pedal cyclist injured in transport accident

2644

25614

1.04

1.11

4.5

4.4

2.13

2.69

ug/l

1.60

2384

23251

Benign neoplasm: Liver

163

1421

1.18

1.11

5.6

4.7

2.80

2.29

ug/l

0.62

152

1267

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

583

1.37

1.11

4.0

2.18

2.20

ug/l

0.01

517

Benign neoplasm: Spinal cord

164

1445

1.20

1.10

5.4

4.7

2.17

2.22

ug/l

0.06

146

1302

Malignant neoplasm of oral cavity, including Hilmo

575

6120

0.91

1.10

4.4

3.7

3.61

1.89

ug/l

1.11

500

5519

Fracture of lower leg, including ankle

6998

67920

1.03

1.10

4.5

2.47

2.96

ug/l

1.87

6272

61397

Hereditary ataxia

132

1512

0.83

1.10

5.0

2.62

2.91

ug/l

0.19

109

1360

Pericarditis

543

5089

1.11

1.10

4.6

4.9

2.08

3.46

ug/l

1.04

488

4592

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

132

1140

1.21

1.09

4.8

4.6

2.11

2.37

ug/l

0.27

119

1023

Symptoms and signs involving emotional state

219

1949

1.15

1.09

4.3

4.2

3.73

2.33

ug/l

0.44

193

1752

Hypertrophy of tongue papillae

129

1115

1.21

1.08

5.2

4.9

1.75

2.67

ug/l

1.42

124

1001

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

252

2296

1.17

1.08

4.2

3.8

2.24

1.94

ug/l

0.30

240

2105

Hyphaema and other vascular disorders of iris and ciliary body

260

2362

1.15

1.08

4.5

5.0

2.19

3.14

ug/l

1.23

223

2098

Infection of intervertebral disc (pyogenic)

220

1998

1.19

1.08

5.3

4.9

1.97

2.66

ug/l

1.78

191

1759

Sequelae of tuberculosis

169

1912

0.85

1.08

4.7

5.5

3.30

6.50

ug/l

0.70

149

1642

Disorders in reading

482

1.29

1.08

2.2

2.5

0.92

1.30

ug/l

2.09

446

Agranulocytosis

1002

10541

0.94

1.08

5.1

5.0

4.45

2.81

ug/l

1.83

877

9415

Sequelae of injuries of neck and trunk

389

3598

1.12

1.07

4.4

4.5

2.02

2.49

ug/l

0.61

349

3257

Non-ischemic cardiomyopathy

4935

40567

0.97

1.07

4.9

5.5

4.15

3.97

ug/l

0.12

4289

36204

Osteomyelitis of vertebra

449

1.42

1.07

4.4

5.0

1.65

3.21

ug/l

1.23

401

Other problems related to primary support group, including family circumstances

497

4468

1.09

1.07

3.9

3.8

1.66

1.86

ug/l

0.61

452

4062

Folate deficiency anaemia

135

1185

1.23

1.07

4.7

5.0

2.22

3.39

ug/l

0.99

119

1049

Malignant neoplasm of trachea, including Hilmo

111

0.45

1.07

2.2

4.3

4.27

2.39

ug/l

—

Other and unspecified mononeuropathies, also in other diseases

322

2947

1.13

1.06

4.7

4.8

1.78

3.10

ug/l

2.64

282

2649

Tick-borne viral encephalitis

496

1.35

1.06

5.1

4.6

2.98

1.88

ug/l

0.46

445

Epilepsy

4135

42232

0.97

1.06

4.2

4.8

3.06

3.37

ug/l

0.46

3682

37896

Glomerulonephritis

1372

13175

1.06

4.2

4.8

2.81

3.07

ug/l

0.23

1241

11850

Helminthiases

244

2187

1.14

1.06

4.8

4.3

5.31

2.30

ug/l

0.41

221

1967

Acquired stenosis of external ear canal

186

1685

1.22

1.06

5.3

4.8

2.00

2.22

ug/l

0.40

164

1522

Injury of muscle and tendon at forearm level

263

2397

1.15

1.06

4.5

4.1

1.95

2.07

ug/l

0.21

244

2177

Contusion of toe(s) without damage to nail

173

1520

1.17

1.06

4.2

2.08

2.24

ug/l

0.12

162

1379

Malignant neoplasm of other and ill-defined sites

288

0.63

1.06

5.5

3.9

2.30

2.40

ug/l

0.05

249

Hypothermia

250

2736

0.87

1.05

4.5

5.0

6.03

2.86

ug/l

0.61

206

2447

Third [oculomotor] nerve palsy

217

1954

1.16

1.05

5.3

5.1

9.38

2.72

ug/l

0.44

193

1731

Burns and corrosions of external body surface, specified by site

1396

13399

1.06

1.05

4.2

4.3

2.11

3.09

ug/l

1.50

1260

12132

Blindness, monocular

101

861

1.25

1.05

5.0

1.58

2.78

ug/l

1.93

767

Acute myeloid leukaemia, helper endpoint

1050

0.80

1.05

4.3

3.9

2.18

2.09

ug/l

0.10

916

Acute myeloid leukaemia

1050

0.80

1.05

4.3

3.9

2.18

2.09

ug/l

0.10

916

Acute myeloid leukaemia, including Hilmo

1050

0.80

1.05

4.3

3.9

2.18

2.09

ug/l

0.10

916

Other disorders of amniotic fluid and membranes

2.00

1.04

1.0

1.1

—

0.54

—

Other psoriatic arthropathies

1182

11301

1.06

1.04

4.3

4.4

1.92

2.43

ug/l

1.99

1050

10230

Asymptomatic human immunodeficiency virus [HIV] infection status

883

0.77

1.04

3.2

1.70

1.46

ug/l

0.51

823

Vertical strabismus

319

2917

1.12

1.04

4.9

2.05

2.77

ug/l

1.18

289

2615

Disseminated intravascular coagulation [defibrination syndrome]

309

0.64

1.04

4.9

4.4

1.23

3.04

ug/l

1.01

271

Polyglandular dysfunction

117

1.67

1.04

4.1

4.3

1.00

1.89

ug/l

2.13

105

Nontoxic diffuse goitre

140

1209

1.18

1.03

5.8

5.1

2.69

2.70

ug/l

0.01

124

1069

Corns and callosities

758

7168

1.08

1.03

4.3

4.8

2.01

2.69

ug/l

2.11

688

6413

Other and unspecified corneal deformities and disorders

314

2871

1.12

1.03

4.9

4.4

2.27

2.21

ug/l

0.06

291

2596

Valgus deformity, not elsewhere classified

427

1.32

1.03

5.0

4.4

2.33

2.15

ug/l

0.12

386

Nephropathy related operations

2051

19892

1.05

1.03

3.5

4.9

2.39

3.24

ug/l

1.41

1896

17899

Endometriosis

103

1.48

1.03

1.2

1.1

—

0.03

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

335

3004

1.11

1.02

3.6

1.44

1.82

ug/l

1.73

300

2745

Malignant neoplasm of floor of mouth, including Hilmo

104

1194

0.80

1.02

4.7

3.7

5.62

2.01

ug/l

0.77

1062

Isolated proteinuria

377

3495

1.12

1.02

4.3

4.9

2.06

2.46

ug/l

1.22

340

3122

Essential (haemorrhagic) thrombocythaemia

389

3597

1.11

1.02

4.3

3.8

3.88

1.94

ug/l

0.66

331

3225

Viral meningitis

255

2301

1.13

1.01

3.5

3.7

1.55

1.94

ug/l

0.77

232

2099

Disorders of brain, other and unspecified

1035

0.80

1.01

4.1

4.9

1.78

2.63

ug/l

1.38

914

Chronic viral hepatitis

489

5243

0.91

1.01

3.0

3.3

2.03

1.73

ug/l

0.16

411

4830

Myeloid leukaemia

290

3161

0.88

1.01

4.3

5.1

3.80

2.85

ug/l

0.20

264

2803

Secondary and unspecified malignant neoplasm of lymph nodes

1145

10969

1.07

1.01

4.7

3.8

4.11

1.95

ug/l

1.79

1019

9833

Inflammatory diseases of the central nervous system

915

8698

1.07

1.01

4.5

2.38

2.61

ug/l

0.26

833

7859

Benign neoplasm: Epididymis

720

1.42

1.01

5.3

4.6

2.07

2.42

ug/l

0.30

648

Recurrent and persistent haematuria

105

904

1.24

1.01

5.3

5.1

3.86

2.72

ug/l

0.51

819

Hypoplasia of dental enamel

1.89

1.01

2.4

2.8

0.95

1.28

ug/l

—

Myelodysplastic syndrome, including Hilmo

421

3927

1.11

1.00

5.0

4.0

2.11

2.16

ug/l

0.10

361

3464

MS-disease / Multiple Sclerosis

418

3856

1.10

1.00

3.5

4.0

1.58

1.93

ug/l

1.68

380

3515

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

855

8118

1.07

1.00

5.0

4.9

4.35

3.62

ug/l

0.18

738

7118

Erectile dysfunction, exclusion

646

0.73

1.00

4.2

5.1

2.11

2.84

ug/l

0.44

576

Scabies

577

5425

1.09

0.99

4.1

4.0

1.72

2.01

ug/l

0.85

509

4950

Hypersomnia

151

1332

1.19

0.99

4.7

4.5

1.92

2.28

ug/l

0.49

135

1194

Chronic mastoiditis

335

3094

1.13

0.99

5.0

5.2

2.19

3.30

ug/l

1.90

280

2745

Malignant neoplasm of bone and articular cartilage of limbs

419

1.36

0.99

4.0

3.8

2.06

2.10

ug/l

0.05

369

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

100

845

1.21

0.99

4.6

4.4

2.14

2.19

ug/l

0.03

751

Need for immunization against other single viral diseases

216

2381

0.87

0.99

3.8

4.3

16.40

2.16

ug/l

0.49

196

2159

Benign neoplasm: Skin of lower limb, including hip

262

2382

1.13

0.98

5.0

4.9

1.99

2.44

ug/l

1.01

233

2127

Optic atrophy

187

1672

1.16

0.98

4.5

4.7

1.80

2.41

ug/l

1.30

164

1503

Generalized epilepsy

276

3035

0.89

0.98

3.5

4.2

1.69

2.19

ug/l

1.69

250

2740

Poisoning by narcotics and psychodysleptics [hallucinogens]

128

1110

1.19

0.98

2.9

3.0

1.24

1.71

ug/l

0.68

106

1025

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

114

982

1.21

0.98

4.2

4.1

1.63

2.13

ug/l

0.72

104

888

Deep bite that required surgery

711

1.24

0.98

3.9

3.1

1.46

1.51

ug/l

0.11

659

Other specified/unspecified deforming dorsopathies

124

1071

1.19

0.98

5.0

4.2

3.43

2.37

ug/l

0.39

107

965

Other specified disorders of kidney and ureter

370

3426

1.11

0.98

4.6

4.9

2.69

2.74

ug/l

0.03

336

3054

Congenital malformations of genital organs

170

1481

1.15

0.97

4.4

4.1

1.70

2.16

ug/l

0.90

145

1316

Non-Hodgkin lymphoma, all

587

6212

0.92

0.97

4.3

3.9

3.42

2.15

ug/l

1.55

502

5512

Open wound of abdomen, lower back and pelvis

371

3436

1.11

0.97

4.1

4.2

3.95

2.08

ug/l

0.39

324

3113

Pure hyperglyceridaemia

343

3183

1.13

0.97

4.4

4.7

1.90

2.93

ug/l

1.92

296

2868

Psoriatic arthropathies, ICD10

1207

11569

1.06

0.97

4.3

4.5

1.91

2.43

ug/l

2.07

1069

10480

Specific development disorders of speech and language

332

2923

1.11

0.97

4.1

4.3

2.98

2.51

ug/l

0.24

292

2610

Other congenital malformations, not elsewhere classified

367

1.33

0.97

3.7

4.2

2.00

1.85

ug/l

0.14

327

Parkinson's disease

2519

24524

1.04

0.97

4.9

5.5

4.55

3.93

ug/l

0.23

2231

21725

Other retinal artery occlusion

341

3165

1.13

0.96

5.1

5.3

2.31

4.21

ug/l

0.81

299

2795

Osteomalacia

634

1.26

0.96

3.7

4.3

1.59

2.46

ug/l

0.96

579

Benign neoplasm: Short bones of upper limb

141

1239

1.18

0.95

4.4

1.85

2.23

ug/l

0.58

130

1119

Other diseases of pleura

8685

75026

1.02

0.95

5.0

5.3

3.84

3.81

ug/l

0.03

7484

66822

Implicit fungal Sepsis

483

4530

1.10

0.95

5.1

5.2

2.92

3.22

ug/l

0.26

430

4052

Other and unspecified primary disorders of muscles

628

1.27

0.95

4.3

4.2

1.65

1.87

ug/l

0.41

561

Viral infections of the central nervous system

688

6494

1.08

0.95

4.3

2.20

2.67

ug/l

0.70

618

5854

Encephalitis

288

2637

1.12

0.95

3.6

4.7

2.39

2.60

ug/l

0.18

267

2365

Coronary artery bypass grafting

6210

46960

0.97

0.94

5.0

5.6

3.41

4.07

ug/l

0.59

5468

41773

Aggressive periodontitis

250

2283

1.14

0.94

5.4

4.9

2.58

2.38

ug/l

0.22

230

2062

Frostbite

123

1395

0.83

0.94

3.4

4.5

1.67

2.30

ug/l

1.08

109

1276

Malignant neoplasm of oral cavity

435

4637

0.91

0.94

4.4

3.7

3.33

1.89

ug/l

0.69

378

4167

Spinal instabilities

261

2377

1.13

0.94

4.6

4.2

1.96

2.19

ug/l

0.21

240

2149

Other and unspecified spinal muscular atrophies

1063

0.81

0.94

5.4

5.3

26.55

2.89

ug/l

0.93

934

Benign neoplasm: Larynx

502

4733

1.10

0.94

5.1

4.9

3.25

3.71

ug/l

0.17

449

4217

Injury of other and unspecified intrathoracic organs

1059

10171

1.07

0.94

4.6

4.8

3.34

3.28

ug/l

0.03

928

9179

Benign neoplasm of major salivary glands

1245

11965

1.06

0.94

5.0

5.1

2.40

3.67

ug/l

1.93

1100

10701

Organ-limited amyloidosis

610

1.31

0.94

4.7

5.6

3.65

5.20

ug/l

0.38

523

Other bursitis of knee

215

1959

1.16

0.94

4.6

4.3

2.06

2.43

ug/l

0.59

198

1766

LeFortI or BSSO operation

245

2215

1.12

0.93

4.4

3.6

1.78

1.75

ug/l

0.04

230

2041

Optic atrophy

176

1574

1.16

0.93

4.4

4.6

1.72

2.26

ug/l

1.32

154

1419

Melanoma in situ, other sites/unspecified

362

1.40

0.93

5.5

5.0

2.54

2.06

ug/l

0.39

316

Mental retardation, wide definition

285

3096

0.90

0.93

3.4

4.0

1.63

2.08

ug/l

1.16

254

2809

Other congenital malformations of upper alimentary tract

783

1.25

0.93

5.1

5.3

2.56

2.73

ug/l

0.11

694

Open bite

177

1566

1.14

0.92

4.1

3.6

1.78

1.84

ug/l

0.09

164

1428

Cholesteatoma of external ear

114

1004

1.23

0.92

5.0

5.2

1.84

2.78

ug/l

1.28

105

911

Chronic myringitis

487

1.32

0.92

5.9

4.8

2.33

1.90

ug/l

0.42

433

Background retinopathy and retinal vascular changes

262

2403

1.13

0.92

4.3

5.0

8.53

2.39

ug/l

0.73

234

2143

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

433

4036

1.10

0.92

4.9

4.6

2.09

2.31

ug/l

0.57

402

3623

Lichen simplex chronicus and prurigo

682

6456

1.08

0.92

4.6

4.8

2.19

2.80

ug/l

1.16

610

5787

Corticotropin deficiency

676

1.25

0.92

4.4

4.9

2.57

2.70

ug/l

0.05

606

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

829

0.79

0.92

4.6

3.8

1.99

2.01

ug/l

0.01

717

Psoriasis vulgaris

2644

25745

1.04

0.92

4.4

4.6

2.13

2.96

ug/l

2.27

2363

23286

Coarctation of the aorta

846

0.80

0.91

3.3

3.9

1.70

2.07

ug/l

0.37

767

Acute suppurative otitis media

1932

17408

1.04

0.91

3.5

3.4

1.58

1.88

ug/l

1.91

1732

15918

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

556

5219

1.08

0.91

3.7

4.2

2.21

3.16

ug/l

0.55

489

4720

Exposure to uncontrolled fire in building or structure

1004

0.81

0.90

3.7

4.3

10.31

2.26

ug/l

0.82

909

Allergic asthma (mode)

1999

18916

1.04

0.90

4.1

4.3

3.10

2.88

ug/l

0.11

1818

17213

Benign neoplasm: Bladder

143

1279

1.20

0.90

6.0

5.5

2.23

3.05

ug/l

1.14

129

1129

Localized skin eruption due to drugs and medicaments

110

956

1.20

0.90

6.0

4.8

2.16

2.45

ug/l

0.24

856

Cysts of oral region, not elsewhere classified

756

7196

1.07

0.89

5.1

4.6

5.07

2.77

ug/l

0.69

679

6488

Achalasia of cardia

222

2023

1.14

0.89

5.2

4.9

2.34

3.43

ug/l

0.78

193

1810

Dissociative [conversion] disorders

157

1384

1.15

0.89

3.8

4.2

3.94

2.10

ug/l

0.35

137

1255

Other lesions of median nerve

224

2030

1.13

0.89

4.8

4.9

2.01

3.19

ug/l

1.96

206

1808

!Aliquae complicationes praecoces traumatis

564

5328

1.09

0.89

4.3

4.5

2.10

2.31

ug/l

0.44

507

4807

Early complications of trauma

564

5328

1.09

0.89

4.3

4.5

2.10

2.31

ug/l

0.44

507

4807

Benign neoplasm: Duodenum

319

2959

1.12

0.89

5.0

5.3

2.05

2.94

ug/l

1.69

279

2629

Melanoma in situ of upper limb, including shoulder

700

1.25

0.88

6.3

5.3

9.56

2.51

ug/l

0.44

621

Left hemicolectomy

263

2853

0.89

0.88

4.9

5.4

3.09

3.39

ug/l

0.18

225

2511

Special screening examination for infectious and parasitic diseases

2767

20953

0.97

0.88

3.7

3.5

1.62

2.05

ug/l

4.78

2464

19287

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

108

942

1.21

0.88

4.3

3.6

1.81

1.88

ug/l

0.12

830

Crohn disease (strict definition, all UC cases excluded)

467

4370

1.09

0.88

4.0

4.2

2.23

2.06

ug/l

0.14

441

3966

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1365

13122

1.05

0.88

3.4

3.7

2.35

1.90

ug/l

0.22

1164

12011

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

194

1702

1.13

0.88

2.7

2.6

1.24

1.27

ug/l

0.11

179

1576

Ankylosing spondylitis, strict definition

492

4623

1.09

0.87

3.8

3.7

1.91

1.83

ug/l

0.17

445

4253

Use of biperiden

574

6071

0.93

0.87

3.3

4.4

1.55

2.51

ug/l

4.66

521

5500

Impacted maxillary molar

180

1601

1.13

0.87

3.9

3.1

1.46

ug/l

0.01

167

1467

Molar incisor enamel hypoplasia, with caries

1.80

0.87

11.5

3.1

3.17

1.57

ug/l

—

Intestinal stricture

4596

45071

1.03

0.87

4.8

5.2

3.02

3.63

ug/l

1.19

4021

40196

Burn and corrosion confined to eye and adnexa

284

2620

1.12

0.87

4.2

3.9

1.83

1.94

ug/l

0.13

259

2389

Other operation for atrial fibrillation

103

922

1.29

0.87

4.7

5.4

1.88

2.65

ug/l

1.11

823

Exposure to noise

229

0.60

0.87

4.9

1.42

2.21

ug/l

1.32

200

Benign neoplasm: Spinal meninges

668

1.23

0.86

5.2

5.0

2.75

2.65

ug/l

0.06

598

Lymphoid leukaemia

806

7707

1.07

0.86

4.9

5.3

6.63

3.85

ug/l

0.31

716

6844

Hypoparathyroidism

177

1580

1.14

0.86

4.7

4.9

2.70

2.48

ug/l

0.19

152

1398

Transient acantholytic dermatosis [Grover]

331

1.52

0.86

6.1

5.3

2.04

2.08

ug/l

0.06

286

Open wound of hip and thigh

416

3896

1.10

0.86

4.1

4.2

1.77

2.07

ug/l

1.06

374

3531

Dystonia

390

3624

1.09

0.86

4.6

1.83

2.37

ug/l

2.10

351

3246

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

127

1139

1.22

0.85

5.1

4.1

4.99

2.14

ug/l

0.96

105

993

Other surgical follow-up care

308

2841

1.11

0.85

4.4

4.7

2.12

2.20

ug/l

0.08

288

2553

Allergic asthma (mode), excluding more controls

1999

18937

1.04

0.85

4.1

4.3

3.10

3.02

ug/l

0.04

1818

17246

Other intracranial haemorrhages

523

4959

1.09

0.85

5.8

5.7

7.68

4.32

ug/l

0.39

468

4363

Somnolence

1023

0.83

0.85

4.1

4.6

1.66

2.58

ug/l

1.48

903

Visual field defects

1065

10230

1.06

0.85

4.8

5.2

3.71

3.56

ug/l

0.05

948

9135

Shock, not elsewhere classified

111

1255

0.83

0.84

4.1

5.1

3.31

2.50

ug/l

0.35

102

1109

Other conjunctival vascular disorders and cysts

217

1975

1.13

0.84

5.2

5.0

2.28

2.54

ug/l

0.39

195

1754

Attention to artificial openings

640

6097

1.08

0.84

5.4

5.2

5.41

2.75

ug/l

2.17

558

5409

Other deformity of hallux (acquired)

431

1.28

0.84

5.5

4.5

2.47

3.07

ug/l

0.25

384

Malignant immunoproliferative diseases

154

1394

1.19

0.84

4.6

5.5

1.85

2.70

ug/l

1.68

135

1238

General- and plastic-surgery devices associated with adverse incidents

172

0.59

0.83

3.3

5.0

1.36

2.14

ug/l

0.67

154

Use of cabergoline

132

1169

1.17

0.83

4.7

4.5

1.59

2.62

ug/l

1.96

119

1055

Infliximab

1133

0.84

0.83

3.2

2.8

1.27

1.36

ug/l

0.23

1053

Panniculitis, unspecified

793

1.21

0.83

4.3

4.7

1.53

2.50

ug/l

1.50

700

Other diseases of the digestive system

5614

55213

1.03

0.83

5.1

5.2

4.12

3.85

ug/l

0.12

4897

49111

Keratoconus

278

2566

1.12

0.83

3.6

3.9

1.50

1.94

ug/l

1.70

253

2359

Asymmetry of jaw

584

1.23

0.83

3.6

3.9

1.65

2.19

ug/l

0.47

534

Other (seronegative) rheumatoid arthritis, wide

1713

16571

1.04

0.83

4.6

5.1

2.48

3.66

ug/l

2.52

1525

14783

Diabetic nephropathy, excluding more controls

2250

18987

0.96

0.82

3.9

4.9

2.36

2.70

ug/l

0.84

2038

16855

Corneal degeneration

144

1283

1.16

0.82

5.0

5.1

2.06

2.51

ug/l

0.71

129

1146

Lumbosacral root disorders, not elsewhere classified

134

1193

1.18

0.82

4.2

4.8

1.69

2.55

ug/l

1.99

122

1067

Disorders of porphyrin and bilirubin metabolism

140

1252

1.17

0.82

5.1

4.5

2.23

2.36

ug/l

0.12

127

1130

Benign neoplasm: Skin, unspecified

402

3761

1.09

0.82

5.3

4.9

2.75

2.70

ug/l

0.04

367

3364

Other infestations

242

1.45

0.82

5.1

4.9

1.49

3.11

ug/l

0.62

211

Calcific tendinitis

101

882

1.20

0.81

4.3

4.7

15.93

2.67

ug/l

0.47

793

Methotrexate

1120

11668

0.95

0.81

4.1

4.8

2.16

3.52

ug/l

2.02

1015

10446

Leiomyoma of uterus

224

1.27

0.81

1.2

1.1

—

0.94

—

Melanocytic naevi of ear and external auricular canal

436

1.29

0.81

5.7

5.3

1.89

3.10

ug/l

0.85

376

Colitis, primary sclerosing

104

1188

0.85

0.81

3.0

3.9

1.48

2.06

ug/l

0.96

1089

Other encephalitis

271

2498

1.11

0.81

3.7

4.7

2.45

2.55

ug/l

0.08

251

2243

Injury of cranial nerves

623

1.25

0.81

3.6

4.1

1.89

1.77

ug/l

0.15

558

Vascular diseases of the intestine

445

4722

0.92

0.81

4.5

5.5

3.30

4.33

ug/l

0.43

383

4161

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

314

2908

1.10

0.80

4.8

5.0

2.05

2.84

ug/l

1.35

289

2579

Thiamine deficiency

850

0.80

3.7

4.6

2.01

2.38

ug/l

0.30

761

Isolated proteinuria with specified morphological lesion

139

1246

1.17

0.80

4.0

5.0

2.27

2.56

ug/l

0.35

127

1129

Thyroiditis

346

3204

1.09

0.80

5.4

4.7

2.77

2.42

ug/l

0.17

315

2861

Benign neoplasm: Other and unspecified parts of small intestine

159

1431

1.15

0.80

5.6

5.2

2.70

3.32

ug/l

0.32

142

1266

Exposure to other and unspecified animate mechanical forces

209

1897

1.12

0.80

4.3

4.0

1.33

2.05

ug/l

2.79

196

1737

Abscess of external ear

144

1288

1.16

0.80

4.7

4.3

2.53

2.16

ug/l

0.23

130

1169

Other and unspecified disorders of psychological development

221

1.35

0.79

1.5

2.3

0.84

0.99

ug/l

0.54

202

Portal vein thrombosis

187

2045

0.88

0.79

4.3

4.8

2.30

2.69

ug/l

0.28

159

1839

Other congenital malformations of male genital organs

380

1.29

0.79

4.0

3.9

1.32

1.69

ug/l

0.74

339

Inflammatory bowel disease

3994

39134

1.03

0.79

4.5

4.4

2.30

2.86

ug/l

1.29

3620

35431

Benign neoplasm of other and unspecified sites

329

3061

1.10

0.79

5.0

4.7

2.04

2.42

ug/l

1.18

291

2738

Migraine

2917

23032

1.03

0.79

4.2

4.1

1.79

2.49

ug/l

7.78

2666

20963

Kyphosis

118

1041

1.17

0.79

4.7

4.6

1.84

2.65

ug/l

1.21

104

928

Disorders of orbit

318

2945

1.10

0.79

4.4

4.6

3.26

2.42

ug/l

0.43

279

2620

Congenital malformations of the circulatory system

1521

14267

1.04

0.78

4.3

4.4

1.80

2.35

ug/l

4.27

1344

12955

Intracranial and intraspinal abscess and granuloma

160

1452

1.16

0.78

4.8

1.81

2.35

ug/l

1.20

138

1306

Embedded teeth, including avohilmo

476

4462

1.07

0.78

3.7

2.21

1.84

ug/l

0.27

436

4057

Ductal carcinoma of pancreas

978

0.82

0.78

3.8

3.9

2.26

1.94

ug/l

0.49

873

Substance abuse, excluding more controls

10189

87894

0.98

0.78

4.1

4.8

2.67

3.11

ug/l

1.14

8891

79760

Intussusception

106

922

1.17

0.78

4.7

4.6

1.90

2.95

ug/l

1.23

819

Bilateral sagittal split ramus osteotomy operation

201

1821

1.12

0.78

4.4

3.6

1.71

1.78

ug/l

0.12

189

1680

Malignant neoplasm of rectum

1540

14946

1.05

0.78

4.6

3.9

2.51

2.02

ug/l

1.63

1322

13392

Viral agents as the cause of diseases classified to other chapters

231

2117

1.12

0.78

5.0

4.6

4.99

2.38

ug/l

0.67

208

1910

Other and unspecified disorders of adult personality and behaviour

309

1.32

0.78

3.5

3.3

0.84

1.58

ug/l

3.86

284

Helminthiases

150

1344

1.15

0.78

4.8

4.6

1.78

2.45

ug/l

1.36

137

1207

Congenital malformations, deformations and chromosomal abnormalities

7086

64251

1.02

0.78

4.2

4.3

2.06

2.69

ug/l

4.37

6386

58298

Dementia in Alzheimer disease

2460

20251

1.04

0.78

4.6

5.9

4.31

5.66

ug/l

1.38

1987

17585

L01XX Other antineoplastic agents

673

7052

0.93

0.78

4.9

5.3

4.91

3.85

ug/l

0.35

585

6238

Other and unspecified pemphigoid

860

1.20

0.77

5.7

5.4

13.45

2.63

ug/l

0.49

754

Ulcerative rectosigmoiditis

970

9314

1.06

0.77

4.5

4.3

2.12

2.35

ug/l

0.64

883

8418

Bullous keratopathy

736

1.21

0.77

5.5

5.2

2.54

2.90

ug/l

0.22

648

Hidradenitis suppurativa

248

2274

1.11

0.77

3.2

3.8

1.23

1.88

ug/l

3.59

229

2078

Cardiomyopathy, Hypertrophic obstructive

231

2498

0.89

0.77

4.8

5.0

2.27

2.62

ug/l

0.41

198

2239

Central retinal artery occlusion

333

3125

1.11

0.76

4.9

5.5

5.00

ug/l

0.00

294

2737

Burn and corrosion, body region unspecified

638

1.24

0.76

4.7

4.3

1.77

2.00

ug/l

0.39

577

Chorioretinal inflammation

280

2593

1.11

0.76

4.6

2.37

2.18

ug/l

0.24

249

2330

Anxious personality disorder

123

1086

1.16

0.76

3.0

3.3

1.25

1.76

ug/l

0.92

111

1012

Guillain-Barre syndrome

208

1912

1.13

0.76

5.4

4.9

2.14

2.93

ug/l

0.63

188

1722

Benign neoplasm: Pancreas

313

2921

1.11

0.76

5.5

5.4

2.41

2.98

ug/l

0.69

283

2600

Myasthenia gravis

212

1950

1.13

0.76

4.5

5.1

2.96

2.62

ug/l

0.18

191

1733

Burn and corrosion of trunk

374

3512

1.10

0.75

4.1

4.6

2.19

2.29

ug/l

0.14

342

3173

Motorcycle rider injured in other and unspecified transport accidents

767

7340

1.06

0.75

4.1

3.8

1.58

1.89

ug/l

2.67

709

6739

Malignant neoplasm of tongue, including Hilmo

348

3701

0.91

0.75

4.5

3.7

2.23

1.88

ug/l

0.75

304

3333

Drug-induced hypoglycaemia without coma

178

1949

0.88

0.75

4.4

4.8

2.38

3.02

ug/l

0.37

144

1727

Cytomegaloviral pneumonitis

250

0.65

0.75

3.5

5.5

1.86

2.01

ug/l

0.13

222

Mild mental retardation

174

1921

0.89

0.75

3.1

4.1

1.52

2.01

ug/l

1.31

155

1759

Oesophagitis

772

7399

1.07

0.75

4.7

4.9

6.31

3.22

ug/l

0.33

699

6624

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

148

1337

1.16

0.75

4.4

3.8

6.77

1.98

ug/l

0.82

132

1184

SLE (Finngen)

161

1443

1.13

0.75

3.8

4.5

1.67

2.39

ug/l

1.61

140

1292

Rhinophyma

132

1212

1.23

0.75

5.6

5.2

3.07

2.89

ug/l

0.12

115

1074

Congenital iodine-deficiency syndrome/hypothyroidism

141

1255

1.14

0.75

5.2

5.1

2.50

3.48

ug/l

0.67

123

1093

Motorcycle rider injured in noncollision transport accidents

392

3687

1.09

0.74

4.1

3.7

2.87

1.82

ug/l

0.62

366

3383

Charcot foot

252

2704

0.89

0.74

3.9

5.1

1.57

2.73

ug/l

4.25

223

2430

Burns and corrosions confined to eye and internal organs

327

3057

1.10

0.74

4.1

3.9

1.87

1.93

ug/l

0.09

295

2787

Arthropathic psoriasis

1321

12776

1.05

0.74

4.3

4.5

2.22

2.53

ug/l

0.48

1177

11567

Familial chondrocalcinosis

142

1.64

0.74

6.8

5.4

2.81

2.30

ug/l

0.23

126

Congenital malformations of cardiac septa

510

4660

1.07

0.73

4.4

4.3

1.65

2.38

ug/l

2.45

436

4228

Dementia in other diseases classified elsewhere

547

5751

0.93

0.73

4.4

5.7

2.76

4.35

ug/l

1.26

445

5074

Carpal tunnel syndrome

7650

66461

1.02

0.73

4.9

4.7

2.14

3.08

ug/l

8.94

6964

59890

SLE, strict definition

150

1341

1.13

0.73

3.9

4.5

1.67

2.28

ug/l

1.22

131

1192

SLE, ICD10

150

1341

1.13

0.73

3.9

4.5

1.67

2.28

ug/l

1.22

131

1192

Disorders of magnesium metabolism

117

1053

1.20

0.73

4.5

5.2

1.89

2.60

ug/l

1.00

951

Benign neoplasm of thyroid gland

200

1821

1.12

0.73

5.7

5.0

2.13

2.60

ug/l

0.74

174

1619

Alopecia areata

125

1106

1.15

0.73

4.5

4.2

8.29

2.18

ug/l

0.52

113

995

Lesion of radial nerve

434

4095

1.08

0.73

4.5

1.58

2.59

ug/l

5.06

387

3687

Shoulder region

160

1452

1.15

0.73

4.6

4.7

1.68

2.36

ug/l

1.61

149

1299

Malignant neoplasm of accessory sinuses, including Hilmo

549

0.78

0.72

4.8

3.7

1.68

2.07

ug/l

0.89

482

Other disorders of bone density and structure

204

1864

1.12

0.72

5.2

4.5

2.37

2.48

ug/l

0.07

186

1689

Other/unspecified mastoiditis and related conditions

501

1.26

0.72

6.2

4.7

2.11

2.12

ug/l

0.00

439

Perforation of oesophagus

696

0.80

0.72

5.0

2.06

2.53

ug/l

0.41

626

Other protozoal intestinal diseases

180

1636

1.13

0.72

4.6

1.54

2.50

ug/l

2.75

169

1479

Malignant neoplasm of penis

767

1.30

0.72

5.6

3.7

2.03

1.94

ug/l

0.14

682

Other congenital malformations of spinal cord

1.66

0.72

2.5

5.2

2.02

2.03

ug/l

0.00

Exposure to smoke, fire and flames

311

3317

0.91

0.72

4.3

5.82

2.23

ug/l

1.02

278

3007

Bus occupant injured in other and unspecified transport accidents

340

1.29

0.72

4.7

4.6

1.82

1.83

ug/l

0.01

305

Seropositive rheumatoid arthritis

2232

22827

0.97

0.72

4.4

5.1

2.52

3.49

ug/l

2.61

1983

20353

Choroidal haemorrhage and rupture

394

1.32

0.72

5.7

4.8

4.06

2.52

ug/l

0.56

339

Clubfoot

644

1.20

0.71

3.9

4.0

1.61

1.66

ug/l

0.05

577

Bronchiectasis

931

8958

1.06

0.71

5.5

5.4

3.18

4.54

ug/l

0.81

811

7940

Benign neoplasm: Peripheral nerves and autonomic nervous system

165

1500

1.14

0.71

5.1

4.7

2.32

2.43

ug/l

0.11

153

1344

Other diseases of pancreas

1181

11432

1.05

0.71

5.0

2.18

3.63

ug/l

2.26

1061

10271

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

162

1778

0.88

0.71

4.5

3.9

3.01

2.14

ug/l

1.32

138

1580

Familial erythrocytosis

569

1.25

0.71

4.2

4.3

1.71

2.53

ug/l

0.74

505

Spotted fever [tick-borne rickettsioses]

2.04

0.71

5.7

4.4

2.31

1.61

ug/l

—

Mental retardation, excluding more controls

263

2762

0.91

0.71

3.2

4.1

1.50

2.42

ug/l

1.81

235

2528

Malignant neoplasm of rectosigmoid junction, including Hilmo

412

3899

1.09

0.71

5.1

3.9

3.78

2.08

ug/l

1.02

368

3481

Evidence of alcohol involvement determined by blood alcohol level

163

1786

0.88

0.71

4.2

2.30

2.06

ug/l

0.17

147

1629

Follicular adenocarcinoma of thyroid gland

471

1.25

0.71

5.4

3.7

2.69

1.93

ug/l

0.73

428

Substance use, excluding alcohol

2327

23850

0.97

0.71

3.7

4.1

1.68

2.53

ug/l

3.14

1988

21813

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

119

1070

1.18

0.70

4.5

4.6

3.17

2.50

ug/l

0.27

108

974

Other factor of the environment

134

1206

1.15

0.70

4.8

2.31

2.44

ug/l

0.11

115

1086

Injury of nerves and spinal cord at neck level

315

2958

1.10

0.70

4.2

4.8

1.80

2.32

ug/l

1.82

288

2660

Idiopathic urticaria

110

969

1.16

0.70

4.6

4.2

1.90

2.12

ug/l

0.15

102

876

Psoriasis

3874

38028

1.03

0.70

4.4

4.7

2.06

2.95

ug/l

4.48

3456

34337

Fungal Sepsis

536

5104

1.08

0.70

5.1

5.2

2.86

3.16

ug/l

0.30

479

4560

Bacterial, viral and other infectious agents

1139

11005

1.05

0.70

3.9

3.8

2.69

2.06

ug/l

0.68

1046

10062

Sicca syndrome [Sjögren]

322

2992

1.08

0.70

4.7

4.9

1.90

2.51

ug/l

1.99

283

2624

Universal erythroderma, KELA reimbursement

174

1893

0.88

0.69

3.8

4.5

1.58

2.38

ug/l

2.51

155

1709

Lifestyle-related condition

125

1122

1.16

0.69

4.8

2.34

2.40

ug/l

0.04

107

1006

Lagophthalmos

147

1334

1.15

0.69

5.7

5.3

3.59

3.71

ug/l

0.04

126

1167

Thyroiditis, unspecified

596

1.20

0.69

5.4

4.7

6.30

2.64

ug/l

0.42

535

Malignant neoplasm of lip

115

1035

1.18

0.69

4.7

4.2

3.17

2.30

ug/l

0.60

101

905

Malignant neoplasm of other connective and soft tissue

301

2818

1.10

0.69

5.0

3.8

2.74

1.96

ug/l

2.13

266

2521

Viral agents as the cause of diseases classified to other chapters

205

1883

1.12

0.69

5.1

4.7

5.48

2.45

ug/l

0.70

184

1698

Hypokalaemia

1265

12235

1.04

0.69

4.7

5.0

3.47

3.82

ug/l

0.17

1105

10958

Previous suicide attempt

684

1.19

0.68

3.0

3.9

1.05

1.66

ug/l

3.53

625

Disorders of tooth development and eruption

1489

11668

1.04

0.68

4.5

4.1

1.90

2.31

ug/l

2.24

1370

10634

Other and unspecified trigeminal disorders

109

965

1.16

0.68

4.9

4.6

2.11

2.47

ug/l

0.35

869

Other maltreatment syndromes

334

3131

1.09

0.68

3.0

3.2

3.01

1.64

ug/l

0.59

300

2892

Poor fetal growth

1.67

0.68

1.0

1.2

—

1.44

—

Intestinal infectious diseases

13651

102500

1.01

0.68

4.3

4.7

2.57

3.28

ug/l

2.34

12295

92191

Foreign body in ear

159

1442

1.13

0.68

5.4

4.7

1.87

2.59

ug/l

1.33

142

1292

Diagnoses used for exclusion with ILD

3852

39204

0.97

0.68

4.6

5.0

3.19

3.55

ug/l

0.49

3348

34980

Mixed hyperlipidaemia

663

6366

1.07

0.68

4.7

4.9

2.45

3.01

ug/l

0.82

580

5714

Enduring personality changes

393

1.28

0.68

3.6

4.1

1.13

1.66

ug/l

2.05

350

Chronic myeloproliferative disease

151

1652

0.87

0.68

4.4

5.4

3.36

2.78

ug/l

0.30

142

1468

Congenital deformities of hip

384

1.24

0.68

3.7

1.86

1.58

ug/l

0.30

343

Malignant neoplasm of rectosigmoid junction

232

2161

1.12

0.67

5.0

3.9

3.46

1.99

ug/l

1.60

206

1931

Other pleural conditions

1640

16827

0.96

0.67

5.0

5.4

5.19

4.19

ug/l

0.20

1391

14934

Morphin

249

2670

0.90

0.67

4.8

5.3

2.35

3.23

ug/l

0.95

203

2350

Choroidal detachment

230

1.38

0.67

5.6

4.6

1.52

2.58

ug/l

0.98

198

Maxillary retrognathism

110

974

1.15

0.67

4.4

3.8

1.63

1.97

ug/l

0.45

888

Dislocation, sprain and strain of joints and ligaments of head

269

2493

1.09

0.67

3.9

4.1

1.73

2.02

ug/l

0.83

242

2287

17020

87104

1.01

0.67

4.7

4.9

2.94

3.49

ug/l

1.79

15174

78101

Torticollis

130

1166

1.14

0.67

3.7

3.8

1.55

2.21

ug/l

1.07

120

1058

Malignant neoplasm of nasopharynx, including Hilmo

627

0.80

0.67

5.3

3.7

2.45

1.96

ug/l

0.60

556

Thyrotoxicosis with toxic single thyroid nodule

388

1.25

0.67

5.6

5.0

3.52

2.85

ug/l

0.19

346

Pedal cyclist injured in noncollision transport accidents

1271

12308

1.04

0.66

4.2

2.03

2.40

ug/l

1.48

1143

11169

Other drug-induced osteomalacia in adults

100

1.69

0.66

2.1

2.7

1.20

1.52

ug/l

0.38

Disease of thymus, other/unspecified

1.58

0.66

3.4

4.5

1.01

1.99

ug/l

2.10

Heart failure,strict

10004

71306

0.98

0.66

4.7

5.3

3.30

3.61

ug/l

0.45

8738

63936

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

192

1753

1.11

0.66

3.5

3.6

1.56

1.97

ug/l

0.95

173

1605

Other congenital malformations of peripheral vascular system

770

1.17

0.65

3.7

4.2

1.57

2.32

ug/l

1.07

702

Brain meningioma

300

2796

1.09

0.65

5.8

3.8

2.94

1.95

ug/l

1.79

265

2486

Stroke, including SAH

11200

80403

1.02

0.65

4.9

5.1

3.50

3.45

ug/l

0.06

9884

71964

Systemic lupus erythematosus

161

1458

1.12

0.65

3.8

4.6

1.67

2.22

ug/l

1.20

140

1297

Infective dermatitis

1494

14524

1.04

0.65

4.5

4.9

2.00

3.53

ug/l

3.59

1333

13042

Fracture of shoulder and upper arm

4152

40740

1.02

0.65

4.7

4.6

2.86

3.08

ug/l

0.30

3686

36662

Polyglandular dysfunction, other/unspecified

1.69

0.65

1.9

4.5

1.22

1.90

ug/l

—

Mental and behavioural disorders due to tobacco

1040

10756

0.95

0.65

4.1

4.6

1.96

2.52

ug/l

2.16

886

9762

Other injuries of lower limb, level unspecified

881

1.17

0.65

4.0

4.6

5.69

2.56

ug/l

0.34

793

Certain zoonotic bacterial diseases

316

2965

1.09

0.65

4.8

1.96

2.56

ug/l

2.20

293

2652

Other specified/unspecified disorders of bone/cartilage

378

3578

1.09

0.65

4.6

4.2

2.00

2.23

ug/l

0.49

342

3257

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

702

0.82

0.64

4.0

4.8

2.91

2.46

ug/l

0.10

626

Systemic lupus erythematosus, unspecified

123

1098

1.13

0.64

3.9

4.5

1.45

2.34

ug/l

2.01

105

982

Smoking dependency

1040

10752

0.95

0.64

4.1

4.6

1.96

2.52

ug/l

2.13

886

9752

Congenital malformations of anterior segment of eye

493

1.22

0.64

5.3

4.8

1.98

2.09

ug/l

0.16

430

Other congenital malformations of intestine

860

1.17

0.64

4.6

4.7

1.89

2.45

ug/l

0.56

767

Other congenital malformations of circulatory system

263

2454

1.10

0.64

4.8

4.7

1.79

2.42

ug/l

1.97

242

2216

Preterm labour and delivery

128

0.62

0.63

1.1

—

0.39

—

Discontinuity and dislocation of ear ossicles

526

1.23

0.63

4.5

4.6

1.64

1.97

ug/l

0.64

473

Use of selegiline

596

6216

0.94

0.63

4.7

5.4

2.18

4.04

ug/l

1.98

521

5484

Somnolence, stupor and coma

466

4902

0.93

0.63

4.0

4.9

2.23

3.88

ug/l

1.12

422

4381

Other infectious diseases

926

9590

0.95

0.63

4.7

5.1

4.05

3.61

ug/l

0.20

826

8532

Delayed milestone in childhood

1.61

0.63

2.3

1.4

0.48

0.78

ug/l

—

L04AC Interleukin inhibitors

544

5182

1.06

0.63

3.4

3.8

1.57

1.95

ug/l

1.97

493

4748

Melanoma in situ of lower limb, including hip

374

1.25

0.63

6.3

5.1

2.72

3.00

ug/l

0.12

331

Other noninfective disorders of lymphatic vessels and lymph nodes

291

2719

1.09

0.63

5.6

4.6

9.17

2.42

ug/l

0.80

255

2448

Other and unspecified hydrocephalus

151

1655

0.89

0.63

3.9

4.9

3.58

2.63

ug/l

0.35

129

1471

Demyelinating diseases of the central nervous system

526

4995

1.06

0.63

3.7

4.1

1.61

2.00

ug/l

2.44

470

4530

Other, unspecified and serous retinal detachments

422

4011

1.08

0.63

5.2

4.8

2.70

2.80

ug/l

0.09

379

3600

Scissor bite

798

1.15

0.62

3.9

3.6

1.52

1.77

ug/l

0.55

732

Obesity, other/unspecified

3101

30381

1.03

0.62

4.1

4.5

1.63

2.74

ug/l

6.77

2740

27582

Cerebral amyloid angiopathy

687

1.23

0.62

5.2

5.8

2.23

2.73

ug/l

0.42

606

Carcinoid syndrome

106

1173

0.86

0.62

4.6

5.2

1.82

2.64

ug/l

1.59

1049

Selective deficiency of immunoglobulin A [IgA]y

275

1.30

0.62

3.5

3.9

1.26

1.68

ug/l

1.29

250

Osteoporosis with pathological fracture (FG)

118

1050

1.13

0.62

5.2

4.8

2.24

2.98

ug/l

0.50

895

Malignant cancer of tonsil and base of tongue, including Hilmo

382

4008

0.92

0.62

4.2

3.7

2.18

1.85

ug/l

1.43

337

3619

ILD, hospital admissions 3, with pneumonia sepsis

1304

13401

0.96

0.62

4.8

5.6

4.58

4.40

ug/l

0.05

1124

11891

Optic neuritis

237

2194

1.09

0.62

4.8

4.3

2.02

2.38

ug/l

0.61

215

1982

Degenerative conditions of globe

626

0.81

0.62

4.9

5.1

6.80

2.87

ug/l

0.39

543

Myotonic disorders

637

1.19

0.62

4.3

4.0

1.53

1.77

ug/l

0.47

574

Degenerative diseases of the nervous system

5461

40672

0.98

0.62

4.7

5.7

6.36

4.59

ug/l

0.73

4619

35693

Cauda equina syndrome

119

1072

1.15

0.62

5.0

4.5

4.01

2.22

ug/l

0.43

111

964

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

599

5722

1.06

0.61

4.1

1.81

2.03

ug/l

1.05

550

5191

Drug-induced gout

641

0.81

0.61

4.7

5.5

3.87

3.14

ug/l

0.24

562

Disorders of optic nerve, not elsewhere classified

250

2339

1.10

0.61

4.8

5.2

2.41

3.15

ug/l

0.82

222

2071

Use of ropinirole

502

4804

1.07

0.61

4.7

5.3

2.36

2.79

ug/l

0.62

437

4273

Glomerular diseases

2872

28193

1.03

0.61

4.0

4.9

2.52

3.25

ug/l

1.78

2587

25327

Bicuspidal aortic valve syndrome

544

5214

1.07

0.61

4.2

4.3

2.03

2.33

ug/l

0.67

488

4739

Other osteochondrodysplasias

616

1.18

0.61

4.7

4.2

1.82

2.24

ug/l

0.30

554

Erythema nodosum

153

1390

1.12

0.61

4.7

2.90

2.32

ug/l

0.42

135

1244

Scar conditions and fibrosis of skin

221

2042

1.10

0.61

4.9

4.5

2.28

2.26

ug/l

0.01

202

1839

Granulomatous disorders of skin and subcutaneous tissue

154

1401

1.12

0.60

4.5

4.7

1.76

2.39

ug/l

1.43

140

1252

Hypertrophy of (infrapatellar) fat pad

865

1.16

0.60

4.5

4.2

2.14

2.37

ug/l

0.14

792

Other nutritional deficiencies

7892

73381

1.02

0.60

4.4

4.6

2.13

2.89

ug/l

2.59

6967

66503

Other conditions related to polyarteritis nodosa

206

1.37

0.60

4.7

4.8

2.59

1.91

ug/l

0.66

181

5-aminosalicylic acid

2586

25321

1.03

0.60

4.4

4.3

2.46

2.69

ug/l

0.22

2342

23005

Non-allergic asthma (mode)

2243

21710

1.03

0.60

4.5

5.1

2.97

3.84

ug/l

0.65

2006

19555

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

219

1.30

0.60

5.0

4.3

3.98

1.89

ug/l

0.49

190

Open wound of shoulder and upper arm

226

2105

1.10

0.60

4.2

4.3

1.86

2.52

ug/l

1.01

200

1910

Mental retardation

263

2798

0.92

0.60

3.2

3.9

1.50

2.03

ug/l

1.98

235

2543

Total colectomy operation

438

4603

0.93

0.59

4.3

4.5

2.33

2.27

ug/l

0.09

391

4144

Total colectomy

438

4603

0.93

0.59

4.3

4.5

2.33

2.27

ug/l

0.09

391

4144

Other and unspecified injuries of thorax

206

1913

1.11

0.59

4.4

4.5

1.50

2.44

ug/l

2.98

185

1721

Contact with other hot fluids

292

2740

1.09

0.59

4.5

4.2

1.83

2.28

ug/l

0.78

260

2485

Algoneurodystrophy

188

1728

1.10

0.59

4.0

3.9

1.56

2.00

ug/l

0.82

172

1576

Allergic bronchopulmonary aspergillosis (ABPA)

593

1.23

0.59

4.7

5.3

1.66

4.21

ug/l

0.99

526

Other and unspecified intracranial injuries

353

3727

0.93

0.59

4.5

4.8

6.44

3.09

ug/l

0.45

311

3334

Congenital edentulism

1.68

0.59

7.0

3.7

7.01

1.51

ug/l

—

Esophageal diverticulum (pouch)

365

1.28

0.59

5.9

5.5

2.75

2.19

ug/l

0.35

317

Non-allergic asthma (mode), excluding more controls

2243

21719

1.03

0.59

4.5

5.2

2.97

4.22

ug/l

0.98

2006

19603

Malignant neoplasm of digestive organs

6309

49170

1.02

0.59

4.6

3.8

2.95

2.00

ug/l

5.84

5429

44087

Superficial frostbite

824

0.84

0.58

3.2

4.4

1.41

2.25

ug/l

2.34

748

Congenital malformations of the respiratory system

121

1091

1.13

0.58

4.7

4.6

4.84

2.21

ug/l

0.38

112

976

Vascular syndromes of brain in cerebrovascular disorders

620

5961

1.06

0.58

4.7

5.5

2.92

4.41

ug/l

1.01

572

5311

Pneumonia due to Streptococcus pneumoniae

534

5575

0.94

0.58

4.1

4.9

2.30

3.74

ug/l

1.09

476

5003

Malignant neoplasm of oropharynx, including Hilmo

319

3356

0.91

0.58

4.1

3.7

2.36

1.85

ug/l

0.90

279

3033

Autoimmune polyglandular failure

1.58

0.58

5.2

4.3

0.94

1.90

ug/l

1.53

Other and unspecified types of non-Hodgkin lymphoma, hilmo

505

5275

0.94

0.58

4.3

5.3

3.61

2.96

ug/l

0.24

440

4671

Mumps

334

3162

1.08

0.58

4.0

3.8

1.85

ug/l

0.00

308

2899

Benign neoplasm: Connective and other soft tissue, unspecified

110

992

1.15

0.58

5.0

4.9

2.05

2.57

ug/l

0.63

895

Congenital deformities of hip

301

1.24

0.57

3.8

3.7

2.16

1.62

ug/l

0.55

270

Deep bite

753

6339

1.05

0.57

4.5

4.2

1.73

2.29

ug/l

2.37

657

5768

Benign neoplasm: Other/unspecified site

153

1404

1.12

0.57

4.9

1.78

2.54

ug/l

1.47

129

1258

Depression or dysthymia

11451

63806

0.99

0.57

4.5

4.8

2.23

3.30

ug/l

6.70

10133

57974

Brain meningioma, including Hilmo

317

2979

1.08

0.57

5.7

3.8

2.88

1.96

ug/l

1.71

279

2650

Fatigue fracture of vertebra

343

1.25

0.57

4.9

4.7

2.55

3.14

ug/l

0.20

309

Acquired clawhand, clubhand, clawfoot and clubfoot

446

1.22

0.57

5.1

4.2

1.50

2.11

ug/l

1.01

409

Severe visual impairment, monocular

832

1.16

0.57

5.7

4.9

3.02

2.83

ug/l

0.06

738

Hypertrophic cardiomyopathy

557

5797

0.94

0.57

4.4

4.9

2.26

2.63

ug/l

0.85

491

5184

Benign neoplasm: Extrahepatic bile ducts

291

1.30

0.57

4.1

4.8

2.18

2.19

ug/l

0.00

255

Other and unspecified abdominal hernia

436

4152

1.07

0.57

5.1

5.0

2.30

2.98

ug/l

1.48

382

3703

Major anomalies of jaw size

235

2192

1.09

0.57

4.1

3.7

1.84

1.85

ug/l

0.01

214

2002

Viral infections of the central nervous system

633

6070

1.05

0.56

4.2

4.3

2.10

2.43

ug/l

0.59

572

5478

Other diseases of biliary tract

940

9712

0.96

0.56

4.6

5.1

2.43

3.93

ug/l

1.74

826

8672

Mesial bite

340

1.23

0.56

4.4

4.0

1.51

1.79

ug/l

0.30

301

Obstructive hydrocephalus

129

1414

0.89

0.56

4.4

4.7

1.63

2.42

ug/l

1.78

119

1263

Other congenital musculoskeletal deformities

1.51

0.56

3.3

2.6

1.99

1.43

ug/l

0.25

Biological medicines for asthma

147

1344

1.12

0.56

4.0

3.8

1.41

1.92

ug/l

1.20

134

1231

Infection due to other mycobacteria

142

1548

0.89

0.56

5.5

5.3

2.77

2.82

ug/l

0.03

124

1363

Malignant neoplasm of gallbladder, including Hilmo

529

0.82

0.56

4.5

3.9

2.40

2.09

ug/l

0.32

461

Increased muscle tone

483

1.20

0.55

5.7

4.7

2.35

2.00

ug/l

0.36

421

Contact with sharp object, undetermined intent

304

2874

1.09

0.55

4.1

1.68

2.09

ug/l

1.19

274

2615

Tooth agenesis EXCLUDE clefts and syndromes

111

994

1.12

0.55

3.9

3.4

1.39

1.61

ug/l

0.49

102

903

Other/unspecified cytomegaloviral diseases

223

2087

1.10

0.55

3.9

4.5

1.92

2.18

ug/l

0.61

208

1871

Poisoning by medicine, drug-induced

1069

0.87

0.55

3.5

3.7

1.21

1.97

ug/l

1.59

977

Generalized epilepsy, strict definition

126

1388

0.89

0.55

2.9

3.8

1.61

1.99

ug/l

0.65

113

1269

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

210

1.36

0.55

4.2

4.3

1.91

2.15

ug/l

0.18

192

Crohn disease (strict definition, require KELA)

551

5271

1.06

0.55

4.1

1.79

2.01

ug/l

0.98

508

4789

Procedures for purposes other than remedying health state

750

1.15

0.55

4.7

4.4

2.18

1.88

ug/l

0.46

683

Dyshidrosis [pompholyx]

115

1039

1.13

0.55

3.9

4.3

1.57

2.24

ug/l

1.21

937

Any dementia

6225

42708

1.02

0.55

4.8

5.9

5.38

4.56

ug/l

0.35

5299

37522

Varicella [chickenpox]

729

7030

1.05

0.55

3.6

3.5

1.72

1.82

ug/l

0.28

667

6496

Hereditary lymphedema

105

0.62

0.55

3.3

4.6

3.21

1.46

ug/l

—

Arthropathies in other diseases classified elsewhere

415

3953

1.07

0.55

3.9

4.7

1.73

2.90

ug/l

3.74

366

3533

Mixed connective tissue disease

322

3030

1.07

0.55

4.2

4.8

1.70

2.54

ug/l

3.72

281

2683

Burn and corrosion of wrist and hand

411

3912

1.07

0.55

3.9

4.1

1.88

2.01

ug/l

0.34

366

3553

Carrier of infectious disease

198

1837

1.10

0.55

3.8

4.8

1.79

2.39

ug/l

1.20

167

1641

Rheumatic fever without mention of heart involvement

341

0.77

0.55

5.4

5.0

1.87

2.20

ug/l

0.34

301

Acute myringitis

455

1.21

0.55

4.8

4.5

1.41

2.01

ug/l

1.55

408

Cysticercosis

2.31

0.55

4.6

6.0

1.47

2.09

ug/l

—

Divergent concomitant strabismus

623

5976

1.05

0.55

4.4

4.3

2.74

2.28

ug/l

0.52

557

5396

Other/unspecified crystal arthropathies

668

1.19

0.54

7.2

5.3

3.28

2.79

ug/l

0.12

590

Pneumoconiosis due to dust containing silica

669

0.81

0.54

5.0

5.3

1.75

2.75

ug/l

1.14

574

Other disorders of optic disc

116

1052

1.13

0.54

5.0

4.6

1.67

2.32

ug/l

0.86

108

940

Bacterial, viral and other infectious agents

1089

10577

1.04

0.54

3.8

3.7

2.75

2.04

ug/l

0.77

999

9673

Other nutritional anaemias

969

0.87

0.54

5.6

5.2

2.33

3.51

ug/l

0.79

847

Congenital malformations of the respiratory system

128

1163

1.12

0.54

4.7

4.5

4.68

2.18

ug/l

0.38

118

1040

Crohn disease (strict definition, require KELA, min 2 HDR)

541

5176

1.06

0.54

4.0

4.1

1.77

2.00

ug/l

1.14

501

4704

Contact with blunt object, undetermined intent

619

1.19

0.54

4.2

4.3

2.20

2.04

ug/l

0.08

565

Disorders of lacrimal system and orbit in diseases classified elsewhere

111

999

1.13

0.54

4.5

2.63

2.26

ug/l

0.27

888

Autoimmune thyroiditis

517

1.17

0.54

5.5

4.7

1.67

2.28

ug/l

1.04

459

Spondylopathies in diseases classified elsewhere

161

1494

1.12

0.54

8.5

5.2

23.71

2.83

ug/l

0.86

145

1315

Other and unspecified epidermal thickening

275

2590

1.08

0.54

4.4

5.0

4.67

2.95

ug/l

0.27

250

2308

Malignant neoplasm of tongue

252

2668

0.91

0.53

4.3

3.7

2.12

1.88

ug/l

0.67

225

2399

Other specified and unspecified disorders of conjunctiva

100

903

1.15

0.53

3.9

4.6

1.46

2.30

ug/l

1.61

814

Carcinoma in situ of penis

383

1.42

0.53

5.7

5.0

3.43

3.39

ug/l

0.01

347

Chloasma

144

1.36

0.53

6.5

4.8

2.01

1.81

ug/l

0.09

126

severe traumatic brain injury, does not include concussion

3955

38992

1.02

0.53

5.0

5.1

4.48

3.61

ug/l

0.60

3493

34697

ILD medications: nintedanib

109

1008

1.19

0.53

3.8

5.5

1.64

2.69

ug/l

2.44

891

Heart failure and hypertrophic cardiomyopathy

242

2562

0.91

0.53

4.0

5.2

2.01

3.02

ug/l

1.57

208

2280

Epidural haemorrhage

125

1358

0.88

0.53

3.8

4.3

7.49

2.26

ug/l

0.44

106

1235

Subacute thyroiditis

178

1642

1.10

0.53

5.7

4.8

3.54

2.29

ug/l

0.36

163

1464

Multifocal fibrosclerosis

458

1.20

0.53

4.9

5.5

2.28

2.89

ug/l

0.34

398

Use of benzatropine

100

0.60

0.53

3.1

4.6

1.27

2.28

ug/l

—

Other injuries of spine and trunk, level unspecified

914

0.86

0.53

4.6

2.27

2.39

ug/l

0.09

819

Atrial septal defect

256

2383

1.08

0.52

3.9

4.2

1.62

2.13

ug/l

1.78

224

2169

Foreign body in genitourinary tract

597

1.17

0.52

5.6

5.0

2.91

2.86

ug/l

0.02

527

Viral conjunctivitis

227

2117

1.08

0.52

4.1

4.3

2.08

ug/l

0.00

211

1908

Colectomy operation

2377

23330

1.03

0.52

5.0

5.2

3.02

3.48

ug/l

0.52

2112

20802

Pedestrian injured in collision with car, pick-up truck or van

185

1992

0.91

0.52

4.7

4.4

3.58

2.16

ug/l

0.52

156

1805

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

715

0.85

0.52

4.4

3.6

3.75

1.89

ug/l

0.52

638

Exfoliative dermatitis

148

1592

0.89

0.52

4.4

5.0

3.79

2.87

ug/l

0.26

128

1407

Use of trihexyphenidyl

163

0.68

0.52

4.3

5.0

1.42

2.07

ug/l

—

134

Streptococcal septicaemia

1373

13405

1.04

0.52

5.1

5.2

7.19

3.27

ug/l

0.49

1210

11986

Tic and related disorders

501

1.18

0.52

3.6

3.3

1.63

1.61

ug/l

0.02

449

Assault by bodily force

789

7620

1.05

0.52

3.3

3.4

1.84

1.73

ug/l

0.28

689

7001

Idiopathic pulmonary fibrosis

1220

12500

0.96

0.52

4.6

5.6

3.54

4.43

ug/l

0.34

1041

11067

Other mosquito-borne viral fevers

591

1.18

0.52

4.7

4.5

1.94

1.92

ug/l

0.02

532

Sequelae of other and unspecified infectious and parasitic diseases

581

5583

1.05

0.52

4.0

3.8

1.51

2.02

ug/l

2.92

531

5109

Glaucoma secondary to other eye disorders

510

4894

1.06

0.52

4.8

5.0

2.90

4.16

ug/l

0.67

452

4354

Deaf mutism, not elsewhere classified

451

1.21

0.52

4.0

4.6

1.81

2.37

ug/l

0.40

403

Pyoderma

187

2005

0.91

0.51

4.7

4.9

2.49

2.71

ug/l

0.16

157

1807

Personal history of allergy to drugs, medicaments and biological substances

687

0.85

0.51

4.4

4.2

1.54

2.07

ug/l

1.12

615

Atypical mycobacterium lung infection

1051

0.88

0.51

5.8

5.1

2.90

3.07

ug/l

0.07

926

Nephrotic syndrome

387

3693

1.07

0.51

3.9

4.8

2.66

2.68

ug/l

0.01

346

3320

Tic and related disorders

502

1.17

0.51

3.6

3.4

1.63

2.31

ug/l

0.44

461

Gender identity disorders

411

0.82

0.51

2.1

3.3

1.01

1.50

ug/l

1.32

375

Family history of other specific disorders

521

1.17

0.51

4.6

4.4

2.57

1.78

ug/l

0.45

470

Gangrene, not elsewhere classified

1032

0.87

0.51

3.5

5.3

2.65

3.09

ug/l

0.29

905

Effects of heat and light

784

1.16

0.51

4.5

4.8

1.73

2.40

ug/l

0.81

694

Biliary cirrhosis, secondary

1.58

0.51

3.3

4.4

1.54

2.14

ug/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

506

4860

1.06

0.51

5.0

4.8

2.34

2.68

ug/l

0.51

450

4356

Mature T/NK-cell lymphomas, hilmo

179

1910

0.90

0.51

4.4

5.2

2.29

2.80

ug/l

0.40

164

1689

Mantle cell lymphoma

140

1500

0.88

0.51

4.9

4.0

3.73

2.06

ug/l

0.51

124

1322

Exophthalmic conditions

828

1.14

0.51

4.6

4.3

2.40

2.38

ug/l

0.01

739

Contact with sharp glass

372

3538

1.07

0.50

3.8

1.89

ug/l

0.00

329

3233

Oral lichen planus and hypothyroidism or thyroxine medication

353

1.20

0.50

6.8

5.0

1.66

3.16

ug/l

0.86

308

Mucosal proctocolitis

1390

14253

0.97

0.50

4.2

4.1

2.08

2.28

ug/l

0.67

1262

12948

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

262

2767

0.92

0.50

4.6

3.7

2.15

1.92

ug/l

0.33

227

2489

Beningn neoplasm: Meninges, unspecified

105

950

1.13

0.50

5.8

4.9

3.10

2.82

ug/l

0.20

839

Other congenital malformations of tongue, mouth and pharynx

508

1.17

0.50

4.2

1.64

1.83

ug/l

0.33

454

Graves ophthalmopathy, strict

890

1.13

0.50

4.5

4.6

2.75

2.31

ug/l

0.30

787

Paranoid personality disorder

167

1797

0.91

0.50

4.1

4.5

2.80

2.29

ug/l

0.25

146

1620

Benign neoplasm: Connective and other soft tissue of head, face and neck

169

1570

1.10

0.50

5.0

4.7

2.06

2.63

ug/l

0.92

152

1400

Other and unspecified injuries of forearm

573

1.17

0.50

4.0

4.1

1.86

1.93

ug/l

0.07

516

Disorders of purine and pyrimidine metabolism

762

1.17

0.50

4.4

5.3

2.50

2.78

ug/l

0.15

683

Dementia due to Parkinson's disease

329

3447

0.93

0.50

4.3

5.8

2.72

5.09

ug/l

1.11

266

3013

Childhood allergy (age < 16)

226

1733

1.08

0.49

1.5

1.4

0.83

0.86

ug/l

0.22

204

1557

Acute drug-induced interstitial lung disorder

845

0.86

0.49

5.3

5.4

2.38

2.83

ug/l

0.30

744

Atopic conjunctivitis

239

2238

1.08

0.49

3.9

4.1

1.40

1.97

ug/l

2.37

217

2012

Juvenile osteochondrosis

261

2457

1.08

0.49

3.6

3.9

1.57

1.95

ug/l

0.97

236

2243

Malignant neoplasm of adrenal gland

379

1.23

0.49

4.8

3.7

3.80

2.00

ug/l

0.62

342

Acute mastoiditis

832

1.14

0.49

3.6

3.8

1.43

1.81

ug/l

1.24

763

Cystic disease of liver

461

1.19

0.49

4.2

5.0

2.01

2.74

ug/l

0.49

417

Gastrointestinal stromal tumor and sarcoma

145

1347

1.12

0.49

6.1

4.0

3.09

2.00

ug/l

1.84

124

1201

Sequelae of injuries of head

730

7069

1.05

0.49

4.2

4.4

2.10

2.40

ug/l

0.56

635

6411

Anorexia (incl.atypical)

252

2684

0.93

0.49

4.2

2.45

2.25

ug/l

0.24

227

2418

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

170

1.41

0.49

4.0

4.5

1.87

1.84

ug/l

0.02

155

Dialysis, with operation codes

2162

21245

1.03

0.49

3.6

4.9

2.41

3.21

ug/l

1.40

1997

19107

Dependent personality disorder

146

1346

1.10

0.48

4.6

4.2

1.74

1.92

ug/l

0.25

132

1231

Sequelae of other and unspecified effects of external causes

530

1.19

0.48

5.4

4.6

2.17

2.10

ug/l

0.07

475

Other acquired deformities of ankle and foot

479

1.18

0.48

5.2

4.2

2.52

2.91

ug/l

0.17

436

Fibrosis of liver

789

1.16

0.48

4.4

4.8

2.01

2.04

ug/l

0.02

707

Other papulosquamous disorders

105

957

1.13

0.48

4.7

4.9

4.85

2.83

ug/l

0.43

839

Hair colour and hair shaft abnormalities

605

0.83

0.48

4.1

5.3

2.06

2.65

ug/l

0.46

532

Tooth eruption problems

595

5569

1.05

0.48

3.6

3.5

2.17

1.77

ug/l

0.36

547

5059

Injury of blood vessels at wrist and hand level

100

917

1.15

0.47

5.9

4.5

1.96

2.40

ug/l

0.43

843

Neuroendocrine tumor and carcinoma of lung

615

0.85

0.47

3.7

3.9

1.50

2.07

ug/l

1.75

544

Benign neoplasm: Brain, supratentorial

147

1361

1.11

0.47

4.8

3.94

2.31

ug/l

0.62

131

1216

Exposure to excessive natural heat

215

0.73

0.47

4.1

4.9

1.21

1.78

ug/l

0.62

189

Other diseases of arteries and capillaries

1060

10885

0.96

0.47

4.9

5.3

7.72

4.18

ug/l

0.31

939

9709

Childhood asthma (age<16), excluding more controls

575

4721

0.96

0.47

2.1

1.02

1.14

ug/l

1.93

527

4392

Injury of blood vessels at lower leg level

524

1.19

0.47

4.3

4.6

1.52

2.22

ug/l

1.37

470

Perioral dermatitis

477

1.16

0.47

4.5

4.2

1.49

2.59

ug/l

0.91

419

Personal history of allergy to analgesic agent

424

0.82

0.47

4.7

4.1

1.48

1.72

ug/l

0.35

378

conjunctival degenerations and deposits

191

1787

1.09

0.47

4.9

1.68

3.06

ug/l

1.81

176

1583

Complications of cardiac and vascular prosthetic devices, implants and grafts

328

3138

1.08

0.46

4.2

5.2

2.32

3.22

ug/l

1.21

287

2769

Unspecified transport accident

447

1.20

0.46

3.6

3.8

1.51

1.68

ug/l

0.22

407

Benign neoplasm: Ciliary body

308

1.26

0.46

4.3

4.8

1.50

2.01

ug/l

1.12

271

Need for immunization against other single infectious diseases

1.55

0.46

2.7

4.6

1.92

1.97

ug/l

—

Soft tissue disorders in diseases classified elsewhere

1.50

0.46

5.6

4.9

2.14

1.69

ug/l

—

Blepharospasm

681

1.15

0.46

4.6

4.8

1.75

2.59

ug/l

0.91

603

Drug-induced hypopituitarism

1.54

0.46

5.2

4.2

1.74

1.84

ug/l

0.07

Other congenital malformations of posterior segment of eye (coloboma)

1.49

0.46

3.8

4.4

1.69

1.65

ug/l

—

Malignant neoplasm of oropharynx, including Hilmo

760

0.85

0.46

3.3

3.8

2.96

1.93

ug/l

0.35

675

Congenital malformations of gallbladder, bile ducts and liver

576

1.16

0.46

4.0

4.9

1.87

2.58

ug/l

0.62

521

Oral leukoplakia, including avohilmo

322

3070

1.07

0.46

4.5

4.6

1.65

2.26

ug/l

2.24

280

2768

Viral conjunctivitis

145

1340

1.10

0.46

3.9

4.2

2.39

2.13

ug/l

0.14

133

1218

Distal bite

109

983

1.11

0.46

4.5

3.9

1.76

1.74

ug/l

0.05

891

Other disorders of choroid

158

1473

1.10

0.46

5.4

4.9

2.51

2.59

ug/l

0.06

141

1318

Glycogen storage disease

1.53

0.45

4.3

4.7

1.51

2.19

ug/l

—

Monkeypox

0.00

0.45

0.0

1.9

—

0.71

—

Other bullous disorders

270

2559

1.07

0.45

4.4

4.9

1.75

2.56

ug/l

3.09

244

2280

Lymphangioma, anys site

466

0.84

0.45

4.5

4.1

1.89

1.80

ug/l

0.08

426

Other hereditary haemolytic anaemias

494

1.18

0.45

4.3

1.58

1.94

ug/l

0.70

446

Unspecified event, undetermined intent

246

2325

1.08

0.45

3.7

4.3

1.81

2.14

ug/l

0.74

215

2098

Neovascular glaucoma

508

4895

1.05

0.45

4.8

5.1

2.91

4.18

ug/l

0.68

450

4352

Dextrocardia

1.46

0.45

2.4

3.5

1.20

1.49

ug/l

—

Degenerative macular diseases, drug-induced

365

1.23

0.45

5.6

5.2

2.51

2.15

ug/l

0.42

315

Traumatic ischaemia of muscle

142

1525

0.90

0.45

4.4

4.2

2.10

2.06

ug/l

0.04

137

1388

Other prurigo

874

1.13

0.45

4.4

4.9

2.80

3.17

ug/l

0.13

770

Malignant neoplasm of base of tongue, including Hilmo

132

1410

0.89

0.45

3.9

3.6

2.26

1.84

ug/l

0.86

118

1258

ILD, hospital admissions

2438

24001

1.03

0.45

4.9

5.4

3.43

3.86

ug/l

0.26

2120

21310

Other specified/unspecified diseases of inner ear

477

1.19

0.45

7.3

5.1

29.25

2.14

ug/l

0.67

417

Congenital malformations of aortic and mitral valves

565

5461

1.05

0.44

4.1

4.3

2.01

2.30

ug/l

0.72

505

4956

Disorders of other and unspecified cranial nerves

515

1.18

0.44

5.7

4.8

7.63

2.98

ug/l

0.74

470

Postprocedural disorders of digestive system, not elsewhere classified

348

3323

1.06

0.44

4.7

5.1

2.23

3.03

ug/l

1.18

304

2960

Neuroendocrine tumor and carcinoma of small intestine

168

1576

1.10

0.44

4.8

3.9

2.28

1.97

ug/l

0.73

148

1409

Disorders of iron metabolism

201

1896

1.09

0.44

4.0

4.5

1.98

2.33

ug/l

0.51

174

1719

Ulcer of lower limb, not elsewhere classified

2288

22509

1.03

0.44

4.3

5.2

2.97

3.64

ug/l

0.63

1989

20064

Non-allergic asthma

894

8680

1.04

0.44

4.6

4.9

4.12

3.51

ug/l

0.16

808

7773

Other specified and unspecified disorders of eye and adnexa

311

2957

1.07

0.44

4.9

4.8

2.10

2.79

ug/l

1.01

277

2626

Monosomies and deletions from the autosomes, not elsewhere classified

1.46

0.44

2.0

3.2

0.85

1.63

ug/l

—

Benign neoplasm: Other parts of oropharynx

839

1.13

0.44

4.8

4.5

1.79

2.16

ug/l

0.55

753

Childhood asthma (age<16)

575

4713

0.96

0.44

2.1

1.02

1.15

ug/l

1.94

527

4385

Fibrothorax

305

0.77

0.43

5.0

5.2

2.24

2.50

ug/l

0.18

263

Mandibular retrognathia AND surgery (BSSO)

149

1381

1.09

0.43

4.4

3.6

1.65

1.63

ug/l

0.05

140

1269

Other viral hepatitis

604

6252

0.96

0.43

3.2

3.5

2.02

1.77

ug/l

0.16

515

5731

Benign neoplasm: Endocrine pancreas

807

1.15

0.43

6.1

5.2

2.25

2.68

ug/l

0.38

725

Malignant neoplasm of eye and adnexa

900

0.88

0.43

4.9

3.9

2.73

2.05

ug/l

1.18

799

Malignant cancer of tonsil and base of tongue

325

3382

0.93

0.43

4.1

3.6

2.25

1.81

ug/l

1.86

284

3052

Lichen simplex chronicus

378

3622

1.06

0.43

4.5

4.7

2.20

2.71

ug/l

0.59

335

3242

Melanoma in situ of scalp and neck

421

1.26

0.43

6.6

5.5

2.34

2.98

ug/l

0.34

362

Acute poliomyelitis

916

0.89

0.43

3.8

4.3

1.41

2.44

ug/l

1.71

818

Other osteochondropathies

846

8226

1.04

0.43

4.3

4.2

1.83

2.23

ug/l

2.05

764

7489

Malignant neoplasm of breast, HER2-negative, including Hilmo

177

1.21

0.43

1.1

—

1.62

—

Malignant neoplasm of breast, including Hilmo

177

1.21

0.43

1.1

—

1.62

—

Maze procedure for atrial fibrillation

724

0.85

0.43

4.5

5.0

2.19

2.63

ug/l

0.32

646

Drug-induced osteoporosis with pathological fracture

114

1048

1.11

0.43

5.3

5.2

2.24

2.50

ug/l

0.15

932

Alcohol-induced acute pancreatitis

649

6668

0.95

0.43

4.1

4.4

1.95

2.24

ug/l

0.79

565

6066

Use of rotigotine

126

1170

1.11

0.43

4.8

2.00

2.32

ug/l

0.46

117

1036

Dermatitis herpetiformis

185

1739

1.09

0.42

4.5

4.8

1.78

2.50

ug/l

1.76

164

1557

Disorders of glycoprotein metabolism, other/unspecified

1.67

0.42

7.5

4.5

26.12

1.96

ug/l

—

Malignant neoplasm of other and unspecified parts of tongue

159

1694

0.91

0.42

4.5

3.7

1.91

1.89

ug/l

0.04

142

1507

Contact with lifting and transmission devices, not elsewhere classified

305

2926

1.08

0.42

4.6

4.4

1.93

2.19

ug/l

0.77

287

2664

Senile degeneration of the brain, not elsewhere classified

447

0.83

0.42

6.1

5.6

3.41

3.17

ug/l

0.07

379

Congenital malformations of posterior segment of eye

431

1.18

0.42

4.2

4.8

2.41

2.91

ug/l

0.23

382

Other birth injuries

1.54

0.42

3.8

4.8

0.54

1.91

ug/l

—

Endometriosis ASRM stages 1,2

0.66

0.42

1.3

1.2

—

1.44

—

Other hypertrophic osteoarthropathy

0.61

0.42

3.2

4.8

0.93

2.31

ug/l

—

Suppurative otitis media, unspecified

206

1938

1.08

0.42

4.7

4.9

2.14

2.62

ug/l

0.86

185

1726

Other eating disorders

803

1.11

0.42

3.6

1.30

2.15

ug/l

1.17

716

Drug-induced autoimmune haemolytic anaemia

124

0.66

0.42

3.3

4.3

1.25

1.92

ug/l

—

112

1.39

0.41

2.3

2.0

0.90

0.77

ug/l

—

Circumscribed brain atrophy

242

2544

0.93

0.41

4.5

5.5

2.36

3.56

ug/l

1.51

202

2250

Glaucoma in diseases classified elsewhere

1.60

0.41

7.2

3.7

15.53

1.80

ug/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

128

1380

0.91

0.41

3.7

4.0

1.71

1.84

ug/l

0.24

117

1257

Enterobiasis

474

1.15

0.41

3.7

3.3

1.24

2.12

ug/l

0.74

438

Certain zoonotic bacterial diseases

205

1938

1.08

0.41

5.0

4.7

1.93

2.54

ug/l

1.44

190

1738

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

109

1176

0.90

0.41

4.1

3.8

2.77

2.02

ug/l

0.35

100

1032

Hypertension, portal

391

0.82

0.41

3.2

4.5

0.86

1.86

ug/l

4.72

346

Foreign body in alimentary tract

654

6344

1.04

0.41

4.7

4.9

2.22

2.96

ug/l

1.63

572

5686

Intentional self-harm by jumping from a high place

375

0.83

0.40

2.2

3.4

1.08

1.42

ug/l

1.09

337

Endometriosis of ovary

1.39

0.40

1.2

1.1

—

0.03

—

Protein-energy malnutrition of moderate and mild degree

698

1.13

0.40

4.6

5.4

2.71

2.40

ug/l

0.21

612

Prolapse and hernia of ovary and fallopian tube

0.00

0.40

0.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

743

1.12

0.40

3.8

4.2

1.67

2.19

ug/l

0.54

666

Other proliferative retinopathy

488

0.84

0.40

4.8

4.2

2.93

2.32

ug/l

0.18

442

Moderate visual impairment, monocular

444

1.18

0.40

6.2

4.8

3.20

2.71

ug/l

0.16

392

Burns and corrosions of multiple and unspecified body regions

287

2742

1.07

0.40

4.5

4.4

2.36

2.19

ug/l

0.23

256

2494

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1048

0.90

0.40

4.3

3.7

2.11

2.01

ug/l

0.11

911

Peptic ulcer

1073

0.90

0.40

6.2

4.9

3.02

2.93

ug/l

0.05

950

Hydrocephalus

869

8919

0.96

0.40

4.6

5.4

2.80

4.53

ug/l

1.61

764

7885

Hereditary motor and sensory neuropathy

825

1.13

0.40

4.4

4.8

2.16

2.57

ug/l

0.39

745

Non-selective monoamine reuptake inhibitors

4310

41032

1.02

0.40

4.8

2.17

3.39

ug/l

5.09

3768

37027

KRA_PSY_EATING, excluding more controls

135

1241

1.09

0.40

3.6

3.7

1.34

1.95

ug/l

1.32

113

1124

Secondary malignant neoplasm of other and unspecified sites

243

2318

1.08

0.40

9.4

4.0

20.84

2.03

ug/l

7.91

226

2053

Varicella [chickenpox]

694

6750

1.04

0.40

3.6

3.5

1.72

1.79

ug/l

0.18

637

6247

Other endocrine disorders

305

2781

1.06

0.40

4.6

1.67

2.67

ug/l

2.04

263

2482

Contact with heat and hot substances

597

5784

1.04

0.39

4.3

4.4

1.75

2.49

ug/l

2.77

528

5234

Other bursitis, not elsewhere classified

111

1029

1.11

0.39

4.9

4.7

2.10

2.67

ug/l

0.64

102

920

Acute inflammation of orbit

557

1.15

0.39

3.6

4.4

6.60

2.58

ug/l

0.36

508

Surgical ablation of atrial fibrillation

995

0.87

0.39

4.3

4.9

1.89

2.49

ug/l

0.84

905

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

618

1.15

0.39

4.4

3.7

4.21

1.94

ug/l

0.67

548

Palindromic rheumatism

863

1.12

0.39

4.7

4.5

2.38

3.06

ug/l

0.59

775

All dysplastic lesions of the cervix uteri

105

1.32

0.39

1.1

—

1.08

—

Benign neoplasm: Retina

482

1.17

0.39

4.8

5.2

2.34

3.01

ug/l

0.42

427

Iliotibial band syndrome

535

1.14

0.39

4.8

4.2

2.23

2.52

ug/l

0.17

484

Benign neoplasm: Urethra

100

1.41

0.39

6.9

5.7

2.63

2.07

ug/l

0.31

Superficial injury of neck

164

1539

1.08

0.38

4.1

3.9

3.07

2.04

ug/l

0.33

146

1415

Crossbite

358

3165

1.05

0.38

4.5

4.0

1.91

2.04

ug/l

0.14

318

2891

Maltreatment syndromes

335

3502

0.95

0.38

3.5

3.2

1.90

1.65

ug/l

0.29

293

3217

Melanocytic naevi of eyelid, including canthus

691

1.13

0.38

4.7

4.9

2.63

2.52

ug/l

0.04

609

Use of rasagiline

354

3411

1.06

0.38

4.8

5.4

2.66

2.90

ug/l

0.23

320

3042

Other acute viral hepatitis

131

1223

1.10

0.38

4.2

3.9

1.91

1.81

ug/l

0.15

114

1119

Enterocolitis due to Clostridium difficile

1189

12149

0.97

0.38

4.9

5.2

4.39

4.18

ug/l

0.07

1059

10768

Blood alcohol or alcohol intoxication level

259

2714

0.94

0.38

3.8

4.0

2.15

2.03

ug/l

0.12

236

2481

Pulmonary eosinophilia, not elsewhere classified

105

1133

0.90

0.38

4.8

5.0

1.69

2.58

ug/l

1.90

998

Persistent delusional disorders

717

7376

0.96

0.38

3.9

4.4

3.75

3.13

ug/l

0.11

630

6666

Azathioprine

1490

15197

0.98

0.37

3.8

4.3

2.71

2.85

ug/l

0.07

1356

13730

Secondary parkinsonism, excluding more controls

327

3140

1.06

0.37

4.3

5.3

2.26

3.99

ug/l

2.29

281

2816

Prurigo nodularis

236

2245

1.07

0.37

4.7

5.0

1.95

2.60

ug/l

1.53

214

1997

Posteruptive colour changes of dental hard tissues

144

1.29

0.37

4.3

3.8

1.79

2.03

ug/l

0.14

132

Cytomegaloviral disease

260

2483

1.07

0.37

3.9

4.5

1.92

2.18

ug/l

0.72

244

2231

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

671

1.15

0.37

4.2

5.2

2.53

2.77

ug/l

0.11

599

Neurological devices associated with adverse incidents

1.62

0.37

4.3

4.6

1.47

1.74

ug/l

—

Hypothyroidism due to medicaments and other exogenous substances

807

1.11

0.37

3.7

5.0

1.65

2.91

ug/l

1.86

722

Asthma and opportunity respiratory infection

451

4354

1.05

0.37

5.1

5.3

2.23

4.57

ug/l

1.50

397

3858

Disorders of glycoprotein metabolism

1.43

0.37

8.2

4.8

14.01

1.81

ug/l

0.48

ILD, hospital admission 2, with pulmonary infections

1542

15685

0.97

0.37

4.8

5.5

4.17

4.34

ug/l

0.06

1329

13949

Necrotizing fasciitis

598

0.86

0.37

3.8

4.6

2.16

2.83

ug/l

0.32

537

Habit and impulse disorders

145

1358

1.09

0.37

3.3

1.30

1.73

ug/l

0.81

134

1258

Assault

1502

14735

1.03

0.37

3.4

2.63

1.74

ug/l

0.81

1316

13547

Malignant neoplasm of tonsil, including Hilmo

268

2788

0.93

0.37

4.2

3.7

2.11

1.85

ug/l

0.84

235

2522

Malignant neoplasm of oropharynx

254

2645

0.93

0.37

4.1

3.7

2.07

1.84

ug/l

0.68

218

2386

Glomerular disorders in diseases classified elsewhere

1867

18384

1.03

0.37

3.8

5.0

2.20

3.40

ug/l

2.94

1682

16520

131

1397

0.91

0.37

3.2

4.3

12.90

2.29

ug/l

0.53

110

1254

Allergic contact dermatitis due to drugs in contact with skin

159

1493

1.08

0.36

4.8

5.1

2.37

2.46

ug/l

0.09

144

1335

Other congenital musculoskeletal deformities

1.49

0.36

3.2

2.2

1.09

1.26

ug/l

—

Hyperchylomicronaemia

300

0.79

0.36

4.4

4.9

2.03

2.08

ug/l

0.03

265

Follicular adenocarcinoma of thyroid gland, including Hilmo

731

1.12

0.36

5.3

3.7

2.43

1.93

ug/l

0.64

658

Graves ophthalmopathy

108

997

1.09

0.36

4.5

4.6

2.66

2.28

ug/l

0.28

881

Other congenital malformations of intestine

694

1.12

0.36

4.5

4.7

2.06

2.14

ug/l

0.07

612

Unspecified organic or symptomatic mental disorder

378

0.83

0.36

4.1

5.1

1.59

2.86

ug/l

1.79

327

Prophylactic surgery

124

0.72

0.36

6.0

4.5

3.04

2.03

ug/l

—

112

Non-neuropathic heredofamilial amyloidosis

130

0.71

0.36

2.4

5.1

1.00

1.93

ug/l

—

113

Acute nephritic syndrome

265

2764

0.94

0.36

4.3

4.8

4.21

2.37

ug/l

0.62

236

2483

Intercostal neuropathy

803

1.12

0.36

4.2

4.9

1.52

2.60

ug/l

1.66

714

Other and unspecified parapsoriasis

664

1.15

0.35

6.1

5.2

1.96

2.72

ug/l

0.65

595

Other renal tubulo-interstitial diseases

135

1260

1.08

0.35

5.0

4.9

2.14

2.59

ug/l

0.58

115

1121

Burn and corrosion of head and neck

280

2686

1.06

0.35

4.6

4.2

2.85

2.11

ug/l

0.50

254

2441

Viral hepatitis

741

7608

0.97

0.35

3.5

3.7

2.36

2.01

ug/l

0.26

637

6947

Wegener granulomatosis

149

1581

0.92

0.35

4.1

4.8

2.52

2.46

ug/l

0.06

133

1423

Nezelof syndrome

378

0.84

0.35

5.2

5.0

4.92

2.96

ug/l

0.27

343

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

375

1.20

0.35

5.5

4.8

2.73

2.82

ug/l

0.03

331

Injury of blood vessels at shoulder and upper arm level

243

1.26

0.35

6.0

5.3

4.69

3.46

ug/l

0.24

215

Protozoal diseases

357

3442

1.06

0.35

4.4

5.0

2.84

2.49

ug/l

0.33

321

3069

Non-seminoma of testis

327

1.21

0.35

4.2

3.0

1.45

1.54

ug/l

0.12

297

Other acute lower respiratory infections

7464

71684

0.99

0.35

4.4

4.7

3.07

3.53

ug/l

0.75

6630

64217

ILD, hospital admissions 1, main diag only

2150

21205

1.02

0.35

4.9

5.5

3.49

3.78

ug/l

0.15

1888

18833

Other bacterial agents as the cause of diseases classified to other chapters

1016

0.91

0.35

4.6

5.1

4.02

2.57

ug/l

0.23

903

Synovial hypertrophy, not elsewhere classified

772

1.11

0.35

3.9

4.0

1.28

2.26

ug/l

1.52

701

Unspecified severe protein-energy malnutrition

138

1.31

0.35

3.0

4.5

10.62

1.94

ug/l

0.57

123

Changes in corneal membranes

174

1.26

0.35

3.7

4.4

1.18

1.70

ug/l

1.41

155

Hypotony of eye

130

1.34

0.34

6.8

5.1

3.08

2.33

ug/l

0.44

113

Atopic dermatitis, strict definition

1810

17412

1.02

0.34

3.7

2.21

2.05

ug/l

0.23

1637

15871

Chronic conjunctivitis

192

1817

1.07

0.34

5.1

4.6

1.79

2.46

ug/l

1.62

173

1631

Asphyxiation

115

0.71

0.34

4.0

5.2

1.04

2.01

ug/l

—

Listeriosis

492

0.86

0.34

5.2

5.6

2.53

3.20

ug/l

0.32

425

Gonarthrosis, primary, with knee surgery

9089

71843

1.01

0.34

5.4

5.2

2.87

3.61

ug/l

0.88

8097

64024

Other corneal oedema

756

1.12

0.34

5.0

1.62

2.73

ug/l

1.46

666

Stroke, excluding SAH

10744

77916

1.01

0.34

4.9

5.2

3.58

3.55

ug/l

0.03

9455

69647

Injury of nerves at lower leg level

106

988

1.10

0.34

4.6

4.3

4.67

2.41

ug/l

0.38

894

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

158

1493

1.08

0.34

4.1

4.0

2.22

2.13

ug/l

0.09

141

1369

Contact with other specified venomous animals

563

1.13

0.34

4.9

4.5

2.69

2.37

ug/l

0.15

505

Cerebral palsy

896

1.10

0.34

2.6

3.5

10.15

2.20

ug/l

0.43

823

Frontotemporal dementia, wide, incl. Pick's disease

832

0.89

0.33

4.8

5.4

2.82

2.72

ug/l

0.04

730

Dermatitis due to ingested food

398

1.14

0.33

2.4

2.8

1.30

1.40

ug/l

0.15

360

Other disorders of white blood cells

621

6044

1.04

0.33

4.9

5.0

4.07

2.84

ug/l

0.26

551

5410

Exposure to other specified electric current

184

1941

0.94

0.33

3.0

3.6

1.74

ug/l

0.00

178

1774

Defect, injury or illness of neck

391

1.16

0.33

5.7

4.6

3.40

1.97

ug/l

1.01

345

Haemorrhagic disorder due to circulating anticoagulants

183

1743

1.08

0.33

4.6

5.5

5.20

5.36

ug/l

0.02

158

1519

Other secondary gout

486

0.85

0.33

4.1

5.4

1.46

3.16

ug/l

1.31

424

Vitiligo

869

0.90

0.33

4.0

4.1

1.84

2.29

ug/l

0.46

788

Follicular lymphoma, hilmo

491

5056

0.96

0.33

4.6

5.2

2.35

2.91

ug/l

1.03

425

4501

Acute epiglottitis

183

1740

1.07

0.33

4.4

1.88

2.24

ug/l

0.58

162

1570

Frontotemporal dementia

706

0.88

0.32

4.7

5.2

2.17

2.87

ug/l

0.47

625

Injuries to the ankle and foot

8500

76079

0.99

0.32

4.3

2.29

2.67

ug/l

1.46

7661

69129

Congenital glaucoma

1.38

0.32

3.6

4.8

1.24

2.17

ug/l

0.75

Other superficial injuries of ankle and foot

507

1.14

0.32

3.9

4.4

1.71

1.87

ug/l

0.14

462

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

844

0.90

0.32

5.5

5.3

2.31

2.96

ug/l

0.53

740

Hypermobility syndrome

607

1.11

0.32

4.0

3.4

1.87

2.02

ug/l

0.06

553

Toxoplasmosis

402

1.15

0.32

3.5

4.4

1.33

1.84

ug/l

1.84

364

Benign neoplasm: Nasopharynx

924

1.10

0.32

5.2

4.8

3.77

2.65

ug/l

0.39

824

Immunodeficiency associated with other specified major defects, or unspecified

1.39

0.32

3.4

4.3

2.55

1.90

ug/l

—

Malignant neoplasm of gallbladder

313

0.84

0.32

4.9

3.9

1.97

1.93

ug/l

0.04

274

Use of levodopa decarbox-comt-inhibitor

469

4820

0.95

0.32

4.4

5.5

3.47

3.22

ug/l

0.14

414

4269

Cytomegalovirus infection, IBD co-morbidity

252

2417

1.06

0.32

3.9

4.6

1.93

2.19

ug/l

0.71

236

2174

Other disorders of kidney and ureter in diseases classified elsewhere

1.41

0.32

4.0

5.1

1.86

1.93

ug/l

—

GI-bleeding

5645

55982

1.01

0.32

5.1

5.2

4.13

3.91

ug/l

0.10

4928

49783

Dermatopolymyositis (FG)

123

1154

1.09

0.32

4.6

4.9

3.80

2.84

ug/l

0.37

112

1033

Ulcerative colitis, NAS

1541

15153

1.02

0.32

4.4

2.60

3.06

ug/l

0.30

1399

13717

Primary_lymphoid and hematopoietic malignant neoplasms

3829

37916

1.02

0.32

4.7

5.3

3.69

3.65

ug/l

0.01

3400

33791

Other congenital malformations of eye

1.37

0.32

3.6

4.8

1.24

2.17

ug/l

0.75

Extreme obesity with alveolar hypoventilation

433

4467

0.96

0.32

4.1

4.8

2.02

2.67

ug/l

0.81

366

4036

Liposarcoma

106

997

1.11

0.32

4.8

3.7

2.20

1.91

ug/l

0.35

888

Injury of blood vessels at neck level

487

0.86

0.32

4.0

4.3

4.32

2.02

ug/l

0.34

443

Other infectious diseases

1115

11363

0.97

0.31

4.9

5.1

4.23

3.77

ug/l

0.23

1001

10112

Deformity of finger(s)

625

1.12

0.31

5.6

5.0

1.97

3.58

ug/l

1.46

562

Acrodermatitis chronica atrophicans

119

0.71

0.31

4.6

5.4

2.07

2.35

ug/l

—

103

Bulimia nervosa (incl. atypical)

211

1.19

0.31

2.7

3.1

0.91

1.46

ug/l

2.07

194

Rubella [German measles]

802

7888

1.04

0.31

3.2

3.5

1.71

1.77

ug/l

0.21

748

7353

Psoriasis (vulgaris), strict definition

427

4142

1.05

0.31

3.5

4.2

1.43

2.09

ug/l

4.85

382

3781

Alzheimer’s disease, strict definition

3431

28561

0.99

0.31

4.7

5.8

7.60

5.05

ug/l

0.67

2926

24850

Other inherited muscular atrophy

192

0.78

0.31

6.8

4.6

1.37

1.85

ug/l

0.77

165

Eating disorder

135

1262

1.07

0.31

3.6

3.5

1.34

1.90

ug/l

1.16

113

1136

Myeloproliferative diseases (CML excluded)

899

8804

1.03

0.31

4.5

5.2

2.39

3.60

ug/l

1.56

790

7825

Acute bronchiolitis

177

1685

0.94

0.31

4.2

4.4

2.24

2.38

ug/l

0.13

159

1487

Other and unspecified bullous disorders

836

1.10

0.31

4.5

5.1

1.85

2.89

ug/l

1.28

748

ILD medications: azathioprine

1490

15154

0.98

0.31

3.8

4.3

2.71

2.94

ug/l

0.12

1356

13710

Malignant neoplasm of breast, HER2-negative

174

1.17

0.31

1.1

—

1.62

—

Any dementia, excluding more controls

5799

40214

0.99

0.31

4.8

5.9

5.53

4.46

ug/l

0.46

4950

35462

Other disorders of peripheral nervous system

675

1.12

0.30

4.7

4.9

1.78

2.66

ug/l

0.85

599

Labyrinthine dysfunction

0.62

0.30

6.4

4.5

1.06

1.97

ug/l

—

Chronic suppurative otitis media, including avohilmo

790

7720

1.03

0.30

4.7

4.9

2.77

3.56

ug/l

0.48

693

6901

Tuberculosis of other organs

203

1938

1.06

0.30

4.8

5.3

3.45

3.49

ug/l

0.01

177

1699

Other drug-induced secondary parkinsonism

110

1034

1.09

0.30

4.1

4.6

1.88

2.32

ug/l

0.54

921

Unspecified lump in breast

0.71

0.30

1.0

1.2

—

0.53

—

Acquired absence of limb

138

1452

0.92

0.30

4.3

4.9

1.83

2.58

ug/l

1.67

122

1280

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

280

2689

1.05

0.30

4.1

1.66

2.03

ug/l

1.08

258

2448

Handgun discharge

0.69

0.30

6.0

3.7

0.84

1.53

ug/l

—

Pedestrian injured in collision with pedal cycle

316

3047

1.05

0.30

3.8

4.4

2.06

2.63

ug/l

0.83

291

2755

Benign neoplasm: Ill-defined sites within the digestive system

520

1.13

0.30

5.0

5.1

2.16

2.70

ug/l

0.33

459

Left ventricular outflow tract obstruction, narrow definition

635

6198

1.04

0.30

4.1

4.3

2.00

2.31

ug/l

0.85

568

5620

Other congenital malformations of integument

282

1.19

0.30

3.3

5.2

10.26

2.16

ug/l

0.41

245

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

896

0.90

0.30

4.1

3.9

1.72

2.16

ug/l

0.48

812

Liposarcoma, including Hilmo

142

1350

1.09

0.30

4.8

3.9

2.09

1.95

ug/l

0.18

127

1205

Erythema multiforme

176

1850

0.94

0.30

5.6

4.8

2.76

2.41

ug/l

0.16

159

1655

Amoebiasis

625

1.11

0.30

5.3

4.4

1.51

1.84

ug/l

0.72

550

Hereditary deficiency of other clotting factors

547

1.12

0.30

4.5

4.6

1.40

2.53

ug/l

1.17

494

Other disorders of carbohydrate metabolism

454

1.14

0.30

3.3

4.2

1.64

2.54

ug/l

0.65

404

Neuroendocrine tumor and carcinoma of pancreas

726

1.12

0.30

4.2

3.7

2.15

1.90

ug/l

0.41

653

Other female pelvic inflammatory diseases

1.29

0.30

1.3

1.1

—

0.80

—

Nonspecific lymphadenitis

484

4698

1.04

0.30

4.0

2.90

2.12

ug/l

0.47

446

4277

Ependymoma

104

1.31

0.29

3.7

3.8

0.75

2.30

ug/l

3.31

Mental disorders, not otherwise specified

532

5169

1.03

0.29

3.7

3.9

1.77

1.96

ug/l

0.38

488

4707

Other parasitologically confirmed or unspecified malaria

236

1.21

0.29

4.7

4.2

2.20

1.66

ug/l

0.82

212

Malignant neoplasm of gum, including Hilmo

1003

0.91

0.29

4.7

3.7

1.71

1.98

ug/l

0.59

879

Acute pancreatitis

3271

32391

1.02

0.29

4.6

4.8

2.99

3.27

ug/l

0.21

2899

29138

Other and unspecified haemorrhagic conditions

146

1384

1.07

0.29

4.5

4.8

2.30

2.49

ug/l

0.21

132

1244

Congenital malformations of oesophagus

522

1.13

0.29

5.1

5.0

2.43

2.11

ug/l

0.25

464

Disorders of phosphorus metabolism and phosphatases

455

1.14

0.29

4.6

2.36

2.70

ug/l

0.15

407

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

182

1905

0.94

0.29

5.3

5.5

4.54

3.00

ug/l

0.51

166

1676

Myeloproliferative diseases

1009

9906

1.03

0.28

4.5

5.1

2.89

3.86

ug/l

0.60

892

8813

Inhalation and ingestion of other objects causing obstruction of respiratory tract

541

1.12

0.28

6.3

4.7

2.07

2.13

ug/l

0.07

483

All dysplastic lesions of the cervix uteri, vagina or vulva

128

1.23

0.28

1.1

—

1.08

—

Malignant neoplasm of other and ill-defined digestive organs

908

0.91

0.28

4.2

3.9

2.82

2.12

ug/l

1.01

797

Benign neoplasm: Floor of mouth

360

1.16

0.28

5.0

4.5

2.18

1.95

ug/l

0.23

321

Disorders of hypoglossal nerve

143

1.29

0.28

5.1

4.9

2.76

2.07

ug/l

0.40

128

Eating disorders

350

3623

0.96

0.28

4.0

4.1

2.15

2.12

ug/l

0.05

306

3259

Contusion of ankle

324

3128

1.04

0.28

4.2

4.3

3.87

2.10

ug/l

0.39

293

2831

Cholangitis (primary sclerosing, PSC)

756

7401

1.03

0.28

4.5

5.0

2.61

3.72

ug/l

0.82

663

6607

Alcohol abuse counselling and surveillance

218

2266

0.94

0.28

3.6

4.0

2.35

1.93

ug/l

0.88

194

2078

Disorders of plasma-protein metabolism, not elsewhere classified

736

1.11

0.28

4.0

4.7

1.78

2.58

ug/l

0.68

671

Shigellosis

589

1.11

0.28

4.5

4.3

3.45

1.84

ug/l

1.20

532

Congenital ptosis

235

1.18

0.28

4.7

1.89

1.92

ug/l

0.02

204

Malignant neoplasm of palate, including Hilmo

630

0.89

0.28

5.2

3.8

2.06

1.91

ug/l

0.12

557

Benign neoplasm: Pharynx, unspecified

677

1.10

0.27

4.3

4.5

1.97

2.50

ug/l

0.47

606

Congenital retinoschisis

324

1.18

0.27

4.3

5.0

2.65

3.34

ug/l

0.23

287

Acute myeloid leukaemia and myelodysplastic syndromes

224

2329

0.95

0.27

4.6

4.0

2.15

2.21

ug/l

0.10

195

2045

Other specified transport accidents

496

0.88

0.27

3.4

4.2

1.73

2.34

ug/l

0.44

445

Other disorders following mastoidectomy

429

1.14

0.27

3.9

5.4

12.50

2.27

ug/l

0.51

367

Other and unspecified hypertrophic disorders of skin

445

1.13

0.27

6.4

4.7

1.70

2.54

ug/l

0.53

400

Other and unspecified nail disorders

176

1679

1.06

0.27

5.3

4.7

2.14

2.46

ug/l

0.33

162

1512

Lack of expected normal physiological development

171

1.18

0.27

2.8

2.7

0.79

3.09

ug/l

0.69

155

Nonsuppurative otitis media

1615

14190

0.98

0.27

4.5

4.3

2.61

2.79

ug/l

0.16

1415

12755

Ventricular septal defect, a heart condition

816

1.08

0.27

3.8

4.2

1.36

2.34

ug/l

1.58

734

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

849

1.08

0.27

4.9

4.5

1.65

2.47

ug/l

1.18

759

1.23

0.27

2.3

2.0

0.90

0.78

ug/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

692

0.90

0.27

5.1

4.3

1.67

2.07

ug/l

0.72

619

Fitting and adjustment of external prosthetic device

275

1.18

0.27

3.9

5.1

1.44

2.02

ug/l

0.99

244

Ulcerative enterocolitis

301

3114

0.96

0.27

4.7

4.4

2.29

2.35

ug/l

0.08

274

2798

Labyrinthine fistula

412

1.16

0.27

5.2

5.1

2.15

2.86

ug/l

0.39

367

Lymphocyte function antigen-1 [LFA-1] defect

0.70

0.27

3.0

5.7

1.04

2.39

ug/l

—

Malignant neoplasm of breast

176

1.15

0.27

1.1

—

1.62

—

Phakomatoses, not elsewhere classified

754

1.09

0.27

4.3

4.2

2.14

1.79

ug/l

0.52

677

Benign neoplasm: Connective and other soft tissue of thorax

448

1.13

0.27

5.0

4.9

3.09

2.66

ug/l

0.12

394

Hypoplasia of dental enamel , including avohilmo

411

1.11

0.26

4.9

2.9

1.53

1.36

ug/l

0.15

372

Malignant neoplasm of base of tongue

1011

0.91

0.26

3.8

3.6

2.45

1.82

ug/l

1.03

896

Disorders of vagus nerve

116

1.31

0.26

5.1

4.8

1.55

4.85

ug/l

0.63

102

Drug-induced obesity

455

0.89

0.26

4.0

4.5

1.49

2.65

ug/l

0.88

399

Ophthalmic devices associated with adverse incidents

126

1.31

0.26

4.1

4.8

1.47

2.23

ug/l

0.68

110

Interstitial myositis

0.74

0.26

3.9

4.7

1.14

2.38

ug/l

—

Malaria

526

1.12

0.26

4.7

2.48

2.59

ug/l

0.05

470

Other and unspecified thalassaemias

0.70

0.26

3.7

4.0

1.49

1.83

ug/l

—

Other and unspecified degenerative diseases of nervous system

326

3358

0.96

0.26

5.1

5.7

2.87

4.99

ug/l

0.94

284

2969

Benign neoplasm of other and unspecified intrathoracic organs

115

1089

1.08

0.26

4.6

4.8

2.32

2.65

ug/l

0.27

105

973

Rheumatoid lung disease

522

0.88

0.26

4.5

5.4

2.09

2.97

ug/l

0.65

458

Cerebral palsy and other paralytic syndromes

1183

12022

0.98

0.26

4.4

4.8

3.85

3.40

ug/l

0.19

1061

10738

Hodgkin lymphoma, hilmo

302

3118

0.96

0.26

4.1

4.8

2.02

2.40

ug/l

0.78

270

2797

Traumatic amputation of ankle and foot

415

0.86

0.26

3.5

4.6

1.69

1.86

ug/l

0.23

370

Toxic liver disease

132

1389

0.94

0.25

4.4

4.6

1.92

2.32

ug/l

0.59

121

1252

Erythema in diseases classified elsewhere

191

1.21

0.25

4.7

5.0

3.64

1.81

ug/l

0.93

168

Upper arm

251

0.83

0.25

4.1

4.5

1.62

1.93

ug/l

0.55

222

Other and unspecified diseases of blood and blood-forming organs

281

2718

1.05

0.25

4.3

5.0

2.09

2.52

ug/l

0.72

250

2424

Hepatomegaly and splenomegaly, not elsewhere classified

118

1120

1.08

0.25

4.5

4.7

1.93

2.32

ug/l

0.54

109

995

Eosinophilia

175

1677

1.06

0.25

5.3

5.0

9.10

2.65

ug/l

0.46

162

1511

Vasculitis limited to skin, not elsewhere classified

262

2530

1.05

0.25

4.5

5.0

2.26

2.85

ug/l

0.61

235

2262

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

761

0.91

0.25

4.1

4.8

2.71

2.40

ug/l

0.08

678

Idiopathic thrombocytopenic purpura

310

3003

1.04

0.25

4.6

5.0

2.20

2.87

ug/l

0.94

284

2658

Crohn's disease NAS

600

5863

1.03

0.25

4.1

4.3

2.28

2.35

ug/l

0.06

540

5291

Systemic sclerosis (FG)

919

1.07

0.25

4.7

4.4

2.37

2.68

ug/l

0.19

823

Cutis laxa senilis

170

1.19

0.25

6.1

4.6

1.39

1.92

ug/l

0.50

143

Abnormality of white blood cells, not elsewhere classified

778

1.09

0.25

4.7

4.4

1.76

2.29

ug/l

0.65

698

Ulcerative colitis

3052

30224

1.01

0.25

4.5

4.4

2.39

2.85

ug/l

0.71

2760

27393

Impetigo

349

3383

1.04

0.25

3.8

4.1

2.15

2.12

ug/l

0.04

314

3076

Late syphilis

172

1790

0.94

0.25

3.9

4.6

1.79

2.24

ug/l

0.81

142

1621

Haemolytic anaemias

358

3477

1.04

0.25

4.2

5.0

2.28

2.68

ug/l

0.63

318

3095

Malignant neoplasm of mesothelium and soft tissue

479

4906

0.97

0.25

4.7

3.9

2.58

2.04

ug/l

2.11

417

4381

Hypersensitivity pneumonitis due to organic dust

176

1688

1.06

0.25

5.4

5.0

2.91

2.67

ug/l

0.13

162

1515

Malignant neoplasm of eye and adnexa, including Hilmo

194

1866

1.06

0.25

5.4

3.8

3.87

2.00

ug/l

0.88

170

1659

Nonpyogenic thrombosis of intracranial venous system

670

1.09

0.25

4.6

1.84

2.41

ug/l

0.46

600

Other sideroblastic anaemias

377

0.87

0.25

4.4

5.2

2.69

2.99

ug/l

0.11

329

Iodine-deficiency-related thyroid disorders and allied conditions

1.41

0.25

5.0

4.7

67.21

1.76

ug/l

—

Sulfasalazine

3376

33448

1.01

0.25

4.3

4.6

2.61

2.82

ug/l

0.25

3017

30195

Other disorders of breast

1.20

0.25

1.1

1.2

—

0.44

—

Other nonthrombocytopenic purpura

827

1.09

0.25

5.1

5.0

2.37

2.43

ug/l

0.05

732

536

0.90

0.25

3.4

3.9

1.83

ug/l

0.00

477

Proteinuria and renal glomerular damage; focal glomerulonephritis

123

0.75

0.24

5.1

4.8

2.79

2.05

ug/l

—

109

Refsum disease

0.69

0.24

6.0

5.1

1.65

2.71

ug/l

—

Café au lait spots

1.39

0.24

2.2

3.7

0.85

1.53

ug/l

—

Ulcerative ileocolitis

395

4059

0.96

0.24

4.1

1.85

2.15

ug/l

0.94

359

3686

Other disorders of central nervous system

904

1.08

0.24

4.2

4.7

2.35

2.63

ug/l

0.26

810

Pedestrian injured in collision with railway train or railway vehicle

108

1.31

0.24

6.0

4.7

1.72

1.82

ug/l

0.05

Hypospadias

354

1.14

0.24

4.7

4.3

2.08

2.70

ug/l

0.27

322

Adalimumab

782

7667

1.02

0.24

3.3

3.8

1.56

1.92

ug/l

3.26

722

7014

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

709

1.09

0.24

3.8

4.5

1.43

2.50

ug/l

1.29

632

Other diseases of blood and blood-forming organs, wide

2680

26534

1.01

0.24

4.8

5.0

3.82

3.22

ug/l

0.47

2356

23818

Birth trauma

171

1.19

0.24

3.0

4.0

1.30

1.92

ug/l

0.90

151

Defects in post-translational modification of lysosomal enzymes

1.44

0.24

9.5

5.3

1.43

1.84

ug/l

—

Perichondritis of external ear

186

1788

1.06

0.24

5.2

5.1

3.05

2.84

ug/l

0.16

164

1592

Glaucoma secondary to eye inflammation

809

1.09

0.24

5.5

4.8

4.34

2.59

ug/l

0.74

719

Deficiency of other/unspecified vitamins

1.29

0.24

2.5

4.7

2.34

1.93

ug/l

0.21

Malignant neoplasm of nasal cavity and sinuses

808

0.91

0.24

3.9

3.6

3.29

1.91

ug/l

0.50

708

Acute lymphadenitis

491

4790

1.03

0.24

3.7

4.2

3.67

2.27

ug/l

0.39

434

4345

Injury of nerves and spinal cord at thorax level

558

1.11

0.24

4.6

4.4

2.13

2.30

ug/l

0.10

504

Motor- or nonmotor-vehicle accident in traffic area

595

0.91

0.24

4.5

4.0

2.09

2.39

ug/l

0.17

534

Abscess of tendon sheath

586

1.10

0.23

4.5

4.7

1.39

2.67

ug/l

1.47

526

Hereditary retinal dystrophy

137

1307

1.06

0.23

4.4

4.2

2.54

1.95

ug/l

1.07

127

1180

Pityriasis lichenoides chronica

384

1.13

0.23

4.3

5.0

1.47

2.13

ug/l

1.40

343

Idiopathic hypoparathyroidism

188

0.83

0.23

4.8

4.7

2.63

1.73

ug/l

0.73

163

Hereditary hypogammaglobulinemia

272

0.86

0.23

5.5

4.6

2.39

3.02

ug/l

0.20

241

COPD/asthma related infections

14710

73320

1.01

0.23

4.6

4.9

3.07

3.32

ug/l

0.49

13152

66059

COPD/asthma/ILD related infections

14710

73320

1.01

0.23

4.6

4.9

3.07

3.32

ug/l

0.49

13152

66059

Injury of blood vessels of thorax

303

0.86

0.23

4.9

4.5

2.16

2.95

ug/l

0.28

272

Meretoja disease

346

1.14

0.23

4.8

5.0

2.43

2.15

ug/l

0.27

307

Mandibular prognathia

102

963

1.07

0.23

4.4

4.1

1.65

1.76

ug/l

0.24

865

Unspecified nephritic syndrome

282

2737

1.05

0.23

4.4

4.7

2.34

2.42

ug/l

0.07

266

2452

Immunodeficiency with predominantly antibody defects

183

1756

1.05

0.23

4.1

4.4

1.76

2.34

ug/l

1.27

175

1598

Ulcerative colitis (strict definition, require KELA)

1920

19423

0.98

0.23

4.3

4.2

2.05

2.57

ug/l

1.60

1731

17632

Use of metixene

0.00

0.23

0.0

6.0

—

5.47

—

Secondary parkinsonism

327

3360

0.96

0.23

4.3

5.2

2.26

3.18

ug/l

1.18

281

2977

Personal history of risk-factors, not elsewhere classified

935

1.07

0.23

3.2

3.9

1.25

1.84

ug/l

2.32

835

Schizoaffective disorder

653

6397

1.03

0.23

3.3

4.0

1.44

2.00

ug/l

3.93

586

5838

Eosinophilic disease (BM)

175

1683

1.06

0.23

5.3

5.1

9.10

2.66

ug/l

0.46

162

1507

Endocarditis

588

5990

0.97

0.23

4.7

5.1

2.72

3.56

ug/l

0.54

519

5420

Benign neoplasm: Skin of upper limb, including shoulder

181

1740

1.05

0.23

5.2

4.8

6.36

2.44

ug/l

0.60

159

1548

Other ulcerative colitis

577

5893

0.97

0.22

4.5

4.3

3.79

2.18

ug/l

0.54

530

5307

Anuria and oliguria

823

1.09

0.22

4.7

4.9

4.64

2.50

ug/l

0.78

716

Other fibroblastic disorders

385

1.13

0.22

4.0

4.4

1.86

2.90

ug/l

0.62

347

Early syphilis

179

1725

1.06

0.22

4.3

3.7

2.95

1.81

ug/l

0.63

165

1575

Pseudomembranous colitis

563

0.91

0.22

3.7

4.4

3.81

2.29

ug/l

0.59

496

Femoral hernia, bilateral

250

1.16

0.22

4.4

4.8

2.38

2.18

ug/l

0.13

220

Benign neoplasm: Bronchus and lung

172

1657

1.06

0.22

4.5

5.0

2.09

3.22

ug/l

1.50

155

1477

Malignant neoplasm of other and unspecified urinary organs

407

1.14

0.22

4.7

4.1

6.89

2.31

ug/l

0.52

361

Schizotypal disorder

203

1956

1.05

0.22

3.0

3.3

1.29

1.69

ug/l

1.31

176

1806

Marginal zone B-cell lymphoma, including Hilmo

190

1833

1.05

0.22

4.7

3.9

2.61

1.92

ug/l

0.92

170

1624

Meckel's diverticulum

677

1.09

0.22

4.3

4.6

2.15

1.94

ug/l

0.21

606

Laparoscopic left hemicolectomy

229

2220

1.05

0.22

4.7

5.1

2.61

2.92

ug/l

0.25

202

1984

Granuloma annulare

702

1.08

0.22

4.9

4.8

1.90

2.76

ug/l

0.95

629

Atopic dermatitis, strict definition with reimbursement

2034

19410

1.01

0.22

3.8

3.9

2.15

2.18

ug/l

0.04

1833

17706

Congenital musculoskeletal deformities of head, face, spine and chest

654

1.08

0.22

4.0

4.1

1.65

2.14

ug/l

0.43

581

Mild or no visual impairment, binocular

288

1.13

0.22

4.7

4.9

1.79

3.23

ug/l

0.66

259

Hyperalimentation, other specified

1.26

0.21

4.7

4.8

4.89

2.41

ug/l

—

Inflammatory myopathy

174

0.81

0.21

6.8

5.7

2.05

2.32

ug/l

0.18

150

Other specified/unspecified systemic involvement of connective tissue

289

2801

1.04

0.21

4.4

4.8

2.19

2.64

ug/l

0.51

255

2486

Disorders of amino-acid transport

195

1.20

0.21

4.2

4.5

1.00

2.38

ug/l

3.86

171

Other and unspecified disorders of white blood cells

446

4361

1.03

0.21

4.8

5.0

2.08

2.72

ug/l

1.40

390

3895

Other specified and unspecified personality disorders

789

7753

1.02

0.21

3.6

4.0

1.91

2.01

ug/l

0.15

701

7062

Toxic effect of other gases, fumes and vapours

661

0.91

0.21

3.6

3.9

1.35

1.74

ug/l

0.90

593

Paraplegia, diplegia of upper limbs

248

2555

0.96

0.21

4.6

4.8

3.91

2.68

ug/l

0.36

219

2269

Malignant neoplasm of small intestine

276

2685

1.04

0.21

4.8

3.9

2.26

1.99

ug/l

0.90

241

2397

Injury of intra-abdominal organs

270

2622

1.04

0.21

4.2

4.1

3.71

2.12

ug/l

0.51

234

2367

Dysplasia of cervi uteri

1.21

0.21

1.1

—

0.03

—

Exposure to ignition of highly flammable material

658

0.91

0.21

4.1

4.2

2.15

1.88

ug/l

0.32

591

Enteropathic arthropathies

187

1802

1.05

0.21

4.5

4.1

2.42

2.52

ug/l

0.06

169

1633

Primary biliary cholangitis (PBC)

100

947

1.06

0.21

4.2

5.0

1.77

2.81

ug/l

1.42

839

Congenital malformations of oesophagus

474

1.11

0.21

5.3

5.0

2.44

2.12

ug/l

0.23

420

Explicit fungal Sepsis

965

0.93

0.21

5.3

5.1

3.40

2.70

ug/l

0.26

854

Knuckle pads

186

1.20

0.21

4.0

4.7

1.92

1.93

ug/l

0.01

160

Acute posthaemorrhagic anaemia

381

3902

0.97

0.20

4.8

5.3

3.12

4.30

ug/l

0.48

335

3450

Agent resistant to multiple antibiotics

0.75

0.20

2.7

6.5

1.36

1.85

ug/l

—

Certain conditions originating in the perinatal period

140

1301

0.95

0.20

2.8

3.1

1.35

1.45

ug/l

0.20

128

1168

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

834

0.92

0.20

4.0

3.7

3.18

1.95

ug/l

0.43

733

Malignant neoplasm of tonsil

232

2384

0.95

0.20

4.2

3.7

2.15

1.84

ug/l

0.94

200

2146

Other and unspecified acquired haemolytic anaemias

100

1049

0.93

0.20

4.1

5.0

2.83

2.60

ug/l

0.12

943

Disorders of parathyroid gland, other and/or unspecified

337

1.12

0.20

6.1

5.1

2.51

3.14

ug/l

0.24

296

Other acantholytic disorders

410

1.14

0.20

6.1

5.2

2.28

2.15

ug/l

0.17

357

Adenocarcinoma of small intestine

329

0.87

0.20

4.7

3.9

1.81

1.95

ug/l

0.15

293

Contracture of joint

135

1295

1.06

0.20

4.1

4.7

1.58

3.54

ug/l

1.87

118

1155

Postdysenteric arthropathy

913

1.07

0.20

4.4

4.3

1.66

1.98

ug/l

0.76

823

Congenital lactase deficiency

1.25

0.20

6.7

5.1

1.90

1.61

ug/l

0.20

Other zoonotic bacterial diseases, not elsewhere classified

290

1.13

0.20

3.8

4.7

2.39

2.43

ug/l

0.02

251

Contact with hot air and gases

778

1.08

0.20

3.9

4.3

1.75

2.29

ug/l

0.58

698

Congenital malformations of lung

166

1.18

0.20

3.7

3.9

1.50

1.70

ug/l

0.25

147

Secondary parkinsonism+Parkinsonism in other disease

337

3451

0.97

0.20

4.4

5.3

2.23

3.21

ug/l

1.34

289

3056

Actinomycosis

402

0.89

0.20

5.6

4.8

1.37

2.04

ug/l

1.93

354

Chronic hepatitis NAS

979

0.94

0.20

4.9

4.4

2.06

2.45

ug/l

0.38

876

Immunodeficiency associated with other major defects

195

1.17

0.19

3.7

4.4

1.93

1.85

ug/l

0.09

173

LSIL lesion of the cervix uteri

1.20

0.19

1.0

1.2

—

0.90

—

Pedestrian injured in other and unspecified transport accidents

917

0.94

0.19

4.1

4.5

1.84

2.12

ug/l

0.58

826

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

610

6214

0.98

0.19

2.9

3.1

1.31

1.64

ug/l

1.36

514

5720

Disorders of globe

247

2399

1.04

0.19

4.9

5.1

5.09

2.80

ug/l

0.72

221

2134

Osteopathies and chondropathies

6522

61063

0.99

0.19

5.1

4.7

3.64

3.15

ug/l

0.25

5771

54995

Unspecified parasitic disease

105

1005

1.07

0.19

4.0

5.0

1.87

2.80

ug/l

1.45

905

Renal tubulo-interstitial disorders in diseases classified elsewhere

120

1152

1.06

0.19

4.5

5.0

2.23

2.56

ug/l

0.30

110

1017

Medullary cystic kidney disease, nephronophthisis

110

1.23

0.19

3.8

4.8

1.79

1.87

ug/l

0.09

Internuclear ophthalmoplegia

350

1.12

0.19

4.7

4.9

8.41

3.01

ug/l

0.43

313

Congenital malformations of lung

176

1.17

0.19

3.9

4.0

1.54

1.67

ug/l

0.16

154

Flatback syndrome

1.28

0.19

6.1

4.6

0.50

2.01

ug/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

118

1129

1.06

0.19

4.8

4.0

2.59

2.14

ug/l

0.18

103

1020

Malignant neoplasm of gum

503

0.91

0.19

3.8

1.83

2.10

ug/l

0.38

446

Malignant neoplasm of nasopharynx

399

0.89

0.19

4.9

3.9

2.30

1.95

ug/l

0.36

356

Rare circulating lymphoid malignancy, including Hilmo

376

3679

1.03

0.19

5.0

3.8

2.60

1.98

ug/l

0.49

332

3269

Defects in the complement system

310

0.89

0.18

3.5

4.4

2.11

1.72

ug/l

0.17

276

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2102

21213

0.99

0.18

4.3

2.13

2.53

ug/l

1.03

1898

19267

Otitis media, unspecified

622

5833

0.98

0.18

4.5

4.2

1.72

2.32

ug/l

2.29

559

5255

Toxic effect of other inorganic substances

0.72

0.18

5.4

4.3

2.81

2.13

ug/l

—

Mental and behavioural disorders due to hallucinogens

359

1.11

0.18

2.2

2.8

0.92

1.30

ug/l

1.27

332

Fibrosarcoma

780

1.07

0.18

4.6

3.8

2.56

2.07

ug/l

0.51

686

Interstitial lung disease

2469

24502

1.01

0.18

4.9

5.4

3.42

3.88

ug/l

0.29

2145

21742

Interstitial lung disease endpoints

2469

24502

1.01

0.18

4.9

5.4

3.42

3.88

ug/l

0.29

2145

21742

Benign neoplasm: other/unspecified salivary gland

280

2729

1.04

0.18

5.1

5.2

2.64

3.40

ug/l

0.62

245

2414

Pneumonia due to Haemophilus influenzae

349

0.89

0.18

6.2

4.8

3.17

3.00

ug/l

0.04

313

Sequelae of poliomyelitis

922

0.93

0.18

4.7

5.2

5.16

2.95

ug/l

0.33

811

Acidosis

318

3249

0.96

0.18

4.7

4.9

3.17

3.02

ug/l

0.09

280

2898

Burn and corrosion of ankle and foot

165

1705

0.95

0.18

4.5

4.4

2.01

2.27

ug/l

0.40

153

1539

Alzheimer’s disease (Late onset)

3159

26377

1.01

0.18

4.8

5.8

8.00

5.28

ug/l

0.65

2695

22880

Congenital malformations of trachea and bronchus

651

1.07

0.18

5.5

5.0

7.25

2.02

ug/l

0.44

571

Pneumonia derived septicemia

396

4043

0.97

0.18

4.6

5.0

2.31

2.66

ug/l

0.52

345

3609

Fibrosarcoma, including Hilmo

888

1.07

0.18

4.8

3.8

2.50

2.00

ug/l

0.59

781

Other osteochondrodysplasias

485

1.09

0.18

4.7

4.1

1.78

2.43

ug/l

0.39

437

Polyarteritis nodosa and related conditions

114

1092

1.06

0.18

4.4

4.8

2.28

2.43

ug/l

0.14

102

983

Diaper [napkin] dermatitis

0.75

0.18

2.4

6.2

3.38

2.31

ug/l

—

Explicit bacterial Sepsis

1568

15523

1.01

0.18

5.1

5.2

6.56

3.53

ug/l

0.42

1386

13871

Other bacterial agents as the cause of diseases classified to other chapters

842

0.94

0.18

4.3

5.2

4.54

2.67

ug/l

0.25

745

Glaucoma secondary to drugs

362

1.12

0.18

4.5

5.1

1.30

2.88

ug/l

1.12

324

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.73

0.18

5.0

3.7

2.04

1.35

ug/l

—

Cushing syndrome

761

0.94

0.18

5.9

5.0

2.42

2.57

ug/l

0.09

672

Other neurotic disorders

545

5356

1.02

0.17

4.9

4.6

5.70

2.53

ug/l

0.72

487

4829

Assault by sharp object

204

2099

0.96

0.17

2.8

3.4

6.08

1.68

ug/l

0.52

170

1942

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

330

1.10

0.17

3.5

2.25

1.62

ug/l

0.71

302

Neuromyelitis optica

101

1.21

0.17

2.9

4.3

1.24

1.64

ug/l

0.33

Other overlap syndromes

935

1.06

0.17

3.8

4.8

1.28

2.47

ug/l

2.53

833

Left ventricular outflow tract obstruction (LVOTO), broad definition

1514

15281

0.99

0.17

3.8

4.2

1.79

2.15

ug/l

3.09

1372

13980

Crushing injury of lower leg

285

1.13

0.17

4.4

4.5

14.50

1.87

ug/l

0.46

255

Secondary thrombocytopenia

131

1358

0.95

0.17

4.6

4.7

2.68

2.31

ug/l

0.25

119

1224

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

809

1.06

0.17

4.4

4.3

1.97

2.33

ug/l

0.27

729

Injury of nerves at ankle and foot level

644

1.07

0.17

5.0

4.4

6.18

2.02

ug/l

0.52

575

Disorder of carbohydrate metabolism, other/unspecified

343

1.11

0.17

3.0

3.9

1.47

1.82

ug/l

0.75

310

Drug-induced Cushing's syndrome

1.21

0.17

5.1

4.6

1.39

2.08

ug/l

—

Rheumatic fever with heart involvement

469

1.09

0.17

5.2

4.9

1.99

2.20

ug/l

0.22

419

Disorders of sexual preference

395

0.88

0.17

3.2

4.2

1.59

2.48

ug/l

0.53

357

Chronic tubulo-interstitial nephritis

240

2333

1.03

0.17

4.4

5.0

3.18

2.70

ug/l

0.18

219

2044

Later onset COPD, excluding more controls

3925

30484

0.99

0.17

5.2

6.0

3.31

4.60

ug/l

1.66

3402

27011

Other other unspecified disorders of the circulatory system

387

3793

1.03

0.17

5.0

5.2

4.07

2.81

ug/l

0.50

348

3368

Convergent concomitant strabismus

372

3639

1.03

0.17

3.5

3.7

1.90

1.95

ug/l

0.04

341

3319

Dermatopolymyositis

125

1203

1.05

0.17

4.6

4.9

3.75

2.36

ug/l

0.65

114

1083

Conduct disorder

115

1199

0.95

0.16

2.5

2.9

8.49

1.38

ug/l

0.50

104

1100

Actinomycosis

409

0.91

0.16

6.9

4.8

1.43

2.03

ug/l

1.62

359

Secondary malignant neoplasm of respiratory and digestive organs

199

2045

0.96

0.16

4.7

4.0

6.65

2.06

ug/l

1.35

172

1807

Other and unspecified vasculitis limited to skin

240

2339

1.04

0.16

4.6

5.0

2.33

2.91

ug/l

0.54

213

2092

Problems related to social environment

222

2158

1.03

0.16

4.9

4.7

3.65

3.22

ug/l

0.11

195

1916

Acute otitis externa, noninfective

151

1460

1.04

0.16

4.8

4.6

1.95

2.78

ug/l

0.92

138

1316

LSIL lesion of the cervix uteri, vagina or vulva

1.16

0.16

1.0

1.2

—

1.62

—

Symptoms and signs involving appearance and behaviour

605

1.07

0.16

3.9

4.6

15.24

2.60

ug/l

0.47

544

Biological medication for rheuma

1423

14379

0.99

0.16

3.4

3.8

1.61

1.91

ug/l

2.79

1310

13171

Congenital malformations of eyelid, lacrimal apparatus and orbit

312

1.10

0.16

4.9

4.5

1.66

1.80

ug/l

0.12

268

Chronic suppurative otitis media

678

6678

1.02

0.16

4.7

4.9

2.89

3.75

ug/l

0.44

585

5962

Drug-induced tremor

676

1.07

0.16

4.1

4.9

1.96

2.46

ug/l

0.41

604

Combined immunodeficiencies

849

0.94

0.16

5.3

5.0

4.79

3.22

ug/l

0.39

756

Other/unspecified rheumatoid arthritis

986

9981

0.99

0.16

4.6

5.2

2.66

4.19

ug/l

1.81

876

8833

Mental and behavioural disorders due to use of other stimulants, including caffeine

208

2139

0.97

0.15

2.3

2.4

0.84

1.22

ug/l

5.38

173

1992

Typhoid and paratyphoid fevers

499

1.08

0.15

4.1

4.5

2.06

2.41

ug/l

0.27

442

Diffuse brain injury

478

4860

0.98

0.15

4.3

4.6

4.49

3.48

ug/l

0.24

429

4403

Etanercept

453

4447

1.02

0.15

3.5

4.1

1.56

2.02

ug/l

2.99

413

4055

Secondary lactase deficiency

0.80

0.15

2.8

4.5

1.76

2.02

ug/l

—

CR(E)ST syndrome

439

1.08

0.15

5.1

4.5

2.65

2.77

ug/l

0.03

390

Cutaneous lupus erythematosus

138

1332

1.04

0.15

4.7

4.6

1.90

2.33

ug/l

0.68

123

1185

Other autoimmune haemolytic anaemias

129

1247

1.05

0.15

4.4

5.3

2.52

2.59

ug/l

0.06

113

1100

HSIL lesion of the cervix uteri

1.15

0.15

1.1

1.2

—

1.18

—

Typhoid and paratyphoid fevers

422

1.09

0.15

4.0

4.5

1.83

2.48

ug/l

0.76

374

Disorders of copper metabolism

107

0.80

0.15

3.9

4.5

1.88

1.56

ug/l

—

Interstitial cystitis (chronic), drug-induced

0.79

0.15

2.3

5.7

1.99

2.77

ug/l

—

Cerebral arteritis

201

0.87

0.15

4.2

4.6

1.97

1.79

ug/l

0.12

181

Other demyelinating diseases of the central nervous system

210

2043

1.03

0.15

4.0

3.9

1.55

1.90

ug/l

0.97

181

1863

Hereditary lymphedema

128

0.83

0.15

4.6

3.72

2.08

ug/l

0.73

113

Abnormal reflex

442

1.08

0.15

4.1

4.6

1.94

1.91

ug/l

0.03

392

Any mental disorder

17598

88331

1.00

0.15

4.4

4.8

3.11

3.14

ug/l

0.03

15531

80065

Other parasitologically confirmed or unspecified malaria

277

1.11

0.14

5.0

4.3

2.18

1.67

ug/l

0.84

249

Mantle cell lymphoma, including Hilmo

217

2218

0.96

0.14

5.2

3.9

3.24

2.01

ug/l

0.60

192

1971

Other dermatomyositis

284

0.90

0.14

3.3

5.0

2.35

1.99

ug/l

0.16

252

Other interstitial pulmonary diseases

2469

24536

1.01

0.14

4.9

5.4

3.42

3.89

ug/l

0.29

2145

21774

Other disorders of thyroid

499

1.07

0.14

6.2

4.9

8.95

2.73

ug/l

0.43

435

Chronic ulcer of skin, not elsewhere classified

921

9109

1.02

0.14

4.4

5.1

3.62

4.03

ug/l

0.12

815

8124

Haemolytic-uraemic syndrome

161

1.15

0.14

3.1

4.5

1.43

2.16

ug/l

1.01

145

Abnormality of red blood cells

502

1.08

0.14

5.0

4.1

1.39

2.16

ug/l

1.54

444

Open wound of neck

996

0.95

0.14

4.3

4.0

1.46

2.09

ug/l

0.96

915

Toxic effect of other and unspecified substances

952

1.05

0.14

3.6

3.4

13.17

1.59

ug/l

0.49

876

Malignant neoplasm of other and unspecified major salivary glands

364

0.91

0.14

3.5

3.8

1.94

1.81

ug/l

0.15

316

Exclusion endpoint for clefts

111

1067

1.04

0.14

3.9

1.84

1.70

ug/l

0.17

102

964

Ischaemic Stroke, excluding all haemorrhages

10088

74824

1.00

0.14

4.9

5.2

3.57

3.70

ug/l

0.15

8844

66761

Antenatal screening

0.80

0.14

1.1

1.2

—

0.75

—

Chronic myeloid leukaemia, including Hilmo

112

1083

1.05

0.14

4.4

3.7

6.66

1.88

ug/l

0.47

104

964

Congenital malformations of heart and great arteries

1326

12730

1.01

0.14

4.3

1.82

2.30

ug/l

3.84

1172

11559

Chondrosarcoma, including Hilmo

483

1.08

0.14

4.0

3.7

3.23

1.94

ug/l

1.03

432

Chylothorax

281

0.89

0.14

3.9

5.4

1.58

3.16

ug/l

0.76

252

Disorders of adrenal gland, other and/or unspecified

404

1.08

0.14

5.4

4.8

3.30

2.79

ug/l

0.12

362

Contact with venomous snakes and lizards

914

1.05

0.14

5.0

4.8

2.21

2.49

ug/l

0.19

819

Monoplegia

143

1473

0.96

0.14

4.1

4.8

2.16

2.59

ug/l

0.60

130

1313

Other contact dermatitis

686

6771

1.02

0.13

4.5

4.6

2.82

2.91

ug/l

0.05

611

6060

Pedestrian injured in transport accident

657

6485

1.02

0.13

4.2

4.5

2.40

2.55

ug/l

0.14

588

5837

Atrial septal defect, secundum type

141

1361

1.04

0.13

4.1

1.63

2.16

ug/l

1.04

120

1245

Burns classified according to extent of body surface involved

121

1173

1.05

0.13

3.7

4.3

2.39

2.32

ug/l

0.05

111

1061

Other immunodeficiencies

631

0.94

0.13

4.0

4.6

1.48

2.34

ug/l

0.75

567

ILD medications: pirfenidone

194

1902

1.04

0.13

4.3

5.6

1.89

3.03

ug/l

1.33

175

1686

Other specified/unspecified nutritional deficiencies

528

0.93

0.13

3.7

4.6

1.75

2.81

ug/l

0.90

475

Chronic hepatitis, not elsewhere classified

272

2664

1.03

0.13

4.4

4.5

1.75

2.23

ug/l

1.33

249

2414

Tumor necrosis factor alpha inhibitors

1226

12376

0.99

0.13

3.3

3.7

1.55

1.85

ug/l

4.41

1131

11316

Benign neoplasm: Oesophagus

122

1258

0.96

0.13

4.7

4.9

1.43

2.70

ug/l

3.14

107

1116

Colorectal neuroendocrine tumor and carcinoma

110

1063

1.04

0.13

4.8

3.6

1.85

ug/l

0.00

949

Other and unspecified localized connective tissue disorders

152

1.14

0.13

4.2

4.7

1.64

1.78

ug/l

0.10

135

Secondary uncertain malignant neoplasm

1838

18507

0.99

0.13

5.2

3.9

6.39

2.06

ug/l

7.73

1637

16543

Normal-pressure hydrocephalus

615

6076

1.02

0.13

4.6

5.7

3.33

4.66

ug/l

0.80

529

5333

Injury of nerves at hip and thigh level

357

1.09

0.13

3.7

5.3

1.83

2.56

ug/l

0.87

311

UC patients in KELA-register (code 208), prior to 1994

533

5400

0.98

0.13

4.8

4.7

2.58

2.67

ug/l

0.06

471

4846

Toxic encephalopathy

390

1.11

0.13

5.0

1.77

3.15

ug/l

0.92

349

Anorexia

541

1.06

0.13

5.0

4.8

2.60

2.51

ug/l

0.04

472

Syphilis

349

3546

0.98

0.13

4.2

4.3

2.46

2.03

ug/l

0.38

308

3215

Syphilis

349

3546

0.98

0.13

4.2

4.3

2.46

2.03

ug/l

0.38

308

3215

Rheumatoid arthritis, including avohilmo

3689

37078

0.99

0.12

4.5

5.0

2.59

3.40

ug/l

2.56

3295

33131

Chronic nephritic syndrome

523

5163

1.02

0.12

4.0

4.8

2.56

2.62

ug/l

0.05

480

4642

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1851

18640

0.99

0.12

4.3

4.2

2.06

2.58

ug/l

1.49

1668

16938

Asthma (mode)

11352

60951

1.00

0.12

4.6

4.7

2.63

3.24

ug/l

1.58

10281

55363

Pemphigus

709

0.94

0.12

4.7

5.0

1.84

2.68

ug/l

0.75

628

Congenital malformations of the musculoskeletal system, not elsewhere classified

375

1.07

0.12

4.8

3.9

1.37

2.62

ug/l

0.78

334

Deficiency of other B group vitamins

200

1955

1.03

0.12

5.5

5.2

2.15

2.96

ug/l

1.52

169

1716

Other and unspecified neuropathies

486

1.07

0.12

4.8

5.1

1.86

2.74

ug/l

0.65

433

Pyoderma gangrenosum

563

1.06

0.12

3.7

4.7

1.65

2.11

ug/l

0.63

494

Hyperfunction of pituitary gland, other and/or unspecified

144

1.15

0.12

4.9

4.8

2.72

2.03

ug/l

0.54

127

Autoimmune hepatitis

445

1.07

0.12

3.7

5.0

0.97

3.20

ug/l

2.45

401

Toxic effects of substances chiefly nonmedicinal as to source

1278

12678

1.01

0.12

4.3

2.98

2.71

ug/l

0.11

1150

11514

Gastrojejunal ulcer

168

1642

1.04

0.12

3.7

5.0

2.12

2.91

ug/l

1.41

148

1438

Mucinous and mucinous cystic tumor of rectum

685

1.07

0.12

3.7

3.9

2.49

2.05

ug/l

0.57

600

Ulcerative colitis (strict definition, all Crohn cases excluded)

1645

16565

0.99

0.11

4.3

4.2

2.04

2.44

ug/l

1.93

1479

15008

Other lack of coordination

191

1869

1.03

0.11

5.3

5.1

2.66

2.71

ug/l

0.04

173

1654

Manic episode

278

2730

1.02

0.11

3.6

4.2

1.65

2.10

ug/l

1.51

244

2486

Problems related to lifestyle

1316

13061

1.01

0.11

3.8

4.3

2.59

2.37

ug/l

0.12

1155

11865

Pityriasis rosea

387

1.07

0.11

3.6

4.3

1.46

1.91

ug/l

0.98

344

Findings of drugs and other substances, not normally found in blood

497

1.07

0.11

6.3

4.4

3.77

1.85

ug/l

1.69

438

Pedal cyclist injured in collision with motor vehicle

276

2711

1.02

0.11

5.1

4.3

2.93

2.18

ug/l

0.63

245

2427

Evidence of alcohol involvement determined by level of intoxication

102

989

1.04

0.11

3.3

4.0

1.86

1.88

ug/l

0.02

903

Disorder of thyroid, unspecified

495

1.06

0.11

6.2

4.9

9.08

2.77

ug/l

0.43

429

Nystagmus and other irregular eye movements

102

988

1.04

0.11

4.6

4.5

1.54

2.34

ug/l

1.46

889

Other anxiety disorders

3839

33412

0.99

0.11

3.9

3.8

2.17

2.27

ug/l

0.11

3404

30599

Rat-bite fevers

1.17

0.11

4.4

5.6

1.85

2.33

ug/l

—

Benign neoplasm: Tonsil

110

1132

0.96

0.11

4.3

4.7

1.71

2.46

ug/l

1.12

1024

Other specified congenital malformation syndromes affecting multiple systems

849

1.04

0.11

3.4

3.7

1.47

1.58

ug/l

0.18

771

Air embolism (traumatic)

0.73

0.11

6.6

3.9

18.97

2.28

ug/l

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

110

1070

1.04

0.11

5.1

5.2

3.97

2.34

ug/l

0.46

102

948

Pneumococcal septicemia

383

3883

0.98

0.11

4.6

5.0

2.34

2.64

ug/l

0.41

333

3454

Other juvenile arthritis

133

1293

1.03

0.11

3.1

3.6

1.65

2.14

ug/l

0.87

122

1160

Other adrenocortical overactivity

173

1.11

0.11

6.4

5.2

4.80

1.92

ug/l

0.50

149

Vitamin B12 deficiency anaemia

1281

12716

1.01

0.10

5.0

5.4

3.50

4.38

ug/l

0.67

1111

11261

Conotruncal defects

525

0.95

0.10

2.9

3.4

0.95

1.55

ug/l

4.28

481

IBD patients in KELA-register

2715

27017

1.01

0.10

4.2

2.06

2.68

ug/l

1.93

2464

24569

Cachexia

563

0.94

0.10

4.6

5.5

1.68

3.13

ug/l

1.63

489

Hereditary factor IX deficiency

1.08

0.10

2.2

4.1

3.33

1.61

ug/l

—

Malignant neoplasm of small intestine, including Hilmo

374

3789

0.98

0.10

4.8

3.9

2.20

1.98

ug/l

0.84

327

3390

Guttate psoriasis

108

1111

0.97

0.10

4.6

4.4

1.36

2.09

ug/l

1.58

996

Pneumocystosis

246

2421

1.03

0.10

4.5

5.2

3.15

2.64

ug/l

0.36

224

2150

Myopathy due to other toxic agents

0.74

0.10

6.6

4.2

1.31

1.90

ug/l

—

Drug-induced polyneuropathy

893

1.04

0.10

6.0

4.9

2.85

2.59

ug/l

0.10

805

Haemorrhage in early pregnancy

131

1.11

0.10

1.0

1.2

—

0.64

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

0.76

0.10

4.4

3.7

3.58

2.47

ug/l

—

Alport

1.17

0.10

4.5

3.8

2.34

1.50

ug/l

0.28

Polymyositis

705

1.05

0.10

4.6

4.7

3.97

2.21

ug/l

0.55

633

Pinta [carate]

1.16

0.10

4.3

4.4

2.21

1.63

ug/l

—

Chronic myeloid leukaemia

529

1.06

0.09

4.3

3.8

1.73

1.77

ug/l

0.06

471

Other acute skin changes due to ultraviolet radiation

350

3453

1.02

0.09

4.7

4.8

4.97

3.17

ug/l

0.46

309

3084

Burn and corrosion of shoulder and upper limb, except wrist and hand

240

2361

1.02

0.09

3.7

4.4

1.88

2.28

ug/l

0.70

211

2135

Carcinoma in situ of middle ear and respiratory system

698

1.05

0.09

5.8

5.4

2.41

2.85

ug/l

0.35

602

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

510

0.94

0.09

5.0

5.6

1.98

2.93

ug/l

0.75

448

Other and unspecified disorders of pigmentation

439

1.06

0.09

4.3

4.6

1.43

2.71

ug/l

0.98

392

ILD medications: immunosuppressive drugs

8580

79876

1.00

0.09

4.0

4.5

2.16

2.53

ug/l

1.77

7769

72274

Degeneration of iris and ciliary body

1.11

0.09

2.2

3.6

1.10

2.06

ug/l

—

HSIL lesion of the cervix uteri, vagina or vulva

1.15

0.09

1.2

1.1

—

1.08

—

Injuries to the hip and thigh

7173

64775

1.00

0.09

4.8

5.0

3.59

3.79

ug/l

0.15

6329

57708

Focal brain injury

1060

10669

0.99

0.09

4.7

4.8

2.35

3.67

ug/l

3.01

924

9624

Acute appendicitis, with complications

2802

27903

1.01

0.09

4.5

4.7

2.75

3.10

ug/l

0.48

2501

25149

Postpartum haemorrhage due to retained placenta

1.04

0.09

1.0

1.1

—

1.31

—

Keratosis punctata

0.79

0.09

3.6

4.2

1.05

1.68

ug/l

—

Acquired haemolytic anaemia

258

2541

1.02

0.09

4.4

5.1

2.61

2.68

ug/l

0.07

229

2246

Allergic purpura

249

2450

1.02

0.09

4.1

4.5

1.77

2.42

ug/l

1.85

223

2217

Hydroxyapatite deposition disease

0.76

0.09

5.4

5.8

0.83

2.23

ug/l

—

Other endophthalmitis

460

1.06

0.09

4.2

5.1

2.38

2.88

ug/l

0.21

407

Benign neoplasm: Ureter

0.78

0.09

5.3

5.2

3.76

1.98

ug/l

—

Yaws

133

0.87

0.09

5.1

4.7

1.36

2.15

ug/l

0.80

123

Indeterminate sex and pseudohermaphroditism

0.76

0.09

4.0

4.8

1.62

1.84

ug/l

—

Pelvic region

0.83

0.09

3.8

5.1

3.87

2.38

ug/l

—

Other and unspecified aplastic anaemias

117

1198

0.97

0.09

5.1

5.0

3.54

3.06

ug/l

0.13

106

1062

Ascorbic acid deficiency

1.10

0.09

3.4

4.5

3.53

1.56

ug/l

—

Early syphilis

168

1650

1.03

0.09

4.4

3.7

3.07

1.80

ug/l

0.66

154

1507

Family history of mental and behavioural disorders

1.08

0.09

3.0

5.0

2.14

1.70

ug/l

—

Other and unspecified firearm discharge, undetermined intent

147

1.14

0.09

7.0

4.1

6.00

1.59

ug/l

0.39

138

Benign neoplasm: Rectum/anal canal icd-9

756

1.04

0.09

6.9

5.5

2.78

4.16

ug/l

0.59

652

Congenital malformation of optic disc

0.83

0.09

2.8

4.0

1.01

1.79

ug/l

—

Embolic stroke with flimmer

359

3630

0.98

0.09

4.6

5.7

3.10

4.88

ug/l

0.73

308

3190

Late syphilis

204

2073

0.98

0.09

4.0

4.6

1.74

2.20

ug/l

1.06

170

1865

Forearm

1.10

0.09

2.3

4.7

0.91

1.83

ug/l

—

Need for immunization against certain single viral diseases

1.04

0.08

12.3

4.0

1.83

1.32

ug/l

—

Congenital mitral valve regurgitation

0.80

0.08

4.8

3.9

2.49

1.57

ug/l

—

Eosinophilic cellulitis [Wells]

0.84

0.08

3.0

5.5

0.85

1.59

ug/l

—

Marginal zone B-cell lymphoma

104

1015

1.04

0.08

4.8

4.0

2.51

1.94

ug/l

1.09

904

Chronic thyroiditis

1.05

0.08

3.7

5.2

2.08

1.99

ug/l

—

Blindness or visual impairment, binocular

431

1.06

0.08

4.3

4.9

2.10

2.12

ug/l

0.02

376

Other and unspecified disorders of refraction

1.11

0.08

7.3

4.5

1.90

1.92

ug/l

—

Isolated patent ductus arteriosus

0.80

0.08

2.2

3.3

1.04

1.55

ug/l

—

Traction detachment of retina

924

0.96

0.08

4.8

4.4

2.04

1.97

ug/l

0.09

829

Schizoid personality disorder

215

2183

0.98

0.08

3.2

3.9

2.74

1.93

ug/l

0.31

192

2004

Osteopathy in diseases classified elsewhere

748

1.04

0.08

6.5

4.9

5.42

2.62

ug/l

0.84

674

412

1.06

0.08

4.6

3.7

1.45

1.61

ug/l

0.23

381

Ulcer of oesophagus, drug-induced

710

0.95

0.08

6.6

5.4

5.33

2.65

ug/l

0.39

618

Muscle wasting and atrophy, not elsewhere classified

721

0.96

0.08

4.3

4.9

2.28

2.35

ug/l

0.07

643

Occupant of special vehicle mainly used on industrial premises injured in transport accident

890

1.05

0.08

4.1

4.5

2.16

2.38

ug/l

0.19

798

Perineal laceration during delivery

1.10

0.08

1.0

1.2

—

0.48

—

Gonococcal infection

197

1936

1.02

0.08

3.0

3.3

1.75

1.53

ug/l

0.82

181

1767

Unspecified threat to breathing

589

1.04

0.08

4.8

4.5

2.09

ug/l

0.00

526

Dementia due to Parkinsons disease, excluding more controls

329

3253

1.02

0.08

4.3

6.1

2.72

4.96

ug/l

3.23

266

2852

Malignant neoplasm of anus and anal canal

442

1.06

0.08

3.2

3.9

1.47

2.01

ug/l

0.69

392

Aspergillosis

121

1186

1.03

0.08

4.7

5.1

1.92

2.59

ug/l

1.19

107

1066

Lipodystrophy, not elsewhere classified

1.08

0.08

6.4

4.7

1.79

1.75

ug/l

—

Kidney diseases associated to Fabry's disease

1.08

0.08

3.9

5.3

1.25

2.40

ug/l

—

Tobacco use

617

6220

0.99

0.08

3.7

4.5

2.97

2.37

ug/l

0.18

538

5637

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.87

0.08

3.4

5.1

2.39

2.06

ug/l

—

Tuberculosis of other organs, strict

226

2227

1.02

0.08

4.8

5.4

3.30

5.31

ug/l

0.47

197

1940

Asthma mixed form (mode), excluding more controls

493

4881

1.01

0.08

4.8

5.1

2.88

4.38

ug/l

0.88

451

4378

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

896

8883

1.01

0.08

4.7

5.5

2.86

4.25

ug/l

1.51

804

7839

Burns and corrosions of multiple body regions

117

1194

0.97

0.07

5.0

4.4

2.57

2.43

ug/l

0.10

102

1076

Assault by unspecified means

192

1951

0.98

0.07

3.3

1.57

1.51

ug/l

0.10

163

1803

Hyperosmolality and hypernatraemia

155

1523

1.03

0.07

3.7

5.2

2.10

2.93

ug/l

1.52

139

1339

Right hemicolectomy

724

7189

1.01

0.07

4.9

5.3

2.68

3.98

ug/l

1.29

639

6363

Systemic sclerosis, icd10

946

1.03

0.07

4.7

4.4

2.39

2.27

ug/l

0.07

840

Other meningitis

121

1184

1.03

0.07

4.9

4.5

4.16

2.27

ug/l

0.44

116

1066

Crohn's disease of large intestine

447

4513

0.99

0.07

3.9

4.1

1.97

2.10

ug/l

0.29

404

4086

6-mercaptopurine

239

2423

0.98

0.07

3.9

3.7

1.74

ug/l

0.01

218

2208

Viral infections of central nervous system, not elsewhere classified/unspecified

912

0.97

0.07

4.6

4.0

1.77

ug/l

0.00

824

Retrobulbar neuritis in diseases classified elsewhere

118

1.11

0.07

3.5

3.8

1.36

1.70

ug/l

0.51

109

General autosomal fish scale disease

0.89

0.07

4.0

3.2

1.60

1.54

ug/l

—

Eccrine sweat disorders

187

1.09

0.07

3.4

4.1

0.85

2.02

ug/l

5.98

168

Other sexually transmitted chlamydial diseases

296

2923

1.01

0.07

3.1

2.6

1.63

1.26

ug/l

0.79

266

2699

Magnesium deficiency

365

0.94

0.07

3.5

4.4

1.51

1.86

ug/l

0.65

323

Viral encephalitis, not elsewhere classified/unspecified

205

2021

1.02

0.07

4.8

2.57

2.53

ug/l

0.03

189

1805

Vitamin deficiency, wide

441

4369

1.01

0.07

4.6

4.9

2.03

3.14

ug/l

2.73

388

3899

Vitamin deficiency

441

4369

1.01

0.07

4.6

4.9

2.03

3.14

ug/l

2.73

388

3899

Car occupant injured in noncollision transport accident

328

3316

0.99

0.07

4.0

4.3

1.72

2.21

ug/l

1.86

289

2993

Operations for atrial fibrillation

257

2597

0.98

0.07

4.5

5.1

1.94

2.79

ug/l

1.40

230

2339

Oesophageal obstruction

508

5041

1.01

0.07

4.9

5.1

2.15

4.16

ug/l

1.59

443

4473

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

166

1627

1.02

0.07

3.7

3.6

1.51

1.83

ug/l

0.58

153

1491

Injury of blood vessels at ankle and foot level

119

1.13

0.07

7.8

4.8

2.96

4.49

ug/l

0.22

107

Other cestode infections

274

0.94

0.07

4.3

4.9

2.47

2.22

ug/l

0.13

238

Sequelae of poliomyelitis

108

1101

0.97

0.06

4.9

5.3

4.83

3.00

ug/l

0.33

969

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

862

1.04

0.06

4.9

5.7

2.60

3.47

ug/l

0.71

747

Intentional self-harm by sharp object

158

1554

1.02

0.06

3.2

3.6

1.96

1.95

ug/l

0.00

140

1420

Amoebiasis

454

1.05

0.06

5.6

4.4

1.63

1.83

ug/l

0.24

393

Acute bronchitis

5311

52170

1.00

0.06

4.6

4.9

3.39

3.91

ug/l

0.61

4648

46470

Myelodysplastic syndrome

136

1338

1.02

0.06

4.7

4.1

2.14

2.24

ug/l

0.16

115

1169

Lordosis

263

0.93

0.06

3.9

4.0

1.28

3.15

ug/l

0.91

236

Meningitis

479

4751

1.01

0.06

4.9

4.4

2.56

2.29

ug/l

0.19

437

4280

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

171

0.90

0.06

2.9

5.3

1.83

3.06

ug/l

0.73

149

Pneumoconiosis due to asbestos and other mineral fibres

423

4260

0.99

0.06

6.0

5.8

5.99

5.12

ug/l

0.13

344

3722

Cerebral aneurysm, nonruptured

823

8277

0.99

0.06

4.5

4.9

2.06

2.81

ug/l

3.62

749

7436

Chronic Coagulation defects

117

1148

1.02

0.06

4.3

4.4

1.94

2.23

ug/l

0.28

103

1038

Disorders of aromatic amino-acid metabolism

273

0.94

0.06

4.7

5.0

1.66

2.82

ug/l

0.86

251

Aortic valve malfunction, age under 60 years

1461

14665

0.99

0.06

3.8

4.2

1.78

2.11

ug/l

2.71

1322

13426

Congenital malformations of cardiac chambers and connections

172

0.92

0.06

1.6

2.7

0.53

1.18

ug/l

5.23

160

Other or unspecified paralytic strabismus

673

1.03

0.06

4.4

4.9

2.33

2.53

ug/l

0.12

602

Renal agenesis and other reduction defects of kidney

515

0.96

0.05

4.1

4.9

2.27

2.58

ug/l

0.12

458

Asthma mixed form (mode)

493

4893

1.01

0.05

4.8

5.1

2.88

4.46

ug/l

0.93

451

4372

Drug-induced cataract

222

2195

1.02

0.05

4.0

4.7

1.82

2.29

ug/l

1.34

192

1984

Other and unspecified psoriasis

830

8259

1.01

0.05

4.3

4.9

2.47

2.77

ug/l

0.31

732

7424

Assault by drugs, medicaments and biological substances

120

0.90

0.05

5.5

3.2

1.31

1.52

ug/l

0.25

110

Multiple myeloma and malignant plasma cell neoplasms

638

6345

1.01

0.05

4.7

5.4

3.00

4.04

ug/l

0.72

567

5603

Acute pancreatitis (for exclusion)

3271

32637

1.00

0.05

4.6

4.8

2.99

3.24

ug/l

0.19

2899

29351

Assault by blunt object

165

1671

0.98

0.05

3.6

3.5

1.74

1.83

ug/l

0.13

147

1538

Monocytic leukaemia

437

1.05

0.05

4.3

5.5

1.80

2.90

ug/l

0.76

383

Sequelae of inflammatory diseases of the central nervous system

292

0.95

0.05

4.3

4.2

1.16

1.98

ug/l

1.31

268

Dissection of cerebral arteries, nonruptured

774

1.03

0.05

4.3

4.4

1.51

2.27

ug/l

1.03

693

Cleft lip and cleft lip and palate

464

0.96

0.05

4.3

3.4

1.51

2.42

ug/l

0.67

420

Renal cell carcinoma of kidney

432

4291

1.01

0.05

5.2

3.9

5.54

2.16

ug/l

1.32

383

3795

Other and unspecified mental retardation

817

1.02

0.05

3.2

3.6

1.22

1.47

ug/l

0.78

747

Vitamin D deficiency

116

1141

1.02

0.05

3.7

4.3

1.63

2.34

ug/l

1.43

107

1027

Other disorders of electrolyte and fluid balance, not elsewhere classified

756

0.97

0.05

5.3

4.8

4.25

4.19

ug/l

0.01

667

Drug-induced osteoporosis

887

0.98

0.05

5.4

4.7

1.38

2.43

ug/l

2.11

792

Carcinoma in situ of oral cavity, oesophagus and stomach

815

1.03

0.05

5.5

5.0

1.60

2.64

ug/l

1.48

724

Thromboangiitis obliterans

463

0.96

0.05

4.0

5.1

2.67

3.18

ug/l

0.21

401

Hypertension, Pulmonary Arterial

605

0.97

0.05

3.9

5.2

2.14

3.61

ug/l

0.98

525

Malignant neoplasm of anus and anal canal, including Hilmo

118

1162

1.02

0.05

4.3

3.9

2.60

2.09

ug/l

0.36

1021

Adrenogenital disorders

298

1.05

0.05

3.6

4.9

1.84

2.35

ug/l

0.59

258

Other disorders of fluid, electrolyte and acid-base balance

4370

41683

1.00

0.05

4.7

5.2

3.50

3.71

ug/l

0.24

3821

37105

Restrictive cardiomyopathy

412

0.96

0.04

4.7

5.1

2.29

2.78

ug/l

0.21

366

Diseases of spleen

196

1980

0.99

0.04

4.9

4.18

2.89

ug/l

0.46

173

1784

Retained (old) intraocular foreign body

151

1.12

0.04

5.6

4.6

22.23

2.07

ug/l

0.53

133

Benign neoplasm: Hypopharynx

647

1.03

0.04

4.2

5.1

1.93

2.83

ug/l

0.91

585

Behavioural disorders

112

1137

0.98

0.04

2.3

2.8

8.65

1.36

ug/l

0.50

101

1047

Contact with hypodermic needle

101

1.09

0.04

3.3

3.1

0.99

1.31

ug/l

0.56

Insulin, combination of fast acting with intermediate-acting or long-acting

10863

99331

1.00

0.04

4.4

4.9

2.74

3.41

ug/l

1.98

9560

89305

Tetraplegia

884

0.98

0.04

5.4

4.8

1.60

2.43

ug/l

2.52

783

Amiodarone users

1753

17570

1.00

0.04

4.4

5.2

3.96

3.64

ug/l

0.08

1533

15725

Cerebral atherosclerosis

152

1532

0.98

0.04

5.0

5.3

2.49

4.09

ug/l

1.11

135

1329

Exposure to other and unspecified man-made environmental factors

147

1453

1.02

0.04

4.2

4.3

1.77

1.94

ug/l

0.27

140

1313

Juvenile arthritis (FINNGEN)

167

1689

0.99

0.04

3.3

3.6

1.76

1.93

ug/l

0.30

155

1531

ILD and respiratory illness in diseases classified elsewhere

498

1.03

0.04

3.7

5.2

1.69

2.86

ug/l

1.03

438

Pneumonia due to other infectious organisms, not elsewhere classified

422

4197

1.01

0.04

4.5

5.1

5.50

3.16

ug/l

0.37

379

3753

Injury of nerves at shoulder and upper arm level

121

1195

1.02

0.04

3.6

4.3

1.73

2.25

ug/l

0.73

109

1090

Pedal cyclist injured in collision with pedestrian or animal

793

0.98

0.03

5.6

4.4

2.16

1.87

ug/l

0.36

704

Gonococcal infection

179

1772

1.01

0.03

3.1

3.3

1.79

1.53

ug/l

0.87

165

1614

Respiratory disorders in diseases classified elsewhere

124

1225

1.02

0.03

4.1

5.1

2.14

2.52

ug/l

0.53

103

1097

Contact urticaria

151

1.07

0.03

3.4

4.1

0.96

1.80

ug/l

3.85

135

Tarsal tunnel syndrome

548

1.03

0.03

4.4

4.5

1.62

2.65

ug/l

1.00

498

Drug-induced myopathy

350

0.96

0.03

3.9

5.0

1.75

2.58

ug/l

0.72

309

Benign neoplasm: Heart

310

1.04

0.03

4.7

5.1

2.15

2.09

ug/l

0.02

271

Systemic sclerosis

966

1.02

0.03

4.7

4.6

2.37

2.29

ug/l

0.05

858

Gastric ulcer - Acute with haemorrhage, drug-induced

249

0.94

0.03

4.3

5.6

1.91

2.52

ug/l

0.59

210

Other and unspecified nonorganic psychotic disorders

1726

17299

1.00

0.03

3.1

3.5

1.73

1.90

ug/l

0.39

1520

15853

Sequelae of infectious and parasitic diseases

836

8387

1.00

0.03

4.2

4.3

2.23

3.17

ug/l

0.86

754

7549

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

201

1.05

0.03

4.5

4.8

2.15

3.80

ug/l

0.48

178

Use of amantadine

127

1284

0.99

0.03

5.0

4.9

2.51

2.48

ug/l

0.02

111

1137

Transepidermal elimination disorders

112

1.09

0.03

3.0

4.3

0.79

1.66

ug/l

3.58

Mental and behavioural disorders due to use of volatile solvents

221

1.05

0.03

2.4

2.8

1.29

1.47

ug/l

0.22

206

Assault by other specified means

768

1.02

0.03

4.0

3.3

1.41

1.52

ug/l

0.28

712

Benign neoplasm: Thymus

261

1.05

0.03

5.7

4.5

3.48

2.03

ug/l

0.68

227

Airway disease due to specific organic dust

261

1.05

0.03

4.6

4.4

4.61

1.98

ug/l

0.40

239

Purulent endophthalmitis

689

1.02

0.03

4.9

5.2

4.07

2.74

ug/l

0.54

611

Immunodeficiencies

359

3571

1.01

0.03

4.3

4.6

2.41

2.87

ug/l

0.43

329

3197

Other Crohn's disease

614

6117

1.00

0.03

3.7

4.0

2.32

2.05

ug/l

0.31

568

5548

Spinal enthesopathy

282

2798

1.01

0.03

4.9

5.1

5.31

6.56

ug/l

0.21

246

2401

Impacted teeth

877

7776

1.00

0.03

3.7

3.3

2.36

1.65

ug/l

0.43

813

7079

Exposure to unspecified smoke, fire and flames

108

1092

0.98

0.03

4.8

4.2

7.18

2.06

ug/l

0.59

981

Sequelae of burns, corrosions and frostbite

520

0.97

0.03

4.0

4.2

1.65

1.86

ug/l

0.36

470

Malignant neoplasm of parotid gland

861

0.98

0.02

5.0

3.8

2.45

1.93

ug/l

0.60

751

Varus deformity, not elsewhere classified

470

1.02

0.02

3.7

4.5

1.99

2.64

ug/l

0.64

423

Unspecified contracted kidney

590

1.02

0.02

4.1

4.9

1.36

2.57

ug/l

1.47

525

Other protozoal intestinal diseases

113

1118

1.01

0.02

5.0

4.6

1.55

2.61

ug/l

2.01

106

1003

Endometriosis ASRM stages 3,4

132

1.06

0.02

1.1

1.2

—

1.44

—

Generalized pustular psoriasis

379

0.97

0.02

5.4

5.2

1.56

2.38

ug/l

1.73

331

Inflammatory bowel disease, strict (require KELA)

2715

27114

1.00

0.02

4.2

2.06

2.67

ug/l

1.92

2464

24639

Other and unspecified acute skin changes due to ultraviolet radiation

298

2995

0.99

0.02

4.7

4.9

5.58

3.27

ug/l

0.51

263

2666

Malignant neoplasm of adrenal gland, including Hilmo

620

1.02

0.02

4.4

3.6

3.12

1.91

ug/l

0.58

551

Muscular dystrophy

660

1.02

0.02

5.4

4.5

2.12

2.17

ug/l

0.04

592

Use of interferon beta-1a

859

1.01

0.02

2.6

3.2

1.36

1.42

ug/l

0.12

793

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

242

1.05

0.02

3.8

4.4

1.94

3.14

ug/l

0.41

216

Cellulitis of external ear

104

1051

0.99

0.02

4.6

4.5

1.59

2.16

ug/l

1.03

953

Retained (old) foreign body following penetrating wound of orbit

117

0.90

0.02

4.5

3.9

2.68

1.92

ug/l

0.33

104

Volvulus

286

2874

0.99

0.02

4.7

5.0

3.43

3.60

ug/l

0.05

253

2554

Other retinal disorders in diseases classified elsewhere

308

0.96

0.02

4.1

5.1

33.82

2.38

ug/l

0.47

273

Syndrome of inappropriate secretion of antidiuretic hormone

559

0.98

0.02

4.6

5.0

1.93

2.54

ug/l

0.62

488

Aortic aneurysm

5581

54769

1.00

0.02

5.1

5.5

2.73

4.12

ug/l

5.22

4830

48724

Measles

100

990

1.01

0.02

2.5

2.8

1.64

1.35

ug/l

0.72

918

Arthropathy in ulcerative colitis

950

1.01

0.02

4.8

4.3

3.28

1.90

ug/l

0.76

856

Reimbursement for rheumatic diseases

6206

61830

1.00

0.02

4.3

4.8

2.35

3.19

ug/l

3.90

5549

55571

Lesion of sciatic nerve

506

5045

1.00

0.02

5.4

3.07

4.95

ug/l

1.21

462

4440

Infarction of spleen

771

1.02

0.02

4.8

5.0

6.39

2.77

ug/l

0.61

689

Cyst of spleen

113

1.07

0.02

3.9

2.05

1.77

ug/l

0.16

102

Mental and behavioural disorders due to cannabinoids

214

2128

1.01

0.02

2.4

2.5

1.15

1.23

ug/l

0.23

167

1974

Golimumab

224

2228

1.01

0.02

3.1

3.4

1.49

1.74

ug/l

0.71

210

2060

Other and unspecified paralytic syndromes

131

1300

1.01

0.02

4.2

4.4

2.40

2.51

ug/l

0.05

117

1170

Malignant neoplasm of pyriform sinus, including Hilmo

267

0.95

0.01

5.9

3.7

5.26

2.02

ug/l

0.52

240

Cleft lip

147

0.95

0.01

4.1

3.0

1.19

1.52

ug/l

0.45

133

Non-follicular lymphoma

1419

14172

1.00

0.01

4.8

5.3

2.86

3.79

ug/l

1.14

1249

12660

Relapsing polychondritis

177

0.95

0.01

6.4

5.1

1.93

1.82

ug/l

0.06

161

Crowding of teeth, including avohilmo

253

2101

1.00

0.01

3.5

3.4

1.48

1.72

ug/l

0.71

233

1914

Malignant neoplasm of other and unspecified parts of mouth

582

1.02

0.01

3.9

10.47

2.01

ug/l

0.52

516

Multiple myeloma

306

3049

1.01

0.01

4.3

4.0

2.45

2.06

ug/l

1.04

265

2698

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

306

3049

1.01

0.01

4.3

4.0

2.45

2.06

ug/l

1.04

265

2698

Other peripheral vascular diseases

723

7216

1.00

0.01

4.4

5.1

2.30

3.63

ug/l

1.36

643

6426

Other diseases of peritoneum

312

3109

1.00

0.01

5.0

5.1

2.45

2.91

ug/l

0.71

282

2756

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

336

3349

1.00

0.01

2.6

3.0

1.12

1.54

ug/l

4.95

309

3134

Other inflammatory liver diseases

684

6826

1.00

0.01

4.5

4.7

5.09

2.57

ug/l

0.53

611

6145

Burn and corrosion of hip and lower limb, except ankle and foot

261

2600

1.01

0.01

4.6

4.4

1.72

2.28

ug/l

2.02

228

2344

Postprocedural disorders of ear and mastoid process, not elsewhere classified

898

0.99

0.01

4.8

5.2

7.23

2.42

ug/l

0.48

779

Pustulosis palmaris et plantaris

279

2780

1.00

0.01

4.3

4.7

1.86

2.58

ug/l

1.47

241

2503

Other diseases of appendix

843

1.01

0.01

5.2

4.6

3.01

2.50

ug/l

0.37

761

Sphingolipidosis, other/unspecified

1.07

0.01

3.4

4.9

1.26

2.17

ug/l

—

Traumatic subcutaneous emphysema

186

0.95

0.00

5.8

4.5

2.51

2.24

ug/l

0.16

165

Other specified/unspecified necrotizing vasculopathies

141

1403

1.01

0.00

4.0

5.0

2.39

2.63

ug/l

0.21

121

1237

Acute and transient psychotic disorders

1102

11011

1.00

0.00

3.4

3.8

1.52

2.09

ug/l

4.33

981

10055

Acquired pure red cell aplasia [erythroblastopenia]

394

1.02

0.00

5.6

5.2

2.15

2.58

ug/l

0.36

345

Dermatopolymyositis, unspecified

514

1.02

0.00

4.7

5.1

3.13

2.84

ug/l

0.07

460

Juvenile Open Angle Glaucoma

526

0.98

0.00

3.9

1.66

2.00

ug/l

0.39

474

Contact with other and unspecified heat and hot substances

734

1.01

0.00

4.4

4.3

2.11

2.64

ug/l

0.34

658

Atypical virus infections of central nervous system

836

0.99

0.00

3.7

4.2

1.65

2.28

ug/l

0.71

745

Behavioural disorders, excluding more controls

112

1111

1.01

0.00

2.3

2.9

8.65

1.42

ug/l

0.49

101

1028

Cleft lip and palate

384

1.02

0.00

3.9

3.4

1.54

1.79

ug/l

0.32

348

Complications following infusion, transfusion and therapeutic injection

137

1375

1.00

0.00

5.0

4.8

4.63

2.61

ug/l

0.56

122

1214

Congenital malformations of eyelid, lacrimal apparatus and orbit

258

1.01

0.00

5.2

4.3

1.77

1.74

ug/l

0.02

227

Malignant neoplasm of retroperitoneum and peritoneum

462

0.99

0.00

3.8

1.76

2.08

ug/l

0.53

418

Toxic effect of carbon monoxide

201

2013

1.00

0.00

4.7

4.5

2.85

2.36

ug/l

0.20

184

1819

Disorders of oesophagus in diseases classified elsewhere

252

2517

1.00

0.00

5.0

5.1

2.50

3.34

ug/l

0.86

227

2243

Chronic myeloid leukaemia [CML], BCR/ABL-positive

110

1098

1.00

0.00

4.4

4.9

6.78

2.60

ug/l

0.38

102

974

Renal agenesis and other reduction defects of kidney

459

1.00

0.00

4.1

4.9

2.38

2.71

ug/l

0.12

409

469

1.00

0.00

3.8

5.3

1.75

2.93

ug/l

0.97

416

Impaction of intestines

571

1.00

0.00

5.2

4.5

1.65

3.66

ug/l

1.85

506

Malignant neoplasm of parotid gland, including Hilmo

112

1116

1.01

0.00

5.0

3.8

2.38

1.91

ug/l

0.74

985

Melanoma of uvea

121

1206

1.00

0.00

5.5

5.1

4.74

2.71

ug/l

0.51

106

1065

Bacterial meningitis

358

3579

1.00

0.00

5.1

4.5

2.03

2.19

ug/l

0.19

320

3232

Crushing injury of ankle and foot

552

0.99

0.00

4.0

4.6

1.25

2.64

ug/l

1.67

495

Pediculosis and phthiriasis

548

1.00

0.00

3.0

3.6

1.58

1.61

ug/l

0.04

500

Cryoglobulinemia

181

0.99

0.00

4.1

5.2

2.30

3.79

ug/l

0.39

162

Fracture of spine, level unspecified

279

1.01

0.00

4.8

5.3

1.52

2.16

ug/l

1.43

236

Congenital malformations of great arteries

111

1091

1.00

0.00

4.0

1.85

2.08

ug/l

0.27

100

989

Dislocations, sprains and strains involving multiple body regions

105

0.94

0.00

7.1

5.4

0.65

1.87

ug/l

—

Pustular psoriasis

325

3245

1.00

0.00

4.4

4.7

1.86

2.56

ug/l

1.76

282

2917

Arteriovenous malformation of cerebral vessels

115

1147

1.00

0.00

5.0

4.6

1.63

2.17

ug/l

1.04

107

1040

Ankyloglossia

279

1.00

0.00

2.8

2.6

1.57

1.22

ug/l

0.43

250

Contact with other hot metals

185

1847

1.00

0.00

4.2

4.5

1.61

2.24

ug/l

2.01

159

1658

Occupant of pick-up truck or van injured in other and unspecified transport accidents

637

1.01

0.00

4.3

4.0

1.43

1.85

ug/l

1.08

573

Thrombotic microangiopathy

553

0.99

0.00

3.4

4.8

1.83

2.61

ug/l

0.67

492

Neuroendocrine tumor and carcinoma of stomach

483

0.99

0.00

4.4

4.1

6.29

2.01

ug/l

0.63

425

Reiter disease

877

1.01

0.00

3.7

4.2

1.63

2.17

ug/l

0.76

793

Drug-induced systemic lupus erythematosus

246

1.02

0.00

3.2

4.5

0.89

2.09

ug/l

2.56

222

Polyarteritis nodosa

625

0.99

0.00

4.0

5.0

1.96

2.37

ug/l

0.46

558

Thoracic root disorders

145

0.96

0.00

4.0

4.6

1.32

4.38

ug/l

0.86

140

Other and unspecified diseases of spleen

432

0.99

0.00

4.4

4.6

2.58

2.99

ug/l

0.19

389

Acrodermatitis continua

155

1.04

0.00

5.0

5.4

2.23

1.86

ug/l

0.21

135

Lichen planopilaris

108

1.02

0.00

2.3

4.4

4.15

1.94

ug/l

0.39

Malignant neoplasm of pyriform sinus

144

0.93

0.00

4.2

3.8

1.30

1.71

ug/l

0.83

133

Other disorders of amino-acid metabolism

472

0.99

0.00

4.6

4.9

1.83

2.93

ug/l

0.62

419

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

945

0.99

0.00

4.1

3.9

7.11

2.01

ug/l

0.50

831

Nutritional marasmus

125

0.95

0.00

2.9

5.1

2.02

2.05

ug/l

0.01

111

Acute hepatitis B

452

0.99

0.00

3.4

4.3

1.48

2.49

ug/l

0.75

411

Benign muscular dystrophy (Becker)

104

0.95

0.00

3.7

4.5

1.25

1.73

ug/l

—

Cleft hard palate NOS

115

0.95

0.00

2.7

3.0

1.45

ug/l

0.00

104

Polyclonal hypergammaglobulinaemia

145

0.95

0.00

3.9

5.4

1.60

4.24

ug/l

0.58

123

Calcium deposit in bursa

221

0.99

0.00

5.4

4.8

1.28

3.37

ug/l

0.81

195

Oesophagitis, drug-induced

251

0.99

0.00

5.1

2.90

2.07

ug/l

0.57

220

Exposure to high and low air pressure and changes in air pressure

156

1.04

0.00

4.9

4.5

1.61

1.75

ug/l

0.15

141

Disorders of glossopharyngeal nerve

166

1.03

0.00

7.8

4.9

1.26

2.76

ug/l

1.36

145

Exposure to high-pressure jet

115

0.92

0.00

2.4

3.8

2.02

1.63

ug/l

0.39

104

Failure in dosage during surgical and medical care

1.04

0.00

4.8

5.2

1.38

1.76

ug/l

—

Myiasis

1.02

0.00

3.7

5.1

0.68

1.84

ug/l

—

Drug-induced nonautoimmune haemolytic anaemia

1.06

0.00

3.8

5.1

1.18

2.29

ug/l

—

Lethal midline granuloma

0.97

0.00

4.2

3.9

0.54

1.81

ug/l

—

Secondary thrombocytopenia, drug-induced

0.00

0.0

2.5

—

0.82

—

Serous carcinoma of ovary

0.00

-0.00

0.0

1.2

—

Congenital syphilis

1.02

-0.00

5.1

4.5

2.64

2.57

ug/l

—

Disorders of muscle in diseases classified elsewhere

0.90

-0.00

4.1

5.1

91.05

2.11

ug/l

—

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.92

-0.00

3.4

4.6

0.51

1.56

ug/l

—

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

0.97

-0.00

7.1

4.8

3.57

1.83

ug/l

—

Chromomycosis and phaeomycotic abscess

0.92

-0.00

6.1

4.7

0.84

1.93

ug/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.93

-0.00

1.0

1.2

—

1.62

—

Traumatic anuria

1.07

-0.00

5.3

5.1

2.98

2.31

ug/l

—

Pityriasis alba

1.04

-0.00

3.3

3.7

0.73

1.89

ug/l

—

Endometriosis of pelvic peritoneum

0.87

-0.00

1.3

1.1

—

0.03

—

Myiasis

1.03

-0.00

3.9

4.6

0.75

1.71

ug/l

—

Rat-bite fevers

1.04

-0.00

4.2

4.9

2.13

2.10

ug/l

—

Hypothyroidism, autoimmune, DX-based

0.91

-0.00

3.3

4.2

1.89

1.68

ug/l

—

Bacterial meningoencephalitis and meningomyelitis

0.91

-0.00

3.1

5.1

2.21

2.56

ug/l

—

Huntington disease

0.89

-0.00

3.6

4.4

1.18

2.20

ug/l

—

Night blindness

0.90

-0.00

4.2

4.3

5.00

1.62

ug/l

—

Other helminthiases

0.90

-0.00

3.6

4.5

1.58

2.31

ug/l

—

Alpha thalassaemia

1.02

-0.00

4.8

4.6

1.28

1.53

ug/l

—

Benign neoplasm of breast

0.93

-0.00

1.3

1.1

—

0.53

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prostate specific Ag [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS